Poster Session
2201
Saturday, February 24, 2007
9:45 AM - 10:45 AM
Asthma Therapy I
1 Paradoxical Bronchospasm With a Near-Fatal Reaction to Albuterol-HFA and Levalbuterol inhalation solution leading to Intubation in an Adult Asthmatic
S. Amara, N. Gupta, B. Silverman, Y. A. K. Rao, A. T. Schneider; Long Island College Hospital, Brooklyn, NY.
2 Gata-3-specific Dnazyme As An Appraoch For Asthma-therapy
T. Dicke, M. Wegmann, S. Sel, H. Renz, H. Garn; Medical Faculty, Philipps University, Marburg, GERMANY.
3 Bronchial Thermoplasty in Refractory Asthma: Interim Results in a Severe Asthma Population (Research in Severe Asthma (RISA) Trial)
R. Niven 1, I. Pavord2, M. Laviolette3, N. Thomson4, P. Corris5, G. Cox6, K. Fan-Chung7, A. Sperb-Rubin8; 1South Manchester University Hospitals NHS Trust, Manchester, UNITED KINGDOM, 2Glenfield General Hospital, University of Leicester, Leicester, UNITED KINGDOM, 3Laval University, Sainte-Foy, PQ, CANADA, 4Gartnaval General Hospital, Glasgow, UNITED KINGDOM, 5Freeman Hospital, Newcastle upon Tyne, UNITED KINGDOM, 6McMaster University, Hamilton, ON, CANADA, 7NHLI-Royal Brompton, London, UNITED KINGDOM, 8Irmandade Santa Casa de Misericordia, Porto Alegre, BRAZIL.
4 Compatability of Levalbuterol Inhalation Solution Mixed with Budesonide, Ipratropium Bromide, Cromolyn Sodium or Acetylcysteine Sodium
W. K. McVicar, P. Bonasia, S. Ong; Sepracor Inc., Marlborough, MA.
5 A Comparison of Bronchodilator Expressions to Identify the Asthmatic Child
S. P. Galant 1,2, T. Morphew3, S. Amaro1,4, O. Liao1,5; 1Children's Hospital of Orange County, Orange, CA, 2Southern California Chapter of Asthma and Allergy Foundation of America (AAFA), Los Angeles, CA, 3Southern California Chapter of Asthma and Allergy Foundation of America (AAFA), Los Anges, CA, 4Breathmobile TM Orange County, Orange, CA, 5Breathmboile TM Orange County, Orange, CA.
6 Adrenergic β2 Receptor Genotyping in Asthma: Case Reports
S. E. Leonard; Virginia Commonwealth University, Richmond, VA.
7 Effect of Budesonide and Formoterol Administered Via One Pressurized Metered-dose Inhaler on Lung Function in Adults and Adolescents With Moderate to Severe Persistent Asthma
M. J. Noonan 1, L. J. Rosenwasser2, P. Martin3, C. D. O'Brien3, L. O'Dowd3; 1Allergy Associates Research Center, Portland, OR, 2Children's Mercy Hospital, Kansas City, MO, 3AstraZeneca, Wilmington, DE.
8 Efficacy and Safety of Intravenous Aminophylline in Children with Acute Exacerbation of Asthma: A Multicenter Randomized Trial
M. Nagao 1,2, T. Katsunuma3,2, C. K. Kim4,2, T. Fujisawa1,2; 1Mie National Hospital, Tsu, JAPAN, 2Mie-Jikei-Inje theophylline study group, Tsu, JAPAN, 3Jikei University, Tokyo, JAPAN, 4University, Seoul, REPUBLIC OF KOREA.
9 Funtional Role Of Glucocorticoid Receptor β In The Steroid-induced Suppression Of Il-8 In Airway Epithelial Cells
Y. Jee 1, J. Park1, Y. Kim1, M. Kim2, Y. Cho2, P. Lavender3; 1College of Medicine, Dankook university, Cheonan, REPUBLIC OF KOREA, 2College of Medicine, Ewha Woman's university, Seoul, REPUBLIC OF KOREA, 3King's College, London, UNITED KINGDOM.
10 Development of Asthma Study Technologies in an Environmental Chamber (ASTEC)
A. Salapatek 1,2, P. Patel1, N. Mec1, L. Nimraj1, A. Ramoutar1, M. D. Chapman3, J. D. Freihaut4; 1Allied Research International, Mississauga, ON, CANADA, 2Centre of Mathematics and Medicine, Fields Institute, Toronto, ON, CANADA, 3INDOOR Biotechnologies Inc., Charlottesville, VA, 4Pennsylvania State University, University Park, PA.
11 Cutaneous CpG Administration Reduces Th2-type Airway Inflammation But Induces Airway Hyperreactivity
R. Haapakoski 1, N. Fyhrquist-Vanni1, T. Savinko1, H. Wolff2, K. Turjanmaa3, T. Palosuo4, T. Reunala3, A. Lauerma5, H. Alenius1; 1Unit of Excellence in Immunotoxicology, Finnish Institute of Occupational Health, Helsinki, FINLAND, 2Team for Biological Mechanisms and Prevention of Work-related Diseases, Finnish Institute of Occupational Health and Department of Pathology, Helsinki University Central Hospital, Helsinki, FINLAND, 3Department of Dermatology, Tampere University and University Hospital, Tampere, FINLAND, 4Laboratory of Immunobiology, National Public Health Institute, Helsinki, FINLAND, 5Control of Hypersensitivity Diseases, Finnish Institute of Occupational Health, Helsinki, FINLAND.
12 New Treatments for Suppression of Ongoing Human and Murine IgE Responses
H. G. Durkin, T. A. Smith-Norowitz, M. Pincus, M. Nowakowski, M. H. Bluth, R. Joks; Center for Allergy and Asthma Research, SUNY Downstate, Brooklyn, NY.
13 Formoterol Treatment plus Tiotropium Results in Greater Improvements in Lung Function Compared with Tiotropium Administered Alone in Patients with COPD
D. Tashkin 1, S. Varghese2; 1David Geffen School of Medicine, Los Angeles, CA, 2Schering-Plough, Kenilworth, NJ.
14 Montelukast Added to Usual Therapy during the September Epidemic of Asthma Exacerbations in Children
N. W. Johnston, P. J. Mandhane, J. Dai, J. M. Duncan, J. M. Greene, K. Lambert, M. R. Sears; Firestone Institute for Respiratory Health, Hamilton, ON, CANADA.
15 Addition of Omalizumab Improves Quality of Life in Moderate-Severe Asthmatics Receiving Fluticasone 500 μg/Salmeterol 50 μg
M. Massanari, R. J. Maykut, F. Kianifard, R. K. Zeldin, G. P. Geba; Novartis Pharmaceuticals Corporation, East Hanover, NJ.
16 Effects Of MN-001 In Patients With Mild-to-moderate Asthma In A Randomized, Double-blind And Placebo-controlled Phase II Study
W. W. Busse 1, H. S. Nelson2, P. E. Korenblat3, M. J. Noonan4, K. W. Locke5, M. S. Munsey5, R. E. Gammans5; 1University of Wisconsin, Madison, WI, 2National Jewish Medical Research Center, Denver, CO, 3Associated Specialists In Internal Medicine, St. Louis, MO, 4Allergy Associates Research Center, Portland, OR, 5MediciNova, Inc., San Diego, CA.
17 Safety of Budesonide and Formoterol Administered Via One Pressurized Metered-dose Inhaler (Budesonide/Formoterol pMDI) in Patients (≥2 Years) With Moderate to Severe Persistent Asthma
L. J. Rosenwasser 1, M. J. Noonan2, P. Martin3, L. O'Dowd3, C. D. O'Brien3; 1Children's Mercy Hospital, Kansas City, MO, 2Allergy Associates Research Center, Portland, OR, 3AstraZeneca, Wilmington, DE.
18 The Effects of Mometasone DPI on Airway Hyperresponsiveness and Markers of Airway Inflammation
F. A. Romero, V. Mehta, A. I. Berro, J. Stokes, T. B. Casale; Creighton University, Omaha, NE.
19 Objective evidence of omalizumab treatment assessed by Forced Oscillation (FO)
C. Saadeh, M. D. Goldman, C. K. Saadeh, J. R. Lemert, Jr.; Amarillo Center for Clinical Research, Amarillo, TX.
20 Saccharomyces (S.) Cerevisiae Mannan Facilitates Airway Epithelial Repair
C. F. Michael, K. Chapman, B. Lew, C. Waters; UT Health Science Center, Memphis, Memphis, TN.
21 Streptomyces cerevisiae 1,3/1,6 Beta-glucan Prevents Airway Hyperreactivity and Pulmonary Inflammation in a Murine Asthma Model
M. Oh 1, T. Zhang1, R. Seljelid2, X. Li1; 1Mt. Sinai School of Medicine, New York, NY, 2University of Tromso, Tromso, NORWAY.
22 The Effect of Discontinuing Omalizumab Therapy on Free IgE Concentration
P. Lowe 1, J. Jaffe2, C. Martin3, L. Brookman3, H. Fox3; 1Novartis Pharmaceuticals AG, Basel, SWITZERLAND, 2Novartis Pharmaceuticals Corporation, East Hanover, NJ, 3Novartis Horsham Research Centre, Horsham, UNITED KINGDOM.
Poster Session
2202
Saturday, February 24, 2007
9:45 AM - 10:45 AM
Asthma Control
23 Quality of Life of Caregivers of Underserved Children with Asthma
D. Sztein 1, M. Streett2, M. Foster3, C. Vibbert2, T. Morphew4, M. E. Bollinger2; 1Haverford College, Philadelphia, PA, 2University of Maryland School of Medicine, Baltimore, MD, 3University of Maryland Hospital for Children, Baltimore, MD, 4Southern CA Asthma and Allergy Foundation, Los Angeles, CA.
24 Asthma Control Test: reliability, validity, and responsiveness in Korean patients
K. Hyouk-Soo 1,2, K. Deok-In1,2, P. Chang-Han1,2, S. Seong-Wook1,2, L. Sang-Min1,2, S. Woo-Jung1,2, K. Yong-Eun3, P. Heung-Woo1,2, K. Sun-Sin1,2, C. Sang-Heon1,2, M. Kyoung-Up1,2, K. You-Young1,2, C. Yoon-Seok1,4; 1Department of Internal Medicine, Seoul National University College of Medicine, Seoul, REPUBLIC OF KOREA, 2Instutute of Allergy and Clinical Immunology, Seoul National University Medical Research Center, Seoul, REPUBLIC OF KOREA, 3Department of Internal Medicine, Chosun University College of Medicine, Gwangju, REPUBLIC OF KOREA, 4Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, REPUBLIC OF KOREA.
25 Self Reported Provider Adherence to NAEPP Guidelines for Control of Factors Contributing to Asthma Severity
P. J. Warrier 1, S. Dever1, M. Shah2, D. M. O'Sullivan3, J. E. Thomas1; 1Hartford Hospital, University of Connecticut, Hartford, CT, 2Bridgeport Hospital, Bridgeport, CT, 3Hartford Hospital, Hartford, CT.
26 Race, Asthma Exacerbations and Leaving against Medical Advice
B. D. Tano; University of Texas Health Center at Tyler, Tyler, TX.
27 Use of a Validated Asthma Symptom Questionnaire to Predict Obstructive Flow Volume Loop in School-Aged Children
M. Michelis, J. F. Hirsh, A. Oughourli, D. J. Lee; Hackensack University Medical Center, Hackensack, NJ.
28 Real-World Evaluation of Asthma Control and Treatment (REACT): Findings from a National Web-Based Survey
S. P. Peters 1, C. A. Jones2, T. Haselkorn3, D. R. Mink4, D. J. Valacer3, S. T. Weiss5; 1Wake Forest University School of Medicine, Winston-Salem, NC, 2University of Southern California Medical Center, Los Angeles, CA, 3Genentech, Inc., South San Francisco, CA, 4Ovation Research Group, San Francisco, CA, 5Brigham & Women's Hospital, Harvard Medical School, Boston, MA.
29 Keeping Asthmatics Out of the Emergency Department and Hospital: Evidence for Asthma Controller Medication Usage for Intermittent Asthmatics
C. C. Spagnola 1, W. W. Crawford2, M. Schatz3, R. K. Nakahiro4; 1Southern California Permanente Medical Group, Los Angeles, CA, 2Southern California Permanente Medical Group, Harbor City, CA, 3Southern California Permanente Medical Group, San Diego, CA, 4Kaiser Permanente Medical Care Program, Los Angeles, CA.
30 Childhood Asthma Control Test: Reliability, Validity And Responsiveness
R. Jan 1,2, I. Liu1, S. Chen1, C. Shieh3, J. Wang1; 1Dept of Ped, College of Medicine, National Cheng Kung University, Tainan, TAIWAN, 2Dept of Ped,College of Medicine, National Cheng Kung University, Tainan, TAIWAN, 3Dept of Microbiology and Immunology, College of Medicine, National Cheng Kung University, Tainan, TAIWAN.
31 Achieving and Maintaining Control of Asthma with Regular Participation in an Urban Pediatric Disease Management Program: The Breathmobile® Program
C. A. Jones 1, L. T. Clement2, T. Morphew3, J. Hanley-Lopez1, K. Y. C. Kwong1, F. Lifson3, L. Opas1, J. J. Guterman4; 1Los Angeles County + University of Southern California Medical Center and the Keck School of Medicine at the University of Southern California, Los Angeles, CA, 2University of South Alabama College of Medicine, Mobile, AL, 3Southern California Chapter of the Asthma and Allergy Foundation of America, Los Angeles, CA, 4Los Angeles County Department of Health Services, Olive-View UCLA Medical Center and the Geffin School of Medicine at the University of California at Los Angeles, Los Angeles, CA.
32 Implementation of GINA Guidelines in Poor Countries May Have Resulted in an Unnecessary Expenditure on Pharmacotherapy
J. E. Gereda; Clinica Ricardo Palma, Lima, PERU.
33 No Correlation Between Airway Obstruction Measured by FEV3/FVC and Asthma Control Test Scores
E. C. Swartz, M. K. Bossard, K. McCarthy, R. López, D. M. Lang; Cleveland Clinic, Cleveland, OH.
34 Does A Www-based Interactive Computer Program change asthma Outcomes, Quality of Life and Asthma Knowledge
U. M. Andersen 1,2; 1Aalborg Sygehus Nord, Aalborg, DENMARK, 2Pediatric Department, Aalborg Sygehus Nord, Aalborg, DENMARK.
35 Update on the Effect of a Multidisciplinary Team Clinic on Asthma Outcome for Medicaid-Eligible Inner City Children with Moderate to High-Risk Asthma
P. P. Patel, P. Munzenberger, R. Marocco, S. Taormina, W. Alame, J. Montejo, M. Pansare, E. A. Secord; Carman and Ann Adams Department of Pediatrics, Children's Hospital of Michigan-Wayne State University, DETROIT, MI.
36 Effect of Omalizumab on Measures of Control in Adolescents with Moderate-Severe Persistent Asthma
S. J. Pollard 1, R. J. Maykut2, M. Massanari2, F. Kianifard2, R. K. Zeldin2, G. P. Geba2; 1Family Allergy and Asthma, Louisville, KY, 2Novartis Pharmaceuticals Corporation, East Hanover, NJ.
37 Assessment of Asthma Control in a United States Population
M. Blaiss1, R. Manjunath 2, A. Dalal2, P. Jhingran2; 1Allergy and Asthma Care, Germantown, TN, 2GlaxoSmithKline, RTP, NC.
38 Risk Factors for Asthma-Related Emergency Hospital Utilization Differ Between High and Low Users of Asthma Medications
R. T. Hsu 1, W. W. Crawford2, W. B. Klaustermeyer1, M. Schatz3; 1VA Greater Los Angeles Healthcare System, Los Angeles, CA, 2Kaiser Permanente, Southern California, Harbor City Medical Center, CA, 3Kaiser Permanente, Southern California, San Diego Medical Center, CA.
39 Change (Δ) in Percent Forced Expiratory Volume in the First Second (FEV1) in 10 patients on Omalizumab Over 23 Months
K. Shamir, A. Hersh, H. Aguila, J. Pepe, A. Wolff, L. Bielory; UMDNJ Medical School, Newark, NJ.
40 Pulmonary Function Test Values Predictive of Success in Decreasing Inhaled Corticosteroid Doses in Asthmatics: A Chart Review
L. M. Miller 1, M. V. White2; 1Washington Hospital Center, Washington, DC, 2Institute for Asthma & Allergy, Wheaton, MD.
Poster Session
2203
Saturday, February 24, 2007
9:45 AM - 10:45 AM
Immunodeficiency Diseases I
41 Evaluation and Standardization of Enzyme-Linked ImmunoSpot (ELISPOT) Assay for Measurement of Pathogen-Specific T-cell Responses in Normal Donors
G. V. Yamshchikov, J. A. Franklin, C. D. Williams, L. K. Wathen, J. F. Halsey; IBT Reference Laboratory, Lenexa, KS.
42 Comèl-Netherton Syndrome - New Insight Into The Molecular Basis of this Rare Syndrome Characterized by Atopic Diathesis and Immune Deficiency
E. D. Renner 1,2, S. Rylaarsdam1, S. Anover1, D. Hartl2, A. Jayakumar3, B. H. Belohradsky2, U. Ermer4, Y. Jin1, G. Kleiner5, F. Nagel2, Q. Zhu1, G. L. Claymann3, T. R. Torgerson1, H. D. Ochs1; 1University of Washington, Seattle, WA, 2Dr. v. Haunersches Kinderspital, Ludwig Maximilian University, Munich, GERMANY, 3The University of Texas M. D. Anderson Cancer Center, Houston, TX, 4Children's Hospital, Neuburg, GERMANY, 5University of Miami Bachelor Children's Research Center, Miami, FL.
43 European Consensus for Gynecologycal and Obstetric Management of Women with Hereditary Angioedema due to C1-Inhibitor Deficiency (HAE): PREHAEAT
T. Caballero 1,2, L. Bouillet3,4, K. Bork5,6, C. Bucher7,8, A. Bygum9,10, C. De Carolis11,12, H. Farkas13,14, H. Longhurst15,16, E. Nielsen17,18, R. Perricone19,12, N. Prior1, M. Cicardi20,21; 1University Hospital La Paz, Madrid, SPAIN, 2PREHAEAT Member, Coordinator of Consensus, Madrid, SPAIN, 3Grenoble University Hospital, Grenoble, FRANCE, 4PREHAEAT Member, Coordinator Work Package 5, Grenoble, FRANCE, 5Johannes-Gutenberg-University of Mainz, Mainz, GERMANY, 6PREHAEAT Member (alphabetic order), Mainz, GERMANY, 7University of Zurich, Zurich, SWITZERLAND, 8PREHAEAT Member (alphabetic order), Zurich, SWITZERLAND, 9Odense University Hospital, Odense C, DENMARK, 10PREHAEAT Member (alphabetic order), Odense, DENMARK, 11San Giacomo Hospital, Rome, ITALY, 12PREHAEAT Member (alphabetic order), Rome, ITALY, 13Semmelweis University, Budapest, HUNGARY, 14PREHAEAT Member (alphabetic order), Budapest, HUNGARY, 15Barts and the London NHS Trust, London, UNITED KINGDOM, 16PREHAEAT Member (alphabetic order), London, UNITED KINGDOM, 17Norland Hospital and University of Tronsø, Bodø, NORWAY, 18PREHAEAT Member (alphabetic order), Bodø, NORWAY, 19PTV and University of Rome “Tor Vergata”, Rome, ITALY, 20Università degli Studi de milano; Ospedale S. Giuseppe, Milan, ITALY, 21Coordinator of PREHAEAT Group, Milan, ITALY.
44 Tolerance To Allogeneic Thymus Transplantation In Complete DiGeorge Syndrome
I. K. Chinn, B. H. Devlin, M. J. Alexieff, J. Li, S. E. Gupton, E. A. McCarthy, M. L. Markert; Duke University Medical Center, Durham, NC.
45 Development Of A Newborn Screening Test For Severe Combined Immunodeficiency Using ELISA And Dried Blood Spots
K. Chen, S. A. McGhee, E. R. B. McCabe; David Geffen School of Medicine at UCLA, Los Angeles, CA.
46 Use of Wiskostatin to Recapitulate the Wiskott-Aldrich Syndrome Phenotype in-vitro
S. Roy-Ghanta, E. P. Williams, R. P. Deering, J. S. Orange; University of Pennsylvania/Children's Hospital of Philadelphia, Philadelphia, PA.
47 Defective Pneumococcal Polysaccarides-induced Cytokine Production in Common Variable Immunodeficiency
R. Hong, S. Gupta; University of California, Irvine, CA.
48 Helicobacter Pylori Infection As A Triggering Factor Of Attacks In Patients With Hereditary Angioedema
B. Visy 1, G. Füst2, A. Bygum3, K. Bork4, H. J. Longhurst5, C. Bucher6, L. Bouillet7, M. Cicardi8, H. Farkas2; 1Madarász street Hospital of Heim Pál' Pediatric Hospital, Budapest, HUNGARY, 2Semmelweis University, Budapest, HUNGARY, 3Odense University Hospital, Odense, DENMARK, 4Johannes Gutenberg University, Mainz, GERMANY, 5Barts and the London NHS Trust, London, UNITED KINGDOM, 6University Hospital, Zurich, SWITZERLAND, 7CHU de Grenoble, Grenoble, FRANCE, 8Università degli Studi di Milano, Milan, ITALY.
49 Genetic Analysis of Autosomal Dominant Common Variable Immunodeficiency
A. Marks 1, H. Meyerson1, B. Grimbacher2, R. W. Hostoffer, Jr.1; 1Case Western Reserve University, Cleveland, OH, 2University Of Friedburg, Friedburg, GERMANY.
50 Role of Toll-like Receptor Signalling Defects in Human Susceptibility to Invasive Infection by Streptococcus Pneumoniae
S. E. Turvey 1, A. F. Hirschfeld1, R. E. Victor1, J. S. Orange2, J. A. Bettinger1; 1BC Children's Hospital and University of British Columbia, Vancouver, BC, CANADA, 2Children's Hospital of Philadelphia and University of Pennsylvania School of Medicine, Philadelphia, PA.
51 Guidelines for “10 Warning Signs of Primary Immunodeficiency” Neither Sensitive Nor Specific
F. P. Aloi, S. S. Mishra, A. J. MacGinnitie; Children's Hospital of Pittsburgh, Pittsburgh, PA.
52 Reimbursement Driven Medicare Patients Receiving IVIgG in the Hospital vs. the Physician's Office
M. Eagam 1, R. W. Hostoffer, Jr.2; 1Lake Erie College of Osteopathic Medicine, Erie, PA, 2Case Western Reserve University, Cleveland, OH.
53 Hypo-IgM Syndrome: A Secretion Defect?
S. P. Silverman, D. W. Rosenthal, P. Ponda, V. R. Bonagura; North Shore-Long Island Jewish Medical Center, Great Neck, NY.
54 Allergic Reaction and Anaphylaxis to IVIg when Administered Through Bromobutyl Vial Closure
M. Solomon, R. W. Hostoffer, Jr.; Case Western Reserve University, Cleveland, OH.
55 NEMO (IKKγ) Mutation Can Be Associated With Opportunistic Infection Without Impairing TLR Function
E. W. Gelfand 1, B. Salt1, A. Jain2, J. E. Niemela2, R. Deering3, R. Pandey3, R. Quinones4, J. Orange3; 1National Jewish Medical and Research Center, Denver, CO, 2National Institutes of Health, Bethesda, MD, 3Children's Hospital of Philadelphia, Philadelphia, PA, 4Children's Hospital of Denver, Denver, CO.
56 Primary Immunodeficiency Disorders: 30 Years of Experience in Shanghai, China
T. Chen, D. Ying; Shanghai Jiao Tong University School of Medicine, Shanghai, CHINA.
57 Antibody Deficiency Disorders in Recurrent/persistent pneumonia and Chronic Sinusitis in Thai Children at Queen Sirikit National Institute of Child Health.
P. Lerdluedeeporn, IV 1, C. Thanee2, N. Pupugdee2, S. Nanthapisal2, G. Phongsamart2, M. Vangveeravong2; 1Bangkok International Hospital, Bangkok, THAILAND, 2Queen Sirikit National Intitute of Child Health, Bangkok, THAILAND.
58 Subcutaneous Bioavailability of Gamunex® in Rabbits
M. Pamarthi, G. Taylor, P. Scuderi, V. Arora; Talecris Biotherapeutics, Research Triangle Park, NC.
59 Infants With Decreased Immunoglobulin Levels
S. J. McGeady, S. Kung; Thomas Jefferson University, Philadelphia, PA.
60 Idiopathic CD4+ T-Lymphocytopenia (ICL) in a Child with Persistent Cryptococcal Meningitis
Y. Yilmaz1, B. Wilson2, M. Lowery-Nordberg3, J. A. Bocchini, Jr.4, S. L. Bahna 2; 1Department of Pediatrics, Louisiana State University Health Sciences Center, Shreveport, LA, 2Allergy/Immunology Section, Louisiana State University Health Sciences Center, Shreveport, LA, 3Department of Pathology, Louisiana State University Health Sciences Center, Shreveport, LA, 4Pediatric Infectious Disease Section, Louisiana State University Health Sciences Center, Shreveport, LA.
61 Novel CYBA Gene Mutation in a Patient with Chronic Granulomatous Disease Associated with Autoimmune Hepatitis
A. Bagg 1, R. Gonzalez-Peralta2, A. Petrovic3, J. W. Sleasman4; 1Division of Allergy and Immunology, James A Haley Veterans Hospital, Tampa, FL, 2University of Florida Pediatric Gastroenterology, Gainesville, FL, 3Department of Pediatrics, University of South Florida College of Medicine, St. Petersburg, FL, 4Department of Pediatrics, Division of Allergy and Immunology, University of South Florida College of Medicine, St. Petersburg, FL.
62 Mannose-Binding Lectin Deficiency in a Family with Frequent Respiratory Infections
W. Zheng 1,2, J. Hester3, C. Kirkpatrick2; 1National Jewish Medical and Research Center, Denver, CO, 2University of Colorado Health Sciences Center, Denver, CO, 3IBT Reference Laboratory, Lenexa, KS.
63 Pediatric Patients With Refractory Autoimmune Cytopenias Displaying Autoimmune Lymphoproliferative Syndrome (ALPS) Phenotypes - Role For Anti-cd20(Rituximab ™) Therapy
T. Chang, D. Schauer, W. Grossman; Medical College of Wisconsin, Milwaukee, WI.
Poster Session
2204
Saturday, February 24, 2007
9:45 AM - 10:45 AM
Autoimmunity
64 β-tubulin Induced Murine Model of Autoimmune Hearing Loss and Regulation of T Cell Cytokines of the Mice
S. H. Cho, B. Zhou, J. Glickstein, M. H. Kermany, C. Cai, Q. Cai, W. Liu, T. J. Yoo; University of Tennessee Health Science Center, Memphis, TN.
65 The Clinical Significance Of Isolated Antinucleolar Antibodies
S. Khan 1, S. Holding2, A. Alvi3, S. Saravana4, W. A. C. Sewell1,5; 1Scunthorpe General Hospital, Scunthorpe, UNITED KINGDOM, 2Hull Royal Infirmary, Hull, UNITED KINGDOM, 3Diana Princess of Wales Hospital, Grimsby, UNITED KINGDOM, 4Worcester Royal Hospital, Worcester, UNITED KINGDOM, 5University of Lincoln, Lincoln, UNITED KINGDOM.
66 Prostate Specific Antigen: Responsible Allergen In Human Seminal Plasma Allergy
M. Basagaña 1, C. Pastor2, B. Bartolomé3, R. Alonso1, M. San Miguel1, A. Cisteró-Bahíma1; 1Institut Universitari Dexeus, Barcelona, SPAIN, 2Fundación Jimenez-Díaz, Madrid, SPAIN, 3I+D Bial-Aristegui, Bilbao, SPAIN.
67 Development of Hypocomplementemic Urticarial Vasculitis Syndrome Following Intracoronary Stent Placement
S. L. Cole, D. K. Ledford; University of South Florida, Tampa, FL.
68 Treatment of Hypoglycemia with Intramuscular Immunoglobulin in Insulin Dependent-Diabetics with Insulin Antibodies
S. A. MacLeish, S. Wallace, Z. Madhun, R. Hostoffer, Jr.; Case Western Reserve University, Cleveland, OH.
69 A Case of a Child with Autoimmune Polyglandular Syndrome(APS-1) associated with Metaphyseal Dysplasia
T. J. Pitt, N. K. Maclaren; St Vincent Hospital Manhattan, Department of Pediatrics, New York, NY.
70 Behçet Disease in a Patient with Autoimmune Polyendocrine Syndrome -Type 1
Ö. Özdemir; Cincinnati Children's Hospital Medical Center, Cincinnati, OH.
71 Autoimmune Neonatal Chondrodysplasia Punctata and Maternal Lupus
R. Herzog 1, L. J. Bernstein1, A. L. Shanske2; 1Division of Allergy and Immunology, Children's Hospital at Montefiore, Albert Einstein College of Medicine, Bronx, NY, 2Center for Craniofacial Disorders, Children's Hospital at Montefiore, Albert Einstein College of Medicine, Bronx, NY.
72 Hyperinsulinemia Hyperammonemia Syndrome in a patient with autoimmune disease
R. V. Basavaraju; Kansas University Medical Center, Kansas City, KS.
73 Fever of Unknown Origin (FUO) and Anemia as Sole Presenting Features of Sarcoid
T. Chacko, D. Ledford, R. F. Lockey; University of South Florida Collge of Medicine, Tampa, FL.
74 Pancytopenia and Myelofibrosis in Autoimmune Polyglandular Syndrome Type I
M. Braskett, M. I. Garcia-Lloret, S. Howenstine, D. McCurdy, S. McGhee; UCLA, Los Angeles, CA.
75 Autoimmune Thyroiditis Developing In A Survivor Of Catastrophic Antiphospholipid Syndrome: A Case Report
C. C. Ocampo, L. T. A. Aleta, M. W. Sumpaico; Section of Allergy and Immunology, Department of Medicine, University of the Philippines - Philippine General Hospital, Manila, PHILIPPINES.
76 Ischemic Events in Pacients with Systemic Lupus Erythematosus
M. E. Flores1,2, M. E. Contreras 1, I. A. Bello1, L. A. Aranguren1, E. Marti1; 1Universidad de Carabobo, Valencia, VENEZUELA, 2Ciudad Hospitalaria Dr. Enrique Tejera, Valencia, VENEZUELA.
77 Antibodies Anti-cmv In Patient With Myocardial Ischemia
M. E. Flores Chávez 1, M. Chacón de Petrola2, C. Celis3, A. Chiquito3, N. Figueroa3, I. Petrola4; 1Unidad de Inmunologia. Ciudad Hospitalaria Enrique Tejera, Valencia, VENEZUELA, 2Unidad de Investigaciones en Inmunologia Clinica. UC., Valencia, VENEZUELA, 3Universidad de Carabobo, Valencia, VENEZUELA, 4Unidad de Cuidados Coronarios. Ciudad Hospitalaria Enrique Tejera, Valencia, VENEZUELA.
78 A 54 Year-Old Woman with Acquired Angioedema, Coagulopathy, and Lymphoma
E. L. Pratt, S. Chegini, T. Craig; Penn State Milton S. Hershey Medical Center, Hershey, PA.
79 Abdominal pain, Nausea, and Vomiting as the Initial Presenting Symptoms of Systemic Lupus Erythematosus
B. Shin, D. K. Ledford, R. F. Lockey; Division of Allergy and Clinical Immunology, University of South Florida College of Medicine, Tampa, FL.
80 Mucosal administration of Escherichia coli Heat-labile toxin B and Classical swine fever E2 Chimeric antigen inhibits collagen-induced rheumatoid arthritis
D. Kim; Chonnam national university, Gwang-ju, REPUBLIC OF KOREA.
Poster Session
2205
Saturday, February 24, 2007
9:45 AM - 10:45 AM
Environmental Determinants and Asthma
81 IgE-Mediated Hypersensitivity Reactions to Cannabis in Laboratory Personnel
T. Herzinger, F. Ruëff, P. Schöpf, B. Przybilla; Ludwig-Maximilians-Universität, Munich, GERMANY.
82 Multiple Chemical Sensitivity: an Unusual Case of Vocal Disorder
M. Medeiros, Jr., H. B. Santos, C. Salles, H. Rosa; Allergic Center Diseases, Salvador - Bahia, BRAZIL.
83 Effect of Training on Asthma and Allergy Symptoms in Recreational Roadrunners
C. C. R. Randolph 1, D. Dreyfus1, D. Bangalore2, L. Wall1; 1Center for Allergy, Asthma and Immunology, Waterbury, CT, 2Waterbury Hospital, Waterbury, CT.
84 Occupational Mouse Allergen Exposure and Incident Skin Test Sensitivity
E. C. Matsui 1, B. J. Paigen2, E. A. O'Neil2, K. A. Hagberg2, P. A. Eggleston1; 1Johns Hopkins University School Medicine, Baltimore, MD, 2The Jackson Laboratory, Bar Harbor, ME.
85 Hypersensitivity Pneumonitis Caused by Trichoderma Viride
A. Enríquez-Matas 1, S. Quirce1, R. Melchor1, M. J. Rodríguez-Nieto1, J. Carnés2, M. Madero1, J. A. Torres1, J. Sastre1; 1Fundación Jiménez Díaz, Madrid, SPAIN, 2Leti, Madrid, SPAIN.
86 An Age-stratified Assessment Of The Incidence Allergic Diseases Among Patients From Western Hungary
L. Sóti 1, Z. Petz1, L. Endre2, L. Réthi3, L. M. DuBuske4; 1Szombathely Allergy-Asthma Outpatient Clinic, Szombathely, HUNGARY, 2Budapest National Health Institute, Budapest, HUNGARY, 3Svábhegy National Institute of Pediatrics, Budapest, HUNGARY, 4Immunology Research Institute of New England, Gardner, MA.
87 Occupational Asthma Secondary To Enzymes Used In Cheese Production
R. M. Casper, M. C. Zacharisen, J. N. Fink; Medical College of Wisconsin, Milwaukee, WI.
88 IgE and Skin Test Reactivity in relation to Anti-parasitic treatment
E. E. Fouda 1, A. I. Ali1, M. Emam2, A. S. Abdel Khalek1; 1Al-Azhar Allergy & Immunology University Center, Cairo, EGYPT, 2Al-Azhar University faculty of medicine, Cairo, EGYPT.
89 Occupational Contact Urticaria Syndrome Caused By Handling Lettuce And Chicory: Cross-reactivity Between Lettuce And Chicory
A. Morita 1, N. Inomata1, M. Kondou2, T. Shirai3, Z. Ikezawa1; 1Department of Dermatology,Yokohama City University, Yokohama, JAPAN, 2Kondou Dermatology Clinic, Yokohama, JAPAN, 3Department of Internal Medicine, Fujinomiya City Hospital, Japan, Fujinomiya, JAPAN.
90 Asthma Prevalence and Morbidity Among Rural Schoolchildren in the Mississippi Delta
T. T. Perry, S. M. Jones, J. R. Stalnaker, K. R. Nichols, P. A. Vargas; University of Arkansas for Medical Sciences, Little Rock, AR.
91 Asthma and Mycoplasma pneumoniae infection
Y. Park; Wonkwang University Sanbon Medical Center, Gunpo City, REPUBLIC OF KOREA.
92 Is Obesity Related To Severity And Frequency Of Asthma Symptoms?
F. Hassan 1,2, P. Patel2, E. Secord2; 1Woodhull medical center, Brooklyn, NY, 2The Carmen and AnAdams Dept. of Pediatrics, Children hospital of Michigan, Wayne State University, Detroit, MI.
93 Characteristics of Asthma Programs with Positive Health Outcomes
A. R. Friedman, L. L. Lachance, S. C. Stoll, D. F. Awad, N. M. Clark; University of Michigan School of Public Health, Ann Arbor, MI.
94 Detection of Underdiagnosed and Poorly Controlled Asthma in a Hospital-Based Outpatient Pediatric Clinic using a Health Risk Assessment (HRA) System
B. Nichols 1, L. Scott1, S. Jones2, K. Kwong1, T. Morphew3, L. T. Clement1, F. Lifson3, C. A. Jones1,3; 1LAC+USC Medical Center, Los Angeles, CA, 2LAC+USC Medical Center Volunteer Program, Los Angeles, CA, 3Southern California Chapter of the Asthma and Allergy Foundation of America, Los Angeles, CA.
95 The Asthma Day Care Project: Identifying and Managing Asthma in Brooklyn Preschools
A. R. Padi, K. Garrett-Szymanski, C. Willis, B. Silverman, R. Giusti, A. Schneider; Long Island College Hospital, Brooklyn, NY.
96 Dust And Airborne Concentrations Of Endotoxins In Strasbourg And In A Rural Environment (Haut-Doubs)
F. de Blay 1, G. Reboux2, A. Casset1, S. Roussel2, K. Humbert2, B. Sudre2, R. Piarroux2, J. Dalphin2; 1Asthma and Allergy Division, Department of Chest Diseases, University Hospital, Strasbourg, FRANCE, 2University Hospital, Besançon, FRANCE.
97 Allergy To Cumaru (Dipterix micrantha Harms) Tropical Wood
F. de la Losa, Sr.; DIATER Laboratories, San Martin de la Vega, SPAIN.
98 Impact of Absences due to Asthma on Total School Absences in Upstate New York Elementary Schools
E. Simons, A. Reddy, M. Gomez, C. Kielb, S. Lin; New York State Department of Health, Center for Environmental Health, Albany, NY.
99 Effects of Cigarette Smoke Extract and Rhinovirus on Expression of B7H1 and B7H3 in Human Airway Epithelial Cells
E. Schafer, S. Favoreto, J. Shen, R. Dave, P. C. Avila; Northwestern University, Chicago, IL.
100 The Long-term Effects Of Diesel Exhaust Particles On Airway Inflammation And Responsiveness In A Mouse Model
A. Jang; Soonchunhyang University Hospital, Bucheon, REPUBLIC OF KOREA.
101 Quantity of Rhinovirus in Nasal Lavage Does Not Predict Illness Severity
J. D. Bufford 1, K. A. Roberg1, T. E. Pappas1, R. F. Vrtis1, M. D. Evans2, R. E. Gangnon2, R. F. Lemanske, Jr.1, J. Gern1; 1University of Wisconsin School of Medicine and Public Health, Madison, WI, 2University of Wisconsin-Madison, Madison, WI.
Poster Session
2206
Saturday, February 24, 2007
9:45 AM - 10:45 AM
Anaphylaxis, Venom and Latex
102 Elucidating The Cause Of Peri-operative Allergic Reactions-Correlation Between Clinical Features, Skin Testing Data And Serum Tryptase Levels
C. H. Katelaris; Westmead Hospital, Westmead, AUSTRALIA.
103 Dose-Dependant Angioedema Due to Sirolimus
A. Kleiner, R. Srinivasan, R. J. Looney; Allergy/Immunology and Rheumatology Unit, University of Rochester Medical Center, Rochester, NY.
104 Differences in the Allergic Response Induced by Live or Dead Anisakis Simplex Larvae in C3H/HeJ Mice
M. L. Baeza, Y. Higaki, L. Conejero, A. Torrecilla, M. Vazquez de la Torre, M. Rubio, J. M. Zubeldia; Hospital General Universitario Gregorio Marañón, Allergy Service and Experimental Medicine Unit, Madrid, SPAIN.
105 Drug Anaphylaxis As Presentation of Systemic Mastocytosis: About 7 Case Reports
F. Codreanu, M. Morisset, J. M. Renaudin, A. Schuller, J. Mouzita, E. Beaudouin, D. A. Moneret-Vautrin, G. Kanny; University Hospital, Nancy, FRANCE.
106 The Availability of EpiPens® Used by Students with Severe Food allergies in Michigan Schools
D. Kassab 1, E. A. Robinson2, A. Russell1, M. McMorris1; 1University of Michigan, Ann Arbor, MI, 2St. Joseph Mercy Hospital, Ann Arbor, MI.
107 Prevalence of Allergy and Anaphylaxis in 210 Patients with Mastocytosis
A Study From The Spanish Network on Mastocytosis (REMA)
D. González de Olano 1, M. B. de la Hoz Caballer1, R. Nuñez López1, L. Sánchez Muñoz1, M. Cuevas Agustín1, M. Dieguez1, M. Castells2, L. Escribano Mora1; 1Hospital Ramón y Cajal, Madrid, SPAIN, 2Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
108 Anaphylaxis As An Initial Manifestation Of Cholangiocarcinoma
P. Ngamjanyaporn 1, S. Janwityanujit1, P. Dekumyoy2; 1Department of Internal Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, THAILAND, 2Department of Helminthology, Faculty of Tropical Medicine, Mahidol University, Bangkok, THAILAND.
109 Superior Vena Cava Syndrome: A Masquerader of Anaphylaxis
B. Khalili 1, P. B. Boggs2, S. L. Bahna1, A. J. Marsala3, M. Tapolyai3, R. O. Bryn3; 1LSUHSC Allergy & Immunology Section, Shreveport, LA, 2Asthma and Allergy Clinic and Center of Excellence, Shreveport, LA, 3Willis-Knighton Medical Center, Shreveport, LA.
110 Use Of Epinephrine In Food-induced Anaphylaxis In Children
K. M. Jarvinen, W. G. Shreffler, H. A. Sampson, S. Noone, A. Nowak-Wegrzyn; Mt. Sinai Hospital, New York, NY.
111 Food-Dependent Exercise-Induced Anaphylaxis Associated with Clonal Mast Cells Carrying an Activating c-Kit Mutation
S. I. Hungness, A. M. Singer, C. Akin; University of Michigan, Ann Arbor, MI.
112 Maturation of the IgE and IgG response to Imported Fire Ant Venom during natural exposure
M. Partridge 1, D. Ownby1, R. Hamilton2, P. Young1, J. Ford1; 1Medical College of Georgia, Augusta, GA, 2Johns Hopkins Hospital, Baltimore, MD.
113 Recent Trends in Hymenoptera Sensitivity Evaluation
L. C. Cary 1, J. Temprano2; 1Department of Internal Medicine, Divison of Allergy, Asthma and Immunology, Univeristy of Kentucky, Lexington, KY, 2Department of Internal Medicine, Division of Allergy, Asthma, and Immunology, Univeristy of Kentucky, Lexington, KY.
114 The Uses of MALDI-TOF Mass Spectrometry in Characterization of Allergens
D. R. Hoffman; Brody School of Medicine at East Carolina University, Greenville, NC.
115 IgE Reactivity to Recombinant Omega-5 Gliadin in Wheat-Dependent Exercise-Induced Anaphylaxis
H. Matsuo 1, J. Dahlström2, K. Kohno3, H. Takahashi3, E. Morita3; 1Graduate School of Biomedical Sciences, Hiroshima University, Hiroshima, JAPAN, 2Research and Development, Phadia, Uppsala, SWEDEN, 3Department of Dermatology, Shimane University School of Medicine, Shimane, JAPAN.
116 Production and Analysis of the Allergenic Venom Serine Protease from Polistes dominulus
C. D. Fitch1, M. Schmidt2, D. R. Hoffman 3; 1Brody School of Medicine, Greenville, NC, 2E. Carolina University, Greenville, NC, 3Brody School of Medicine, Greenville, NC.
117 New Diagnostic Approaches for Wasps Venom Allergy
R. I. Monsalve 1, R. Gutierrez1, F. Polo1, M. Lombardero1, A. Galan1, T. P. King2, L. Marques3, D. Barber1; 1ALK-ABELLO, Madrid, SPAIN, 2Rockefeller University, New York, NY, 3SEAIC Hymenoptera Committee, Lleida, SPAIN.
118 Identification of an Allergenic Lipid Transfer Protein in Pomegranate-Induced Anaphylaxis
M. San Miguel-Moncín 1, M. Lombardero2, D. Barber2, E. Enrique3, R. Alonso1, M. Basagaña1, A. Cisteró-Bahima1; 1Allergy Department. Institut Universitari Dexeus, Barcelona, SPAIN, 2R & D Dept. ALK-Abello S. A., Madrid, SPAIN, 3Servicio de Alergia. Hospital General de Castellón, Castellón, SPAIN.
119 Anaphylaxis Due To Buckwheat Skin Testing
Y. K. Cheng; Tan Tock Seng Hospital, Singapore, SINGAPORE.
120 Sensitization to Egg Via Inhalation of Egg Aerosol Resulting in Anaphylaxis
J. E. Yoo; University CA-San Francisco, San Francisco, CA.
121 Comparison of a Modified Yellow Jacket Venom Extract (Allergoid) with Conventional Yellow Jacket Venom (Aluminium hydroxide bounded) for the Treatment of Yellow Jacket Allergy by Sting Challenges
H. N. G. Oude Elberink 1, H. A. Kleinjans2, H. de Groot3; 1University Medical Center of Groningen, Groningen, THE NETHERLANDS, 2HAL Allergy, Haarlem, THE NETHERLANDS, 3Erasmus Medical Center, Rotterdam, THE NETHERLANDS.
122 Hospitalizations for Anaphylaxis in Florida: Epidemiologic Analysis of a Population-Based Dataset
Z. D. Mulla 1, M. R. Simon2; 1Texas Tech University HSC School of Medicine at El Paso, El Paso, TX, 2Wayne State University School of Medicine, Detroit, MI.
123 Prevalence of Latex Sensitization and Allergy among handicapped patients
I. Kobayashi 1,2, K. Kitsuki3,2, S. Yamamoto2, T. M. Horiuti1, R. M. Goldblum1, Y. Hamasaki2; 1University of Texas Medical Branch, Galveston, TX, 2Medical University of Saga, Saga city, JAPAN, 3Saga seishi-gakuen Child Development Medical Center, Saga city, JAPAN.
124 Fast-Disintegrating Sublingual Epinephrine Tablets: High Temperature Stability Study
M. M. Rawas-Qalaji, F. E. R. Simons, K. J. Simons; University of Manitoba, Winnipeg, MB, CANADA.
125 Latex Allergy: Low Prevalence of IgE to Highly Purified Hev b 2 and Hev b 13
T. Palosuo 1, M. Lehto2, A. Kotovuori3, N. Kalkkinen3, C. Blanco4, P. Poza4, T. Carrillo4, R. G. Hamilton5, H. Alenius2, T. Reunala6, K. Turjanmaa6; 1National Public Health Institute, Helsinki, FINLAND, 2Finnish Institute of Occupational Health, Helsinki, FINLAND, 3Institute of Biotechnology, University of Helsinki, Helsinki, FINLAND, 4Servicio de Alergia, Hospital Universitario de Gran Canaria, Las Palmas de Gran Canaria, SPAIN, 5Division of Allergy and Clinical Immunology, Johns Hopkins University School of Medicine, Baltimore, MD, 6Department of Dermatology, Tampere University and University Hospital, Tampere, FINLAND.
126 Imported Fire Ant Sublingual Immunotherapy for Large Local Reactions
M. H. Tucker, C. W. Calabria, L. L. Hagan, J. P. Dice; Wilford Hall Medical Center, San Antonio, TX.
127 Single Intragastric Peanut Feeding Leads To Anaphylactic Shock In C3H/HeJ But Not In BALB/c Or C57BL/6 Mice
B. Proust 1, C. M. N. Astier2, S. Jacquenet3, V. Ogier3, E. Magueur3, B. Thouvenot3, M. Morisset1, D. A. Moneret-Vautrin1, H. A. Sampson4, A. W. Burks5, B. E. Bihain3, G. Kanny1; 1University Hospital, Vandoeuvre-Les-Nancy, FRANCE, 2INPL, Vandoeuvre-Les-Nancy, FRANCE, 3Laboratory of Molecular Medicine and Therapeutics, Vandoeuvre-Les-Nancy, FRANCE, 4Mount Sinaï Hospital, New-York, NY, 5Duke University Medical Center, Durham, NC.
128 Methylene Blue as a Treatment for Refractory Anaphylaxis
S. S. Sheth, D. Del Duca, P. Ergina, A. E. Clarke; McGill University Health Centre, Montreal, PQ, CANADA.
129 Anaphylaxis: Report of Two Fatal Yellow Jacket (YJ) Stings in Alaska (AK)
M. L. Oswalt 1, J. T. Foote2, S. F. Kemp1; 1University of Mississippi Medical Center, Jackson, MS, 2Tanana Valley Clinic, Fairbanks, AK.
130 Anaphylaxis Caused by Younger Garlic: Two Cases Report in China
J. Yin, H. Li; Allergy Department, Peking Union Medical College Hospital, Beijing, CHINA.
131 Recurrent Panic/Anxiety Attacks: Masquerader of Anaphylaxis and Challenge to Comprehensive History Taking
C. D. Friesen 1, R. J. M. Engler2; 1Carl R. Darnall Army Medical Center, Fort Hood, TX, 2Walter Reed Army Medical Center-VHC, Washington, DC.
132 Anaphylaxis in a Patient with Long QT Syndrome
P. Permaul, L. C. Schneider, J. Triedman; Children's Hospital Boston, Boston, MA.
133 A Case Report on Immunotherapy in Recurrent Anaphylaxis using the Whole-Body Extract of Fire Ant
P. Rojponpradit 1, S. Benjaponpitak1, W. Kamchaisatian1, C. Direkwattanachai1, C. Sasisakulporn2; 1Division of Pediatric Allergy and Immunology, Ramathibodi Hospital, Mahidol University, Bangkok, THAILAND, 2Center of Research, Ramathibodi Hospital, Mahidol University, Bangkok, THAILAND.
134 Anaphylaxis to Honey in a Patient Sensitized to Compositae Pollen
N. Fuiano 1, G. Riario-Sforza2, C. Incorvaia2; 1Pediatric Allergy Service, A.USL Fg1, San Severo, ITALY, 2Allergy and Pulmonary rehabilitation, ICP Hospital, Milano, ITALY.
135 Successful Desensitization in a Severe Hemophilia B patient with IgE-mediated Anaphylaxis to Factor IX
Y. Moonsup 1, S. Benjaponpitak1, A. Chuansumrit2, W. Kamchaisatian1, C. Direkwattanachai1; 1Division of Allergy and Clinical Immunology, Department of Pediatrics, Ramathibodi hospital, Mahidol University, Bangkok, THAILAND, 2Division of Hematology, Department of Pediatrics, Ramathibodi hospital, Mahidol University, Bangkok, THAILAND.
Poster Session
2207
Saturday, February 24, 2007
9:45 AM - 10:45 AM
Drug Allergy I
136 Humoral Immune Responses to Cosmetically-Administered Hyaluronic Acid (Perlane and Restylane)
R. G. Hamilton 1, J. Strobos2, N. F. Adkinson, Jr.1; 1Johns Hopkins University School of Medicine, Baltimore, MD, 2Medicis Pharmaceutical Corporation, Scottsdale, AZ.
137 Safety of a Single Day Aspirin Desensitization Protocol
B. L. Buchmiller, D. A. Khan; University of Texas Southwestern Medical School at Dallas, Dallas, TX.
138 Rapid Oral Aspirin Challenge-Desensitization in Patients With Symptomatic Acute Coronary Syndrome
M. Michelis, K. Bianco, T. Selvaggi, A. Oughourli; Hackensack University Medical Center, Hackensack, NJ.
139 Severe Drug-Induced Anaphylaxis: Survey of Case Reports by Allergy Vigilance Network
J. M. C. Renaudin, G. Kanny, F. Codreanu, E. Beaudouin, D. A. Moneret-Vautrin; University Hospital, Nancy, FRANCE.
140 Specific Subpopulation Involved in Allergic Delayed Responses to Amoxicillin in an in Vitro System with Autologous Dendritic Cells
R. R-Pena 1, S. Lopez1, C. Antunez1, P. Chaves1, C. Mayorga1, M. J. Torres2, T. D. Fernandez1, J. A. Cornejo-Garcia1, M. Blanca2; 1Research Laboratory, Fundacion IMABIS-Carlos Haya Hospital, Málaga, SPAIN, 2Allergy Service, Carlos Haya Hospital, Málaga, SPAIN.
141 Coexistence of Atopic Diseases and Idiosyncratic Reactions to Aspirin
A. A. Nowak 1,2, M. Nowak2, A. Muszyñska3,2, A. M. Fal4; 11st Department of Paediatrics, Allergology and Cardiology, Medical University, Wroclaw, POLAND, 2Allergology and Clinical Immunology Students Scientific Research Group, Medical University, Wroclaw, POLAND, 3Department of Family Medicine, Medical University, Wroclaw, POLAND, 4Department of Internal Medicine and Allergology, Medical University, Wroclaw, POLAND.
142 Exudative Erythema Multiforme With Hydroxyzine
A. Losada, E. Gonzalez, A. Henriquez, B. Huertas, P. Berges, E. Alvarez; Servicio de Alergia. Hospital Ramon y Cajal, Madrid, SPAIN.
143 Reliability of Drug Allergy History in Foreign Tourists
M. OKADA; St. Luke's International Hosiptal, 104-8560 Tokyo, JAPAN.
144 Putative B-cell Apoptosis as a Cause of Hypogammaglobulinemia in Carbamazepine Hypersensitivity: A Case Report
J. A. Bird, D. M. Anmuth, E. Muscal, M. K. Dishop, C. L. Nance, S. L. Abramson; Baylor College of Medicine, Houston, TX.
145 Cross-reactivity Between Penicillins and Cephalosporins with the Same Side Chain: Amoxicillin and Cefadroxil
M. J. Torres 1, N. Blanca-Lopez2, E. Martin1, C. Mayorga3, J. L. Rodriguez-Bada3, I. Doña1, G. Canto2, C. Antunez3, J. J. Romero1, M. Blanca1; 1Allergy Service, Carlos Haya Hospital, Málaga, SPAIN, 2Allergy Service, Doce de Octubre Hospital, Madrid, SPAIN, 3Research Laboratory, Fundacion IMABIS-Carlos Haya Hospital, Málaga, SPAIN.
146 Stevens-Johnson Syndrome From Oral Acetazolamide In A 19-Year Old Male
G. B. Velez 1, K. S. Estrellado2, R. G. Tabigo-on2, C. J. Gloria1, M. W. Sumpaico1; 1University of the Philippines-Philippine General Hospital Section of Allergy and Immunology, Manila, PHILIPPINES, 2University of the Philippines-Philippine General Hospital Department of Medicine, Manila, PHILIPPINES.
147 Metronidazole-Induced Encephalopathy in a Pediatric Patient
A. Gaye, A. Sanghavi; Loyola University Medical Center, Maywood, IL.
148 Sequential Drug Provocation Testing in Diagnosis of an Unusual Fixed Drug Eruption to Pseudoephedrine
Y. K. Cheng; Department of Rheumatology, Allergy and Immunology, Tan Tock Seng Hospital, SINGAPORE.
149 Eosinophilia During Piperacillin-Tazobactam (Pip/Taz) IV Desensitization
J. G. Kemp, N. L. Rider, G. Ghaffari, E. L. Pratt, J. G. Gibbs, S. Chegini, T. J. Craig; Penn State College of Medicine Milton S. Hershey Medical Center, Hershey, PA.
150 New Orleans Seniors on Polypharmacy: The Impact of Intervention on Adverse Drug Reactions (ADR) and Cost of Medications
P. Kumar, K. Elshatory, C. Vital, S. Kamboj; LSU medical center, New Orleans, LA.
151 Optimising the Lymphocyte Transformation Test in Drug Allergy Diagnosis
E. M. M. Tomaz, M. R. Viseu, A. F. Ferrão, S. H. Correia, M. J. Peres, R. P. Reis, L. A. Patricio, F. C. Inacio; Hospital S. Bernardo, Setúbal, PORTUGAL.
152 Persistent Eosinophilia Following Aspirin Desensitization in a Patient with Aspirin Exacerbated Respiratory Disease
N. M. Vogel, D. M. Lang, F. H. Hsieh; The Cleveland Clinic Foundation, Cleveland, OH.
153 Type I Allergy to Benzoimidazole Antihelmintics
R. González-Mendiola 1, T. Palomeque Rodríguez1, N. Martínez Borque1, M. Torrecillas Toro1, D. Martínez Bohigas1, J. Solera2; 1Complejo Hospitalario Universitario de Albacete. Allergy Department, Albacete, SPAIN, 2Complejo Hospitalario Universitario de Albacete. Internal Medicine Department, Albacete, SPAIN.
154 Immediate Hypersensitivity Reactions to Methylprednisolone in Children
A. Nahum 1,2, B. Garty1, Y. Levy1; 1Kipper Institute of Immunology, Schneider Children's Medical Center of Israel, Petah Tiqva, ISRAEL, 2Department of Pediatrics, Kaplan Medical Center, Rehovot, ISRAEL.
155 Prevalence of Drug Adverse Reactions in Out-Patients
M. Palma-Carlos, M. Medina, A. G. Palma-Carlos; Clinical Allergy Immunology Center, Lisbon, PORTUGAL.
156 Skin Reaction after Desensitization Not Predict the Outcome of Short Course Sulfa Desensitization Protocol among AIDS Patients
W. Maek-A-Nantawat 1, H. Chantaphakul2, K. Ruxrungtham2; 1Mahidol University, Bangkok, THAILAND, 2Chulalongkorn University, Bangkok, THAILAND.
157 Monitoring the Peripheral Blood Lymphocyte Subtypes in Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)
M. Yazicioglu 1, R. Elmas1, T. Genchallacoglu1, S. Yildirim1, B. Turgut2; 1Trakya University, Department of Pediatrics, Edirne, TURKEY, 2Trakya University, Department of Internal Medicine, Edirne, TURKEY.
158 Allergy To Multiple Local Anesthetics
A. B. Caron; Clinique Concorde, Laval, PQ, CANADA.
Poster Session
2208
Saturday, February 24, 2007
9:45 AM - 10:45 AM
Quality of Life
159 Development of Health-Related Quality of Life Questionnaires for Children, Adolescents and Adults with Food Allergy: the Item Reduction
B. M. J. de Blok 1, A. DunnGalvin2, J. N. G. Oude Elberink3, B. J. Vlieg-Boerstra1, E. J. Duiverman1, J. B. Hourihane2, A. E. J. Dubois1,3; 1University Medical Center Groningen, University of Groningen, Beatrix Children's Hospital, Department of Paediatric Pulmonology and Allergology, Groningen, THE NETHERLANDS, 2Cork University Hospital, Department of Paediatrics and Child Health, Cork, IRELAND, 3University Medical Center Groningen, University of Groningen, Department of Allergology, Groningen, THE NETHERLANDS.
160 Impact of Pediatric Asthma and Treatment on Care-givers Visiting Specialist Clinics in Japan
Y. Ohya 1, H. Watanabe1, N. Kojima1, T. Katsunuma2, N. Kondo3, A. Akasawa1; 1National Center for Child Health and Development, Tokyo, JAPAN, 2The Jikei University, Tokyo, JAPAN, 3Gifu University, Gifu, JAPAN.
161 Once-A-Day Olopatadine Improves the Health-Related Quality-Of-Life of Allergic Conjunctivitis Patients
G. J. Berdy 1, S. V. Scoper2, S. J. Lichtenstein3, J. M. Rubin4, C. Waycaster5, T. Pasquine5, R. D. Gross5, S. Robertson5; 1Ophthalmology Associates, St. Louis, MO, 2Virginia Eye Consultants, Norfolk, VA, 3Louisville Children's Eye Specialists, Louisville, KY, 4Eye Clinics of South Texas, San Antonio, TX, 5Alcon Research Ltd., Fort Worth, TX.
162 Health Related Quality of Life in Lithuanian Children with Asthma
E. Vaitkaitiene; Biomedical Research Institute of Kaunas University of Medicine, Kaunas, LITHUANIA.
163 Developmental Trajectories in Food Allergy: Sex and Age Differences
J. O. B. Hourihane, A. DunnGalvin; University College Cork, Cork, IRELAND.
164 Does Childhood Asthma Affect The Quality Of Life Of Caregivers?
Z. Tamay 1, A. Akcay2, N. Guler1, A. Suleymanoglu1, G. Kilic1, U. Ones1; 1Istanbul Medical Faculty, Istanbul, TURKEY, 2Pamukkale Medical Faculty, Denizli, TURKEY.
165 Adverse Effects of Danazol in the Prophylactic Treatment of Hereditary or Acquired C1-Inhibitor Deficiency
W. Kreuz, E. Aygören-Pürsün, I. Martinez-Saguer, E. Rusicke, T. Klingebiel; University Hospital Frankfurt, Frankfurt, GERMANY.
Poster Session
2209
Saturday, February 24, 2007
9:45 AM - 10:45 AM
T cells
166 T-Cell Receptor (TCR)-Mediated Upregulation of BLT1 (LTB4 Receptor) Expression and Activation of Human T Cells by LTB4
A. Ahuja, A. Dakhama, H. Ohnishi, J. J. Lucas, E. W. Gelfand; National Jewish Medical and Research Center, Denver, CO.
167 The Role Of Th1 And Th2 Response In Allergic Rhinitis Children With Or Without Sensitization To Food Allergens
A. Nakonechna 1, T. Umanetz2, V. Lapshin2, A. R. D. van Bergen3; 1National Medical University, Kiev, UKRAINE, 2Institute of Pediatry, Obstetrics and Gynaecology, Kiev, UKRAINE, 3Novidec Ltd, Neston, UNITED KINGDOM.
168 CD4+CD25+ Cells and Laboratory Animal Allergy
H. Jeal, A. Newman Taylor, M. Jones; NHLI @ Imperial College, London, UNITED KINGDOM.
169 IL-5 production In Response To Candida Albicans Secretory Aspartic Protease 2 Is Associated With Isolated Late-phase Bronchial Response Upon Inhalation Challenge
A. Mori, N. Kitamura, T. Hashimoto, M. Taniguchi, M. Otomo, Y. Maeda, M. Hasegawa, K. Akiyama; National Sagamihara Hospital, Clinical Research Center, Sagamihara, JAPAN.
170 Critical Role For Adaptive T Cell Immunity In Experimental Eosinophilic Esophagitis In Mice
A. Mishra, J. Schlotman, M. Wang, M. E. Rothenberg; Childrens Hospital Medical Center, Cincinnati, OH 45229, Cincinnati, OH.
171 Allergen-specific CD4 T & B Cells in Allergic Patients are NOT Increased Compared to Nonallergic Individuals
A. Ueno, C. Lu, B. Serushago, T. Bowen, J. Storek; University of Calgary, Calgary, AB, CANADA.
172 Profound Lymphopenia in Two Immunocompetant Children With Allergic Fungal Sinusitis
D. R. Naimi, J. M. Spergel; The Children's Hospital of Philadelphia, Philadelphia, PA.
173 Association Between Second Hand Smoke Exposure (SSE) and T-Helper Type 2 (TH2) Cytokine Production During Early Childhood
A. Patel, D. A. Gentile, J. M. Koehrsen, D. P. Skoner, M. Varga, C. A. Schad, T. J. Schaffner; Allegheny General Hospital, Pittsburgh, PA.
174 Activation Of Allergen-specific T Cells In Vivo During Specific Immunotherapy With Depigoid Allergen Extracts
E. O. Luger, H. Lee, D. Ernst, M. Worm; Dept. of Dermatology and Allergy, Berlin, GERMANY.
175 EBI3 Deficient Naive T cells Show Increase in Expression of Th2 Mediated Cytokines In-vitro
E. Dokmeci 1, L. Xu1, R. Blumberg2, K. Bottomly1; 1Yale University, New Haven, CT, 2Brigham & Womens Hospital, Boston, MA.
176 The Tyrosine Kinase Txk/Rlk Rescues The Development Of Allergic Asthma In Mice Lacking Tec Kinase Itk
N. SAHU; PENNSTATE UNIVERSITY, State college, PA.
177 Mast Cell Mediated LTB4-BLT1 Pathway in Asthma and the Therapeutic Role of Zileuton in Regulating Early T Cell Trafficking in Airways
Z. Mikhak, M. Fukui, P. Hesterberg, A. D. Luster; Massacusetts General Hospital, Charlestown, MA.
178 Living in Farming Communities (FC) Provides Children Greater Protection Against Asthma Attacks than Living in Poor Hygienic Conditions (PHC)
S. Sur 1, S. Chitranshi2, S. Ganesh3, R. Moona3, M. Sharma3, S. Bajpai3, S. K. Katiyar4; 1University TX Medical Branch, Galveston, TX, 2RAMA Hospital, Kanpur, INDIA, 3Indian Institute of Technology, Kanpur, INDIA, 4GSVM Medical College, Kanpur, INDIA.
179 Pharmacological Effects of ASM8, an Antisense Oligonucleotide to CCR3 and the Common Beta Chain Receptor in Mild Asthmatics
G. M. Gauvreau 1, L. P. Boulet2, D. W. Cockcroft3, M. Duong1, H. D'Anjou4, P. M. Renzi4,5, P. M. O'Byrne1; 1McMaster University, Hamilton, ON, CANADA, 2Hopital Laval, Université Laval, Quebec City, PQ, CANADA, 3University of Saskatchewan, Saskatoon, SK, CANADA, 4Topigen Pharmaceuticals Inc, Montreal, PQ, CANADA, 5University of Montreal, Montreal, PQ, CANADA.
180 Adoptive Transfer of Splenocytes from Immunotherapy Group Ameliorating the Histopathological Changes and Increased IL-10 and IFN-g Levels in the Recipient Mice
T. Akkoc; Marmara University, Istanbul, TURKEY.
181 Airway Exposures to House Dust Extracts Provide Th2 Adjuvant Activity with Intermittent Delivery and Long Term Tolerogenic Activity with Daily Delivery
G. M. Batzer, N. Ng, D. P. Lam, A. A. Horner; UCSD, La Jolla, CA.
182 Neonatal Education of Dendritic and T Cells by LPS results in Tolerance in an Adoptive Transfer Model of Airways Allergy
Y. Wang, C. T. McCusker; McGill University, Montreal, PQ, CANADA.
183 Peripherally-Induced Allergen-Specific Foxp3+ Regulatory T Cells are Essential for the Control of Chronic Allergic Lung Inflammation
M. A. Curotto de Lafaille, N. Kutchukhidze, Y. Ding, S. Shen, J. J. Lafaille; New York University School of Medicine, New York, NY.
184 Sublingual Immunotherapy Induce Systemic T-cell Tolerance in Naive Mice
J. Brimnes, J. Kildsgaard, H. Jacobi, K. Lund; ALK-Abello, Hoersholm, DENMARK.
185 Mast Cells Promote the Development of CD103+ Regulatory T cells
Z. Allakhverdi, G. Delespesse; CHUM Research Center, Montreal, PQ, CANADA.
186 An Environmental Fungus, Alternaria, Stimulates OX40L and CCR7 Expression by Dendritic Cells (DCs)
T. Kobayashi 1, S. Radhakrishnan2, L. R. Pease2, H. Kita1; 1Division of Allergic Diseases, Mayo Clinic College of Medicine, Rochester, MN, 2Department of Immunology, Mayo Clinic College of Medicine, Rochester, MN.
187 The Major Allergen From Peanut, Ara h 1, Induces Transcription Of Genes In Dcs That Are Important For Th2 Priming
Z. Y. Kucuk; Mount Sinai School of Medicine, New York, NY.
188 Eosinophils Modulate the Allergen-Indcued Th2 Pulmonary Immune Microenvironment
E. A. Jacobsen, S. Ochkur, A. G. Taranova, R. Pero, C. Protheroe, J. J. Lee; Mayo Clinic Arizona, Scottsdale, AZ.
189 Concomitant Use Of Glucocorticoids During Allergen Immunotherapy Upregulates Il-10 Production By Peripheral Blood Mononuclear Cells (pbmc)
P. Majak 1, J. Jerzyńska1, W. Stelmach1, P. Kuna2, I. Stelmach1; 1N.Copernicus Hospital, Lodz, POLAND, 2Medical University, Lodz, POLAND.
190 The Effect Of Allergen-pulsed Bone Marrow-derived Dendritic Cells In Mouse Asthma Mod Dose Not Depends On The Route Of Administration
M. Kim 1, Z. Hahn2, Y. Hahn1; 1Chungbuk National University, Cheongjoo, REPUBLIC OF KOREA, 2Chungbuk National University, Postgraduate School, Cheongjoo, REPUBLIC OF KOREA.
Poster Session
2210
Saturday, February 24, 2007
9:45 AM - 10:45 AM
Mast Cells I
191 Conservation of Connective Tissue Mast Cells (MCs) for >500 Million Years of Evolution
R. L. Stevens 1, L. Zhuo2, B. Lam1, K. Kimata2, G. W. Wong3; 1Brigham and Women's Hospital, Boston, MA, 2Aichi Medical University, Aichi, JAPAN, 3Whitehead Institute of Biomedical Research, Cambridge, MA.
192 Environmental Estrogens Induce Mast Cell Degranulation and Enhance IgE-mediated Release of Allergic Mediators
S. Narita, R. M. Goldblum, E. G. Brooks, C. S. Watson, M. D. Estes, E. M. Curran, T. Midoro-Horiuti; University of Texas Medical Branch, Galveston, TX.
193 Induction of Suppressor of Cytokine Signaling (SOCS)-1/3 by IFN-alpha in Suppressing IL-3- but not IgE- Dependent Signaling in Human Basophils
J. T. Schroeder, A. P. Bieneman, K. L. Chichester; Johns Hopkins University, Baltimore, MD.
194 Short Term Culture of Functional Human Mast Cells from Buffy Coat Preparations
M. Holm 1,2, H. B. Andersen1, C. Dahl1, H. J. Hoffmann3, S. Junker2, P. O. Schiotz1; 1Aarhus University Hospital, Aarhus, DENMARK, 2Institute of Human Genetics-University of Aarhus, Aarhus, DENMARK, 3Aarhus University Hospital-Resp. Dept, Aarhus, DENMARK.
195 Ras Guanine Nucleotide Releasing Protein 4 (RasgrP4) Dependent Pathways and Genes that Reversibly Control the Development, Phenotype, and Function of Human Mast Cells (MCs)]
G. P. Katsoulotos1, K. Tanaka2, T. J. Molloy3, R. L. Stevens4, S. A. Krilis 5; 1St. George Hospital, University of New South Wales, Sydney, AUSTRALIA, 2St. George Hospital, University of, Sydney, AUSTRALIA, 3St. Vincent's Hospital, Sydney, AUSTRALIA, 4Harvard Medical School and Brigham and Women's Hospital, Boston, MA, 5St. George Hospital, Sydney, AUSTRALIA.
196 Trans-basement Membrane Migration of Human Basophils: Role of Matrix Metalloproteinase-9
M. Suzukawa 1, A. Komiya1, M. Iikura1, H. Nagase2, C. Yoshimura-Uchiyama1, H. Yamada1, H. Kawasaki3, K. Ohta2, K. Matsushima1, K. Hirai1, K. Yamamoto1, M. Yamaguchi1; 1University of Tokyo Graduate School of Medicine, Bunkyo-ku, Tokyo, JAPAN, 2University of Teikyo School of Medicine, Tokyo, JAPAN, 3University of Tokyo, Bunkyo-ku, Tokyo, JAPAN.
197 NGF-β-Induced Enhancement of FcɛRI-Mediated Activation in Human Basophils is Associated with Reduced SHIP Activity
B. F. Gibbs 1,2; 1Medway School of Pharmacy, Chatham Maritime, Kent, UNITED KINGDOM, 2Department of Dermatology, University of Lübeck, GERMANY.
198 Identification and Characterization of Cis-Acting Regulatory Elements of the PAI-1 Gene in Human Mast Cells
C. K. Oh, Z. Ma; Harbor-UCLA Medical Center, Torrance, CA.
199 Mast Cells Stimulate Cytokine Release from Fibroblasts of Asthmatic Airways
L. C. K. Lau, P. N. Sanders, P. H. Howarth, A. F. Walls; Southampton General Hospital, Southampton, UNITED KINGDOM.
200 Role of Mast Cells in the Development of Pulmonary Allergic Inflammation of SHP-1 Deficient Mice
S. Oh, T. Zheng, J. Schroeder, B. Vonakis, O. Choi, Z. Zhu; The Johns Hopkins University, Baltimore, MD.
201 Abnormal Expression of Fcγ Receptors by Human Bone Marrow Mast Cells in Systemic Mastocitosis
L. B. Sanchez-Muñoz 1, A. Prados1, R. Nuñez1, C. Ruiz1, C. Teodosio2, A. Lopez2, M. Jara2, J. Almeida2, A. Orfao2, L. Escribano1; 1Mast Cell Unit and K. Frank Austen Laboratory, Hospital Ramón y Cajal, Madrid, SPAIN, 2Servicio General de Citometría, Centro de Investigación del Cáncer, Universidad de Salamanca, Salamanca, SPAIN.
202 The 4G/5G-Genotype-Specific Regulation of Plasminogen Activator Inhibitor (PAI)-1 Expression in Human Mast Cells
Z. Ma, C. K. Oh; Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA.
203 Susceptibility to Cow's Milk Allergy (CMA) in C3H/HeJ Mice and Oral Tolerance in BALB/c Mice are Associated With Different Mast Cell Profiles
I. Kirman, R. Du, H. Sampson, X. Li; Mount Sinai School of Medicine, New York, NY.
204 Mature hyphae of Aspergillus fumigatus Induce IgE-Independent Mast Cell Degranulation
M. Urb, P. Pouliot, M. Olivier, D. C. Sheppard; McGill University, Montreal, PQ, CANADA.
205 Leukotriene E4 (LTE4) Is More Potent Than LTD4 For Inducing Cytokine Generation And Proliferation Of Human Mast Cells
S. Paruchuri, J. A. Boyce; Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, MA.
206 IgE Reversibly Enhances FcɛRI levels on the Surface of Human Skin Mast Cells and Increases Sensitivity to Low Levels of FcɛRI Cross-Linking
G. V. Gomez, S. Jogie-Brahim, M. Shima, L. B. Schwartz; Virginia Commonwealth University, Richmond, VA.
207 Cigarette Smoke Exposure Activates Human Mast Cells (MC) In Vitro
L. H. Bellehsen; Hebrew University of Jerusalem, Jerusalem, ISRAEL.
208 Atrial Natriuretic Peptide is Released from Human Mast Cells following IgE-Mediated Activation
M. C. Glaum, S. Nimal, R. F. Lockey, S. S. Mohapatra; University of South Florida College of Medicine, Tampa, FL.
209 When is a Mouse Basophil not a Basophil?
J. J. Lee, M. P. McGarry; Mayo Clinic Arizona, Scottsdale, AZ.
210 Immunological Response to Cat Allergen: A Comparison of the Effects of Environmental Exposure vs Specific Immunotherapy
C. T. Cady 1,2, R. J. Harbeck1, P. C. Giclas1, J. R. Murphy1, R. K. Katial1, R. W. Weber1, J. C. Cambier1,2; 1National Jewish Medical and Research Center, Denver, CO, 2University of Colorado at Denver Health Sciences Center, Denver, CO.
211 Human Lung Mast Cells Express Functional Receptors for Extracellular Adenosine 5′-Diphosphate (ADP)
H. Nishi, A. Pelleg, E. Schulman; Drexel University College of Medicine, Philadelphia, PA.
212 Role of Hydrogen Peroxide in Mycoplasma pneumoniae-induced Mast Cell IL-4 Production
T. P. Atkinson, Y. Dai, L. B. Duffy; Univ of Alabama at Birmingham, Birmingham, AL.
213 Atrial Natriuretic Peptide Can Modulate Human Mast Cell Gene Expression
S. Nimal, M. C. Glaum, P. K. Jena, R. F. Lockey, S. S. Mohapatra; University of South Florida, Tampa, FL.
214 Inhibition of Message for FcɛRI α Chain in RBL Cells Blocks IL-4 Production Induced by Co-Culture with Mycoplasma pneumoniae
D. Luo, Y. Dai, L. B. Duffy, T. P. Atkinson; Univ of Alabama at Birmingham, Birmingham, AL.
Poster Session
2211
Saturday, February 24, 2007
9:45 AM - 10:45 AM
Immunotherapy Mechanisms and Outcomes
215 [Withdrawn]
216 Aggressive Anti-Leukotriene (LT) Prophylaxis Decreases Anaphylaxis Severity during Rush Desensitization (RD)
A. B. Vegh; Puget Sound Allergy Asthma and Imm., Tacoma, WA.
217 Immunomodulator Adjunctive Effects in Treatment of Allergic Diseases
M. Rudenko 1, L. Siziakina1, E. Urban1, L. Du Buske2; 1Research Institute of Clinical Immunology and Allergology, Rostov-on-Don, RUSSIAN FEDERATION, 2Immunological Research Institute of New England, Gardner, MA.
218 Influence Of Anti-IgE On Nasal Polyps
G. Rasp; Katharinenhospital, Stuttgart, GERMANY.
219 Use of a Multimedia Presentation to Increase Knowledge and Safety of Allergen Immunotherapy
P. Hemmers, S. Amara, B. Silverman, A. T. Schneider; Long Island College Hospital, Brooklyn, NY.
220 Sublingual Immunotherapy with Allergoid Tablets: A Double Blind Placebo Controlled Assay
A. G. Palma-Carlos; Clinical Allergy Immunology Center, Lisbon, PORTUGAL.
221 The Glycerin Induced Large Local Reaction (GILL) study
C. Calabria, M. Tankersley; Wilford Hall Medical Center, San Antonio, TX.
222 Tree Pollen Allergoids in Pollinex Quattro Tree Immunotherapy Reduce the Residual Allergenicity as Assessed with Skin Prick Tests (SPTs)
M. Chudak 1, P. Patel1, A. Salapatek1, K. Jethwa1, K. J. Fischer von Weikersthal-Drachenberg2, J. Amersdorffer2; 1Allied Research International, Mississauga, ON, CANADA, 2Allergy Therapeutics plc, Worthing, UNITED KINGDOM.
223 Quantitative Measurements of Allergen Specific IgG4 and IgG Antibodies using ImmunoCAP Technology
A. Kober, P. Lundin, L. Söderström, I. Cressy; Phadia AB, Uppsala, SWEDEN.
224 Comparision of Compositional Differences and Relative Potency Between Different Manufacturers of Ragweed Pollen Extracts
P. S. Creticos 1, S. Balcer-Whaley1, P. Moldt2, O. Pedersen2; 1Johns Hopkins Asthma and Allergy Center, Baltimore, MD, 2Curalogic, Copenhagen, DENMARK.
225 Systemic Reactions to Percutaneous (P) and Intradermal (ID) Skin Tests (ST)
T. Chacko, M. Glaum, D. Ledford, R. Fox, R. F. Lockey; University of South Florida Collge of Medicine, Tampa, FL.
226 Effects of a Novel Symbiotic, ImmuBalance, as a Food Supplement in Relieving Clinical Symptoms of Japanese Cedar Pollonosis: A Pilot Study
W. PAN 1,2, Y. Otsuka3; 1Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, MA, 2Nichimo Co., Ltd., Tokyo, JAPAN, 3Tokorozawa Otolaryngology, Saitama, JAPAN.
227 Segmental Laryngeal Dystonia: A Difficult Differential of Vocal Cord Dysfunction Presenting During Immunotherapy
R. P. Harvey, J. Poole, W. S. Silvers; Allergy Asthma & Immunology Clinic of Colorado, Englewood, CO.
228 Allergy Tests Available over the Internet;‘Caveat emptor!’
A. J. Frew, J. Wade, H. Smith; Brighton & Sussex Medical School, Brighton, UNITED KINGDOM.
229 Allergen-specific Immunotherapy Using A Highly Modified Allergen And The Immunomodulator Polyoxidonium In A Murine Model Of Allergic Asthma
A. A. Babakhin 1, L. S. Litvin1, S. M. Andreev1, O. N. Stetzenko1, L. N. Voronkova1, M. R. Khaitov1, G. G. Barsegyan2, I. V. DuBuske3, L. M. DuBuske3; 1National Research Center - Institute of Immunology, Moscow, RUSSIAN FEDERATION, 2All-Russia Research Center for Molecular Diagnostics and Treatment, Moscow, RUSSIAN FEDERATION, 3Immunology Research Institute of New England, Gardner, MA.
230 Immunotherapy with Dermatophagoides pteronyssinus. Monitoring with Western-blot technique
F. Pineda; DIATER Laboratories, San Martin de la Vega, SPAIN.
231 Aeroallergens in the Valley of Mexico (Frequency)
D. Aguilar, M. I. Rojo, M. A. Bermejo, M. Gonzalez, K. Lopez, K. E. Lopez, T. Sandoval; Juarez Hospital, Mexico, MEXICO.
232 IgE Mediated Sensitization to Weeds Pollen in Saudi Arabia
A. R. Al Frayh; College of Medicine and KKUH, Riyadh, SAUDI ARABIA.
233 A Strategy For Absolute Quantification Of Allergens: Quantification Of Group 2 Isoallergens From A Mixture Of Two Different House Dust Mite Species
U. Seppälä, H. Ipsen, M. D. Spangfort; Research Department, ALK-Abelló, Horsholm, DENMARK.
Poster Session
2212
Saturday, February 24, 2007
9:45 AM - 10:45 AM
Therapy of Allergic Conjunctivitis and Allergic Rhinitis
234 Effect of Montelukast on Collagen Deposition of the Eyes in a Murine Model of Chronic Allergic Eye Disease
E. Marzo, Z. Ma, C. Oh; Harbor UCLA, Torrance, CA.
235 A Single-Center, Double Masked, Randomized, Placebo Controlled Study to Evaluate the Efficacy of Multiple Doses of 10 mg Montelukast Sodium (Singulair®) on the Signs and Symptoms of Allergic Conjunctivitis Using the Conjunctival Allergen Challenge (CAC) Model
P. J. Gomes, M. B. Abelson; Ophthalmic Research Associates, North Andover, MA.
236 Intravenous Immune Globulin (IVIG) in the Treatment of Ocular-Cicatricial Pemphigoid (OCP)
J. A. Lagos, S. F. Kemp, G. D. Marshall; University of Mississippi Medical Center, Jackson, MS.
237 Ocular Symptoms of Seasonal Allergic Rhinitis Can Be Treated Effectively With An Inhaled Corticosteroid (Mometasone Furoate Nasal Spray)
L. Bielory 1, M. Danzig2, D. Gates2; 1UMDNJ-New Jersey Medical School, Newark, NJ, 2Schering-Plough Research Institute, Kenilworth, NJ.
238 Total Ocular Symptom Scores in Patients With Seasonal Allergic Rhinitis are Reduced With Mometasone Furoate Nasal Spray
G. Sussman 1, M. Danzig2, D. Gates2; 1University of Toronto Faculty of Medicine, Toronto, ON, CANADA, 2Schering-Plough Research Institute, Kenilworth, NJ.
239 Mometasone Furoate Nasal Spray Improves Nasal and Ocular Symptoms of Seasonal Allergic Rhinitis in Adolescent Patients
R. Anolik 1, D. Pearlman2, M. Danzig3, D. Gates3; 1Allergy & Asthma Specialists, PC, Blue Bell, PA, 2Colorado Allergy and Asthma Centers, PC, Denver, CO, 3Schering-Plough Research Institute, Kenilworth, NJ.
240 Mometasone Furoate Improves Total Ocular Symptom Score in Patients With Allergic Rhinitis
J. Hébert 1, M. Danzig2, D. Gates2; 1Université Laval Faculté de Médecine, Québec City, PQ, CANADA, 2Schering-Plough Research Institute, Kenilworth, NJ.
241 Safety and Tolerability of Repeated Nasal Allergen Challenges
I. Hussain 1, P. Sayre1, F. Romero2, W. W. Busse3, J. N. Kline4, T. B. Casale2; 1University of California San Francisco, San Francisco, CA, 2Creighton University, Omaha, NE, 3University of Wisconsin, Madison, WI, 4University of Iowa, Iowa City, IA.
242 Comparative Responses to Nasal Allergen Challenge in Allergic Rhinitic Subjects With or Without Asthma
M. Rousseau; Centre de recherche de l'hôpital Laval, Québec, PQ, CANADA.
243 Effect of Antibiotic Treatment on Nasal and Maxillary Sinus Nitric Oxide in Patients with Acute Bacterial Sinusitis
M. J. Lanz, S. Prendes, G. Toledo, C. M. Ferrer; Allergy, Asthma, Rhinitis & Sinusitis CRC, Coral Gables, FL.
244 Criterion for Eosinophilic Nasal Polyp: A Clinicopathologic Correlation
C. Rhee, W. Jeong, J. Kim, S. Kim, T. Won, Y. Kim, C. Lee, S. Cho, Y. Min; Seoul National University College of Medicine, Seoul, REPUBLIC OF KOREA.
245 Efficacy of Mometasone Furoate Nasal Spray in Seasonal Allergic Rhinitis According to Baseline Symptom Severity
M. J. Derebery; House Clinic, Los Angeles, CA.
246 Evaluation Of Respiratory Pressure Meter In Atopic And Non-atopic Rhinitis
Y. Park 1, H. Park2, J. Lee3; 1Department of Pediatrics, Konkuk University Hospital, Konkuk University School of Medicine, Seoul, REPUBLIC OF KOREA, 2Department of Pediatrics, Konkuk University Hospital, Seoul, REPUBLIC OF KOREA, 3Department of Pediatrics, Samsung Masan Hospital, Sungkyunkwan University School of Medicine, Masan, REPUBLIC OF KOREA.
247 Use of Acoustic Rhinometry In Allergic Children
C. Nunes, S. Ladeira; Center of Allergy of Algarve, Portimao, PORTUGAL.
248 Improvement of Symptoms in Children 6 to 12 Years With Allergic Rhinitis Seen With Desloratadine Therapy With or Without Concomitant Corticosteroids
P. Tassinari 1, N. R. Suárez2, J. Centeno3, J. Vergara Velásquez4, H. Aguirre-Mariscal5, S. N. Gonzàlez Dìaz6, A. Fernández de Córdova Jerves7; 1Universidad Central de Venezuela, Caracas, VENEZUELA, 2Policlínica Metropolitana, Caracas, VENEZUELA, 3Universidad Peruana Cayetano Heredia, Lima, PERU, 4Centro Especializado San Fernando, Panama City, PANAMA, 5Hospital Angeles Pedregal, Mexico City, MEXICO, 6Hospital Universitario, Monterrey, MEXICO, 7Hospital Universitario del Rio, Cuenca, ECUADOR.
249 Improved Symptom Relief and Quality of Life With Desloratadine in Pollen-Induced Allergic Rhinitis
D. Dumitrascu; University of Medicine and Pharmacy Iuliu Hatieganu, Cluj Napoca, ROMANIA.
250 Efficacy and Safety of Desloratadine in Combination with Mometasone Furoate in Patients With Moderate-to-Severe SAR
G. Grevers 1, B. Karmann2; 1Nose and Sinus Center, Starnberg, GERMANY, 2Medical Affairs, Essex Pharma GmbH, Munich, GERMANY.
251 Mometasone Furoate Nasal Spray Rapidly and Enduringly Relieves Nasal Congestion and Other Symptoms of Seasonal Allergic Rhinitis
G. N. Gross 1, M. R. Danzig2, D. Gates2; 1Dallas Allergy and Asthma Center, Dallas, TX, 2Schering-Plough Research Institute, Kenilworth, NJ.
252 Desloratadine Treatment Improves Symptoms in Patients With Seasonal Allergic Rhinitis
I. Braverman 1, M. Beiser2, Z. Gilad3; 1Hillel Yaffe Medical Center, Hadera, ISRAEL, 2The Tel Aviv Sourasky Medical Center, Tel Aviv, ISRAEL, 3Schering-Plough Israel AG, Petach Tikva, ISRAEL.
Poster Session
2213
Saturday, February 24, 2007
9:45 AM - 10:45 AM
Allied Health Poster Session
253 Respiratory Protection and Incident Skin Test Sensitivity Among Laboratory Mouse Workers
J. M. Curtin-Brosnan 1, P. A. Eggleston1, B. J. Paigen2, E. A. O'Neil2, K. A. Hagberg2, E. C. Matsui1; 1Johns Hopkins University, Baltimore, MD, 2The Jackson Laboratory, Bar Harbor, ME.
254 Once Daily Fluticasone Furoate∗ Nasal Spray (FFNS), a Novel Enhanced Affinity Steroid, Provides 24-hour Relief for the Nasal Symptoms of Perennial Allergic Rhinitis (PAR)
R. Nathan 1, W. Berger2, W. Yang3, A. Cheema4, M. J. Silvey5, W. Wu5, M. Faris5, E. Philpot5; 1Asthma & Allergy Associates, P.C., Colorado Springs, CO, 2Southern California Research, Mission Viejo, CA, 3Allergy & Asthma Research Centre, Ottawa, ON, CANADA, 4Private Practice, Mississauga, ON, CANADA, 5GlaxoSmithKline, Research Triangle Park, NC.
255 Identification Of Ige-mediated Drug Allergy In Patients With Adverse Drug Reactions Categorized By World Health Organization-the Uppsala Monitoring Centre (who-umc) System
C. Tantikul, N. Dhana, K. Jongjareornprasert, S. Rithikot, N. Visitsunthorn, P. Vichyanond, O. Jirapongsananuruk; Siriraj Hospital, Bangkok, THAILAND.
256 A Survey of Community Physicians' Perceptions Related to Asthma Education
C. A. Gillespie, A. B. Becker; Health Sciences Centre, Winnipeg, MB, CANADA.
257 Improving Asthma Communication With Inner City Parents: Does It Work?
A. Butz 1, C. Land1, J. Walker1, M. E. Bollinger2; 1Johns Hopkins University, Baltimore, MD, 2University of Maryland, Baltimore, MD.
258 Innovative Reporting of Penicillin Allergy in an Integrated Electronic Medical Record
P. J. Markus, D. M. Erickson, J. T. C. Li, R. R. Bessette, J. E. Rueter, D. R. Osmon, N. J. Larson, K. E. Kloos, M. A. Park; Mayo Clinic and Foundation, Rochester, MN.
259 Unusual Side Effect Of Treatment To Large Local Reaction To Immunotherapy
C. W. Wagner 1,2, A. G. Mery1; 1Allergy and Asthma Associates, Houston, TX, 2Texas Woman's University, Houston, TX.
260 Comparison Of Efficacy Of Once Daily ZyrtecR(cetirizine), CetrizinR(cetirizine), Desloratadine And Placebo: Suppressive Effects On Allergen And Histamine Induced Wheal And Flare Responses In Allergic Rhinitis Patients
A. Sukkul, K. Ruxrungtham; Chulalongkorn Hospital, Bangkok, THAILAND.
261 Pyrimethamine Desensitization In Cerebral Toxoplasmosis And Aids
E. Gonzalez, A. Henriquez, A. Losada, B. Huertas, J. Gonzalez, P. Berges, E. Alvarez; Servicio de Alergia Hospital Ramon y Cajal, Madrid, SPAIN.
262 Evolution of Asthma Population Management
C. A. Martin 1, C. Tacinas2, C. Lamb2, K. Baldwin2, S. Hay2, S. Heermann2, J. Hoban2, V. Perry2, B. J. Spiecher2; 1Kaiser Permanente, Westminster, CO, 2Kaiser Permanente, Denver, CO.
263 Evaluation of Penicillin Allergy in an Allergy Immunology Practice
C. S. Wright; Allergy Medical Clinic, Los Angeles, CA.
264 A Comparison of Peak Pollen Times in the Missoula Valley from 1978 and 2006
K. L. Crispen 1, D. N. Gillespie2, T. J. Ward3, A. Holian4; 1University of Montana Center for Environmeantal Health Sciences, Missoula, MT, 2Allergist, Missoula, MT, 3University of Montana Center for Environmental Health Sciences, Missoula, MT, 4University of Montana Center for Environmental Health Sciences, Missoula, MT.
265 Frontal Sinusitis Complicated by an Epidural Abscess and Seizures
D. C. Wirth, S. B. Tanner; Vanderbilt Univeristy Medical Center: Asthma, Sinus, Allergy Program, Nashville, TN.
266 Respiratory Health of Kentucky Farm Children
P. V. Burkhart 1, S. R. Browning2, S. Westneat3, C. A. Knox4, D. Abshire1; 1University Of Kentucky, Lexington, KY, 2University Of Kentucky College of Public Health, Lexington, KY, 3University Of Kentucky College of Nursing, Lexington, KY, 4Kosair Children's Hospital, Louisville, KY.
267 Do Parents Follow Breastfeeding And Weaning Recommendations Given By The Pediatric Nurses? A Study With Emphasis On Introduction Of Cow's Milk Protein In Allergy Risk Families
A. Mikkelsen 1, L. Rinné-Ljungqvist2, M. P. Borres, Sr.3, J. van Odijk4; 1Dep. of Primary Health Care, Göteborg, SWEDEN, 2Primary Health Care Services of Partille, Partille, SWEDEN, 3Dep. of Pediatrics, Sahlgrenska Academy, Göteborg University, Göteborg, SWEDEN, 4Dep. of Clinical Nutrition, Sahlgrenska Academy, Göteborg University, Göteborg, SWEDEN.
Oral Abstract Session
2601
Saturday, February 24, 2007
2:00 PM - 3:15 PM
Allergen Sensitization and Asthma
268 Effect Of Age And Aeroallergen Sensitivities On Acquisition Of Aeroallergen Sensitivities Among Children With Asthma In The Childhood Asthma Management Program (CAMP)
K. A. DeMuth 1, R. Strunk1, G. Bloomberg1, A. Liu2, L. Bacharier1; 1Washington University in St. Louis, Saint Louis, MO, 2National Jewish Hospital Medical & Research., Boulder, CO.
269 Asthma at Age 6 is Associated with an Early and Variable Pattern of Allergic Sensitization in Childhood
C. J. Tisler 1, K. A. Roberg1, E. L. Anderson1, L. E. Salazar1, R. A. Grabher1, D. F. DaSilva1, T. E. Pappas1, K. Sullivan Dillie1, R. E. Gangnon2, M. D. Evans2, J. E. Gern1, R. F. Lemanske, Jr.1; 1University of Wisconsin School of Medicine and Public Health, Madison, WI, 2University of Wisconsin-Population Health Sciences Biostatistics and Medical Informatics, Madison, WI.
270 Allergen Sensitization as a Predictor of Wheezing Phenotype at Age Six Years
C. M. Virnig, K. Roberg, E. Anderson, L. E. P. Salazar, R. A. Grabher, C. Tisler, D. F. DaSilva, T. E. Pappas, K. Sullivan Dillie, M. D. Evans, R. E. Gargnon, J. E. Gern, R. F. Lemanske, Jr.; UW School of Medicine and Public Health, Madison, WI.
271 Association Of The Genetic Polymorphism Of The Surfactant Protein (SP)-D With Mite-sensitization In Childhood Asthma
M. Lei 1,2, W. Dai1, C. Tan1, J. Wang1; 1Dept of Ped, College of Medicine, National Cheng Kung University, Tainan, TAIWAN, 2Institude of molecular medicine, Tainan, TAIWAN.
272 Effect of a Single Nucleotide Polymorphism in the Surfactant Protein D Gene on Atopy and Asthma Susceptibility
E. B. Brandt, N. Wang, E. Grube, M. Stevenson, G. K. Khurana Hershey, M. E. Rothenberg; Cincinnati Children's Hospital Medical Center, Cincinnati, OH.
273 Allergen and Endotoxin Exposure, Infection, and Breastfeeding in Early Life, and Recurrent Wheezing in Infants: 18-month Follow-up of a Cohort Study
V. E. V. Rullo 1, D. Solé1, V. Valente1, C. Nakamura1, A. S. Zampolo2, L. K. Arruda2, R. C. Cardoso3, F. J. Nóbrega4, C. K. Naspitz1; 1Pediatrics, Federal University of São Paulo, São Paulo, BRAZIL, 2Medicine, School of Medicine of Ribeirão Preto-USP, Ribeirão Preto, BRAZIL, 3School of Public Health-USP, São Paulo, BRAZIL, 4Pediatrics, Albert Einstein Hospital, São Paulo, BRAZIL.
Oral Abstract Session
2602
Saturday, February 24, 2007
2:00 PM - 3:15 PM
Highlights in Immunodeficiency 2007
274 T-B+NK+ Severe Combined Immunodeficiency Caused by Complete Deficiency of the CD3zeta Subunit of the T Cell Antigen Receptor Complex
J. L. Roberts 1, J. P. H. Lauritsen2, M. Cooney1, R. E. Parrott1, E. O. Sajaroff1, C. M. Win1, M. D. Keller1, J. H. Carpenter1, M. Sarzotti1, X. Zhong1, D. L. Wiest2, R. H. Bucley1; 1Duke University Medical Center, Durham, NC, 2Fox Chase Cancer Center, Philadelphia, PA.
275 Lysophosphatidylserine (Lyso-PS), a Signaling Phospholipid, is Deficient in Models of Chronic Granulomatous Disease (CGD)
D. L. Bratton 1, K. Zemski-Berry2, R. C. Murphy3, P. M. Henson1, S. C. Frasch1; 1National Jewish Medical and Research Center, Denver, CO, 2Univeristy of Colorado at Denver and Health Science Center, Aurora, CO, 3University of Colorado at Denver and Health Science Center, Aurora, CO.
276 Immunologic and Clinical Features of 21 Amish Patients with Cartilage-Hair Hypoplasia
N. L. Rider 1, D. Morton2, K. A. Strauss2; 1Penn State Milton S. Hershey Medical Center, Hershey, PA, 2The Clinic for Special Children, Strasburg, PA.
277 Lymphocyte Proliferation to Antigens Develops Over Time in Partial DiGeorge Syndrome
V. S. Kancherla, A. P. Reddy, L. M. Noroski, J. Chinen, H. W. Yeh, C. M. Davis; Baylor College of Medicine, Houston, TX.
278 Association Between Mannose-Binding Lectin Deficiency and Immunoglobulin Subclass 4 Deficiency in Children with Recurrent Infections
M. M. Dowd 1, N. Tangsinmankong2, D. D. Siri2, A. S. Hartel2, K. S. Brauer1, I. N. Umeh1, N. K. Day2, J. W. Sleasman2; 1Department of Pediatrics, University of South Florida College of Medicine, St. Petersburg, FL, 2Division of Allergy and Immunology, University of South Florida College of Medicine, St. Petersburg, FL.
279 Specialist Physician Perspectives On Primary Immunodeficiency Diseases: A 2006 Survey Of The AAAAI Membership
J. S. Orange 1, J. Boyle2; 1Children's Hospital of Philadelphia, Philadelphia, PA, 2Immune Deficiency Foundation, Towson, MD.
Oral Abstract Session
2603
Saturday, February 24, 2007
2:00 PM - 3:15 PM
Predictors of Response and Methods of Improving Asthma
280 Monocyte Chemotactic Protein-4 (MCP-4; CCL-13) and the CC chemokine Receptor 3 (CCR3) in Sputum of Asthmatic Children
Y. M. El-Gamal 1, N. M. Heshmat1, K. S. Awwad1, M. H. M. Ezzat1, M. M. Abd Al-Aziz2, Z. M. El-Gabbas1; 1Department of Pediatrics, Faculty of Medicine, Ain Shams University, Cairo, EGYPT, 2Department of Clinical Pathology, Faculty of Medicine, Ain Shams University, Cairo, EGYPT.
281 Exhaled Nitric Oxide as a Predictor of Response to Anti-inflammatory Treatment in Asthma
A. Michils, S. Baldassarre, A. Van Muylem; Erasme University Hospital, Brussels, BELGIUM.
282 Impact and Use of Asthma Control Test (ACT™) on Healthcare Resource Use (HCRU) in a Managed Care (MC) Setting
J. R. CarranzaRosenzweig, P. M. Jhingran, A. A. Dalal; GlaxoSmithkline, RTP, NC.
283 Improving Asthma Care in Disadvantaged Elderly: A Randomized, Controlled Trial Using Telephone Intervention Conducted by Non-Medically Trained Personnel
R. R. Patel, W. L. Gray, C. A. Saltoun, L. C. Grammer; Department of Medicine, Division of Allergy-Immunology, Northwestern University Feinberg School of Medicine, Chicago, IL.
284 Longitudinal Patterns of Predominant Disease Activity (PDA) in Pediatric Patients Receiving Care in an Inner City Asthma Disease Management Program: The Breathmobile Program™
L. Scott 1, B. Nichols1, K. Y. Kwong1, T. Morphew2, L. T. Clement1, F. Lifson2, C. A. Jones1; 1LAC+USC, Los Angeles, CA, 2Southern California Chapter of the Asthma and Allergy Foundation of America (AAFA), Los Angeles, CA.
285 Development and Validation of ‘Asthma Control in Paediatrics’ Questionnaire (CAN)
M. Ibero 1, X. Badia2, N. Cobos3, J. Garde4, E. G. Pérez-Yarza5, J. Villa6, C. Badiola7; 1Hospital de Terrassa, Terrassa, SPAIN, 2Healt Outcomes Research Europe, Barcelona, SPAIN, 3Hospital Vall d'Hebró, Barcelona, SPAIN, 4Hospital General d'Elx, Elx, SPAIN, 5Hospital de Donostia, San Sebastián, SPAIN, 6Hospital del Niño Jesús, Madrid, SPAIN, 7Medical Department GSK, Madrid, SPAIN.
Oral Abstract Session
2604
Saturday, February 24, 2007
2:00 PM - 3:15 PM
Food Allergies: Natural History, Diagnosis and Treatment
286 The Natural History of Cow's Milk Allergy (CMA)
J. M. Skripak; Johns Hopkins Medical School, Baltimore, MD.
287 Clinical Manifestations and Natural History of Egg Allergy in Infants and Children
R. G. Heine 1,2, N. Laske1, D. J. Hill2; 1Royal Children's Hospital, Melbourne, AUSTRALIA, 2Murdoch Childrens Research Institute, Melbourne, AUSTRALIA.
288 The Utility of Combining Skin Prick and Specific IgE Antibody Testing as a Predictor of Clinical Reactivity to Milk, Egg, and Peanut
D. R. Naimi, N. M. Paranich, J. M. Spergel, J. L. Beausoleil; The Children's Hospital of Philadelphia, Philadelphia, PA.
289 Consumer Awareness and Response Following the Food Allergen Labeling and Consumer Protection Act (FALCPA)
H. Lemon-Mule 1, T. J. Furlong2, S. H. Sicherer1; 1Mt Sinai School Of Medicine, New York, NY, 2Food Allergy & Anaphylaxis Network, Fairfax, VA.
290 Preliminary Support for a Group Intervention for Children with Food Allergy and Their Parents
J. S. LeBovidge, K. G. Timmons, C. Rich, A. Rosenstock, K. Fowler, L. C. Schneider; Children's Hospital Boston, Boston, MA.
291 Oral Desensitization Therpy In Children With Egg Allergy
M. Akashi, M. Narita, A. Saito, T. Suda, I. Nomura, A. Akasawa, Y. Ohya; National Center for Child Health and Development, Tokyo, JAPAN.
Oral Abstract Session
2605
Saturday, February 24, 2007
2:00 PM - 3:15 PM
Underserved Population
292 Prevalence of Obesity in Severe Asthma Differs by the Anthropometric Measure
S. M. Musaad 1,2, G. K. Hershey2; 1University of Cincinnati, Cincinnati, OH, 2Cincinnati Childrens Hospital Medical Center, Cincinnati, OH.
293 The Role of Allergy Treatment in Asthma Management among Urban Children
J. A. Stingone, L. Claudio; Mount Sinai School of Medicine, New York, NY.
294 Utilization of Non-Traditional and Alternative Therapies (CAM) in Inner City Under-Served Children with Asthma
K. Tai 1, M. Tsoukleris1,2, V. Hsu1, I. H. Zuckerman1, M. E. Bollinger2, K. Mudd3, M. Donithan4, A. M. Butz3; 1University of Maryland School of Pharmacy, Baltimore, MD, 2University of Maryland School of Medicine, Baltimore, MD, 3The Johns Hopkins University School of Medicine, Baltimore, MD, 4The Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD.
295 Patterns of Asthma Mortality in Ohio: 1999-2003 Compared with 1990-98
D. R. Stukus 1, N. Nock2, D. M. Lang1; 1The Cleveland Clinic, Cleveland, OH, 2Case Western Reserve University, Cleveland, OH.
296 Characteristics and Outcomes of Asthmatics Who Leave Against Medical Advice (AMA)
A. P. Baptist, J. Ager, M. Massanari; Wayne State University, Detroit, MI.
297 Population Density and Race as Factors in Asthma Mortality
N. M. Lebak, L. B. Schwartz; Medical College of Virginia, Virginia Commonwealth University, Richmond, VA.
Oral Abstract Session
2606
Saturday, February 24, 2007
2:00 PM - 3:15 PM
Allergic Inflammation
298 Effects of Lipoxin A4 (LX) on Glucocorticoid Receptor (gr) Function
J. M. Terasaki 1, N. N. Bulayeva1, B. D. Levy2, W. J. Calhoun1; 1Division of Allergy, Pulmonary, Immunology, CCM, & Sleep (APICS), University of Texas Medical Branch, Galveston, TX, 2Department of Internal Medicine and Center for Experimental Therapeutics and Reperfusion Injury, Brigham and Women's Hospital and Harvard Medical School, Boston, MA.
299 Blockage of IL-10 Modulates Airway Inflammation-Associated Eosinophilia And IL-4 Levels in C57Bl6 Mice
Y. Ogawa, E. A. Duru, J. L. Parks, IV, W. J. Calhoun, B. T. Ameredes; University of Texas Medical Branch, Galveston, TX.
300 CysLT1 Receptor Signaling Induces Transcriptional Upregulation of Proprotein Convertase Furin Expression: Potential Implications in Airway Remodeling
M. Rola-Pleszczynski, C. Thompson, S. McMahon, Y. Bossé, C. M. Dubois, J. Stankova; Université de Sherbrooke, Sherbrooke, PQ, CANADA.
301 Fractional Exhaled Nitric Oxide (FeNO) is Elevated in School Aged Children who have Culture-Documented Frequent Viral Respiratory Illnesses during Infancy
L. E. Salazar, M. D. Evans, E. L. Anderson, D. F. DaSilva, R. A. Grabher, T. E. Pappas, K. A. Roberg, K. Sullivan Dillie, C. J. Tisler, R. E. Gangnon, J. E. Gern, R. F. Lemanske, Jr.; University of Wisconsin-Madison, Madison, WI.
302 A Anisakis Simplex Homolog of Macrophage Migration Inhibitory Factor Inhibits Allergic Airway Responses in Mice
H. Park 1, J. Lee1, K. Kim1, H. Jeong2, Y. Jeong3, J. Jeong4, Y. Kim1, M. Lee1, S. Park1, H. Yu2; 1Internal Medicine, Pusan National University School of Medicine, Busan, REPUBLIC OF KOREA, 2Department of Parasitology, Pusan National University School of Medicine, Busan, REPUBLIC OF KOREA, 3Internal Medicine, Gyeonsang National University School of Medicine, Jinju, REPUBLIC OF KOREA, 4Internal Medicine, Iilsan Paik Hospital, Kyungki-do, REPUBLIC OF KOREA.
303 Sensitization to Multiple Allergens Breaks Through Tolerance and Establishes Chronic Asthma That is Unresponsive to Anti-Cytokine Therapy
R. Alam, N. Goplen, Q. Liang, S. Rozario, Y. Morimoto, M. Gorska; National Jewish Medical and Research Center, Denver, CO.
Oral Abstract Session
2607
Saturday, February 24, 2007
2:00 PM - 3:15 PM
Allergen Immunotherapy: From Bench to Bedside
304 Stability of Protease Rich Periplaneta americana Allergen Extract During Storage: Formulating Preservatives to Enhance Shelf life
V. Thangam Sudha 1,2, N. Arora1, S. N. Gaur3, B. P. Singh1; 1Institute of Genomics and Integrative Biology, Delhi, INDIA, 2Department of Biotechnology, University of Pune, Pune, INDIA, 3V. P. Chest Institute, Delhi, INDIA.
305 Usefulness Of Specific Ige Determination To Recombinant Grass Pollen Allergens (cap-feia) In Pollinic Patients
J. M. de la Borbolla, R. Escudero, J. Antón, M. J. Goikoetxea, M. L. Sanz, M. Ferrer; University Clinic, School of Medicine, University of Navarra, Pamplona, SPAIN.
306 Correlation Between SIT Induced Inhibition of IgE Binding, Histamine Release and Facilitated Allergen Presentation
P. A. Würtzen 1, G. Lund1, J. Holm1, M. Arvidsson2, K. Lund1, S. Rak3, H. Ipsen1; 1ALK-Abello, Hørsholm, DENMARK, 2Department of Medical Sciences, Clinical Chemistry, University Hospital, Uppsala, SWEDEN, 3Asthma and Allergy Research Group, Department of Respiratory Medicine and Allergology, Sahlgrenska University Hospital, Goteborg, SWEDEN.
307 Safety and Efficacy of the Novel Vaccine TOLAMBA™ in Ragweed Allergic Adults, a Dose Finding Study
D. I. Bernstein 1, N. Segall2, A. Nayak3, T. Casale4, P. Korenblatt5, E. Martins6; 1Bernstein Allergy Group, Cincinnati, OH, 2Clinical Research of Atlanta, Stockbridge, GA, 3Sneeze, Wheeze and Itch Associates, Normal, IL, 4Creighton U., Omaha, NE, 5Clinical Re-search Center, St. Louis, MO, 6Dynavax Technologies, Berkeley, CA.
308 Venom Immunotherapy (VIT) Reduces Large Local Reactions (LLR) to Insect Stings
D. Kelly 1, D. B. K. Golden1, R. G. Hamilton1, T. J. Craig2; 1Johns Hopkins University, Baltimore, MD, 2Penn State Hershey Medical Center, Hershey, PA.
309 Prolonged Pre-seasonal Treatment Phase with Sublingual Immunotherapy Increases Clinical Efficacy
M. A. Calderon 1, A. O. Birk2, J. S. Andersen2, S. R. Durham1; 1Imperial College, National Heart and Lung Institute, London, UNITED KINGDOM, 2ALK-Abelló, Hörsholm, DENMARK.
Oral Abstract Session
2608
Saturday, February 24, 2007
2:00 PM - 3:15 PM
Allied Health Oral Abstracts Session
310 Predicting Outcome of Repeated Oral Food Challenges
K. E. Mudd, M. Paterakis, J. Curtin-Brosnan, R. A. Wood; Johns Hopkins University, School of Medicine, Baltimore, MD.
311 Analysis of a System to Provide Consistent Care of Patients with Fatality-Prone Asthma (FPA)
L. C. Kertz, R. C. Strunk, L. B. Bacharier; Washington University School of Medicine, St. Louis, MO.
312 The Integration of Web-based Asthma Education with Nurse Case Management
K. Kelly-Shanovich 1, A. D. Pulvermacher1, C. A. Sorkness2, A. Bhattacharya3, D. H. Gustafson1; 1Center for Health Enhancement Systems Studies, University of Wisconsin - Madison, Madison, WI, 2Schools of Pharmacy and Medicine, University of Wisconsin - Madison, Madison, WI, 3Center for the Study of Cultural Diversity in Healthcare, University of Wisconsin - Madison, Madison, WI.
313 A Needs Assessment Project to Enhance Patient and Provider Asthma Communication
P. M. Fritz, F. L. Schottenfeld, C. Spampinato, G. Gallinger; NYS Dept of Health, Troy, NY.
314 The Impact of Home Visits on Retention in a Low-Income School Based Mobile Asthma Clinic
C. M. Carcel 1, S. Amaro1, F. Sowa2, T. Morphew3, S. P. Galant1; 1Children's Hospital of Orange County, Orange, CA, 2Latino Health Access, Santa Ana, CA, 3AAFA, Los Angeles, CA.
315 Does Use of Asthma Controllers Really Indicate Asthma “Control?”
C. L. Vibbert 1, A. Butz2, M. Tsoukleris3, V. D. Hsu3, M. E. Bollinger1; 1University of Maryland School of Medicine, Baltimore, MD, 2Johns Hopkins University School of Medicine, Baltimore, MD, 3University of Maryland School of Pharmacy, Baltimore, MD.
Poster Session
3201
Sunday, February 25, 2007
9:45 AM - 10:45 AM
Asthma Diagnosis
316 Sputum Mediators in Children with Mild Persistent Asthma Indicate Immune Dysregulation and Correlate with Lower Lung Function
N. Patel 1, A. M. Schiltz1, R. Harbeck1, R. A. Covar1,2, S. M. Wood3, S. J. DeMichele3, E. W. Gelfand1,2, S. J. Szefler1,2, A. H. Liu1,2; 1National Jewish Medical and Research Center, Denver, CO, 2University of Colorado School of Medicine, Denver, CO, 3Ross Products Division/Abbott Laboratories, Columbus, OH.
317 Clinical Implication of Vascular Endothelial Growth Factor (VEGF) in Childhood Asthma
K. Kim 1, E. Kim1, J. Park1, G. Jang2, C. Kim3, H. Lee3, M. Sohn1, K. Kim1; 1Department of Pediatrics and Institute of Allergy, Severance Children's Hospital, Yonsei University College of Medicine, Seoul, REPUBLIC OF KOREA, 2Department of Pediatrics, NHIC Ilsan Hospital, Goyang, REPUBLIC OF KOREA, 3Department of Pediatrics, Kwandong University, Goyang, REPUBLIC OF KOREA.
318 The Predictive Power of Frequent eNO Measurements in Patients with Asthma
J. D. Wolfe 1, D. M. Dreon2, B. R. Parikh2, E. E. Hutchins2, M. N. Bates3; 1Asthma and Allergy Associates of Northern California, San Jose, CA, 2Aperon Biosystems Corp., Menlo Park, CA, 3University of California - Berkeley, Berkeley, CA.
319 Exhaled Nitric Oxide and Pulmonary Function Tests in Children with Asthma
S. Choi 1, H. Koh2, C. Bae2, Y. Rha2; 1Department of Pediatrics, College of Medicine, Seoul National University, Seoul, REPUBLIC OF KOREA, 2Department of Pediatrics, College of Medicine, Kyung Hee University, Seoul, REPUBLIC OF KOREA.
320 Diagnostic Value of Eosinophil Cationic Protein (ECP) in Children with Asthma Undergoing Food Challenges
A. Krogulska, K. Wasowska-Królikowska, J. Dynowski; Medical University Lodz, Poland, Lodz, POLAND.
321 Longitudinal Changes in Bronchial Hyperresponsiveness and Exposure to High Levels of Domestic Pet Allergens
S. J. Fowler 1,2, N. Truman1, A. Simpson1, A. A. Woodcock1, S. J. Langley1, A. Custovic1; 1University of Manchester, Manchester, UNITED KINGDOM, 2Lancashire Teaching Hospitals, Preston, UNITED KINGDOM.
322 Roc Curve Analysis Of Serum-specific Ige Levels To Predict Airway Reactivity To Dog Allergens In Asthmatic Subjects
A. Matito, S. Blanco, P. Gajate, L. Martín, R. Vives, C. Ortega, C. Fernandez; Hospital 12 de Octubre, Madrid, Spain.
323 Correlation between Clinical Parameters of Asthma and Airway Dimension, Air Trapping and Airway Collapsibility Measured by Volumetric Inspiration and Expiration CT
H. Moon 1,2, T. Kim1,2, E. Chae3,2, N. Kim3, Y. Lee3, C. Park1,2, B. Yoo1, J. Seo3,2, Y. Cho1,2; 1Department of Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, REPUBLIC OF KOREA, 2Clinical Research Center for Chronic Obstructive Airway Disease, Asan Medical Center, University of Ulsan College of Medicine, Seoul, REPUBLIC OF KOREA, 3Department of Radiology and Research Institute of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, REPUBLIC OF KOREA.
324 Effect of Emergency Room Treatment of Acute Asthma on Plasma Levels of Complement Split Products
D. Dure 1, I. Kalampokis1, E. Monk, Jr.1, C. Charlot1, E. Gilbert1, M. Nowakowski1, R. Sinert2, R. Joks1; 1Center for Allergy and Asthma Research, SUNY, Brooklyn, NY, 2Kings County Hospital Center, Brooklyn, NY.
325 Standard Range Of Peak Expiratory Flow Rate Of Korean Children In Seoul
W. H. Seo 1, H. K. Shin1, S. H. Ahn2, S. H. Park2, K. M. Ahn2, S. I. Lee2; 1College of Medicine, Korea University, Seoul, REPUBLIC OF KOREA, 2Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, REPUBLIC OF KOREA.
326 Airflow Obstruction Of Adolescent Asthmatics Without Current Respiratory Symptoms
H. Nishimura 1, K. Tokuyama2, M. Suzuki1, T. Mizuno3, H. Koyama3, H. Arakawa3, H. Mochizuki3, A. Morikawa3; 1Tone Central Hospital, Numata, JAPAN, 2Takasaki Univ. of health and Welfare, Takasaki, JAPAN, 3Gunma Univ., Maebashi, JAPAN.
327 Dynamic Oxygen-Enhanced Magnetic Resonance Imaging is Not Useful in Assessing Severity or Airway Inflammation in Asthmatic Children
T. F. Leung 1, W. C. W. Chu2, C. W. Y. Kam1, D. T. Yeung2, C. Y. Li1, G. W. K. Wong1, P. C. Ng1; 1Department of Pediatrics, The Chinese University of Hong Kong, Hong Kong, HONG KONG, 2Department of Diagnostic Radiology and Organ Imaging, The Chinese University of Hong Kong, Hong Kong, HONG KONG.
328 Measurement of Specific IgE Levels in Korean Allergic Disease Children by Using CAP system
J. Lee 1, J. Jung2, J. Kim3, C. Kim4, Y. Park5; 1Masan samsung hospital, Masan si, REPUBLIC OF KOREA, 2Dong A university, Busan, REPUBLIC OF KOREA, 3Ulsan university, Ulsan, REPUBLIC OF KOREA, 4Kwan Dong University, Seoul, REPUBLIC OF KOREA, 5Konkuk university, Seoul, REPUBLIC OF KOREA.
329 The Impact of Electronic Medical Records on Timeliness of Diagnosis of Asthma
K. H. Yoo 1, S. Bagniewski2, A. L. Weaver2, S. V. Pankrantz2, R. M. Jacobson2, Y. J. Juhn2; 1Mayo Clinic/Konkuk University, Rochester, MN, 2Mayo Clinic, Rochester, MN.
330 Cutaneous Sensitization to Indoor allergens in children with Asthma and Rhinitis in Chiclayo, Peru
F. V. Maticorena Agramonte, L. Suarez, W. Presentacion; Hospital Belen, Chiclayo, PERU.
331 Cell-specific Activation of ERK1/2 and p38 MAPK in Airway Biopsy Samples from Asthmatic patients
Q. Liang, S. Balzar, S. Wenzel, M. Gorska, R. Alam; National Jewish Medical and Research Center, Denver, CO.
332 The Severity of Historical ASA/NSAID-Induced Asthma Attacks Does Not Correlate with Severity of Asthma Induced During Oral ASA Challenges
A. N. Williams, R. A. Simon, K. M. Woessner, D. D. Stevenson; Scripps Clinic, San Diego, CA.
333 Serum TGF-β1 in Allergic Asthma
W. Manuyakorn 1, S. Benjaponpitak1, W. Kamchaisatian1, C. Setthaudom2, K. Atamasirikul2, C. Sasisakulporn3, C. Direkwattanachai1; 1Division of Allergy/Immunology, Department of Pediatrics, Ramathibodi Hospital, Mahidol University, Bangkok, THAILAND, 2Department of Pathology, Ramathibodi Hospital, Mahidol University, Bangkok, THAILAND, 3Research Center, Ramathibodi Hospital, Mahidol University, Bangkok, THAILAND.
Poster Session
3202
Sunday, February 25, 2007
9:45 AM - 10:45 AM
Asthma Pathogenesis
334 Systemic Autoimmunity Significance in Patients with Asthma
I. Agache 1, L. Duca1, M. Anghel2; 1Transylvania University Brasov, Faculty of Medicine, Brasov, ROMANIA, 2Brasov County Hospital, Brasov, ROMANIA.
335 Allergy, Serum IgE, and Lung Function in Children and Adolescents With Severe or Difficult-to-Treat Asthma
T. Haselkorn 1, S. J. Szefler2, F. E. R. Simons3, D. R. Mink4, B. E. Chipps5, D. A. Wong1, L. Borish6; 1Genentech, Inc., South San Francisco, CA, 2Department of Pediatrics, National Jewish Medical and Research Center, Denver, CO, 3Department of Pediatrics and Child Health, University of Manitoba, Winnipeg, MB, CANADA, 4Ovation Research Group, San Francisco, CA, 5Capital Allergy and Respiratory Disease Center, Sacramento, CA, 6University of Virginia Health Systems, Charlottesville, VA.
336 Asthma and Lung Dysfunction Among Disadvantaged Wheezing Infants Followed to Age 7 Years
M. D. Klinnert 1,2, A. H. Liu1,2, G. Herrera-Garcia1, K. Walsh1; 1National Jewish Medical and Research Center, Denver, CO, 2University of Colorado Health Sciences Center, Denver, CO.
337 Short-term Growth Suppression assessed by Knemometry may predict Height Growth Suppression in Children with Asthma treated with Inhaled Glucocorticoids
O. D. Wolthers; Asthma and Allergy Clinic, Children's Clinic Randers, Randers, DENMARK.
338 IRF-1 Interferes with Steroid Function in Airway Smooth Muscle Cells
O. Tliba, H. Baidouri, Y. Amrani; University of Pennsylvania, Philadelphia, PA.
339 Predictive Factors for Air Trapping Measured by CT Scan in Asthma
A. A. Busacker 1,2, C. Kotaru2, T. Keefe1, J. Newell2, E. Hoffman3, S. E. Wenzel4; 1Colorado State University, Fort Collins, CO, 2National Jewish Medical and Research Center, Denver, CO, 3University of Iowa, Iowa City, IA, 4University of Pittsburgh Medical Center, Pittsburgh, PA.
340 Exhaled Nitric Oxide Decreases during Acetylcholine-induced Bronchoconstriction in Children with Asthma
Y. Noma, M. Nagao, T. Fujisawa; Mie National Hospital, Tsu, JAPAN.
341 Forced Expiratory Maneuvers - Most Of Healthy Children Do Not Meet ATS Criteria For Spirometry
G. Siergiejko 1, B. E. Nowowiejska2, M. G. Kaczmarski2, Z. Siergiejko2; 1Children Hospital, Bialystok, POLAND, 2Medical University, Bialystok, POLAND.
342 Diurnal Assessment of Airways Inflammation in Patients with Asthma Utilizing eNO
J. D. Wolfe 1, D. M. Dreon2, B. R. Parikh2, E. E. Hutchins2, M. N. Bates3; 1Asthma and Allergy Associates of Northern California, San Jose, CA, 2Aperon Biosystems Corp., Menlo Park, CA, 3University of California - Berkeley, Berkeley, CA.
343 Detection of Tissue Eosinophils and Evidence of Extensive Degranulation in Archived Clinical Biopsies Using a Novel Anti-Eosinophil Peroxidase Monoclonal Antibody
C. Protheroe, J. C. Lewis, T. N. Lunsford, G. DePetris, M. P. McGarry, N. A. Lee, J. J. Lee; Mayo Clinic Arizona, Scottsdale, AZ.
344 Adiposity May Enhance Pulmonary Dysfunction in Obese Asthmatics Adolescents
P. Rojas, P. Sakali, J. Estrada, R. Pasternak, C. Moore; louisiana state university, New Orleans, LA.
345 Gastroesophageal Reflux (GER) Cause Increase In Bronchial Reactivity
B. E. Nowowiejska 1, G. Siergiejko2, M. G. Kaczmarski1, Z. Siergiejko1; 1Medical University, Bialystok, POLAND, 2Children Hospital, Bialystok, POLAND.
346 Effect of Smoking Cessation on AMP and Methacholine Airway Hyperresponsiveness in Cigarette Smokers
C. Russo, G. Piccillo, P. Caponnetto, A. Origlio, A. Bonaccorsi, A. Di Maria, R. Polosa; University Of Catania, Catania, ITALY.
347 Exhaled Breath Condensate (EBC) pH in the Evaluation of Asthma
C. A. Coop, L. L. Hagan, J. P. Dice; Wilford Hall Medical Center, San Antonio, TX.
348 Monitoring the Fractional Concentration of Exhaled Nitric Oxide (FENO) in Uncontrolled Asthma Before and After Steroid Therapy Using a New Portable Monitor
W. E. Berger; Allergy and Asthma Associates of Southern California, Mission Viejo, CA.
349 Is Spirometry a Better Tool Than Measurement of Peak Flow Rate for Monitoring a Rub-Test for Screening Exercise-Induced Asthma?
C. A. Charpin-Kadouch 1, J. Ercoli1, J. Quéralt1, A. Palot2, F. Pelleing3, D. Charpin2; 1Maison de l'Allergie et de l'Environnement, Marseille, FRANCE, 2Assistance publique-Hôpitaux de Marseille, Marseille, FRANCE, 3Inspection d'Académie des Bouches-du-Rhône, Marseille, FRANCE.
350 Nitric Oxide Metabolites In Asthma And Copd
J. V. Garmendia 1, D. Moreno, Jr.2, N. E. Larocca1, C. Tálamo3, J. B. De Sanctis1; 1Instituto de Inmunología. Universidad Central de Venezuela, Caracas, VENEZUELA, 2Cátedra de Fisiopatología del Instituto de Medicina Experimental y Servicio de Neumonología del Hospital Universitario de Caracas. Facultad de Medicina, Universidad Central de Venezuela., Caracas, VENEZUELA, 3IServicio de Neumonología. Hospital Universitario. Universidad Central de Venezuela, Caracas, VENEZUELA.
351 Performance Characteristics of a New Device for Assessment of Asthmatic Inflammation by Measurement of Exhaled Breath Temperature, the Dunev Thermometer, a Unique Tool for Asthma Management
T. A. Popov 1, S. Dunev1, T. Kralimarkova1, S. Kraeva1, L. M. DuBuske2; 1Sofia Medical University, Sofia, BUL-GARIA, 2Immunology Research Institute of New England, Gardner, MA.
Poster Session
3203
Sunday, February 25, 2007
9:45 AM - 10:45 AM
B Cells and T Cells
352 Kainic Acid Treatment of B Cells Causes Increased CD23 Shedding
J. L. Sturgill; Virginia Commonwealth University, Richmond, VA.
353 Eosinophilic Fasciitis Associated with X-Linked Agammaglobulinemia: Report of Two Cases
P. Sriaroon 1, N. Tangsinmankong1, S. Skoda-Smith2, M. E. Elder2, J. W. Sleasman1; 1University of South Florida College of Medicine, St. Petersburg, FL, 2University of Florida College of Medicine, Gainesville, FL.
354 An Uncommon Familial Presentation of Long Standing Diarrhea and Common Variable Immunodeficiency Improved with IVIG Therapy
V. VELAZQUEZ, C. A. Camacho, C. A. Camacho; Hospital Episcopal San Lucas, Ponce, PR.
355 MR1, a Class Ib Molecule, Utilizes a MHC Class II Like Pathway to Activate Mucosal Associated Invariant T Cells
S. Huang 1, A. Sant2, T. Hansen1; 1Washington University in St. Louis, St. Louis, MO, 2University of Rochester, New York, NY.
356 Analysis of T Cell Skewing by a Receptor Targeted Allergen Variant Reveals Selective Enhancement of Th1-Promoting Cytokines at the APC Level
K. Hulse 1, A. J. Reefer1, S. M. Satinover1, M. D. Chapman2, V. Engelhard1, J. A. Woodfolk1; 1University of Virginia, Charlottesville, VA, 2Indoor Biotechnologies Inc., Charlottesville, VA.
357 Synergy Between LPS and Immobilized anti-human CD3 mAb for Activation of Cord Blood CD3+ T cells
Y. Katz, M. Goldberg, N. Luknar-Gabor, G. Zadik-Mnuhin, P. Koch, J. Tovbin; Assaf-Harofeh Medical Center, Zerifin, ISRAEL.
358 Impaired Corticosteroid-induced Transactivation In Human CD8+ T Cells
L. Li, D. Y. M. Leung, E. Goleva; National Jewish Medical and Research Center, Denver, CO.
359 Circulating Foxp3+CD4+ regulates both Th1 and Th2 responses in vivo
K. Orihara 1,2, M. Narita3, T. Tobe2, A. Akasawa3, Y. Ohya3, K. Matsumoto1, H. Saito1; 1National Research Institute for Child Health and Development, Tokyo, JAPAN, 2Showa University, Tokyo, JAPAN, 3National Center for Child Health and Development, Tokyo, JAPAN.
360 Delivery Of Augmented Il-2 Receptor Signals To Cd8+ T Cells Replaces The Requirement For Helper Function In The Generation Of Primary But Not Secondary Cd8+ T Cell Responses
L. E. Cheng 1, P. D. Greenberg2; 1University of California, San Francisco, San Francisco, CA, 2University of Washington, Seattle, WA.
361 Up-regulation of Granzyme B Gene Expression by Chemical Allergens
R. J. Dearman, H. T. Caddick, C. J. Betts, I. Kimber; Syngenta CTL, Macclesfield, UNITED KINGDOM.
362 The MAb CHO-131 Identifies a Subset of Cutaneous Lymphocyte-Associated Antigen T cells Enriched in P-Selectin Binding Cells
Z. Ni; University of Minnesota, St. Paul, MN.
363 IL-12/TGF-β1 Regulation of TCR Signal Transduction in Human Memory T Cells Associated with Malignant and Non-malignant Chronic Inflammatory Microenvironments
L. Broderick, R. B. Bankert; University at Buffalo, Buffalo, NY.
364 Activated CD4+ And CD4- Subsets Of T Lymphocytes Increase In Experimentally Induced Eosinophilic Esophagitis (EE)
M. Wang, E. B. Brandt, M. E. Rothenberg, A. Mishra; Division of Allergy and Immunology, Cincinnati Children Hospital Medical Center, Cincinnati, OH.
365 Effects of Stress Hormones on Regulatory T cell (Treg) and Intracellular TH1/TH2 Cytokine Levels in Normal Human PBMC
G. D. Marshall, D. D. Montgomery, S. R. Roy, J. B. Brock; University MS Medical Center, Jackson, MS.
366 Regulatory T Lymphocytes Distribution And Eosinophilic Gastroenteropathy
P. Vannelli, T. Yan, C. Barone, S. McGeady; Thomas Jefferson University, Philadelphia, PA and A.I. duPont Hospital for Children, Wilmington, DE.
367 Complete DiGeorge Syndrome Due to CHD7 Mutation
M. Sanka, N. Tangsinmankong, M. Loscalzo, J. W. Sleasman, M. J. Dorsey; University of South Florida College of Medicine, St. Petersburg, FL.
368 Factors Inducing Development of Childhood-onset Myasthenia Gravis by CD3 Spectratyping Analysis
H. Dokai, Y. Fujikawa, K. Nihei, N. Shinomiya; Toho University Medical Center, Tokyo, JAPAN.
369 Identification of Cytokine Heterogeneity within the Th2 Subset
N. Kim, B. A. Foster, C. Prussin; Laboratory of Allergic Diseases, NIAID/NIH, Bethesda, MD.
370 Variable Effects of Combination Corticosteroids and Catecholamines on Total β2-Adrenergic Receptors in Human CD4+ T-Lymphocytes
A. N. Salicru 1, B. E. Crucian2, M. A. Nelman-Gonzales2, J. K. Actor1, C. F. Sams3, G. D. Marshall, Jr.4; 1Department of Pathology and Laboratory Medicine, The University of Texas Health Science Center, Houston, TX, 2NASA-Johnson Space Center Bioastronautics Team Inc, Houston, TX, 3NASA Human Adaptation and Countermeasures Office, Houston, TX, 4Division of Clinical Immunology and Allergy, The University of Mississippi Medical Center, Jackson, MS.
371 Idiopathic CD4 Lymphocytopenia With Cryptococcal Pneumonia: A Case Report In Literature In Review
R. W. Hostoffer, Jr. 1, M. Eagam2; 1Case Western Reserve University, Cleveland, OH, 2Lake Erie College of Osteopathic Medicine, Erie, PA.
372 Evaluation of NKT Cells in Leishmaniasis
R. A. Campos, J. M. Cunha, O. F. Jesus, O. Bacellar, F. C. C. Figueiredo, R. G. D. Lima, R. S. Matos, E. M. Carvalho; Universidade Federal da Bahia, Salvador-BA, BRAZIL.
373 B Cell Superantigen-induced Immune Complex Lung Inflammation
A. L. Anderson, A. I. Levinson; University of Pennsylvania, Philadelphia, PA.
Poster Session
3204
Sunday, February 25, 2007
9:45 AM - 10:45 AM
Vaccines and Immunodiagnostics
374 Long-term Clinical Outcomes Following Vaccinia Associated Myopericarditis
M. R. Nelson 1, L. C. Collins1, J. E. Atwood1, R. E. Eckert2, E. A. Shry2, D. J. Shelton1, W. Scott1, R. J. M. Engler1; 1Walter Reed Army Medical Center, Washington, DC, 2Brooke Army Medical Center, Fort Sam Houston, TX.
375 Does Early BCG (Tokyo Strain) Vaccination have Potency to Prevent Allergy in Infants?
R. Ito, H. Saito, K. Matsumoto; National Research Institute for Child Health & Development, Tokyo, JAPAN.
376 A Pilot Study: Trivalent Inactivated Influenza Vaccine (TIV) and Myopericarditis
M. I. Slingluff 1, M. M. Klote1, B. A. Hemann1, M. R. Nelson1, M. A. Yacavone1, J. E. Atwood1, S. Black2, R. J. M. Engler1; 1Walter Reed Army Medical Center, Washington, DC, 2Kaiser Permanente Vaccine Study Center, Oakland, CA.
377 Headache After Trivalent Inactivated Influenza Vaccine (TIV): Gender Differences and Severity
S. Kim-Delio 1, M. M. Klote1, M. R. Nelson1, W. W. Carr2, R. D. Deguzman1, C. P. Mikita1, B. L. Martin1, R. J. M. Engler1; 1Walter Reed Army Medical Center, Washington, DC, 2Walter Reed Army Medical Ctr-WRAIR, Washington, DC.
378 Adverse Reactions To Pneumovax Pneumococcal Vaccine-cases Of Hyperimmunization?
S. E. Mannan, E. Yousef; A. I. duPont Hospital for Children/Thomas Jefferson University Hospital, Wilmington, DE.
379 Knowledge, Attitudes and Beliefs (KAB) Regarding Reporting of Adverse Events Following Immunizations (AEFI)
P. A. Hutchinson 1, M. R. Nelson1, S. L. Hill1, L. L. Duran2, R. J. M. Engler1; 1Walter Reed Army Medical Center, Washington, DC, 2Walter Reed Army Medical Center-VHC, Washington, DC.
380 Primary Smallpox Vaccination Temporally Associated with New Onset Urticaria-Angioedema (UrtAng) Evolving to Chronic Disease
R. J. M. Engler, MD 1, A. Marini2, J. Green3, M. Klote1, L. Collins4, P. V. Belandres4, S. T. Chang3, J. F. Williams5, M. R. Nelson1; 1Walter Reed Army Med Ctr.; Uniformed Services University of the Health Sciences, Washington, DC, 2Uniformed Services University of the Health Sciences, Bethesda, MD, 3Walter Reed Army Med Ctr, Washington, DC, 4Walter Reed Army Med Ctr., Washington, DC, 5Walter Reed Army Med Ctr-VHC, Washington, DC.
381 Thrombocytopenia and Measles-Mumps-Rubella (MMR) Vaccine: Managing Loss Of Immunity to MMR
L. C. Collins, Jr. 1,2, M. C. Minor1,2, N. C. Blacker3,4, G. J. Robinson3,4, R. J. M. Engler1,2; 1Walter Reed Army Medical Center, Washington, DC, 2Vaccine Healthcare Centers Network, Washington, DC, 3Womack Army Medical Center, Fayetteville, NC, 4Vaccine Healthcare Centers Network, Fayetteville, NC.
382 Pre-transplant Cellular Alloimmunity as Assessed by a Panel of Reactive T-Cells (PRT) and Risk of Post-transplant Allograft Rejection
M. R. Gupta 1, M. Vieyra1, D. E. Hricik2, J. J. Augustine2, L. Coleman1, R. Starling1, E. Poggio1, P. S. Heeger1; 1Cleveland Clinic Foundation, Cleveland, OH, 2University Health Systems, Cleveland, OH.
383 Chimeric EGF Receptor That Detects IgE-binding/crosslinking
R. Nakamura; Natl Inst Health Sci, Tokyo, JAPAN.
384 Low Values of Allergen Specific IgE Antibodies are Clinically Useful and Give Predictive Information for Very Young Children
L. Soderstrom 1, M. Nordlund2, C. Nilsson2, G. Lilja21Phadia AB, Uppsala, SWEDEN, 2Sachs' Children's Hospital, Sodersjukhuset, Stockholm, SWEDEN.
385 Development of a Clinical Flow Cytometry Assay to Measure in Vitro Lymphocyte Responses
E. C. Chenworth 1, V. Nandakumar2, R. S. Abraham2; 1Division of Allergic Diseases, Mayo School of Graduate Medical Education, Rochester, MN, 2Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN.
386 Component Resolved IgE, IgG and IgG4 Antibody Levels for Grass Pollen Allergic Patients in Specific Immunotherapy. A Pilot Study
J. Arnved1, S. Ronborg1, B. Kristensen2, L. Soderstrom 3; 1Lung and Allergy Clinic, Copenhagen, DENMARK, 2Sweden Diagnostics Denmark, Copenhagen, DENMARK, 3Phadia AB, Uppsala, SWEDEN.
387 Comparison of Skin Prick Tests and Allergen-specific IgE by MAST-CLA Technique in Allergic Thai Children
P. Vilaiphan, S. Numkiatwongsa, P. Chatchatee, J. Ngamphaiboon; King Chulalongkorn Memorial Hospital, Bangkok, THAILAND.
388 Allergen Recognizing Pattern in Patients Sensitized to Dermatophagoides pteronyssinus and Lepidoglyphus destructor
R. P. Reis 1, A. P. Pires1, T. Fonseca2, R. Murta2, A. F. Ferrão1, L. A. Patrício1, E. M. Tomaz1, F. C. Inácio1; 1Hospital S. Bernardo, Setúbal, PORTUGAL, 2Amerlab DPC, Lisboa, PORTUGAL.
Poster Session
3205
Sunday, February 25, 2007
9:45 AM - 10:45 AM
Indoor and Outdoor Allergens and Risk Factors for Sensitization
389 Airborne Spore Levels and Skin Test Reactivity in New Orleans following Hurricane Katrina
E. Levetin 1, E. Horner2, E. Davis3, S. B. Lehrer4; 1University of Tulsa, Tulsa, OK, 2Air Quality Science, Marietta, GA, 3Ochsner Clinic Foundation, New Orleans, LA, 4Tulane University, New Orleans, LA.
390 Indoor Molds and Allergic Potential
M. D. W. Ward 1, Y. Chung1, L. B. Copeland1, M. K. Selgrade1, S. Vesper2; 1US EPA, Research Triangle Park, NC, 2US EPA, Cincinnati, OH.
391 Seasonal Distribution of Airborne Alternaria Spores
J. D. K. McNairn; Children's Mercy Hospital, Kansas City, MO.
392 A Comparative Study of Airborne Grass Pollen and Grass Pollen Hypersensitivity in Tulsa and Sorrounding Areas in Northeast Oklahoma
R. S. Medagoda 1, E. Levetin2, J. Purser3, D. Stewart1; 1University of Ok, College of Medicine, Tulsa, OK, 2University of Tulsa, Tulsa, OK, 3Allergy Clinic of Tulsa, Tulsa, OK.
393 Respiratory Allergy and Airborne Pollen Concentrations in Italy from 1992 to 2004
E. Ridolo, R. Albertini, D. Giordano, L. Soliani, I. Usberti, P. Dall'Aglio; University of Parma, Parma, ITALY.
394 An Eight Year Survey (1998-2005) of the Major Tree Pollens in the Washington, DC Area
J. Yoon, M. R. Nelson, M. S. Marks, S. E. Kosisky; Walter Reed Army Medical Center, Washington, DC.
395 Typical Outdoor Levels of Airborne Fungal Spores Collected at Ground Level During Both The Rainy and Dry Seasons in Florida
R. Codina, L. S. Cohen, Jr., J. J. Mele; SDII Global Corporation, Tampa, FL.
396 The Air Spora Surrounding a Compost Facility in Northeast, Oklahoma
S. Gillum, E. Levetin; The University of Tulsa, Tulsa, OK.
397 Influence of Meteorological Conditions on Early Spring Pollen in the Tulsa Atmosphere from 1987-2006
E. Lo, E. Levetin; University of Tulsa, Tulsa, OK.
398 Predominant Weed and Grass Aeroallergens of the Washington, DC Area: an Eight Year Survey (1998-2005)
S. E. Kosisky, Sr.; Walter Reed Army Medical Center, Washington, DC.
399 Effect of Trimming Cypress Tree on Pollination
D. A. Charpin 1, M. Calleja2, C. Pichot3; 1Assistance publique-Hôpitaux de Marseille, Marseille, FRANCE, 2Ecole Supérieure d'Agronomie de Montpellier, Montpellier, FRANCE, 3Institut National de la Recherche Agronomique, Avignon, FRANCE.
400 Characteristics of the Casuarina Pollen Season in the Sydney District, NSW
P. K. Burton, C. H. Katelaris; Institute of Immunology and Allergy Research, Westmead, AUSTRALIA.
401 September Asthma Spikes And Mold Aeroallergen Levels In A Southwestern Ontario Community: Correlation Or Coincidence?
J. Ohayon 1, J. Anderson2; 1McMaster University, Hamilton, ON, CANADA, 2London Health Sciences, London, ON, CANADA.
402 Seasonal Pollinosis Symptoms, Atmosphere Conditions And Pollens Count
C. Nunes, S. Ladeira; Center of Allergy of Algarve, Portimao, PORTUGAL.
403 “Farmhouse Mycosis”: Mold Assessment
J. J. Anderson 1, P. J. Pityn2; 1London Health Sciences Centre, London, ON, CANADA, 2Oshtech Inc., London, ON, CANADA.
404 Concordance Rates of Allergen Sensitization Amongst Family Members at an Inner City Asthma Center
F. Hajee, H. Solomon, M. Castro, C. Bowser, M. Rao, R. Joks; Center for Allergy and Asthma Research, SUNY Downstate Medical Center, Brooklyn, NY.
405 Risk Factors for Asthma in Adolescents: ISAAC Phase II in a Brazilian Coast City
L. M. Spinelli, N. A. Rosario, C. A. Riedi, A. V. Schmidt, J. J. Jorge, M. Malucelli, M. S. Cramer, J. C. Correa-Celi, A. Albanus; Federal University of Parana, Curitiba, BRAZIL.
406 Allergic Asthma and Rhinitis Caused by Household Rabbit Exposure: Identification of Seum-Specific IgE and Its Allergens
J. Choi 1, H. Kim2, H. Park2; 1Bundang JeSaeng General Hospital, Seongnam-si, Kyunggido, REPUBLIC OF KOREA, 2Ajou University Hospital, Suwon-si, Kyunggido, REPUBLIC OF KOREA.
407 The Relationship Between Obesity, Menstrual Cycle, And Lung Function In Korean Adolescent Girls
H. J. Yang, Y. H. Jeon, B. Y. Pyun; Department of Pediatrics, College of Medicine, Soonchunhyang Univ Hospital, Seoul, REPUBLIC OF KOREA.
408 Development of a Murine Model for Assessment of Chronic Beryllium Disease
F. Salehi 1, S. Audusseau1, N. Karp1, J. Zayed2, B. Mazer1; 1McGill University, Montreal, PQ, CANADA, 2University of Montreal, Montreal, PQ, CANADA.
409 Tobacco Smoke Relation With Chronic Sinusitis And Nasal Polips
J. Martín-Lázaro 1, D. D. Stevenson2; 1Hospital Juan Canalejo, La Coruna, SPAIN, 2Scripps Clinic, La Jolla, CA.
Poster Session
3206
Sunday, February 25, 2007
9:45 AM - 10:45 AM
Allergens: Molecular Biology, Structure and Function, and Cross Reactivity
410 Cockroach Allergen Bla g 2 Dimerizes in a Crystal Complex with an Antibody Fragment
A. Pomés 1, M. Li2, S. Wünschmann1, M. D. Chapman1, A. Wlodawer3, A. Gustchina3; 1INDOOR Biotechnologies, Inc., Charlottesville, VA, 2Basic Research Program, SAIC-Frederick, Frederick, MD, 3Macromolecular Crystallography Laboratory, National Cancer Institute, Frederick, MD.
411 Purification And Characterization Of Allergens From Harmonia Axyridis (asian Lady Beetle): An Evolving Indoor Allergen
T. NAKAZAWA 1, B. Dragulev1, L. Goddard1, J. Shannon1, E. Peters2, T. A. Platts-Mills1; 1University of Virginia, Charlottesville, VA, 2Asthma and Allergy Consultants, Austin, TX.
412 Mapping of Antigenic Determinants on Bla g 2 surface
S. Wünschmann 1, M. Li2, A. Gustchina3, A. Wlodawer3, M. Chapman1, A. Pomés1; 1INDOOR Biotechnologies Inc., Charlottesville, VA, 2Basic Research Program, SAIC, Frederick, MD, 3Macromolecular Crystallography Laboratory, NCI, Frederick, MD.
413 IgE Recognition Pattern of Homologous Allergens Tested by Microarray-based Nanotechnology
E. Scala, A. Zaffiro, D. Quaratino, C. D'Ambrosio, M. Bernardi, P. Palazzo, M. Giani, A. Mari; Center for Clinical and Experimental Allergology, IDI-IRCCS, Rome, ITALY.
414 Stability of Major Allergen Proteins in Extract Mixes Diluted in Human Serum Albumin (HSA), Normal Saline (NSP), or Glycerin (GLY)
G. Plunkett; ALK-Abelló, Inc., Round Rock, TX.
415 Mapping Conformational Epitopes On Jun A 1, The Major Allergen Of Mountain Cedar Pollen
R. Tiwari, B. Ning, S. Negi, M. Endsley, D. Estes, C. Schein, W. Braun, T. Midoro-Horiuti, R. Goldblum; University of Texas Medical Branch, Galveston, TX.
416 Natural and Recombinant Amb a 1: Immunologic Analysis of IgE and Monoclonal Antibody Epitopes
N. Wopfner 1,2, R. Bauer1, J. Thalhamer1,2, F. Ferreira1,2, M. Chapman3; 1University of Salzburg, Department of Molecular Biology, Salzburg, AUSTRIA, 2Christian Doppler Laboratory for Allergy Diagnosis and Therapy, Salzburg, AUSTRIA, 3Indoor Biotechnologies, Charlottesville, VA.
417 Proteomics Of The Major Pollen Allergen From Birch (Bet v 1), Hazel (Cor a 1), Oak (Que a 1), And Hornbeam (Car b 1)
A. M. Erler 1,2, F. Ferreira1,2, P. Briza1; 1University of Salzburg, Department of Molecular Biology, Salzburg, AUSTRIA, 2Christian Doppler Laboratory for Allergy Diagnosis and Therapy, Salzburg, AUSTRIA.
418 Molecular Cloning of Chortoglyphus arcuatus Allergens
E. Fernandez-Caldas 1, L. Vailes2, O. Troubina2, E. King2, L. Arlian3, M. Boquete4, V. Iraola1, S. Lafosse-Marin5, M. Chapman2; 1Laboratorios LETI S. L., Tres Cantos, SPAIN, 2Indoor Biotechnologies Inc., Charlottesville, VA, 3Wright State University, Dayton, OH, 4Hospital Xeral, Lugo, SPAIN, 5Cabinet d'Immuno-allergologie, Fort de France, MARTINIQUE.
419 Identification of an Allergen of Harmonia Axyridis (Multicolor Asian Lady Beetle)
J. E. Knuffman 1,2, M. A. Opsahl1, B. H. Gern1, A. S. Pratt1, H. Sanchez1, R. K. Bush1,2; 1William S. Middleton Veterans Affairs Hospital, Madison, WI, 2University of Wisconsin Hospital and Clinics, Madison, WI.
420 N-terminus Amino Acid Analysis Of Four Independently Produced Recombinant Alt a1
H. Sanchez 1, R. K. Bush1,2; 1William S. Middleton VA Hospital, Madison, WI, 2University of Wisconsin-Madison, Madison, WI.
421 Extraction and Purification of Art v 1, the Mugwort Pollen Major Allergen
M. Egger, P. Gruber, F. Ferreira; Department of Molecular Biology, Division of Allergy and Immunology, University of Salzburg, Salzburg, AUSTRIA.
422 Characterization of Ascaris lumbricoides Tropomyosin: Use of Recombinant Protein to Investigate IgE Antibody Responses
A. B. R. Santos1, G. C. Arruda1, A. S. Zampolo1, M. C. Rodrigues1, V. P. L. Ferriani1, C. Oliver1, M. S. Palma2, V. S. Sales3, L. K. Arruda 1; 1School of Medicine of Ribeirão Preto-University of São Paulo, Ribeirão Preto, BRAZIL, 2Bioscience Institute, State University of São Paulo, Rio Claro, BRAZIL, 3Federal University of Rio Grande do Norte, Natal, BRAZIL.
423 The Cross-allergenecity of Pollens from Compositae Family: Dendranthema grandiflorum, Artemisia vulgaris and Taraxacum officinale
Y. W. Lee 1, S. Y. Choi2, E. K. Lee2, J. H. Sohn2, J. W. Park1, C. S. Hong1; 1Dept of Int Med & Institute of Allergy, Yonsei University College of Medicine, Seoul, REPUBLIC OF KOREA, 2Institute of Allergy, Yonsei University College of Medicine, Seoul, REPUBLIC OF KOREA.
424 Biochemical Characterization Of Intact Allergen Extracts Vaccine (Alutard SQ®) And Chemically Modified Allergoid Vaccines Representing Birch, Grass And House Dust Mite
H. Henmar, K. Meno, L. Friberg, H. Ipsen; ALK-Abelló A/S, Hørsholm, DENMARK.
425 Senecio jacobea Pollen: A New Allergenic Source
O. Luengo 1, R. Mollá2, V. Pozo2, V. Cardona1, C. Geller-Bernstein3, Y. Waysel4, C. Lahoz2, A. Cadahia1; 1Allergy Unit. Hospital Universitari Vall d'Hebron., Barcelona, SPAIN, 2Department of Immunology. Fundación Jiménez Díaz, Madrid, SPAIN, 3Kaplan Medical Center, Rehovot, ISRAEL, 4Tel Aviv University, Tel Aviv, ISRAEL.
426 Physicochemical and Immunochemical Characterization of Cyn d 24 from Bermuda Grass Pollen
S. Su 1, l. chiu2, s. yang1, S. Huang3, L. Chou2; 1Veterans General Hospital-Taipei, Taipei, TAIWAN, 2National Taiwan University, Taipei, TAIWAN, 3University of Florida, Gainesville, FL.
427 Epidemiological Evaluation of Allergenic Molecules IgE Reactivity Detected by means of a Proteomic Microarray Method
M. Giani, E. Guerra, M. Locanto, C. Mondino, L. Pirrotta, D. Pomponi, E. Scala, A. Mari; Center for Clinical and Experimental Allergology, IDI-IRCCS, Rome, ITALY.
428 Identification of the Russian Hamster Allergens (Phodopus sungorus)
J. A. Torres, M. de las Heras, C. Pastor, M. Fernandez-Nieto, S. Quirce, M. Madero, A. Enriquez-Matas, J. Sastre; Fundacion Jimenez Diaz, Madrid, SPAIN.
429 Assessment of the Potential Cross-Allergenicity between Hen's Egg Lysozyme and Recombinant Human Lysozyme
D. A. Moneret-Vautrin 1, C. M. N. Astier2, P. Franck1, M. Morisset1, F. Codreanu1, O. Roitel3, S. L. Taylor4, D. R. Bethell5; 1University Hospital, Nancy, FRANCE, 2INPL, Vandoeuvre-Les-Nancy, FRANCE, 3Laboratory of Molecular Medicine and Therapeutics, Vandoeuvre-Les-Nancy, FRANCE, 4University of Nebraska, Lincoln, NE, 5Ventria Bioscience, Sacramento, CA.
430 Specific IgE levels to Der p 1 and Der p 2 in patients sensitized to Dermatophagoides spp.
M. Boquete 1, F. Carballada1, C. Carballas1, J. Carnés2, V. Iraola2, E. Fernández-Caldas2, M. Chapman3; 1Hospital Xeral de Calde, Lugo, SPAIN, 2Laboratorios LETI, SL, Tres Cantos, SPAIN, 3Indoor Biotechnologies Inc., Charlottesville, VA.
431 Production of Purified Native Alt a 1 at an Industrial Scale
M. Osterberg 1, S. Jabbari1, E. Hogbom2, P. Brostedt2; 1Allergon AB, Angelholm, SWEDEN, 2Phadia AB, Uppsala, SWEDEN.
Poster Session
3207
Sunday, February 25, 2007
9:45 AM - 10:45 AM
Food Allergy I
432 Fig Allergy: Not Just Oral Allergy Syndrome (OAS)
N. V. Cruz, S. L. Bahna, A. K. Knight; Louisiana State University Health Sciences Center-Shreveport, Shreveport, LA.
433 A Case Series of Eosinophilic Esophagitis: Importance of Allergy Evaluation, Detection of Food Allergy and Avoidance Diet
V. Patel, S. Kearney; Lehigh Valley Hospital, Allentown, PA.
434 Prevalence of Sensitization to Food Allergens Among Food Allergy Index and Control Families
D. Caruso, F. Ouyang, J. A. Pongracic, R. Kumar, A. Schroeder, J. Costello, X. Wang; Children's Memorial Hospital, Chicago, IL.
435 Trends in Sensitisation to Aero and Food Allergens-Comparison between different Birth Cohorts
T. Dean 1,2, C. Venter2, R. Kurukuralaatchy2, B. Pereira2, S. Matthews2, J. Grundy2, C. B. Clayton2, M. Fenn2, B. Higgins1, S. H. Arshad2; 1University of Portsmouth, Portsmouth, UNITED KINGDOM, 2The David Hide Asthma and Allergy Research Centre, Isle of Wight, UNITED KINGDOM.
436 Racial Differences in Early Introduction of Solid foods, IgE and Incidence of Atopic Dermatitis and Wheeze
C. L. M. Joseph 1, D. R. Ownby2, S. L. Havstad1, E. M. Zoratti3, C. C. Johnson1; 1Dept of Biostatistics and Research Epidemiology, Henry Ford Hospital & Health System, Detroit, MI, 2Medical College of Georgia, Augusta, GA, 3Section of Allergy & Clinical Immunology, Henry Ford Hospital & Health System, Detroit, MI.
437 Prevalence of Peanut and Shellfish Allergy in Singapore Children Estimated from a Questionnaire Survey
L. P. Shek 1, J. Y. Soh2, P. Z. Ng1, E. A. Morales1, S. Ma3, B. W. Lee1; 1National University of Singapore, Singapore, SINGAPORE, 2National University Hospital, Singapore, SINGAPORE, 3Ministry of Health, Singapore, SINGAPORE.
438 Food Allergen Sensitization is Independently Associated with Decreased Lung Function in Children
R. Kumar 1, Y. Yu2, J. A. Pongracic1, A. Schroeder2, B. Wang2, X. Liu3, H. Xing3, X. Wang2; 1Division of Allergy, Children's Memorial Hospital, Chicago, IL, 2The Mary Ann and J. Milburn Smith Child Health Research Program, Children's Memorial Hospital and Children's Memorial Research Center, Chicago, IL, 3Biomedical Institute, Anhui Medical University, Hefei, CHINA.
439 Demographic Information for Patients with Eosinophilic Esophagitis
M. L. Heltzer, J. P. Franciosi, M. Shuker, C. A. Liacouras, J. M. Spergel; Children's Hospital of Philadelphia, Philadelphia, PA.
440 Food Hypersensitivity (FHS) And Sensitisation To Food Allergens Over The First Three Years Of Life
C. Venter 1, B. N. Pereira1, J. Grundy1, C. B. Clayton1, B. Higgins2, T. Dean1,2; 1The David Hide Asthma and Allergy Research Centre, Isle of Wight, UNITED KINGDOM, 2University of Portsmouth, Portsmouth, UNITED KINGDOM.
441 Cookies and Avoidance Diets - Impact of the Food Allergen Labeling and Consumer Protection Act (FALCPA) and Other Industry Practices on Ingredient Labeling of Cookies
S. L. Taylor 1, G. A. Knudsen1, S. L. Hefle1, T. J. Furlong2; 1Food Allergy Research and Resource Program (FARRP) at University of Nebraska, Lincoln, NE, 2Food Allergy & Anaphylaxis Network (FAAN), Fairfax, VA.
442 Transfer of Shrimp Allergens to Other Foods Through Cooking Oil?
S. B. Lehrer 1, L. Kim1, T. Rice1, J. Saidu2, J. Bell2, R. Martin3; 1Tulane University Health Sciences Center, New Orleans, LA, 2LSU Ag Center, Baton Rouge, LA, 3National Fisheries Institute, McLean, VA.
443 Familial Aggregation of Total and Food-Specific IgE
H. Tsai, R. Kumar, J. Pongracic, Y. Yu, J. Costello, M. O'Gorman, X. Wang; Children's Memorial Hospital and Children's Memorial Research Center, Chicago, IL.
444 ELISA and HPLC Comparison of Pediatric Amino Acid-based Nutritionals
G. O. Duska-McEwen; Abbott Laboratories, Columbus, OH.
445 Peanut Allergic Child Increases Risk for Peanut Allergy in Siblings
S. Huq 1,2, J. Liem1,2, A. Kozyrskyj1,2, A. Becker1,2; 1University of Manitoba, Winnipeg, MB, CANADA, 2Manitoba Institute of Child Health, Winnipeg, MB, CANADA.
446 Study and Development of Food Allergy Herbal Formula (FAHF-2)
Y. Chen, K. Srivastava, H. Sampson, X. Li; Mt. Sinai School of Medicine, New York, NY.
447 Cross Reactivity in Mountain Cedar-Tomato Oral Allergy Syndrome
R. S. Bonds, R. Tiwari, B. Ning, E. W. Czerwinski, R. G. Goldblum, T. Midoro-Horiuti; University of Texas Medical Branch, Galveston, TX.
448 Investigation of the Safety to Allergic Patients of Biotechnologically Derived Enzymes used in the Food Industry
C. Bindslev-Jensen 1, P. Skov2, E. Roggen3, E. Friis3, T. Gehring3, P. Hvass3, D. Brinch3; 1Odense University Hospital, Odense, DENMARK, 2RefLab, Copenhagen, DENMARK, 3Novozymes A/S, Bagsvaerd, DENMARK.
449 Food-Induced Anaphylaxis and Repeat Epinephrine Treatments
E. Oren, A. Banerji, S. Clark, C. A. Camargo, Jr.; Massachusetts General Hospital, Boston, MA.
450 Evaluation of Pediatric Patients Admitted with Adverse Food Reactions to an Inner-City Pediatric ED
S. Kiratiseavee, S. Ramesh; University of Buffalo, Buffalo, NY.
451 Roasted Peanuts Are More Likely to Sensitize Mice than Raw Peanuts
S. J. Maleki 1, K. Yamaki2; 1USDA-Agricultural Research Service, New Orleans, LA, 2National Food Research Institute, Tsukuba, JAPAN.
452 Children with Multiple Food Allergies are Not More Likely to be Underweight than Other Children
J. L. P. Protudjer, J. J. Liem, A. L. Kozyrskyj, A. B. Becker; University of Manitoba, Winnipeg, MB, CANADA.
453 The Natural History of Egg Allergy
J. H. Rabe, E. C. Matsui, K. E. Mudd, J. M. Skripak, R. A. Wood; Johns Hopkins Hospital, Baltimore, MD.
454 Identification of a MnSOD-like Protein as a New Major Pistachio Allergen
R. Ayuso, G. Grishina, K. Ahn, L. Bardina, K. Beyer, H. Sampson; Mt Sinai Medical Center, New York, NY.
455 Immunochemical and Biological Methods for Estimation of Allergen Content Used for Soy Allergy Risk Assessments of Biotechnologically Derived Products
M. H. Pedersen 1, P. S. Skov1, T. Holzhauser2, C. Bindslev-Jensen3, D. S. Brinch4, L. K. Poulsen1; 1National university hospital of Denmark, Copenhagen, DENMARK, 2Paul-Ehrlich-Institut, Langen, GERMANY, 3Odense university hospital, Odense, DENMARK, 4Novozymes A/S, Bagsvœrd, DENMARK.
456 Basophil Activation In Food Allergic Patients
M. Worm; Dept. of Dermatology and Allergy, Berlin, GERMANY.
457 Association Between Milk Allergy, Steroid Use, And Rate Of Hospitalizations In Children With Asthma
A. B. Sympson1,2, E. Yousef 1,2; 1DuPonts Children's Hospital, Wilmington, DE, 2Thomas Jefferson Uiniversity, Philadlephia, PA.
458 Epicutaneous Testing Using Peanut Extracts Prepared by a Variety of Cooking Methods
M. Peng 1, G. Hubbard1, J. A. Nordlee2, S. L. Hefle2, M. B. Levy1; 1Medical College of Wisconsin, Milwaukee, WI, 2University of Nebraska, Food Allergy Research and Resource Program, Lincoln, NE.
459 Sunflower Seed Food Allergy as a Co-allergy With Peanut
S. S. Comstock, C. Kath, S. S. Teuber; Univ CA-Davis School Medicine, Davis, CA.
460 Identification of a New Sesame Seed Allergen - Ses i 7, an 11 S Globulin belonging to the Seed Storage Proteins
K. Beyer 1, G. Grishina2, L. Bardina2, H. A. Sampson2; 1Charité, Berlin, GERMANY, 2Mount Sinai School of Medicine, New York, NY.
Poster Session
3208
Sunday, February 25, 2007
9:45 AM - 10:45 AM
Food Allergy II
461 A Phase II, Randomized, Double-Blind, Parallel-group, Placebo-Controlled, Oral Food Challenge Trial of XOLAIR® (omalizumab) in Peanut Allergy (TOPS)
H. A. Sampson; Mount Sinai School of Medicine, New York, NY.
462 Relative Potency of Oral Antigens in Provoking Food Allergy in the Mouse
C. C. Bowman, M. K. Selgrade; USEPA, Research Triangle Park, NC.
463 Increased Prevalence of Vitamin D Deficiency Rickets Due to Inadequate Dietary Restrictions for the Treatment for Allergic Diseases
T. Muto 1, S. Morii1, R. Kimura1, M. Futamura2, K. Ito2, T. Sakamoto1; 1Nagoya University Graduate School of Medicine, Nagoya, JAPAN, 2Aichi Children's Health and Medical Center, Obu, JAPAN.
464 Recognition of Clinical Tolerance to Baked Milk Products in Milk-Allergic Children
K. A. Bloom, A. Nowak-Wegrzyn, S. M. Walsh, E. D. Robinson, M. Mishoe, H. A. Sampson; The Mount Sinai Medical Center, New York, NY.
465 Novel Clinical Course Of IgE-mediated, Late-onset Anaphylaxis After Ingestion Bacillus Subtilis-Fermented Soybeans (natto): Clinical Review Of 7 Patients
N. Inomata, H. Osuna, K. Kawano, J. Yamaguchi, M. Yanagimachi, Z. Ikezawa; Yokohama City University Hosipital, Yokohama, JAPAN.
466 Cherry Allergy: How To Decrease The Allergenicity Of Cherry Industrial Derivatives
V. Pravettoni 1, O. Brenna2, L. Farioli3, L. Primavesi2, S. Bonomi1, S. Tonoli1, C. Pompei2, E. Pastorello3; 1Operative Unit of Allergy and Clinical Immunology, Ospedale Maggiore Policlinico, Mangiagalli e Regina Elena Foundation, IRCCS, Milan, Italy, 2Department of Food Science and Technology and Microbiotechnology, University of Milan, Milan, Italy, 3Operative Unit of Allergy and Clinical Immunology, Niguarda Ca' Granda Hospital, Milan, Italy.
467 Treatment of Natural Peanut Butter with Phytic Acid
S. CHUNG, E. T. Champagne; USDA-ARS, New Orleans, LA.
468 Multifaceted Food Allergy Education Program: Healthcare Provider Educational Resource Development
J. E. Yu 1, S. Teuber2, S. H. Sicherer1; 1Mt Sinai School Of Medicine, New York, NY, 2University of California, San Diego, San Diego, CA.
469 Assessment of Hypoallergenic Properties of the Santana Apple
H. S. Kootstra 1, B. J. Vlieg-Boerstra1, M. P. van der Maas2, A. E. J. Dubois1; 1University Medical Center Groningen, Groningen, THE NETHERLANDS, 2Applied Plant Research, Wageningen UR, Wageningen, THE NETHERLANDS.
470 Can Egg-Allergic Children Recognize Egg Proteins In Breast Milk?
I. Cerecedo 1, C. Alonzi2, J. Wang3, L. Bardina3, A. Nowak-Wegrzyn3; 1Hospital Ramon y Cajal, Madrid, SPAIN, 2Policlinico Gemelli, Università Cattolica del Sacro Cuore, Rome, ITALY, 3Mount Sinai School of Medicine, New York, NY.
471 Assessment of Oral Allergy to Apple with Rat Basophil Leukemia (RBL) Cells Transfected with Human Fcɛ Receptor and Passively Sensitized with Sera from Apple- and Birch-Allergic Individuals
R. Bencharitiwong, A. Nowak-Wegrzyn; Mount Sinai School of Medicine, New York, NY.
472 A New Murine Model of beta-Lactoglobulin-Specific IgE-Mediated Cow's Milk Hypersensitivity
K. Dairiki, N. Shimizu, T. Kaneko; Food Science Institute, Meiji Dairies Corporation, Odawara, Kanagawa, JAPAN.
473 Weaning to a Partially Hydrolyzed Whey Formula at Three Months of Age Protects Against the Later Development of Anti-Cow Milk IgE Antibodies in Comparison to Whole Cow's Milk or Extensively Hydrolyzed Whey Formulas
R. U. Sorensen 1, J. Inostroza2, E. Hebel2, A. M. Vinet2, J. Fierro2, A. Roman2, K. Mason1; 1LSU Health Sciences Center, New Orleans, LA, 2University of La Frontera, Temuco, CHILE.
474 Specific IgE Antibodies To ω-5 Gliadin - Indicator Of Wheat Anaphylaxis And Its Tolerance In Wheat Sensitized Children
R. Shibata 1, S. Nishima1, K. Kohno2, E. Morita2, H. Matsuo3, A. Tanaka4; 1Fukuoka National Hospital, Fukuoka, JAPAN, 2Department of Dermatology, Shimane University School of Medicine, Shimane, JAPAN, 3Graduate School of Biomedical Scineces, Hiroshima University, Hiroshima, JAPAN, 4Phadia KK, Tokyo, JAPAN.
475 Food Allergy Symptoms As A Consequence Of Subconscious Stress Responses
K. Nekam 1, K. Toth2, L. M. DuBuske3; 1Hospital of the Hospitaller Brothers of St. John of God, Budapest, HUNGARY, 2Institute of Psychology, University of Pécs, Pecs, HUNGARY, 3Immunology Research Institute of New England, Gardner, MA.
476 Cashew Allergy Demographics, Presentation and Cross Reactivity in a US Cohort
A. W. Grigg 1, I. C. Hanson1,2, C. M. Davis1,2; 1Baylor College of Medicine, Houston, TX, 2Section of Allergy and Immunology, Department of Pediatrics,Texas Children's Hospital, Houston, TX.
477 Identification of Pistachio (Pistacia vera) Allergens of 11s Globulin and 2s Albumin Family
K. Ahn; Samsung Medical Center, Sunkyunkwan University School of Medicine, Seoul, REPUBLIC OF KOREA.
478 Accidental Allergic Reactions (AAR) In Children With Cow's Milk Allergy (CMA)
M. Boyano; Hospital Infantil La Paz, Madrid, SPAIN.
479 Associations of Prick Skin Tests and Allergen Specific IgE in Children and Adults
J. A. Pongracic 1, F. Ouyang2, J. S. Kim1, D. Caruso2, H. Wang2, X. Wang2; 1Division of Allergy, Children's Memorial Hospital, Chicago, IL, 2The Mary Ann and J. Milburn Smith Child Health Research Program, Children's Memorial Hospital and Children's Memorial Research Center, Chicago, IL.
480 Utility of the Direct Basophil Activation Test in Predicting Tolerance to Dietary Milk Protein in Children With a History of Cow's Milk Allergy
N. Wanich, A. Nowak-Wegrzyn, S. Walsh, B. Robinson, S. Noone, H. A. Sampson, W. G. Shreffler; Mount Sinai School of Medicine, New York, NY.
481 Establishing Objective Detection Limits for the Pepsin Digestion Assay Used in the Assessment of Genetically Modified Foods
A. O. Ofori-Anti, L. Chen, H. L. Lee, R. E. Goodman; University of Nebraska, Lincoln, Lincoln, NE.
482 Bird-egg Syndrom In A 80 Years Old Patient
A. Losada 1, M. Dieguez1, E. González1, B. de Valdés1, J. Carnes2, M. Díez1; 1Servicio de Alergia Hospital Ramon y Cajal, Madrid, SPAIN, 2Laboratorios LETI I+D, Madrid, SPAIN.
483 Egg-bird Syndrome In A Five Year Old Patient
B. de Valdés 1, E. Gonzalez1, M. Diéguez1, J. Carnés2, B. De la Hoz1, S. Terrados1; 1Allergy Department. Hospital Ramon y Cajal, Madrid, SPAIN, 2I+D Laboratorios LETI, Madrid, SPAIN.
484 IgE Mediated Food Allergy in Childhood: Novel Concepts in Allergic Immune Response
S. Donnanno 1, M. Rosado2, G. Trimarco3, F. Capolunghi2, S. Cascioli2, M. C. Artesani1, R. Carsetti2, G. Cavagni1; 1C.O.U. of Allergy, Pediatric Medicine Department, IRCCS, Osp. Pediatrico Bambino Gesù, Rome, Roma, ITALY, 2Research Laboratory of Flow Cytometry and B cells Development, IRCCS, Osp. Pediatrico Bambino Gesù, Rome, Roma, ITALY, 3O.U. of Allergy, Pediatric Department, University of Parma, Roma, ITALY.
485 Analysis of Peanut Allergenic Components for Chinese Patients
H. Li; Peking Union Medical College Hospital, Beijing, CHINA.
486 Allergic Proctocolitis Associated With Cow's Milk With An Unusual Evolution
C. M. A. Jacob, D. L. A. Pitarello, A. C. Pastorino, M. M. F. Trevisan, Y. L. Koda, E. Vidolin, A. P. B. M. Castro; Depto. of Pediatrics, São Paulo, BRAZIL.
487 Presence, Loss, and Recurrence of Walnut Allergy after Chemotherapy
W. L. Ebbeling; William L. Ebbeing, MD, INC, APMC, Fresno, CA.
488 Egg's allergy: an experience from Brazilian Food Allergy Reference Center
C. M. A. Jacob, A. C. Pastorino, D. Munhoz, R. G. Ramos, T. Batelochio, A. C. Brandão, A. K. F. Gushken, G. H. Yonamine, A. P. B. M. Castro; Faculty of Medicine of University of Sao Paulo, Sao Paulo, BRAZIL.
Poster Session
3209
Sunday, February 25, 2007
9:45 AM - 10:45 AM
Epidemiology and Informatics
489 The Effect of Increasing Study Enrollment on Willingness to Adopt Newly Validated Asthma Therapies
P. Khoury, J. O'Brien, S. K. Aberegg; The Ohio State University, Columbus, OH.
490 Adherence To Immunotherapy Protocols, SLIT Vs. SCIT
R. Garcia-Ibanez, D. M. Pollina; The AllergiGroup, Tampa, FL.
491 Low Temperature is a Strong Risk Factor for the Onset of Atopic Dermatitis in Children in Japan
K. Matsumoto, H. Saito; National Research Institute for Child Health and Development, Tokyo, JAPAN.
492 Prevalence of Self-reported Adverse Drug Reaction/Drug Allergy in a Singaporean Paediatric Population
T. Tan 1, H. Van Bever2; 1National University of Singapore, Singapore, SINGAPORE, 2Department of Paediatrics, National University of Singapore, Singapore, SINGAPORE.
493 Locating Evidence-based Literature in Immunology Using PubMed/MEDLINE
K. E. Deeney, A. F. Carr; NN/LM Pacific Southwest Region, UCLA, Los Angeles, CA.
494 Childhood Obesity as a Possible Aggravating Factor of Atopic Dermatitis
T. Kusunoki 1,2, T. Morimoto3, R. Nishikomori2, T. Heike2, M. Ito1, S. Hosoi4, T. Nakahata2; 1Shiga Medical Center for Children, Moriyama, Shiga, JAPAN, 2Department of Pediatrics, Graduate School of Medicine, Kyoto University, Kyoto, JAPAN, 3Medical Education Center, Kyoto University, Kyoto, JAPAN, 4Ako City Hospital, Ako, Hyogo, JAPAN.
495 Prevalence of Atopy in Rural China among Children and Adults
J. S. Kim 1, F. Ouyang2, J. A. Pongracic1, B. Wang2, X. Liu3, H. Xing3, D. Caruso2, X. Wang2; 1Division of Allergy, Children's Memorial Hospital, Chicago, IL, 2The Mary Ann and J. Milburn Smith Child Health Research Program, Children's Memorial Hospital and Children's Memorial Research Center, Chicago, IL, 3Biomedical Institute, Anhui Medical University, Hefei, CHINA.
496 Risk Factors of Atopy in the First Two Years of Life in Indonesian Children
B. Setiabudiawan, C. B. Kartasasmita; Hasan Sadikin General Hospital, Bandung, INDONESIA.
497 Does Breastfeeding (BF) Prevent Allergic Sensitization? Results of Probit II
B. D. Mazer 1,2, L. Matush3, R. Platt1, I. Vanilovich3, M. Kramer1; 1McGill University/Montreal Children's Hosp., Montreal, PQ, CANADA, 2Meakins Christie Laboratories, Montreal, PQ, CANADA, 3National Research and Applied Medicine Mother and Child Centre, Minsk, BELARUS.
498 Association of Parental Gender and Allergic Sensitization with the Patterns of Sensitization in 18 year-old Offspring in the Detroit Area Childhood Allergy Study
R. T. Misiak 1, G. Wegienka1, S. Havstad1, D. R. Ownby2, C. C. Johnson1, E. M. Zoratti1; 1Henry Ford Health System, Detroit, MI, 2Medical College of Georgia, Augusta, GA.
Poster Session
3210
Sunday, February 25, 2007
9:45 AM - 10:45 AM
Allergic Inflammation I
499 Plasmacytoid Dendritic Cells from Asthmatic Patients Exhibit Increased FcERI Expression
M. A. Gill, T. A. George, V. Gan, K. Long, I. Dougherty, R. Gruchalla; UT Southwestern Medical Center at Dallas, Dallas, TX.
500 The Anti-Inflammatory Effect of Ciglitazone is Partially Mediated by Glucocorticoid Induced Leucine Zipper in Human Airway Epithelial Cells
A. L. Wagelie-Steffen 1, J. Eddleston1,2, J. Herschbach1,2, B. L. Zuraw1,2; 1University of Califonia, San Diego, San Diego, CA, 2Veterans Medical Research Foundation, La Jolla, CA.
501 Mice Deficient in Atrial Natriuretic Peptide Receptor A (NPRA) Exhibit Decreased Lung Inflammation: Implication of NPRA Signaling in Asthma Pathogenesis
X. Kong 1,2, X. Wang1, G. Hellermann1, R. F. Lockey1, S. Mohapatra1; 1University of South Florida, Tampa, FL, 2James A. Haley Veterans Hospital, Tampa, FL.
502 [Withdrawn]
503 The Effect of Daily Apolipoprotein A-I Mimetic Therapy on T15-Type Autoantibodies Against Oxidized Phosphatidylcholine in a Murine Model of Asthma
K. S. Konduri 1, S. D. Nandedkar1, D. Weilrauch1, D. A. Rickaby1, N. Duzgunes2, K. A. Pritchard1; 1Medical College of Wisconsin and Zablocki VA Medical Center, Milwaukee, WI, 2University of Pacific School of Dentistry, San Franscisco, CA.
504 LILRB4 Suppresses the Development of Th2 Allergic Airway Inflammation
J. J. Rao, N. A. Barrett, F. I. Hsu, Y. Kanaoka, K. F. Austen, H. R. Katz; Brigham and Women's Hospital, Brookline, MA.
505 Inhibiting Pollen Nadph Oxidase-induced Signal By Intrapulmonary Administration Of Antioxidants Blocks Allergic Airway Inflammation
N. G. Dharajiya 1, B. K. Choudhury1, A. Bacsi2, I. Boldogh1, R. Alama3, S. Sur1; 1University of Texas Medical Branch, Galveston, TX, 2Institute of Immunology, University of Debrecen, Debrecen, HUNGARY, 3National Jewish Medical & Research Center, Denver, CO.
506 IL-4 Bypasses Innate Immune Signals in Inhalational Priming
A. Dittrich, K. Bottomly; Yale University School of Medicine, New Haven, CT.
507 A Murine Model Of Childhood Asthma
H. Mayuzumi 1, Y. Ohki2, K. Tokuyama3, T. Mizuno2, H. Arakawa2, H. Mochizuki2, A. Morikawa2; 1Gunma Children's Medical Center, Shibukawa, JAPAN, 2Gunma University Graduate School of Medicine, Maebashi, JAPAN, 3Takasaki University of Health and Welfare, Takasaki, JAPAN.
508 Nerve Growth Factor Induces Goblet Cell Hyperplasia And Muc5ac Production In A Human Epithelial Cell Line
A. Micera 1,2, B. Stampachiacchiere1, A. Lambiase2, S. Bonini2, S. Bonini3,4; 1IRCCS-G.B. Bietti Eye Foundation, Rome, ITALY, 2Dept. of Ophthalmology, University Campus Bio-Medico, Rome, ITALY, 3Internal Medicine, Second University of Naples, Naples, ITALY, 4CNR, Institute of Neurobiology and Molecular Medicine, Rome, ITALY.
509 Role of Insulin-like Growth Factor (IGF)-I in Human and Experimental Asthma
H. Yoshihara 1, T. Adachi1, H. Nagase1, N. Yamashita2, K. Ohta1; 1Teikyo University School Medicine, Tokyo, JAPAN, 2Musashino University, Tokyo, JAPAN.
510 Effect of Inflammatory Cytokines on the Expression of Tie-2 Receptors in Structural Cells of the Lung
T. O. Makinde 1, D. K. Agrawal2; 1Creighton University, Department of Biomedical Sciences, Omaha, NE, 2Creighton University, Departments of Biomedical Sciences, Internal Medicine, Medical Microbiology and Immunology., Omaha, NE.
511 Role of Protein Tyrosine Phosphatase SHP-1 in Oxidative Stress and Development of Allergic Airway Inflammation
Y. Cho, S. Oh, Z. Zhu; Johns Hopkins Asthma and Allergy Center, Baltimore, MD.
512 Comparison of Central and Peripheral Airway Inflammation between Cough Variant Asthma and Mild Asthma by Examination of Hypertonic Saline Inhalation-Induced Sputum
T. Shimoda 1, Y. Obase2, R. Kishikawa1, S. Shoji1, S. Nishima1; 1Fukuoka National Hospital, Fukuoka, JAPAN, 2Kawasaki Medical School, Kurashiki, JAPAN.
513 Role of Inducible Nitric Oxide Synthase Pathway in the Development of Non-eosinophilic Asthma
H. Park 1, S. Sohn1, C. Park1, H. Kwon1, D. Kim1, S. Kim1, Y. Chang2, S. Lee3, D. Choi4, S. Cho1, S. Chang5, K. Min1, Y. Kim1; 1Seoul National University Hospital, Seoul, REPUBLIC OF KOREA, 2Seoul National University Bundang Hospital, Seongnam, REPUBLIC OF KOREA, 3Cheongju St. Mary's Hospital, Cheongju, REPUBLIC OF KOREA, 4Samsung Medical Center, Seoul, REPUBLIC OF KOREA, 5Sungae General Hospital, Gwangmyung, REPUBLIC OF KOREA.
514 Increase of Amphiregulin Level in Sputum during Exacerbation of Acute Asthma Attacks in Children
Y. Enomoto 1,2, T. Takamasu2, M. Nakazawa3, K. Kurihara2, M. Minami3, H. Saito1, Y. Okayama1; 1RIKEN Yokohama Institute, Yokohama, JAPAN, 2Kanagawa Children's Medical Center, Yokohama, JAPAN, 3Yokohama City University Graduate School of Medicine, Yokohama, JAPAN.
515 siRNA Targeting the Natriuretic Peptide Receptor-A Prevents Airway Inflammation in a Mouse Model of Allergic Asthma
X. Wang 1,2, W. Xu1, X. Kong1, S. Shirley1, R. Lockey1,2, S. Mohapatra1,2; 1University of South Florida, Tampa, FL, 2James A. Haley Veterans Hospital, Tampa, FL.
516 Volume-regulated Chloride Channel-3 in PDGF-Induced Proliferation of Human Bronchial Smooth Muscle Cells
A. Ramanathan Arumugham 1, D. K. Agrawal1,2; 1Dept of Biomedical Sciences, Creighton University School of Medicine, Omaha, NE, 2Dept of Internal Medicine, Creighton University School of Medicine, Omaha, NE.
517 Microsomal Prostaglandin E Synthase-1 Deficiency Increases Dust Mite Antigen-Induced Airway Inflammation
S. N. Nallamshetty 1, S. Uematsu2, S. Akira2, J. A. Boyce1; 11Division of Rheumatology, Immunology, and Allergy, Brigham and Women's Hospital, Boston, MA, 2Department of Host Defense, Research Institute for Microbial Diseases, Osaka University, Osaka, JAPAN.
518 Role of Glycogen Synthase Kinase 3 in regulating Vascular Permeability associated with Asthma
Y. Morimoto, N. Goplen, R. Alam; National Jewish Medical and Research Center, Denver, CO.
519 Towards Systems Biology In Allergy Research
R. Renkonen; Biomedicum & Haartman Institute, University of Helsinki, Helsinki, FINLAND.
520 Effect Of Tnf-α (-308g/a) Polymorphism And Combined Effect With Il-13 Polymorphisms In Bronchial Responsiveness Of Korean Children With Asthma
H. Kim 1, M. Kang2, S. Lee3, J. Kim1, B. Kim1, S. Jang2, M. Sohn4, K. Kim4, S. Hong1; 1Asan Medical Center, Seoul, REPUBLIC OF KOREA, 2Asan Institute for Life Science, Seoul, REPUBLIC OF KOREA, 3Hallym Medical Center, Seoul, REPUBLIC OF KOREA, 4Yonsei University, Seoul, REPUBLIC OF KOREA.
521 Internalization of CysLT1 Receptor Through the Clathrin Endocytic Pathway
K. Audette, J. Larrivee, C. Thompson, M. Rola-Pleszczynski, J. Stankova; Universite de Sherbrooke, Sherbrooke, PQ, CANADA.
522 Clearance of Mycoplasma Pneumoniae Is Impaired in Mice with Established Allergic Airway Inflammation
D. D. Chaplin, C. L. Zindl, L. B. Duffy, T. P. Atkinson, J. Lai; University of Alabama at Birmingham, Birmingham, AL.
523 Ascaris Antigens Suppress Experimental Allergic Inflammation
S. Trivedi 1, M. G. Hodges1, V. Bundoc1, H. H. Norris2, A. Boesen1, S. Madala1, J. F. Urban3, A. Keane-Myers1; 1LAD/NIAID/NIH, Rockville, MD, 2NIAID/NIH, Rockville, MD, 3NRFL, USDA, Beltsville, MD.
524 Hookworm Protein Necator Americanus - Ancyclostoma Secreted Protein 2 (na-asp-2) Inhibits Allergic Airway Inflammation
J. G. Patel 1, P. J. Hotez2, N. G. Dharajiya1, S. Sur1; 1University of Texas Medical Branch, Galveston, TX, 2George Washington University, Washington, DC.
Poster Session
3211
Sunday, February 25, 2007
9:45 AM - 10:45 AM
Cytokines I
525 Tumour Necrosis Factor Alpha (TNFα) Peptide-based Vaccines Suppress Murine Airway Allergic Responses
A. G. Ma, Y. Ma, T. Zhang, A. B. Becker, Z. Peng; University of Manitoba, Winnipeg, MB, CANADA.
526 Role of the RNA-binding Protein HuR in Posttranscriptional Regulation of IL-13 in T Cells
C. Stellato 1, X. Fang1, B. Tancowny1, J. Fan1, F. Wu1, S. Y. Asaki1, U. De Fanis1, S. Huang1, M. Gorospe2, U. Atasoy3, V. Casolaro1; 1Johns Hopkins University School of Medicine, Baltimore, MD, 2National Institute of Aging, NIH, Baltimore, MD, 3University of Missouri-Columbia, Columbia, MO.
527 A New Immunotherapy Approach: Mucosal Immunization With An Il-13 Vaccine Suppresses Murine Airway Allergic Responses
Y. Ma, A. G. Ma, S. Basu, Y. Zhou, A. J. Halayko, K. T. HayGlass, A. B. Becker, F. E. R. Simons; University of Mnitoba, Winnipeg, MB, CANADA.
528 Role of the RNA-binding Protein Tristetraprolin (TTP) in Glucocorticoid (GC)-mediated Gene Regulation
F. T. Ishmael 1, X. Fang1, N. Heller1, J. Fan1, P. J. Blackshear2, U. Atasoy3, C. Cheadle1, C. Stellato1; 1Johns Hopkins University School of Medicine, Baltimore, MD, 2National Institute of Environmental Health Sciences, Research Triangle Park, NC, 3University of Missouri-Columbia, Columbia, MO.
529 Comparison of Expression and Cellular Provenance of Thymic Stromal Iymphopoietin and Chemokines in Patients with Severe Asthma, COPD and Controls
Q. Meng 1, B. O'Connor1, J. Ratoff1, D. Cousins1, G. Z. Zhang2, S. Y. Gu2, J. S. Zhao2, T. H. Lee1, C. J. Corrigan1, S. Ying1; 1King's College London, London, UNITED KINGDOM, 2Third Clinical College, Jilin University, Jilin, CHINA.
530 The Role Of Il-25 In Airway Allergic Response
P. Angkasekwinai 1, H. Park2, Y. Wang1, Y. Wang1, Y. Liu1, Z. Zhu3, C. Dong1; 1MD Anderson Cancer Center, Universtiy of Texas Health Science Center, Houston, TX, 2University of Washington, Seattle, WA, 3Johns Hopkins University School of Medicine, Baltimore, MD.
531 Humanized Anti-IL-5 Therapy (Mepolizumab) Reduces Eosinophil Responsiveness to the Eotaxins
M. L. Stein, B. K. Buckmeier, M. E. Rothenberg; Cincinnati Childrens Hospital Medical Center, Cincinnati, OH.
532 Effect Of Breast Milk Feeding From Allergic And Non-allergic Mothers On Infant During The First 4-years Of Life
W. Kim 1, H. Yoon2; 1Inje University, Seoul, REPUBLIC OF KOREA, 2Hallym University, Seoul, REPUBLIC OF KOREA.
533 Synergistic Effect of Double-Stranded RNA and TGF-α on MUC5AC production in Human Bronchial Epithelial Cells
H. Tadaki, H. Arakawa, T. Mizuno, T. Suzuki, H. Mochizuki, K. Tokuyama, A. Morikawa; Gunma University, maebashi, JAPAN.
534 Nitric Oxide (NO) Inhibits Human Rhinovirus (HRV)-16-Induced Transcription of IP-10 (CXCL10) in Human Airway Epithelial Cells (HAE)
R. Koetzler, D. Proud; University of Calgary, Calgary, AB, CANADA.
535 Role of Th2-molecules in OVA-Induced Intestinal Anaphylaxis
E. E. Forbes 1,2, K. R. Groschwitz1, R. Ahrens1, E. B. Brandt1, M. E. Rothenberg1, P. S. Foster2,3, K. I. Matthaei2, S. P. Hogan1; 1Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 2John Curtin School of Medical Research, Australian National University, Canberra, AUSTRALIA, 3Asthma, Allergy and Inflammation Research Center, University of Newcastle, Newcastle, AUSTRALIA.
536 Sputum Epithelial Cell-Derived Neutrophil-Activating Peptide-78 (ENA-78/CXCL5) in Asthmatic Children
N. M. Heshmat 1, G. A. Mostafa1, M. M. Abd Al-Aziz2, E. M. Abd El-Bary1; 1Pediatrics Department, Ain Shams University, Cairo, EGYPT, 2Clinical Pathology Department, Ain Shams University, Cairo, EGYPT.
537 Small-interfering RNA Decreases IL-13 Receptor α1 (IL-13Rα1) Expression and Signalling in Human Tonsillar B Cells
O. Hajoui, J. Guay, A. Banville-Langelier, B. Mazer; Meakins Christie Laboratories, Montreal, PQ, CANADA.
538 Effect of IL-13 and IL-13 Mutant (IL-13E13K) on Airway Hyperresponsiveness (AHR) and Airway Smooth Muscle (ASM) In Mice
P. R. Gendapodi 1, M. Kioi2, R. K. Puri2, P. Abel1, R. G. Townley1; 1Creighton University, Omaha, NE, 2NIH, Bethesda, MD.
539 Protein Microarray Analysis in Patients with Asthma: Elevation of the Chemokine PARC/CCL18 in Sputum
C. Kim 1,2, H. Kim1, T. Kurian1, T. Kobayashi2, K. Hirohito2; 1Inje University, Seoul, REPUBLIC OF KOREA, 2Mayo Clinic, Rochester, MN.
540 Level Of Cytokine In Children Of Acute Mycoplasma Pneumoniae Infection And Wheeze
H. Yoon 1, W. Kim2; 1Hallym University, Seoul, REPUBLIC OF KOREA, 2Inje University, Seoul, REPUBLIC OF KOREA.
541 Aspartate Protease From Alternaria Induced Cytokine Production, And Calcium Signaling In Human Airway Epithelial Cells Through A Protease-activated Receptor-2 (par-2)
Y. Matsuwaki 1,2, T. White1, K. Hotta1, Y. Inoue1, C. B. Lawrence3, H. Kita1; 1Mayo Clinic, Rochester, MN, 2Jikei university, school of medicine, Tokyo, JAPAN, 3Virginia Biotech Institute, Blacksburg, VA.
542 CXCR2 Chemokines Regulate Tube Formation of Human Lung Microvascular Endothelial Cells
A. Matsuda, H. Saito, K. Matsumoto; National Research Institute for Child Health and Development, Tokyo, JAPAN.
543 Oxidative Stress Regulates IL-4 Gene Expression In Mast Cells Through Reduction Of Histone Deacetylase (HDAC)
Y. Nakamaru 1, D. Takagi1, M. Maeda1, P. J. Barnes2, S. Fukuda1, K. Ito2; 1Hokkaido univ. graduate school of med., Sapporo, JAPAN, 2NHLI, Imperial College, London, UNITED KINGDOM.
544 Targeted Disruption of Smad3 Affects the IL-13 Expression of Lung in a Mouse Model of Asthma
M. Anthoni 1, G. Wang1,2, M. Leino1, A. Lauerma1, H. Alenius1, H. Wolff1,3; 1Finnish Institution of Occupational Health, Helsinki, FINLAND, 2Department of Dermatology and Venereology, Qingdao University Medical College Hospital, Qingdao, CHINA, 3Department of Pathology, Helsinki University Central Hospital, Helsinki, FINLAND.
545 Immunomodulating Properties of Stored Product Mite Extracts on Human Dermal Fibroblasts
L. G. Arlian, M. S. Morgan, K. T. Peterson, D. Vyszenski-Moher; Wright State University, Dayton, OH.
546 Inhibition Of Airway Inflammation And HIV Entry By NNY-CCL14 Treatment: Role Of CCR1 And CCR5
S. Gupta 1, B. Fuchs2, S. Schulz-Maronde1, A. Heitland1, S. E. Escher1, J. Münch3, F. Kirchhoff3, M. Mack4, H. C. Tillmann5, A. Braun2, W. G. Forssmann1, U. Forssmann6, J. Elsner7; 1Hannover Medical School, Hannover, GERMANY, 2Fraunhofer Institute of Toxicology & Experimental Medicine, Hannover, GERMANY, 3University of Ulm, Ulm, GERMANY, 4University of Regensburg, Regensburg, GERMANY, 5VIRO Pharmaceuticals GmbH & Co. KG, Hannover, GERMANY, 6IPF PharmaCeuticals GmbH, Affiliated Institute of Hannover Medical School, Hannover, GERMANY, 7Fachklinik Bad Bentheim, Bad Bentheim, GERMANY.
547 IP-10 Moderates Rhinovirus Induced IFN-α Production and Stimulates IL-10
S. Kakumanu, W. W. Busse, J. E. Gern; University of Wisconsin Hospital and Clinics, Madison, WI.
548 Effects Of Intranasal TNFα On Granulocyte Recruitment In Healthy Individuals And Patients With Allergic Rhinitis
H. D. Widegren 1, M. Korsgren1, J. Erjefalt2, M. Andersson1, L. Greiff1; 1Lund University Hospital, Lund, SWEDEN, 2Lund University, Lund, SWEDEN.
549 Plasma Concentration of CCR4 Ligands in Asthma Patients During Bronchial Challenge with Dermatophagoides Pteronyssinus (Dp) Allergen
K. Kowal 1, S. Zukowski1, L. DuBuske2, A. Bodzenta-Lukaszyk1; 1University Medical School of Bialystok, Bialystok, POLAND, 2Immunology Research Institute of New England, Gardner, MA.
550 Determination of mRNA Expression and Serum Levels for IL-4 and IL-13 in Asmathic Patients
R. Farid, J. Tavakol Afshari, M. Boskabadi; Mashad University Medical Sciences, Mashad, IRAN (ISLAMIC REPUBLIC OF).
Poster Session
3212
Sunday, February 25, 2007
9:45 AM - 10:45 AM
Rhinosinusitis, Mechanisms and Treatment
551 Prevalence of Nonallergic Triggers among Seasonal Allergic Rhinitics and Normals
D. Shusterman 1, M. Murphy2; 1University of Washington, Seattle, WA, 2University of California, San Francisco, CA.
552 Role Of Prostaglandin D2 And E2 Terminal Synthases In Chronic Rhinosinusitis
M. Okano 1, T. Fujiwara1, M. Yamamoto1, H. Hattori1, K. Nishizaki1, Y. Sugata1, Y. Urade2; 1Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, JAPAN, 2Osaka Bioscience Institute, Osaka, JAPAN.
553 Cytokines and Chemokines in NARES and Nasal Polyposis
C. Klemens 1, F. Jund1, A. Klemens2, C. Devens1, M. F. Kramer1; 1Oto-Rhino-Laryngology, Head and Neck Surgery, Ludwig-Maximilians-University Munich, Munich, GERMANY, 2Department of Oto-Rhino-Laryngology, Head and Neck Surgery, Zentralklinikum Augsburg, Augsburg, GERMANY.
554 Population-Based Association Study Of TLR Gene Polymorphisms In Chronic Rhinosinusitis
M. A. Tewfik 1, Y. Bossé2, T. J. Hudson2, M. Desrosiers1; 1McGill University, Montreal, PQ, CANADA, 2McGill University and Genome Quebec Innovation Centre, Montreal, PQ, CANADA.
555 The Role Of Fungi In Sinus Polyposis
A. M. Hofman, T. Hofman, W. Skrobisz; Center of Allergology, Poznan, POLAND.
556 Remodelling in Nasal Polyposis is Independent of TH-Cell Polarisation
N. Zhang, T. v. Zele, P. Gevaert, G. Holtappels, P. v. Cauwenberge, C. Bachert; Universitair Ziekenhuis Gent, Ghent, BELGIUM.
557 Correlations between Rhinitis associated Impairment of Quality of Life and Levels of ECP and Tryptase
F. Jund 1, C. Klemens1, R. Jund2, C. Devens1, M. F. Kramer1; 1Oto-Rhino-Laryngology, Head and Neck Surgery, Ludwig-Maximilians-University Munich, Munich, GERMANY, 2ENT Clinic, Puchheim, GERMANY.
558 The Correlation between Allergen Skin Prick Test (SPT) Wheal Diameters and Nasal Symptoms to Aeroallergen Challenge in Environmental Exposure Chamber (EEC)
D. Wilson, A. Salapatek, P. Tanna, P. Patel; Allied Research International, Mississauga, ON, CANADA.
559 Investigation Of Olfactory Threshold Responses In Chronic Rhinitis Subtypes
M. Rezvani 1, L. Hastings2, D. Brandt1, J. Bernstein1; 1University of Cincinnati, Cincinnati, OH, 2Osmic Enterprises, Cincinnati, OH.
560 A Pilot, Prospective, Double Blind, Placebo-Controlled Treatment Trial with Itraconazole Orally in Patients with Chronic Rhinosinusitis and Asthma
E. Frigas; Mayo Clinic, Rochester, MN.
561 Intranasal Corticosteroids That Provide Sustained Efficacy May Improve Patient Satisfaction and Adherence to Therapy
E. Meltzer 1, J. Boyle2, J. Droar3; 1Allergy and Asthma Medical Group and Research Center, San Diego, CA, 2Schulman, Ronca and Bucuvalas, Inc., New York, NY, 3Altana Pharma US, Florham Park, NJ.
562 Coadministration of Intranasal Ciclesonide and Inhaled Fluticasone Propionate-Salmeterol in Perennial Allergic Rhinitis (PAR)
K. Kim 1, J. Quesada1, M. A. Wingertzahn2, N. Szmaydy-Rikken2, P. Darken2, T. Shah2; 1West Coast Clinical Trials, LLC, Long Beach, CA, 2Altana Pharma US, Florham Park, NJ.
563 The Pharmacokinetics (PK), Safety and Tolerability of Fexofenadine HCl 6mg/mL Suspension in Children with Allergic Rhinitis (AR): a Multicenter, Open-label, Single-dose Study
R. E. Grubbe 1, A. S. Nayak2, B. Kittner3, N. Segall4; 1Center Of Research Excellence, L.L.C., Oxford, AL, 2Sneeze, Wheeze & Itch Associates, LLC, Normal, IL, 3sanofi-aventis U.S. Inc., Bridgewater, NJ, 4Clinical Research Atlanta, Atlanta, GA.
564 The 30mg Dose of Fexofenadine HCl 6mg/mL Suspension is Bioequivalent to the Marketed 30mg Tablet in Healthy Adult Subjects under Fasted Conditions: a Randomized, Crossover, Open-label Study
D. N. Morrison 1, S. Sahasranaman2; 1Bio-Kinetic Clinical Applications, Inc., Springfield, IL, 2sanofi-aventis U.S. Inc., Bridgewater, NJ.
565 How Effective Are New Generation Antihistamines In Combination With Nasal Steroids In Patients Suffering From Severe Allergic Rhinitis And Concomitant Asthma?
R. Mosges, J. Koberlein; University of Cologne, Cologne, GERMANY.
566 Long-term Efficacy of Ciclesonide in Adult and Adolescent Patients With Perennial Allergic Rhinitis
P. Chervinsky 1, S. Kunjibettu2, D. Miller1, B. Prenner3, G. Raphael4, T. Shah5; 1Northeast Medical Research Associates, North Dartmouth, ME, 2Altana Pharma US, Florham Park, NJ, 3Allergy Associates Medical Group, Inc., San Diego, CA, 4Bethesda, MD, Bethesda, MD, 5Altana Pharma, Florham Park, NJ.
567 Onset of Action of Azelastine Nasal Spray Compared to Mometasone Nasal Spray and Placebo in Patients with Seasonal Allergic Rhinitis (SAR)
P. Patel 1, D. Wilson1, C. D'Andrea2, H. Sacks2; 1Allied Research International, Mississauga, ON, CANADA, 2MedPointe Pharmaceuticals, Somerset, NJ.
568 A Case of Chronic Rhinosinusitis
S. Sattar, A. Casillas; UCLA Medical Center, Los Angeles, CA.
569 Evidence for Elevated IL-6 and its Signaling Components in Chronic Rhinosinusitis with Nasal Polyps
A. T. Peters, B. Tancowny, L. Suh, M. Agashe, K. Harris, D. Conley, R. Kern, L. Grammer, R. Schleimer; Northwestern University Medical School, Chicago, IL.
570 Nasal and Airway Inflammatory Features of Subjects with Nasal Polyposis With or Without Asthma
M. Boulay; Centre de recherche, Hôpital Laval, Quebec, PQ, CANADA.
Oral Abstract Session
3601
Sunday, February 25, 2007
2:00 PM - 3:15 PM
The Role of Infection in Asthma
571 Absence of Relationship between History of Tuberculosis Infection, Skin Tuberculin Responses and Development of Adult Bronchial Asthma, Allergic Rhinitis and Atopy
J. Li, S. Y. Li, Z. M. Zhou, D. F. Luo, J. Y. An, B. Q. Sun, N. S. Zhong; Guangzhou Institute of Respiratory Disease, Guangzhou, CHINA.
572 Viral Etiology and Rhinovirus Serotypes of Recurrent Respiratory Illnesses during Infancy
T. Jartti 1, T. Pappas1, W. Lee1, R. F. Lemanske, Jr.2, J. E. Gern1; 1Department of Pediatrics, University of Wisconsin, Madison, WI, 2Department of Medicine, University of Wisconsin, Madison, WI.
573 Respiratory Syncytial Virus-Induced Gene Expression Profiles in Human Respiratory Epithelial Cells: Effect of pretreatment with Th1/Th2-type cytokines
Y. Yamada 1, S. Yoshihara1, K. Matsumoto2, M. Saikusa3, N. Hashimoto2, T. Homma2, O. Arisaka1, H. Saito2; 1Dokkyo University School of Medicine, Mibu, Tochigi, Japan, 2National Research Institute for Child Health and Development, Department of Allergy and Immunology, Tokyo, Japan, 3Yokohama Health Research Institute, Kanagawa, Japan.
574 Coronavirus NL63 Illnesses in Infancy are a Risk Factor for Asthma at Age Six
T. E. Pappas 1, K. T. Sullivan Dille1, W. Lee1, K. A. Grindle1, K. A. Roberg1, D. F. Da Silva1, C. J. Tisler1, E. L. Anderson1, K. M. Hansen1, R. A. Grabher1, L. E. Pleiss Salazar1, M. D. Evans2, R. Gagnon2, J. E. Gern1, R. F. Lemanske, Jr.1; 1University of Wisconsin School of Medicine and Public Health, Madison, WI, 2University of Wisconsin Population Health Sciences Biostatistics and Medical Informatics, Madison, WI.
575 Seasonal Distribution Of Respiratory Viruses In Pediatric Asthma In Trinidad West Indies
J. Matthew 1, L. M. PintoPereira1, T. E. Pappas2, C. Swenson2, K. Grindle2, K. Roberg2, R. F. Lemaske, Jr.2, W. Lee2, J. E. Gern2; 1The University of the West Indies, St Augustine, TRINIDAD AND TOBAGO, 2University of Wisconsin-Madison, Madison, WI.
576 Analysis of Airway Immune System Responses to Rhinovirus Infection in Children and Resultant Tendency to Wheeze
B. K. Smith 1, C. J. Tisler2, T. E. Pappas2, D. Mueller2, D. F. DaSilva3, J. E. Gern4, R. F. Lemanske, Jr.4; 1University of Wisconsin School of Medicine and Public Health, Madison, WI, 2University of Wisconsin Hospital, Madison, WI, 3University of Wisconsin Hospital, Madison, WI, 4University of Wisconsin, Madison, WI.
Oral Abstract Session
3602
Sunday, February 25, 2007
2:00 PM - 3:15 PM
Genetic Regulation of Immune Function
577 Myosin Light Chain Kinase (MYLK) Variants that Confer Increased Risk of Sepsis and Acute Lung Injury are Associated with Asthma and Associated Phenotypes
L. Gao 1, A. Grant1, P. Chi1, P. Gao1, M. Stockton1, H. Watson2, N. N. Hansel3, G. Diette3, G. Dunston4, R. A. Mathias5, A. Togias1, R. Brower3, J. Sevransky3, J. P. Maloney6, M. Moss6, C. Shanholtz7, J. G. N. Garcia8, T. H. Beaty9, K. C. Barnes1; 1Johns Hopkins Asthma and Allergy Ctr., Baltimore, MD, 2University of the West Indies, West Indies, BARBADOS, 3Division of Pulmonary and Critical Care Medicine, The Johns Hopkins University, Baltimore, MD, 4National Human Genome Center at Howard University, Washington, DC, DC, 5National Human Genome Research Institute, Baltimore, MD, 6Division of Pulmonary and Critical Medicine, University of Colorado Health Sciences Center, Denver, CO, 7University of Maryland School of Medicine, Baltimore, MD, 8Department of Medicine, The University of Chicago Biological Sciences, Chicago, IL, 9Department of Epidemiology, Johns Hopkins University, Bloomberg School of Public Health, Baltimore, MD.
578 Comprehensive Analysis of Mannan-Binding Lectin (MBL) Status in a Cohort of Healthy Donors as Determined by MBL Protein Concentration, MBL Complement Pathway Function and MBL and MASP-2 Genotypes
J. Yu, D. Sheets, J. F. Halsey, J. D. Hester; IBT Reference Laboratory, Lenexa, KS.
579 Clara Cell secretory 10-Kd Protein Sequence Variation Is Associated with the Severity of Asthma and Glucocorticoid Responsiveness
L. Chen 1,2, J. Huang2, M. Kuo3, K. Yeh2, S. Huang4; 1Chang Gung Children's Hospital, Taiwan, LA, 2Division of Allergy, Asthma, and Rheumatology, Department of Pediatrics, Chang Gung Children's Hospital, and Chang Gung University, Taoyuan, TAIWAN, 3Chang Gung University, Taoyuan, TAIWAN, 4Johns Hopkins Asthma and Allergy Center, Johns Hopkins University School of Medicine, Baltimore, MD.
580 Ethnicity Plays a Role in Differential Human Toll-like Receptor Responsiveness
K. T. HayGlass, Y. Lissitsyn, A. Kozyrskyj, A. B. Becker; Univ Manitoba, Winnipeg, MB, CANADA.
581 Single Nucleotide Polymorphism in IL-9 Promoter Influences Promoter Strength
P. Huyett, S. Early, E. Barekzi, L. Borish, J. W. Steinke; Asthma and Allergic Diseases Center, Charlottesville, VA.
582 A Polymorphism In Human CD40 Correlates With Autoimmunity And Enhances B Cell Activation
A. L. Peters 1, P. M. Gaffney2, G. A. Bishop1,3; 1University of Iowa, Iowa City, IA, 2University of Minnesota, Minneapolis, MN, 3VA Medical Center, Iowa City, IA.
Oral Abstract Session
3603
Sunday, February 25, 2007
2:00 PM - 3:15 PM
Anaphylaxis and Venoms
583 Anaphylactic Mechanisms in Sudden Unexpected Infant Death: Elevated Concentrations of Mast Cell Carboxypeptidase in the Serum
X. Zhou 1, M. G. Buckley1, J. Lucas1, S. Variend2, A. F. Walls1; 1Southampton General Hospital, Southampton, UNITED KINGDOM, 2Children's Hospital, Sheffield, UNITED KINGDOM.
584 HLA Class I and Class II Associations with Bee and Wasp Venom Allergy
B. A. Sin 1,2, H. Tutkak3, G. Pasaoglu4, K. Köse5, Z. Misirligil6; 1Ankara University School of Medicine, Ankara, TURKEY, 2Ankara University School of Medicine Department of Allergic Diseases, Ankara, TURKEY, 3Ankara University School of Medicine, Dept.of Rheumatology and Immunology, Ankara, TURKEY, 4Ankara University School of Medicine, Dept. of Allergic Diseases, Ankara, TURKEY, 5Ankara University School of Medicine, Dept. of Biostatistics, Ankara, TURKEY, 6Ankara University School of Medicine, Dept.of Allergic Diseases, Ankara, TURKEY.
585 Seafood Allergy & Risk of Adverse Reactions to Radiocontrast Media: Are Physicians Unwittingly Propagating A Medical Myth?
A. D. Beaty 1, P. L. Lieberman2, R. G. Slavin1; 1Division of Allergy & Immunology, Saint Louis University School of Medicine, St. Louis, MO, 2University of Tennessee Center for the Health Sciences, Memphis, TN.
586 Immunologic Characteristics Correlate With Reactions to Sting Challenge
D. B. K. Golden 1, J. S. Schroeder1, R. G. Hamilton1, L. B. Schwartz2, T. J. Craig3, A. Kagey-Sobotka1; 1Johns Hopkins University, Baltimore, MD, 2Virginia Commonwealth University, Richmond, VA, 3Penn State Hershey Medical Center, Hershey, PA.
587 A 1-Day Rush Immunotherapy Schedule for Imported Fire Ant Hypersensitivity
J. J. Dietrich, L. M. Moore, S. Nguyen, L. L. Hagan, M. S. Tankersley; Department of Allergy and Immunology, Wilford Hall Medical Center, Lackland Air Force Base, San Antonio, TX.
588 Parental Use of EpiPen for Inner-City Children with Food Allergy
J. A. Sinacore 1, J. S. Kim2, A. S. Murthy2, J. A. Pongracic2; 1Department of Preventive Medicine and Epidemiology, Loyola University Stritch School of Medicine, Maywood, IL, 2Division of Allergy, Children's Memorial Hospital, Chicago, IL.
Oral Abstract Session
3604
Sunday, February 25, 2007
2:00 PM - 3:15 PM
Outcomes and Quality of Life
589 Parental Anxiety Before And After Food Challenges In Children With Suspected Peanut And Hazelnut Allergy
W. T. Zijlstra; UMC Utrecht, Utrecht, THE NETHERLANDS.
590 Addition of Omalizumab Reduces School Absenteeism in Children with Moderate-Severe Persistent Asthma
H. Milgrom 1, M. Massanari2, R. J. Maykut2, F. Kianifard2, R. K. Zeldin2, G. P. Geba2; 1National Jewish Medical and Research Center, Denver, CO, 2Novartis Pharmaceuticals Corporation, East Hanover, NJ.
591 Numerical Skills and Asthma Outcomes
A. J. Apter, J. Cheng, D. Small, I. M. Bennett, C. Albert, D. G. Fein, M. George, S. Van Horne; University of Pennsylvania, Philadelphia, PA.
592 Reliability and Validity of the Paediatric Food Allergy Questionnaire (PFAQ;Parent Form): A New Scientific Measure of HRQoL
A. DunnGalvin 1, A. DuBois2, B. De Blok2, H. Oude-Elberink2, J. O. B. Hourihane1; 1University College Cork, Cork, IRELAND, 2Groningen Universiteit, Groningen, THE NETHERLANDS.
593 Assessment of the Psychometric Properties of the Paediatric Asthma Quality of Life Questionnaire (PAQLQ) in Moderate to Severe Pediatric Asthma Patients
F. S. Lobo 1, D. Revicki2, W. Grant3, F. Turk4, M. Massanari1; 1Novartis Pharmaceuticals, East Hanover, NJ, 2UnitedBioSource, Bethesda, MD, 3James Madison University, Harrisonburg, VA, 4Novartis Pharmaceuticals, Basel, SWITZERLAND.
594 Tracking Quality of Life Changes in Asthma Requires Disease-Specific Measure for Optimal Sensitivity
K. M. Shanovich, K. T. Sullivan Dillie, M. D. Evans, K. A. Roberg, E. L. Anderson, K. M. Hanson, R. A. Grabher, D. F. DaSilva, T. E. Pappas, L. E. P. Salazar, C. J. Tisler, R. E. Gangnon, J. E. Gern, R. F. Lemanske; University of Wisconsin, School of Medicine and Public Health, Madison, WI.
Oral Abstract Session
3605
Sunday, February 25, 2007
2:00 PM - 3:15 PM
Eosinophils as Effectors and Regulators of Allergy
595 Co-Expression of IL-5 and Eotaxin-2 in Mice Creates a Novel and Eosinophil-dependent Pulmonary Model of Respiratory Inflammation Characteristic of Human Disease
S. I. Ochkur 1, T. Biechele1, E. Jacobsen1, B. McElhinney2, C. Protheroe1, R. S. Pero1, M. T. Borchers3, K. R. O'Neill1, D. C. Colbert1, M. P. McGarry1, Y. Janssen-Heininger2, C. Irvin2, H. H. Shen4, J. J. Lee1, N. A. Lee1; 1Mayo Clinic Arizona, Scottsdale, AZ, 2Vermont Asthma Center, Burlington, VT, 3University of Cincinnati College of Medicine, Cincinnati, OH, 4Second Hospital, Zhejiang University, Hangzhou, PR, CHINA.
596 A Causative Link Exists Between Eosinophil Major Basic Protein-2 and Allergen-Induced Airway Hyperresponsiveness
K. O'Neill 1, C. Protheroe1, S. I. Ochkur1, E. Jacobsen1, D. C. Colbert1, L. Rinaldi2, C. Irvin2, M. P. McGarry1, J. J. Lee1, N. A. Lee1; 1Mayo Clinic Arizona, Scottsdale, AZ, 2Vermont Asthma Center, Burlington, VT.
597 Inducible Expression of the IL-13 Transgene in the Lung Results in IL-13 Accumulation, Eosinophilia, and Tissue Remodeling in the Esophagus
L. Zuo, P. C. Fulkerson, C. Blanchard, M. E. Rothenberg; Cincinnati Children's Hospital Medical Center, Cincinnati, OH.
598 Extra-vasation of Leukocytes from Circulation is Controlled by Gαi2 Signaling Events in the Endothelium
R. S. Pero 1, M. T. Borchers2, K. Spicher3, S. I. Ochkur1, L. Sikora4, S. P. Rao5, K. R. O'Neill1, H. Abdala-Valencia6, H. Shen7, M. I. Simon8, M. P. McGarry1, N. A. Lee1, J. M. Cook-Mills6, P. Sriramarao9, L. Birnbaumer10, J. J. Lee1; 1Mayo Clinic Arizona, Scottsdale, AZ, 2University of Cincinnati College of Medicine, Cincinnati, OH, 3Heinrich Heine University, Dusseldorf, GERMANY, 4La Jolla Institute for Molecular medicine, San Diego, CA, 5La Jolla Institute for Molecular Medicine, San Diego, CA, 6Northwestern University Feinberg School of Medicine, Chicago, IL, 7Zhejiang University College of Medicine, Hangzhou, CHINA, 8California Institute of Technology, Pasadena, CT, 9La Jolla Institute of Melecular Medicine, San Diego, CA, 10National Institute of Environmental Health Sciences, Triangle Park, NC.
599 T-Cell Death-Associated Gene 8 Critically Regulates Airway Eosinophilia in Allergen-Challenged Mice
A. R. Collier 1, C. G. Radu2, O. N. Witte3, M. E. Rothenberg1, N. Zimmermann1; 1Cincinnati Children's Hospital, Cincinnati, OH, 2University of California - Los Angeles, Los Angeles, CA, 3University of California - Los Angeles and Howard Hughes Medical Institute, Los Angeles, CA.
600 Eosinophils are Required for T Cell Infiltration of Lungs During Allergic Asthma Responses
E. Walsh, N. Sahu, A. August; The Pennsylvania State University, University Park, PA.
Oral Abstract Session
3606
Sunday, February 25, 2007
2:00 PM - 3:15 PM
Rhinitis and Ocular Disorders
601 Anticholinergic Effects of Antihistamine Drugs Used in the Clinic
S. C. Wolff, K. Brubaker, T. Navratil, E. H. Fulcher, J. R. Lankford, J. L. Boyer; Inspire Pharmaceuticals, Durham, NC.
602 Vernal Keratoconjunctivitis (vkc) Treated With 0.1% Fk-506 Ophthalmic Ointment: Result Of A Three Years Follow-up
P. Pacharn, N. Visitsunthorn, O. Jirapongsananuruk, P. Vichyanond; Siriraj Hospital, Bangkok, THAILAND.
603 Shedding of the Soluble Receptor for TNFα, TNFR1, is Inhibited by the TACE Inhibitor TAPI2 in Conjunctival Epithelial Cells
E. B. Cook, J. L. Stahl, N. P. Barney, F. M. Graziano; University of Wisconsin-Madison, Madison, WI.
604 Ocular Allergy: A National Epidemiologic Study
K. Singh, L. Bielory; UMDNJ, Newark, NJ.
605 Symptoms of Allergic Rhinitis in Mothers during Early Pregnancy are Associated with Higher Prevalence of Allergic Rhinitis in their Offspring
M. Shinohara 1,2, H. Wakiguchi1, H. Saito2, K. Matsumoto2; 1Kochi University, Kochi Medical School, Department of Pediatrics, Kochi, JAPAN, 2National Research Institute for Child Health and Development, Tokyo, JAPAN.
606 Allergic Rhinitis and Inner-City Children — Is There a Relationship to Sleep-Disordered Breathing?
N. Gupta 1, U. Emre1, S. Kearney2, R. A. Fermo1, B. Silverman1, A. T. Schneider1; 1Long Island College Hospital, Brooklyn, NY, 2Lehigh Valley Hospital, Allentown, PA.
Featured Poster Session
3801
Sunday, February 25, 2007
5:30 PM - 6:30 PM
Genetics and Pharmacology of Asthma Response
607 Haplotype Tagging SNPs in the Beta Adrenergic Receptor (ADRB2) Gene are Associated with Pre and Post-bronchodilator Lung Function in Preschool Children
A. Simpson, J. Hankinson, S. Borg-Bartolo, L. Lowe, S. John, A. Woodcock, W. Ollier, A. Custovic; University of Manchester, Manchester, UNITED KINGDOM.
608 Effect of Anti-IgE Antibody Omalizumab on Airway Remodeling and the Expression of Interleukins in Asthma
O. Korzh, S. Krasnokutskiy, E. Lavrova; Kharkov Medical Academy of Postgraduate Education, Kharkov, UKRAINE.
609 Exhaled Nitric Oxide Levels are Associated with Daily Lung Function Declines and Increased Medication Usage in Urban Children with Moderate to Severe Asthma Despite Use of Inhaled Corticosteroids and Long-acting Bronchodilators
N. Rabinovitch 1, L. Zhang2, E. W. Gelfand1; 1Department of Pediatrics, NJMRC, Denver, CO, 2Division of Biostatistics, NJMRC, Denver, CO.
610 Airway Remodeling and Lack of Bronchodilator Response in Steroid Resistant (SR) Asthma
E. Goleva, P. J. Hauk, J. Boguniewicz, R. J. Martin, D. Y. M. Leung; National Jewish Medical and Research Ctr., Denver, CO.
Featured Poster Session
3802
Sunday, February 25, 2007
5:30 PM - 6:30 PM
Innate Mechanisms Regulating Allergy and Host
611 IL-4 and IL-13 Induction of SOCS-3 Negatively Regulates TNF-α and IFN-γ Induced Human β Defensin (HBD)-3 Expression in Keratinocytes
H. R. Fairchild, D. Y. M. Leung, M. D. Howell; National Jewish Medical and Research Center, Denver, CO.
612 Tumour Necrosis Factor Alpha (TNFα) Vaccines in the Downregulation of Bowel Inflammatory Responses in Mice
Y. Zhou, A. G. Ma, Y. Ma, G. Qing, T. Zhang, Z. Peng; University of Manitoba, Winnipeg, MB, CANADA.
613 A Novel Card-Card Interaction is revealed by the Crystal Structure of Nod1-Card
N. P. Coussens; University of Iowa, Iowa City, IA.
614 Txk, A Nonreceptor Tyrosine Kinase of The Tec Family, Selectively Downregulates TRIF-Dependent Activation Program in LPS-Stimulated Mast Cells
T. Ohno 1, J. Kashiwakura1,2, H. Saito3,1, Y. Okayama1; 1RIKEN Yokohama Institute, Yokohama, JAPAN, 2La Jolla Institute for Allergy and Immunology, San Diego, CA, 3National Research Institute for Child Health and Development, Tokyo, JAPAN.
615 Regulatory Role for Gr-1+ Cells and CD11b+ Cells in Lungs of Mice
J. Lai, C. L. Zindl, Y. Jung, L. Duffy, T. P. Atkinson, D. D. Chaplin; University of Alabama at Birmingham, Birmingham, AL.
Featured Poster Session
3803
Sunday, February 25, 2007
5:30 PM - 6:30 PM
The Best of EORD
616 High Environmental Tobacco Smoke Exposure and Presence of IL4 Polymorphism (C-589T) Increases Risk of Infant Wheezing: the Cincinnati Childhood Allergy and Air Pollution Study (CCAAPS)
A. M. Smith 1, D. I. Bernstein1, G. K. LeMasters2, N. L. Huey3, G. K. Khurana Hershey3; 1University of Cincinnati, Department of Internal Medicine, Cincinnati, OH, 2University of Cincinnati, Department of Environmental Health, Cincinnati, OH, 3Cincinnati Children's Hospital Center for Translational Research in Allergy and Asthma, Cincinnati, OH.
617 BASE a Major Cat Allergen
S. E. O'Neil, W. Smith, T. K. Heinrich, B. J. Hales, W. R. Thomas; Telethon Institute for Child Health Research, West Perth, AUSTRALIA.
618 Cockroach Allergen Reduction by Extermination Alone in Low-Income, Urban Homes-A Randomized Control Trial
M. L. Sever 1, S. J. Arbes, Jr.1, D. C. Zeldin1, C. Schal2, R. G. Santangelo2, J. C. Gore2, B. Vaughn3, H. Mitchell3; 1NIEHS, Research Triangle Park, NC, 2NCSU, Raleigh, NC, 3Rho, Inc., Chapel Hill, NC.
619 Wheezing Severe Rhinovirus Illnesses During Infancy Predict Childhood Asthma at Age 6 Years
K. A. Roberg 1, K. T. Sullivan-Dillie2, M. D. Evans2, T. E. Pappas2, E. L. Anderson2, K. M. Hanson2, D. F. DaSilva2, C. J. Tisler2, L. E. P. Salazar2, R. E. Gangnon2, J. E. Gern2, R. F. Lemanske, Jr.2; 1University of Wisconsin School of Medicine and Public Health, Madison, WI, 2UW School of Medicine and Public Health, Madison, WI.
620 Epigenetic Regulation of Th1/Th2- Recall Responses in Atopic Asthmatic Individuals
R. Su 1, A. Becker1,2, A. L. Kozyrskyj2,3, K. T. HayGlass1,2; 1CIHR National Training Program in Allergy and Asthma Research, Departments of Immunology, University of Manitoba, Winnipeg, MB, CANADA, 2Community Health Sciences, Winnipeg, MB, CANADA, 3Pediatrics/Child Health, Winnipeg, MB, CANADA.
Featured Poster Session
3804
Sunday, February 25, 2007
5:30 PM - 6:30 PM
All About Peanuts
621 Peanut Allergy in Infant: is Breastfeeding a Risk Factor?
A. Des Roches 1, L. Paradis1, J. Paradis1, C. Infante-Rivard2; 1Allergy Section, Hôpital Sainte-Justine, Montréal, PQ, CANADA, 2Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montréal, PQ, CANADA.
622 Oral Peanut Immunotherapy For Peanut Allergic Patients
S. D. Nash 1, P. H. Steele1, J. S. Kamilaris1, L. Pons1, M. Kulis1, L. A. Lee1, K. Althage2, L. Christie2, A. M. Scurlock2, S. M. Jones2, A. W. Burks1; 1Duke University Medical Center, Durham, NC, 2University of Arkansas Medical Sciences, Little Rock, AR.
623 Minimum Elicitation Dose Determination Using Roasted Peanut-Low Dose Challenges
J. A. Nordlee 1, S. L. Hefle1, S. L. Taylor1, A. C. Knulst2, K. A. B. M. Peeters2, R. K. Bush3, J. O. Hourihane4, D. A. Moneret-Vautrin5, M. Morisset5, P. S. Smailes3, C. A. Swenson3, J. B. T. Trewin6; 1University of Nebraska, Lincoln, NE, 2University Medical Center, Utrecht, THE NETHERLANDS, 3University of Wisconsin Medical School, Madison, WI, 4University of Southampton School of Medicine, Southampton, UNITED KINGDOM, 5Hopital Universitaire, Nancy, FRANCE, 6Wellcome Trust Clinical Research Facility, Southampton, UNITED KINGDOM.
624 Clinical Features and Outcomes of Peanut-Allergic Patients Who Underwent Follow-up Oral Food Challenges
J. M. Maloney, W. G. Shreffler, S. H. Sicherer, H. A. Sampson; Mount Sinai Medical Center, New York, NY.
625 Clinical Predictors of Peanut Allergy Remission in Children
K. J. Allen 1, M. Ho1, R. Heine1, W. Wong2, C. Hosking1, D. Hill1; 1Royal Children's Hospital, Parkville, AUSTRALIA, 2The University of Hong Kong, Hong Kong SAR, CHINA.
Featured Poster Session
3805
Sunday, February 25, 2007
5:30 PM - 6:30 PM
The Best of HCEDQ
626 Allergy Immunotherapy Practice Patterns and Associated Outcomes of Care
C. S. Hankin 1, L. Cox2, Z. Wang1, A. Bronstone1; 1BioMedEcon, South San Francisco, CA, 2Nova Southeastern University School of Osteopathic Medicine, Davie, FL.
627 Physician and Patient Perception Differ for Symptoms Associated with Allergic Rhinitis (AR)
A. E. Williams 1, M. Schatz2, S. Kay3; 1GlaxoSmithKline R&D, London, UNITED KINGDOM, 2Allergy Department, Kaiser-Permanente Medical Center, San Diego, CA, 3Adelphi Group Products, Macclesfield, UNITED KINGDOM.
628 Corticosteroid-Sparing Effects of Mepolizumab, an Anti-Interleukin-5 Monoclonal Antibody, in Patients With Hypereosinophilic Syndrome
L. J. Rosenwasser 1, L. B. Schwartz2, J. Sheikh3, A. D. Klion4, M. E. Rothenberg, on behalf of the Mepolizumab HES Study5; 1Allergy-Immunology Division, Children's Mercy Hospital, Kansas City, MO, 2Department of Internal Medicine, Virginia Commonwealth University, Richmond, VA, 3Beth Israel Deaconess Medical Center/Harvard Medical School, Boston, MA, 4Laboratory of Parasitic Diseases, National Institutes of Health, Bethesda, MD, 5Division of Allergy and Immunology, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.
629 Persistence and Compliance with Omalizumab in a Managed-Care Population
B. Gutierrez; Partnership for Health Analytic Research, Los Angeles, CA.
630 How Readable are our Patient Information Leaflets?
H. E. Smith, J. Wade, A. Frew; Brighton & Sussex Medical School, Brighton, UNITED KINGDOM.
Featured Poster Session
3806
Sunday, February 25, 2007
5:30 PM - 6:30 PM
T Cells and Allergic Inflammation
631 Onset of Clinical Tolerance to Milk Protein is Associated with Increased CD25+ CD27+ Casein Specific T Cells
W. G. Shreffler, N. Wanich, S. Noon, A. Nowak-Wegrzyn, H. A. Sampson; Mount Sinai School of Medicine, New York, NY.
632 Human Airway Epithelial Cells Produce Thymic Stromal Lymphopoietin (TSLP) after Stimulation with Th2 Cytokines and TLR3 Ligand
A. Kato, R. P. Schleimer; Allergy-Immunology Division, Northwestern University Feinberg School of Medicine, Chicago, IL.
633 Programmed Death One (PD1): Friend or a Foe of Regulatory T cells in the Modulation of Immune Response in Allergic Asthma
H. S. McGee 1, H. Yagita2, D. K. Agrawal3; 1Creighton University, Department of Biomedical Sciences, Omaha, NE, 2Juntendo University School of Medicine, Department of Immunology, Toyko, JAPAN, 3Creighton University, Departments of Biomedical Sciences, Internal Medicine, Medical Microbiology and Immunology, Omaha, NE.
634 A Novel Adhesion Molecule Plays a Critical Role in T Cell Migration to Inflamed Skin
M. E. Gainers 1,2, L. Descheny1,2, C. J. Dimitroff1,2; 1Harvard Skin Disease Research Center, Boston, MA, 2Brigham and Women's Hospital, Boston, MA.
635 IL-4 Upregulates FceRI-Mediated TSLP Expression by Human Mast Cells
Y. Okayama 1, H. Sagara2, S. Okumura1,3, K. Yuki1, T. Fukuda2, H. Saito1; 1RIKEN Yokohama Institute, Yokohama, JAPAN, 2Dokkyo University School of Medicine, Mibu, JAPAN, 3Stanford University School of Medicine, Stanford, CA.
Featured Poster Session
3807
Sunday, February 25, 2007
5:30 PM - 6:30 PM
Upper Airway Allergic and Inflammatory Disease: Searching for Causes and Connections
636 Effect of Allergen Challenge on Key Inflammatory Mediator Receptors Expression in Rat Nasal Tissues
N. Ferrari 1, J. Brault1, J. G. Wagner2, M. Fortin1, J. R. Harkema2, P. M. Renzi1, L. Paquet1; 1Topigen Pharmaceuticals Inc., Montreal, PQ, CANADA, 2Department of Pathobiology and Diagnostic Investigation, Michigan State University, East Lansing, MI.
637 Nasal Ocular Reflexes Occur After Nasal Challenge With Allergen
F. M. Baroody, K. Foster, A. Markarian, M. deTineo, R. Naclerio; The University of Chicago, Chicago, IL.
638 Cytokines, Growth Factors And MMPs In Tears Of Vernal Keratoconjunctivitis (VKC) Patients
A. Leonardi 1, M. Bortolotti1, V. Calder2, J. S. Curnow3, S. Sathe4, R. Sack4; 1University of Padua, Padova, ITALY, 2UCL, London, UNITED KINGDOM, 3University of Birmingham, Birmingham, UNITED KINGDOM, 4SUNY College of Optometry, New York, NY.
639 Is Allergic Fungal Sinusitis A Distinct Form Of Chronic Rhinosinusitis?
P. S. Hutcheson 1, M. S. Schubert2, R. G. Slavin1; 1Saint Louis University Medical School, Saint Louis, MO, 2Allergy Asthma Clinic, Ltd., Phoenix, AZ.
640 Non Allergic Rhinitis In Competitive Swimmers
M. Gelardi 1, M. Bonini2,3, S. Bonini3,4, T. Candreva1, M. Fiorella1, M. Ventura5; 1Dept. of Ophthalmology and Otolaryngology, University of Bari, Bari, ITALY, 2Institute of Sports Medicine, UCSC, Rome, ITALY, 3CNR, Institute of Neurobiology and Molecular Medicine, Rome, ITALY, 4Chair of Allergy and Clinical Immunology, Second University of Naples, Naples, ITALY, 5Dept. of Internal Medicine, MIDIM, University of Bari, Bari, ITALY.
Poster Session
4201
Monday, February 26, 2007
9:45 AM - 10:45 AM
Epidemiology of Asthma
641 The Growing Gender Gap In Adult Asthma Hospitalizations: New York State 1990-2004
R. Y. Lin 1,2; 1St Vincents Hospital, Manhattan-SVCMC, New York, NY, 2New York Medical College, Valhalla, NY.
642 The Relationship Between Wheezing Patterns During Early Childhood and Six Year Asthma Diagnosis in a High Risk Birth Cohort
K. M. Hanson, M. D. Evans, C. J. Tisler, D. F. DaSilva, T. E. Pappas, R. A. Grabher, L. E. P. Salazar, K. T. Sullivan Dillie, E. L. Anderson, K. A. Roberg, R. E. Gangnon, J. E. Gern, R. F. Lemanske, Jr.; University of Wisconsin School of Medicine and Public Health, Madison, WI.
643 Caesarean Delivery Could Be A Risk Factor For Asthma?
C. Nunes, S. Ladeira; Center of Allergy of Algarve, Portimao, PORTUGAL.
644 Dog Ownership: A Risk Factor Of Corticosteroid-Resistant (CR) Asthma?
P. J. Hauk, E. Goleva, A. H. Liu, C. F. Hall, R. J. Martin, D. Y. M. Leung; National Jewish Medical and Research Center, Denver, CO.
645 Development of a Specific Questionnaire for the Suspicion of DPV
P. Giavina-Bianchi, L. Eduardo Pinto, S. Sayed, A. Cukier, J. Kalil; FMUSP, São Paulo, BRAZIL.
646 The Effect of Body Mass Index on Asthma Related Quality of Life Measurements in Children
B. Catalina; Long Island College Hospital, Brooklyn, NY.
647 Asthma, Obesity, And The Effect On Airway Inflammation
P. Sakali, A. Arreh-mensah, J. Estrada, P. Rojas, O. Ozdemir, K. Paris, C. Moore; Louisiana State University, New Orleans, LA.
648 Demographic Characteristics of Males and Females With Acute Asthma
I. Warrier, A. P. Baptist; Wayne State University, Detroit, MI.
649 Perinatal outcomes (PO), potencial pregnancy variables (PPV), comorbidity occurence (CO) and asthma severity in two successive pregnancies (2SP)
B. Novotna 1,1, T. Pavlik2; 1University Hospital, Brno, CZECH REPUBLIC, 2The Center of Biostatistics and Analyses Masaryk University, Brno, CZECH REPUBLIC.
650 The Role Of Fungi In Patient With Chronic Sinusitis And Bronchial Asthma
T. Hofman, A. M. Hofman, J. Michalik; Center of Allergology, Poznan, POLAND.
651 The Correlation Between Skin Prick Tests and Bronchial Hyperresponsiveness in Children with Atopic Conditions
J. J. Liem 1, R. Rabbani2, A. L. Kozyrskyj1, A. B. Becker1; 1University of Manitoba, Winnipeg, MB, CANADA, 2The Manitoba Institute of Child Health, Winnipeg, MB, CANADA.
652 Comparison Of ΔFVC (% Fall In FVC At The Methacholine PC20) Between Asymptomatic And Symptomatic BHR
Y. Yoo 1, J. Choung1, J. Yu2, S. Choi3, Y. Koh3; 1Korea University Anam Hospital, Seoul, REPUBLIC OF KOREA, 2Dongguk University International Hospital, Goyang, REPUBLIC OF KOREA, 3Seoul National University Hospital, Seoul, REPUBLIC OF KOREA.
653 Respiratory Symptoms, Spirometry and Skin-Prick Tests in Patients with a Family History of Asthma: A 12-year Follow-up
J. P. Raasch; University of Minnesota, Minneapolis, MN.
654 Prevalence of Asthma among Childrend and Teenagers in Quito Ecuador
S. F. Barba, Jr.; Hospital General FF AA, QUITO, ECUADOR.
655 Prevalence and Factors affecting Asthma and Allergic Rhinitis among Adolescent children in Mysore, South India
P. A. Mahesh 1, R. Bharath2, A. D. Holla2, A. K. Prabhakar2, P. K. Vedanthan3; 1JSS Medical College, Mysore, Karnataka, INDIA, 2Allergy Asthma and Chest Center, Mysore, Karnataka, INDIA, 3University of Colorado Health Sciences, Denver, CO.
656 Prevalence Of Asthma And Allergic Rhinitis In Children And Adolescents Of Nuevo Leon, Mexico
A. Arias-Cruz, M. Zárate-Hernández, S. N. González-Díaz, S. N. González-Díaz; Hospital Universitario, Monterrey, MEXICO.
657 Persistent Cough: The Link Between Asthma and Chlamydia pneumoniae Respiratory Infections
M. G. Ghoshhajra, A. A. Petrov; University of Pittsburgh Medical Center, Pittsburgh, PA.
658 Asthma at 6 Yrs is Not Associated with Overweight Status or Pro-Inflammatory Markers in a High-Risk-for-Asthma Birth Cohort
S. L. Friedlander, K. A. Roberg, M. D. Evans, R. E. Gangnon, Z. Zhang, H. J. Lai, J. E. Gern, R. F. Lemanske, Jr.; University WI - Madison, Madison, WI.
659 Children with Viral Respiratory Infections in the First Year of Life and Food Allergy at Age 5 Years
E. L. Anderson, K. S. Dillie, M. D. Evans, K. A. Roberg, L. E. P. Salazar, D. F. DaSilva, T. E. Pappas, C. J. Tisler, R. Gangnon, C. Ober, J. E. Gern, R. F. Lemanske, Jr.; University of Wisconsin School of Medicine and Public Health, Madison, WI.
660 Parental Smoking Modifies Effects Of Genetic Variation In Tumor Necrosis Factor-α On Childhood Asthma
H. Wu 1, I. Romieu2, J. Sienra-Monge3, B. Rio-Navarro3, D. M. Anderson1, E. W. Dunn1, L. L. Steiner4, I. Lara-Sanchez2, S. London1; 1National Institute of Environmental Health Sciences, Research Triangle Park, NC, 2National Institute of Public Health, Cuernavaca, MEXICO, 3Hospital Infantil de Mexico Federico Gomez, Mexico City, MEXICO, 4Roche Molecular Systems, Alameda, CA.
661 Interactions Between Rhinovirus-Induced IFN-alpha Production at Birth and the Severity of Rhinovirus Illnesses in the First Year of Life
D. F. G. DaSilva, C. J. Tisler, T. E. Pappas, M. D. Evans, K. T. Sullivan Dillie, K. A. Roberg, E. L. Anderson, L. E. P. Salazar, R. A. Grabher, K. M. Hanson, R. E. Gangnon, J. E. Gern, R. F. Lemanske, Jr.; University of Wisconsin - Madison, Madison, WI.
662 Frequent Moderate to Severe Viral Respiratory Illnesses During Infancy Significantly Influence the Development of Asthma but Not Immunologic and Clinical Markers of Atopy During Early Childhood
R. A. Grabher, K. T. Sullivan Dillie, T. E. Pappas, D. F. DaSilva, K. A. Roberg, E. L. Anderson, K. M. Hanson, L. E. P. Salazar, C. J. Tisler, M. D. Evans, R. E. Gangnon, J. E. Gern, R. F. Lemanske, Jr.; University of Wisconsin School of Medicine and Public Health, Madison, WI.
663 Association of Environmental Allergen Sensitization with Asthma Morbidity
J. Wang 1, C. M. Visness2, A. Calatroni2, P. J. Gergen3, H. E. Mitchell2, H. A. Sampson1; 1Mount Sinai Medical Center, New York, NY, 2Rho Federal Systems Division, Inc, Chapel Hill, NC, 3National Institutes of Allergy and Infectious Disease, National Institutes of Health, Bethesda, MD.
664 Factors Associated with Asthma Mortality: a National United Kingdom Database Analysis
L. Watson 1, F. Turk2, S. T. Holgate3; 1Phimap, Bollington, Cheshire, UNITED KINGDOM, 2Novartis Pharma, Basel, SWITZERLAND, 3Southampton University Hospital, Southampton, UNITED KINGDOM.
665 Influence of Body Mass Index on Lung Function in Korean Children With No Asthma Symptoms Residing in Urban Area
Y. H. Shin 1, K. W. Kim2, K. E. Kim1, H. Y. Yum1, K. E. Lee2, T. W. Song2, E. S. Kim2, M. H. Sohn2, K. E. Kim2; 1Pochon CHA University College of Medicine, Seoul, REPUBLIC OF KOREA, 2Yonsei University College of Medicine, Seoul, REPUBLIC OF KOREA.
666 The First Nationwide Survey of Asthma Prevalence in Japan using ISAAC and ECRHS questionnaire
A. Akasawa 1, M. Akashi1, A. Aota1, A. Saito1, N. Kojima1, M. Futamura1, Y. Ohya1, Y. Adachi2, H. Odajima3, K. Takahashi4, T. Nakagawa5, K. Akiyama6; 1National Ctr for Child Health and Development, Tokyo, JAPAN, 2Toyama Medical and Pharmaceutical University, Toyama, JAPAN, 3NHO Fukuoka National Hospital, Fukuoka, JAPAN, 4NHO Minami-Okayama Medical Center, Okayama, JAPAN, 5Kawasaki Municipal Tama Hospital, Kanagawa, JAPAN, 6NHO Sagamihara National Hospital, Kanagawa, JAPAN.
667 Risk Factors for Fatal Asthma in Three U.S. States, 2004
C. A. Camargo, Jr. 1, A. J. Pelletier1, R. Hammel2, D. Vasas3, D. M. Lang3; 1Massachusetts General Hospital, Boston, MA, 2University of Arkansas Medical Sciences, Little Rock, AR, 3Cleveland Clinic, Cleveland, OH.
668 Advair Prescribing Patterns in a State Medicaid and Child Health Insurance Program
M. E. Helm 1, P. A. Vargas2, S. M. Jones2; 1University of Arkansas for Medical Sciences, Little Rock, AR, 2University of Arkansas for Medical Sciences/Arkansas Children's Hospital Research Institute, Little Rock, AR.
669 Comorbidity of Life-Threatening Arrhythmia in Children with Asthma
Y. Ito, Y. Adachi, T. Itazawa, K. Saito, K. Uese, F. Ichida, T. Miyawaki; University of Toyama, Toyama, JAPAN.
670 Electrocardiograph (ekgs) And Echocardiograph (ecos) Alterations Determined And Compared In Obese Adolescents With Asthma (oa) And Without Asthma (ona) (preliminary Results)
J. S. Calderon Rivera, B. E. del Rio Navarro, J. J. L. Sienra Monge; Hospital Infantil de Mexico, Federico Gomez, Mexico City, MEXICO.
Poster Session
4202
Monday, February 26, 2007
9:45 AM - 10:45 AM
Miscellaneous/Potpourri from ADT
671 Genetic Association between Asthma and Atopy and CD14 Promoter Variants in Chinese Children
Y. S. Wong1, T. F. Leung 1, C. Y. Li1, I. H. S. Chan2, E. Yung1, C. W. K. Lam2, G. W. K. Wong1; 1Department of Pediatrics, The Chinese University of Hong Kong, Hong Kong, HONG KONG, 2Department of Chemical Pathology, The Chinese University of Hong Kong, Hong Kong, HONG KONG.
672 TNFA -308 G/A Polymorphism And Asthma In Different Ethnicities: Systematic Review and Meta-analysis
I. R. Genov, A. Gonçalves-Primo, D. Solé, C. K. Naspitz; UNIFESP, São Paulo, BRAZIL.
673 Synergistic Modulation Of Eotaxin And Il-4 Secretion By Constituents Of An Anti-asthma Herbal Formula (ashmi) In Vitro
J. Bolleddula; Mount Sinai School of Medicine, New York, NY.
674 Development of a Cell Culture Model for the Study of Genes Regulated by Inhaled Corticoids During Asthma Treatment
C. J. Pantoja; University of California, San Francisco, San Francisco, CA.
675 Safety and Tolerance of a Novel Medical Food (NMF) in Children with Mild Persistent Asthma
S. J. Szefler 1, R. Covar1, B. Macomber1, L. Stewart1, M. Gleason1, K. Engelhardt1, J. Murphy1, A. Liu1, S. Wood2, S. DeMichele2, A. Wennberg2, E. Gelfand1; 1National Jewish Med Res Ctr, Denver, CO, 2Ross Products, Abbott Laboratories, Columbus, OH.
676 Harnessing the RNA-interference for Anti-inflammatory Therapeutics
P. N. Pushparaj 1, J. J. Aarthi2, S. D. Kumar1; 1National University of Singapore, Singapore, SINGAPORE, 2Singapore General Hospital, Singapore, SINGAPORE.
677 Rescue-Free and Symptom-Free Days With Mometasone Furoate Dry Powder Inhaler Used Once or Twice Daily in the Evening by Patients With Persistent Asthma
G. W. Bensch 1, J. Corren2, R. Lockey3, R. Yao4, H. Staudinger4; 1Allergy, Immunology and Asthma Medical Group, Stockton, CA, 2Allergy Research Foundation, Inc., Los Angeles, CA, 3University of South Florida College of Medicine, Tampa, FL, 4Schering-Plough Research Institute, Kenilworth, NJ.
678 A Case Study; Extracorporeal Gas Exchange for Severe Asthma Treatment
Y. Ogawa, E. G. Brooks, L. Williams, J. Lynch, J. B. Zwischenberger; University of Texas Medical Branch, Galveston, TX.
679 Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia (DIPNECH) in a Patient with Cough and Dyspnea Resistant to Standard Therapy
N. Singhania, Q. Liang, C. Cool, R. Tate, R. Alam; National Jewish Medical and Research Center, Denver, CO.
680 Management of Asthma Exacerbation in a Patient with Wiskott Aldrich Syndrome
M. A. Rank, J. B. Hagan; Mayo Clinic, Rochester, MN.
681 A Tale of Two Pediatric Patients: Using High Resolution CT (HRCT) to Distinguish Severe Asthma and Bronchiolitis Obliterans (BO)
P. A. Szefler, M. E. Krawiec, J. D. Newell, S. J. Szefler, R. W. Hendershot; National Jewish Medical and Research Center, Denver, CO.
682 A Case Study Utilizing Exhaled Nitric Oxide - An Aid in Determining Asthma Treatment
J. Bishop, B. Miller; Univeristy of Kentucky, Lexington, KY.
Poster Session
4203
Monday, February 26, 2007
9:45 AM - 10:45 AM
Immunogenetics and Other BCI
683 Correlation of Plasma Ghrelin And Serum Immunoglobulin Levels: A Hormonal Link Between Immunity and Obesity?
K. Matsuda, Y. Okamatsu, H. Tani, K. Kimura, T. Matsuishi; Kurume university school of medicine, Kurume ciry, Fukuoka, JAPAN.
684 Association of a Haplotype Related to TGFb1 with Allergy and Its Potential Race Dependent Effect
J. Meng; Children's Mercy Hospital, UMKC School of Medicine, Kansas City, MO.
685 A Genetic Variant in the Promoter of the Siglec8 Gene is Associated with Wheeze in a Brazilian Population
A. V. Grant 1,2, B. S. Bochner2, J. P. Guo2, M. I. Araujo3, E. V. Ponte4, A. A. Cruz4, T. H. Beaty1, P. S. Gao2; 1Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, 2Johns Hopkins Asthma and Allergy Center, Johns Hopkins University School of Medicine, Baltimore, MD, 3Servico de Imunologia, Hospital Universitario Professor Edgard Santos, Salvador, BRAZIL, 4Brazil Center for Respiratory Diseases, Federal University of Bahia, Salvador, BRAZIL.
686 A Network-based Analysis Of Lung From A Novel Mouse Model Of Experimental Asthma
S. B. Sarpong 1, S. Ghimbovschi2, E. Hoffman2; 1Howard University, Washington, DC, 2Childrens National Medical Center, Washington, DC.
687 A G-protein-coupled Receptor 154 (GPRA) Gene Polymorphism is Associated with Asthma in a Colombian population
C. Vergara 1, N. Acevedo1, S. Jiménez1, B. Martínez1, L. Gusmão2, D. Mercado1, L. Caraballo1; 1Institute for Immunological Research, University of Cartagena, Cartagena, COLOMBIA, 2IPATIMUP, Instituto de Patologia e Inmunologia Molecular da Universidade do Porto, Portugal, Porto, PORTUGAL.
688 The Interleukin 1β Gene (IL1B) is Upregulated in CD14+ Monocytes But Not Alveolar Macrophages after Lipopolysaccharide (LPS) Stimulation by Genomic Expression Profiling
Y. J. Tsai 1, P. Gao1, M. A. Williams2, D. Grigoryev1, M. Stockton1, T. Watkins1, C. Cheadle1, S. Georas2, M. C. Liu1, L. Breslin1, K. C. Barnes1; 1Johns Hopkins University, Baltimore, MD, 2University of Rochester, Rochester, NY.
689 GATA-3 Induces Transcriptional Activation of CRTh2
R. Quapp, T. Seibert, N. Madsen, K. Madsen, L. Cameron; University of Alberta, Edmonton, AB, CANADA.
690 Keratins: Important Candidate genes for Asthma and Immune Responsiveness to Cockroach
P. Gao 1, D. Grigoryev1, L. Breslin1, C. Cheadle1, R. A. Mathias2, T. H. Beaty3, A. Togias1, K. Barnes1; 1JHAAC, Baltimore, MD, 2Center for Inherited Disease Research, NIH, Baltimore, MD, 3Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD.
691 Copy Number Variations in del22q11.2 Syndrome
S. A. McGhee, M. Suchard, U. Bhardwaj, Y. Zhang, E. R. B. McCabe; David Geffen School of Medicine at UCLA, Los Angeles, CA.
692 Effect of Montelukast on IL6, IL12 from Inflamatory Exudation in Gouty Arthritis Model
J. A. Corado, M. Bermudez, A. Linares, L. Ponce, Z. Mora, J. Lucar, A. Acosta, R. Tovar; Universidad de Carabobo, Valencia, VENEZUELA.
693 Hydrodynamics Based in vivo siRNA Transfection: Legal or Lethal?
P. N. Pushparaj, H. S. Chen, A. J. Melendez; National University of Singapore, Singapore, SINGAPORE.
694 Prevalence Of IgE Anti-parvovirus B19 Antibodies In Asymptomatic Healthy Adult Humans
M. H. Bluth, H. G. Durkin, L. Wright, M. Nowakowski, T. A. Smith-Norowitz; SUNY Downstate Medical Center, Brooklyn, NY.
695 Detection Of IgE Anti-Parvovirus B19 Antibodies In Human Breast Millk: A Case Study
T. A. Smith-Norowitz, K. B. Norowitz, H. Drew, M. Nowakowski, E. F. Bluth, H. G. Durkin, M. H. Bluth; SUNY Downstate Medical Center, Center for Allergy and Asthma Research, Brooklyn, NY.
696 The Role of Surfactant Protein D (SP-D) and IgA in Schaedler's E.coli Induced Diminished Translocation of Lactobacillus salivarius Into the Lung: Crosstalk Between Innate and Adaptive Immunity
K. Krytska 1,2, N. V. Boyko2, N. Kushnir1, D. Kobuley1, S. A. Keilbaugh1, G. D. Wu1, Y. Yu1, J. J. Cebra1, A. Haczku1; 1University of Pennsylvania, Philadelphia, PA, 2Uzhgorod National University, Uzhgorod, UKRAINE.
697 Changes in Cytokine Levels in The First Year of Life in WHEALS Cohort Infants
K. R. Bobbitt, K. J. Woodcroft, S. Havstad, L. K. Williams, C. C. Johnson; Henry Ford Hospital, Detroit, MI.
698 Effect Of Nasal And Bronchial Grass Pollen Challenges On Plasma Cytokine Levels
C. Barnig 1, B. Uring-Lambert2, A. Purohit1, C. Donnay1, A. Casset1, S. Bahram2, F. de Blay1; 1Asthma and Allergy Division, Department of Chest Diseases,University Hospital, Strasbourg, FRANCE, 2Laboratory of Immunology, University Hospital, Strasbourg, FRANCE.
699 Influence Of H1, H2 And H3 Antagonists On Apoptosis Of Lymphoid Cells
I. Kaidashev 1, I. Yastremskaya1, N. Kutzenko1, L. M. DuBuske2; 1Ukrainian Medical Stomatological Academy, Poltava, UKRAINE, 2Immunology Research Institute of New England, Gardner, MA.
700 Leukemoid Reaction in Children: Lymphocytes Flow Cytometry Characterization and Clinical Etiologies
A. Beigelman 1,2, J. Kapelushnik1, G. Shubinsky1, A. Haim1, A. M. Moser1; 1Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, ISRAEL, 2Washington University School of Medicine, Saint Louis, MO.
701 Inhibition of Phosphoinositide 3 Kinase by Masoprocol Ameliorates IgE-mediated Anaphylaxis in vivo and ex vivo
J. J. A. Aarthi 1, P. N. Pushparaj2, S. D. Kumar2; 1Singapore General Hospital, Singapore, SINGAPORE, 2National University of Singapore, Singapore, SINGAPORE.
702 Altered Histone Acetylation in Monocytes in Response to Polarization with IFN-gamma and IL-4
S. L. Garrett 1,2, K. Sullivan1; 1Children's Hospital of Philadelphia, Philadelphia, PA, 2University of Pennsylvania, Philadelphia, PA.
703 Macrophages Accumulation in Visceral and Subcutaneous Adipose Tissue Correlates with Age
E. Jerschow 1, S. Anwar2, N. Barzilai1, D. Rosenstreich1; 1Albert Einstien College Medicine, Bronx, NY, 2Montefiore Medical Center, Bronx, NY.
704 The Role Of c-FLIP Isoform II In Il-2 Production
B. K. Al-Saud, Z. Alli, M. Abdelhaleem; the hospital for sick children, Toronto, ON, CANADA.
Poster Session
4204
Monday, February 26, 2007
9:45 AM - 10:45 AM
Immunodeficiency II and HIV
705 Pattern Of Cd28 Expression On Cd8+ T Cells In A Group Of Coinfected And Monoinfected HIV And HCV Patients
A. Paravisini 1, M. S. Cianchetta1, R. Garcia1, S. Raso2, P. Llorente1, M. Fernandez-Guerrero3, M. Gorgolas3; 1Immunology.Fundacion Jimenez Diaz Capio, Madrid, SPAIN, 2Immunology.Fundacion Jimenez Diaz Unilabs, Madrid, SPAIN, 3Infectious Diseases.Fundacion Jimenez Diaz Capio, Madrid, SPAIN.
706 Multidrug-Resistant (MDR) HIV Transmission to a Third Generation Offspring
D. W. Rosenthal 1,2, C. Colter1, L. Maroldo3, E. Coakley3, S. J. Schuval1; 1Long Island Jewish Medical Center, Schneider Children's Hosptial, New Hyde Park, NY, 2Feinstein Institute for Medical Research at North Shore Long Island Jewish Health System, Manhasset, NY, 3Mongram Biosciences, South San Francisco, CA.
707 A Protocol for the Desensitization to Intravenous Immunoglobulin (IVIg)
M. Salomon, R. Hostoffer, Jr.; Case Western Reserve University, Cleveland, OH.
708 3 Cases of Common Variable Immune Deficiency Associated With Absence of CD19+ B Lymphocytes
J. R. Sigmon, E. Kasabeh, G. Krishnaswamy; Division of Allergy and Immunology, Department of Internal Medicine, East Tennessee State University, College of Medicine, Johnson City, TN.
709 Intrathoracic Disease and Nontuberculous Mycobacteria (NTM) in a 6 Month Old Female: Immunodeficiency or Bad Luck? Case Report/Proposal
D. M. Anmuth 1, M. S. Edwards1, N. Tatevian1, S. M. Holland2, I. C. Hanson1; 1Baylor College of Medicine/Texas Children's Hospital, Houston, TX, 2National Institute of Allergy and Infectious Diseases, Bethesda, MD.
710 Lymphomatoid Granulomatosis in a Young Male with Hypogammagobulinemia
M. A. Netravali 1, A. J. MacGinnitie1, L. Teot2, D. R. Nash1; 1Children's Hospital of Pittsburgh, Pittsburgh, PA, 2University of Pittsburgh Medical Center, Pittsburgh, PA.
711 Myocardial Infarction After Replacement-Dose Intravenous Immunoglobulin
J. M. Klein 1, A. Tevrizian2, D. Adelman1, P. Avila3; 1University of California, San Francisco, San Francisco, CA, 2Allergy and Asthma Medical Group of the Bay Area, Pleasanton, CA, 3Northwestern University, Chicago, IL.
712 Specific Antibody Deficiency in a Patient with Factor IX Deficiency
M. A. Travassos, S. W. Alexander, J. E. Arnold, A. K. Chouksey; Rainbow Babies & Children's Hospital, Cleveland, OH.
713 Mannose Binding Lectin Deficiency In An Adolescent With Recurrent Infections And Idiopathic Thrombocytopenic Purpura
S. M. Nyenhuis, J. E. Gern; Department of Medicine, Section of Allergy and Clinical Immunology, University of Wisconsin, Madison, WI.
714 Atypical Presentation of DiGeorge Syndrome in an 14 Year Old Male
S. Najm Masoud, W. Blouin, R. A. Stoudt, J. Carro, V. P. Hernandez-Trujillo; Miami Children's Hospital, Miami, FL.
715 Cystic Fibrosis and Associated Common Variable Immunodeficiency
M. M. Sikora, R. Bansal, J. El-Dahr; Tulane University, New Orleans, LA.
716 Improved Tolerability with IVIG Switch in Patients With Common Variable Immunodeficiency
H. N. Taki 1,2, H. Karen1; 1Fort Wayne Medical Institute, Fort Wayne, IN, 2Medical Universilty of Ohio, Toledo, OH.
717 Neutropenia And Primary Immunodeficiency Disease (PID)
S. N. Mathew; University of New Mexico, Albuquerque, NM.
718 Food Allergy in a Patient with Hyper-IgE Syndrome (HIE) in Exclusive Breast-Feeding
A. M. S. Neves 1, P. A. Cunha2, T. Lawrence1, S. S. Lima3, M. C. Mallozi4, B. T. Costa-Carvalho4, D. Solé5; 1Fellow in Training of the Division of Allergy, Clinical Immunology, and Rheumatology of the Department of Pediatrics, Federal University of São Paulo-Escola Paulista de Medicine, São Paulo, BRAZIL, 2Felow in Training of the Division of Pediatric DermatologyHospital Darcy Vargas, São Paulo, BRAZIL., São Paulo, BRAZIL, 3Professor of the Division of Pediatric Dermatology, Hospital Darcy Vargas, São Paulo, BRAZIL, 4Associate Professor of the Division of Allergy, Clinical Immunology, and Rheumatology of the Department of Pediatrics, Federal University of São Paulo-Escola Paulista de Medicine, São Paulo, BRAZIL, 5Full Professor of the Division of Allergy, Clinical Immunology, and Rheumatology of the Department of Pediatrics,Federal University of São Paulo-Escola Paulista de Medicine, São Paulo, BRAZIL.
719 Relationship Of Immune Response To Endotoxin And Candida To Clinical Status Of Patients With Combined Bacterial And Candidal Periodontitis
V. A. Beloglazov 1, N. S. Lukojanova1, A. I. G_rdienko1, N. V. Khimich1, A. A. Bakova1, I. V. DuBuske2, L. M. DuBuske2; 1Crimean Medical State University, Simferopol, UKRAINE, 2Immunology Research Institute of New England, Gardner, MA.
720 Transient Neonatal Hypocalcemic Seizures Identifying Partial DiGeorge Syndrome
S. Ramanuja, D. C. Jerome, M. R. Baskin; University of California at Irvine, Irvine, CA.
721 The Role of IVIG in Treatment of Hyper-IgE Syndrome (HIES)
S. I. Krassilnikova, M. Davies, J. Rosch; Penn State's Milton S. Hershey Medical Center, Hershey, PA.
722 Primary Selective IgM Deficiency (SIgMD) Associated With Functional Antibody Deficiency In Two Boys
F. I. Khan, M. Pansare, E. A. Secord; Carman and Ann Adams Department of Pediatrics, Children's Hospital of Michigan, Detroit, MI.
723 14 Year Old Boy With ill-defined Immunodeficiency
R. S. Watkins 1, A. L. MacDowell1, M. Fontana-Penn1, S. De Ravin2, H. L. Malech2; 1Wake Forest University Baptist Med. Ctr., Winston Salem, NC, 2National Institute of Allergy and Infectious Diseases; National Institutes of Health, Bethesda, MD.
724 An Adolescent Patient with Chronic Granulomatous Disease (CGD) Presenting with Renal Failure
P. D. Niolet, K. Paris, C. Moore; LSU Health Sciences Center, New Orleans, LA.
725 Positive Prick Test in an X-Linked Agammaglobulinemia Patient
T. C. Lawrence; UNIFESP-EPM, São Paulo, BRAZIL.
726 A 3 Years Old Female With SCID T(-) B(-) Nk(+) Treated With Halogenic Bone Marrow Transplantation. Case Report
H. Del Olmo Tellez, G. Treviño Garza, N. Ramire, C. Ramos Becerril, F. Rivas Larrauri; National Institute of Pediatrics Mexico, Mexico City, MEXICO.
727 Case Report. Recessive Pediatric Hyper Ige Syndrome
K. I. G. C. Giron, II, A. A. S. Alcantara, III, H. G. C. Campos, IV, S. E. E. P. Espinosa, Jr.; National Institute of Pediatric, Mexico D.F, MEXICO.
Poster Session
4205
Monday, February 26, 2007
9:45 AM - 10:45 AM
Airborne Allergens, Environmental Exposure Assessment and Abatement
728 A Quantitative Exposure Assessment for Eight Indoor Allergens by Fluorescent Multiplex Array
C. D. Earle 1, A. Tsay1, K. Pittman1, L. Vailes1, R. Godbout2, K. G. Oliver3, M. D. Chapman1; 1Indoor Biotechnologies Inc., Charlottesville, VA, 2Radix Biosolutions Inc., Austin, TX, 3Radix Biosolutions Inc, Austin, TX.
729 The Risk of Asthma in Children Sensitized to Alternaria
R. Chooniedass 1,2, R. Rabbani1,2, J. Liem1,2, A. Becker1,2; 1University of Manitoba, Winnipeg, MB, CANADA, 2Manitoba Institute of Child Health, Winnipeg, MB, CANADA.
730 Fel d 1 In The Bed Dust Of Cat Non-Owners Differs Among Ethnicities But Not Neighborhood In Two NYC Cohorts
K. Panjwani 1,2, G. L. Chew1, A. Divjan1, A. M. Reardon1, F. P. Perera1, R. L. Miller1, M. S. Perzanowski1; 1Columbia's Center for Children's Environmental Health (CCCEH), New York, NY, 2Department of Environmental Health Sciences, Columbia University, New York, NY.
731 Content of (1-3)-β-D-glucan in Common Indoor Air Fungi
Y. Iossifova, C. Crawford, T. Reponen; University of Cincinnati, Cincinnati, OH.
732 Comparison of Protein Antigens Among Commercially Available Dog Extracts
T. M. Hrabak, J. Dice, L. Hagan, B. Whisman; Wilford Hall Medical Center, Lackland AFB, TX.
733 Effects of Climate And Flooding On Mold And Pollen Sensitization
D. Dalan 1, W. Brooks, IV2, E. Levetin3; 1University of North Dakota, Fargo, ND, 2Allergy & Asthma Care Center, Fargo, ND, 3Biological Science, University of Tulsa, Tulsa, OK.
734 Are There House-Dust Mites on Moldy Wall Surfaces?
Y. Gernez 1, P. Parola1, A. Palot1, G. Maurel2, J. Ercoli2, C. Charpin-Kadouch2, D. Charpin1, H. Dumon1; 1Assistance publique-Hoˆpitaux de Marseille, Marseille, FRANCE, 2Maison de l'Allergie et de l'Environnement, Marseille, FRANCE.
735 Acute Asthma with High Grass Pollen in Oregon
K. W. Jacobson 1, S. E. Zakarian1, J. C. Jensen1, J. A. Moran1, M. Glovsky2; 1Allergy and Asthma Research Group, Eugene, OR, 2California Institute of Technology, Pasadena, CA.
736 IgE Reactivity to Paecilomyces variotii Antigens in Fungal Sensitized Patients
B. J. Green 1, F. M. Blachere1, D. H. Beezhold1, D. N. Weissman1, M. B. Hogan2, N. W. Wilson2, D. Schmechel1; 1Centers for Disease Control and Prevention, Morgantown, WV, 2West Virginia University School of Medicine, Morgantown, WV.
737 Rat and Mouse Allergens in Homes of Patients with Acute Wheezing Living in Brazil
M. Thiesen1, A. S. Zampolo1, A. R. Santos1, A. A. Camara2, V. P. L. Ferriani1, L. K. Arruda 1; 1School of Medicine of Ribeirão Preto-University of São Paulo, Ribeirão Preto, BRAZIL, 2Santa Lidia Hospital, Ribeirão Preto, BRAZIL.
738 Mites Whose Time Has Come: Sensitization to Blomia Tropicalis, and Other Mites in Allergic Patients in Israel
K. Sade, D. Roitman, S. Kivity; Tel-Aviv Sourasky Medical Center, Tel-Aviv, ISRAEL.
739 A Two-stage Personal Cyclone Sampler for the Collection of Fungal Aerosols and Direct ELISA and PCR Sample Analysis
D. Schmechel, W. G. Lindsley, T. B. Chen, F. M. Blachere, B. J. Green, R. A. Brundage, D. H. Beezhold; CDC/Natl. Inst. Occup. Safety & Health, Morgantown, WV.
740 Risk Factors and Distribution of Mite Allergens in Spain
V. Iraola, E. Fernández-Caldas; Laboratorios LETI S.L., Tres Cantos, SPAIN.
741 Relative Potency of Mold and House Dust Mite Extracts in Inducing Allergic Responses in BALB/c Mice
Y. Chung, L. B. Copeland, M. D. W. Ward; US/EPA, Research Triangle Park, NC.
742 Meteorological Effects May Alter the Incidence of Rye-grass Pollen Related Asthma
M. M. Glovsky 1, K. Jacobson2, S. Zakarian2, J. Jensen2, J. Moran2, P. E. Taylor1; 1Huntington Asthma and Allergy Center, Pasadena, CA, 2Allergy and Asthma Research Group, Eugene, OR.
743 Home Cleaning Awareness Improves Asthma Quality Of Life
M. Amado, F. Pacheco, L. Gard, E. Forrest, L. Johnson, C. Barnes; Childrens Mercy Hospital, Kansas City, MO.
744 Reduction in Aspergillus and Penicillium Spore Counts Results in Reduction of Aspergillus and Penicillium Antigen Level in House Dust
D. R. Ward, P. Dowling, F. Hu, L. Johnson, K. Kennedy, C. Barnes; Children's Mercy Hospital, Kansas City, MO.
745 Initial Characterization of a cDNA Encoding a Heat Shock Protein Homolog From Stachybotrys chartarum
F. M. Blachere, B. J. Green, D. Schmechel, D. H. Beezhold; Centers for Disease Control and Prevention, Morgantown, WV.
746 The Relationship between Skin Test Responses and Nasal Responses to Mouse Allergen
H. P. Sharma, R. A. Wood, A. R. Bravo, E. C. Matsui; Johns Hopkins University, Baltimore, MD.
747 Statewide and Intrastate Assessments of Allergenic Tree, Grass and Weed Species
R. S. Jacobson, T. J. Grier; Greer Laboratories, Inc., Lenoir, NC.
748 Decreased Dust Antigen Levels Resulting from Specific Cleaning Practices
B. Jones, C. Barnes, F. Pacheco, L. Johnson, L. Gard, E. Forrest, J. Portnoy; Children's Mercy Hospital, Kansas City, MO.
749 The Impact of Cleaning Practices on Antigen Levels and Spirometry in an Asthmatic Population
C. S. Barnes, F. Pacheco, L. Gard, E. Forrest, L. Johnson, J. Portnoy; Childrens Mercy Hospital, Kansas City, MO.
Poster Session
4206
Monday, February 26, 2007
9:45 AM - 10:45 AM
Food Allergy III
750 Sensitization to Cor a 8, a Lipid Transfer Protein, in Children with Objective Reactions to Hazelnut from a Birch Endemic Country
A. E. Flinterman 1, J. H. Akkerdaas2,1, C. F. den Hartog Jager1, M. O. Hoekstra1, A. C. Knulst1, R. van Ree2, S. G. M. A. Pasmans1; 1University Medical Center, Utrecht, THE NETHERLANDS, 2Academic Medical Center, Amsterdam, THE NETHERLANDS.
751 Omega-5-Gliadin Specific IgE as a Predictor of Wheat Allergy in Children
K. Ito 1, Y. Takaoka1, M. Futamura1, T. Sakamoto2, K. Kohno3, E. Morita3, H. Matsuo4, A. Tanaka5; 1Aichi Children's Health and Medical Center, Obu, JAPAN, 2Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, JAPAN, 3Department of Dermatology, Shimane University School of Medicine, Shimane, JAPAN, 4Graduate School of Biomedical Sciences, Hiroshima University, Hiroshima, JAPAN, 5Phadia KK., Tokyo, JAPAN.
752 Impact of an Inpatient Program to Improve Safety of Food Allergic Patients During Hospitalization
A. R. Auerbach 1, M. E. Bollinger1, E. Loreck2, M. Simke2, C. Vibbert1, J. Gladstein1, A. Kewalramani1; 1Univ. of Maryland School of Medicine, Baltimore, MD, 2Univ. of Maryland Medical System, Baltimore, MD.
753 Contamination of Probiotic Preparations With Milk Allergen Can Cause Anaphylaxis in Cow's Milk Allergic Patients
M. Morisset 1, T. T. Lee2, C. M. N. Astier3, D. A. Moneret-Vautrin1, V. Cordebar1, E. Beaudouin1, F. Codreanu1, B. E. Bihain4, G. Kanny1; 1University Hospital, Nancy, FRANCE, 2Laboratory of Molecular Medicine and Therapeutics, Vandoeuvre-Les-Nancy, FRANCE, 3INPL, Vandoeuvre-Les-Nancy, FRANCE, 4Laboratory of Molecular Medicine and Therapeutics, Nancy, FRANCE.
754 Usefulness Of Serum Interleukin-10 In The Determining Food Tolerance
F. Pineda; DIATER Laboratories, San Martin de la Vega, SPAIN.
755 Oral Food Challenge with Boiled Egg Yolk and Boiled and Raw Egg White
Y. Takaoka 1, K. Ito1, M. Futamura1, T. Sakamoto2; 1Aichi Children's Health and Medical Center, Obu, JAPAN, 2Department of Pediatrics, Nagoya University Graduate School of Medicine, Nagoya, JAPAN.
756 IgE Mediated Cow's Milk Allergy (CMA): Evaluation of Weight and Height of Patients at Admission and After one-year Follow-up in Use of Soy Products
G. H. Yonamine, G. A. Corradi, F. R. P. Afonso, A. P. B. M. Castro, A. C. Pastorino, C. M. A. Jacob; Depto. of Pediatrics, São Paulo, BRAZIL.
757 Detection of Legume Proteins Cross-reactivity by Immunoblot Using Human Plasma of Individuals with Food Allergies to Peanut and/or Soybean
L. Chen, A. O. Ofori-Anti, R. E. Goodman; University of Nebraska, Lincoln, NE.
758 Assessment Of The Allergenicity To Raw Tuna And Canned Tuna
Y. Kondo 1, Y. Nakajima1, R. Komatsubara1, M. Kawamura1, M. Kakami1, I. Tsuge1, T. Yasuda2, A. Urisu1; 1Fujita Health University, Toyoake, Aichi, JAPAN, 2Toyo Suisan Kaisha, Ltd, Tokyo, JAPAN.
759 Ara H 2.02 Is A More Potent Cross-linker Of Anti-Peanut IgE Than Is Ara H 2.01
R. El Mezayen 1, L. Pons2, A. W. Burks2, M. West3, S. Stanley3, M. El Gazzar1, M. W. Duncan1, K. C. Hansen1, S. C. Dreskin1; 1University of Colorado Health Sciences Center, Denver, CO, 2Duke University, Durham, NC, 3University of Arkansas Medical Center, Little Rock, AR.
760 The Majority of the Effector Activity of a Crude Peanut Extract Co-purifies with Ara h 2 but not Ara h 1 or Ara h 3
H. S. Porterfield, M. W. Duncan, K. C. Hansen, S. C. Dreskin; University of Colorado Health Sciences Center, Denver, CO.
761 Diagnosis of Cow's Milk Allergy: Are Low Levels of Specific IgE Significant?
A. M. Plaza, M. Piquer, M. T. Giner, M. A. Martin Mateos, J. I. Sierra; Hospital Sant Joan de Déu, Esplugues, SPAIN.
762 An Objective Approach for the Assessment of Interchangeability of Cross-Reactive Food Allergens in Diagnostic Tests for Specific IgE
J. Lidholm 1, A. Marknell DeWitt1, L. Mattsson1, J. Ostling1, G. Lilja2, M. Nordlund2, B. Ballmer-Weber3, S. Scheurer4, A. Wangorsch4, H. Kofler5, J. Sastre6, E. Enrique7, S. Vieths4, K. Andersson1; 1Phadia AB, Uppsala, SWEDEN, 2Sachs' Children's Hospital, Stockholm, SWEDEN, 3University Hospital Zurich, Zurich, SWITZERLAND, 4Paul-Ehrlich-Institut, Langen, GERMANY, 5Allergieambulatorium Hall, Hall, AUSTRIA, 6Fundación Jiménez Díaz, Madrid, SPAIN, 7Hospital General de Castellón, Castellón, SPAIN.
763 Seasonal Palatal Pruritus is a Risk Factor for Oral Allergy Syndrome
D. A. Fischer; University of Western Ontario, Barrie, ON, CANADA.
764 A Trial of a Diet Containing Baked Egg in Children with Egg Allergy
A. H. Nowak-Wegrzyn, S. H. Sicherer, W. G. Shreffler, E. Thanik, S. Mofidi, S. Noone, H. A. Sampson; Jaffe Food Allergy Institute, Mount Sinai School of Medicine, New York, NY.
765 Dioscorea batatas (Sanyak) Allergy, Identification of an IgE-binding Component
G. Hur 1, S. Shin2, H. Park1, H. Kim1, Y. Ye1, S. Kim3, D. Nahm1, H. Park1; 1Ajou University School of Medicine, Suwon, REPUBLIC OF KOREA, 2KyungHee University College of Medicine, Seoul, REPUBLIC OF KOREA, 3Yonsei University Wonju College of Medicine, Wonju, REPUBLIC OF KOREA.
766 Severe Peripheral Eosinophilia and Failure to Thrive with Complete Resolution of Symptoms with Milk Elmination
H. Ahluwalia, L. Bernstein, J. Shliozberg; Albert Einstein The Children's Hospital at Montefiore, Bronx, NY.
767 Clinical And Laboratorial Findings From Ige Mediated Cow's Milk Allergy (CMA) In Brazilian Pediatric Patients
A. K. F. Gushken, D. L. A. Pitarello, G. H. Yonamine, E. Ciccone, A. C. Brandão, A. P. B. M. Castro, A. C. Pastorino, C. M. A. Jacob; Depto. of Pediatrics, São Paulo, BRAZIL.
768 Isolated Food Pollen Syndrome in Response to Fresh Pineapple
E. S. Lavine 1, A. R. Atkinson1, A. K. Ellis2; 1University of Toronto and Division of Immunology and Allergy, The Hospital for Sick Children, Toronto, ON, CANADA, 2Division of Clinical Immunology and Allergy, McMaster University, Hamilton, ON, CANADA.
769 Sensitization to Cannabis sativa in Tomato Sensitized Patients
C. Hernando de Larramendi 1, J. García Abujeta1, J. Carnés2, E. Fernández-Caldas2; 1Hospital Marina Baixa, Villajoyosa, SPAIN, 2Laboratorios LETI, SL, Tres Cantos, SPAIN.
770 Biological Standardization Of Hazelnut Extract In Selected Patients With Dbpcfc
F. Pineda; DIATER Laboratories, San Martin de la Vega, SPAIN.
771 Peanut Allergy and Peanut-specific IgG4 characteristics among Xhosa Children in Cape Town
G. Du Toit 1, M. Levin2, C. Motala2, M. Perkin3, A. Stephens4, V. Turcanu4, G. Lack1; 1Children's Allergy Service. Evelina Children's Hospital, Guy's & St Thomas' NHS Foundation Trust, Kings College London, UNITED KINGDOM, 2Red Cross Children's Hospital, University of Cape Town, SOUTH AFRICA, 3Division of Community Health Sciences, St George's Hospital Medical School, UNITED KINGDOM, 4Kings College London, London, UNITED KINGDOM.
772 Angioedema Due to Blueberry Hypersensitivity
M. P. Wolbert, J. Baldwin; University of Michigan, Ann Arbor, MI.
773 Responses of Treatment Primary Eosinophilic Gastrointestinal Disorders with Corticosteroid, Montelukast and Ketotifen, 3 Cases Report
S. Nanthapisal, N. Vithayasai, T. Dangsuwan, S. Jennuwat, J. Sirikul, G. Pongsamat, M. Vangveeravong; Queen Sirikit National Institute of Child Health, Bangkok, THAILAND.
774 Atypical Presentation of Eosinophilic Gastroenteritis (EGE)
P. Kapur, B. Silverman, A. T. Schneider; Long Island College Hospital, Brooklyn, NY.
775 Eosinophilic Esophagogastritis In A Child With Atopy And Abdominal Pain
J. L. Caicedo, R. A. Caicedo; Wake Forest University, Winston-Salem, NC.
776 Anti-Allergic Effects of the Traditional Chinese Medicine Herbal Formula FAHF2 are Partially Dependent on Interferon-γ Activity
K. D. Srivastava, H. A. Sampson, X. Li; The Mount Sinai School of Medicine, New York, NY.
777 Severe Eosinophilia in a Pediatric Patient Following Hemolytic-Uremic Syndrome
G. C. Pien, T. Brown-Whitehorn; Children's Hospital of Philadelphia, Philadelphia, PA.
778 Total Serum Level Of Ige, Allergen-specific Ige And Blood Eosinophils In Food Allergy
J. T. Kim 1, H. Kim1, J. Yoon2, J. Lee2, S. Kim3; 1Catholic University of Korea, Kyunggi-Do, REPUBLIC OF KOREA, 2Catholic University of Korea, Seoul, REPUBLIC OF KOREA, 3Pusan St.Mary's Hospital, Pusan, REPUBLIC OF KOREA.
Poster Session
4207
Monday, February 26, 2007
9:45 AM - 10:45 AM
Urticaria and Other Immunologic Skin Disorders
779 A Case of Hemolytic Anemia Following Intravenous Immuno-globulin Administration in a Patient With Chronic Urticaria
S. M. Herman 1, S. Betschel2, G. Sussman2; 1McMaster University, Hamilton, ON, CANADA, 2University of Toronto, Toronto, ON, CANADA.
780 Localized Heat Induced Urticaria: A Case Report
C. O. Barnes, A. Kulczycki; Washington University, St. Louis, MO.
781 Chronic Idiopathic Urticaria May Not Be Idiopathic
M. E. Masching-Wright; Sneeze, Wheeze, and Itch Associates, Normal, IL.
782 Hydroxychloroquine in the Treatment of 12 Patients With Severe Chronic Idiopathic Urticaria; A Case Series
A. M. Ditto; Northwestern University Feinberg School of Medicine, Chicago, IL.
783 Evaluation of a Functional Assay for the Diagnosis of Autoimmune Chronic Urticaria (CU)
M. L. Altrich 1, J. F. Halsey1, L. C. Altman2; 1IBT Reference Laboratory, Lenexa, KS, 2Dept Medicine University of Washington and Northwest Asthma and Allergy Center, Seattle, WA.
784 Serological Factors in Chronic Idiopathic Urticaria (CIU) in Relation To Disease Activity Over Time
J. A. Eckman, L. M. Gober, P. M. Sterba, R. G. Hamilton, S. S. Saini; Johns Hopkins Asthma and Allergy Center, Baltimore, MD.
785 Association of Chronic Idiopahic Urticaria with Autoimmunity and IgE levels
A. Chomiciene 1, L. M. DuBuske2, A. Blaziene1; 1Vilnius University, Vilnus, LITHUANIA, 2Immunology Research Institute of New England, Gardner, MA.
786 Investigation Of Complement Activation In Patients with Chronic Idiopathic Urticaria
S. N. Sharif, B. Goldberg; Kaiser Permanente Los Angeles, Los Angeles, CA.
787 Colchicine Use in Resistant Urticaria and Angioedema Patients: A Case Series
B. A. Martinez, I. C. Hanson, C. M. Davis; Baylor College of Medicine, Houston, TX.
788 Eosinophilic Fasciitis Masquerading as Angioedema
A. M. Dowden 1,2, Z. K. Ballas1,2; 1University of Iowa, Iowa City, IA, 2Veterans Affairs Medical Center, Iowa City, IA.
789 Generalized Urticaria Due to Nickel Sensitivity
J. K. Lemmon, A. P. Knutsen, R. G. Slavin; St. Louis University School of Medicine, Saint Louis, MO.
790 Lymphocyte Response Pattern of Eczema Herpeticum Patients to Herpes Simplex Virus Antigen
H. C. Rerinck, S. Kamann, A. Wollenberg; Ludwig-Maximilian University, Munich, GERMANY.
791 A Murine Model of Eczema Vaccinatum
A. Elkhal 1, J. Scott1, D. H. MacArthur1, R. He1, M. D. Howell2, E. Freyschmidt1, H. C. Oettgen1, D. Y. M. Leung2, R. S. Geha1; 1Childrens Hospital Boston, Boston, MA, 2National Jewish Medical and Research center, Denver, CO.
792 Re Vaccination of Children with a History of an Allergic Reaction to a Vaccine After a Negative Intradermal Skin Test
M. Primeau, A. Des Roches; Sainte-Justine Hospital, University of Montreal, Montreal, PQ, CANADA.
793 Effects of Olopatadine on the Recovery of Skin Barrier Function and Epidermal Hyperplasia Induced by Skin Barrier Disruption in Mice
T. Amano, T. Takeda, H. Yano, T. Tamura; Kyowa Hakko Kogyo Co., Ltd., Shizuoka, JAPAN.
794 Olopatadine Ameliorates Rat Experimental Cutaneous Inflammation by Improving the Skin Barrier Function
T. Tamura, T. Amano, M. Chida, H. Yano; Kyowa Hakko Kogyo Co., Ltd., Shizuoka, JAPAN.
795 IL-13 Receptors in Cutaneous Inflammation
M. R. Warrier, A. Gibson, Y. Tabata, M. O. Daines, W. Chen, H. S. Akei, M. E. Rothenberg, G. K. Khurana Hershey; Cincinnati Children's Hosp. Med. Center, Cincinnati, OH.
796 Overexpression of Interleukin 13 (IL-13) in the Skin Induces Dermatitis and Pulmonary Inflammation and Airway Hyperresponsiveness to Allergen Challenge
T. Zheng, S. Oh, M. Oh, M. Wang, A. Myers, J. Schroeder, Z. Zhu; Johns Hopkins University, Division of Allergy & Clinical Immunology, Baltimore, MD.
797 Eyelid Dermatitis Due To Contact Allergy To Cocamidopropyl Betaine
H. D. Oei; Albert Schweitzer Hospital, Dordrecht, THE NETHERLANDS.
798 Contact Dermatitis To Atropine
C. A. Villanueva Alvarez-Santullano, V. Tovar Flores, P. Tornero Molina, M. De Barrio Fernandez, M. Baeza Ocho de Ocariz, S. Perez Bustamante, A. Prieto Garcia; HospitaL Universitario Gregorio Marañon, Madrid, SPAIN.
799 Perception of Factors Restricting Widely Performing Allergy Patch Testing: Comparison Between Allergists and Allergy Program Directors
G. Ghaffari, T. Craig; Penn State Milton S Hershey Medical Center, Hershey, PA.
800 Mast cell tryptase generate C3a from keratinocyte derived C3: Implication for allergic skin inflammation
R. Purwar 1, M. Wittmann1, J. Zwirner2, M. Oppermann2, M. Kracht1, O. Dittrich-Breiholz1, R. Gutzmer1, T. Werfel1; 1Hannover Medical School, Hannover, GERMANY, 2Georg-August-University, Göttingen, GERMANY.
801 Serum IgE Concentrations in Bullous Pemphigoid Correlate with Disease Activity
L. A. Kelly, R. Holubkov, M. A. Campbell, K. S. Herlevi, T. Taylor, C. Hull, G. J. Gleich, J. J. Zone, K. M. Leiferman; University of Utah, Salt Lake City, UT.
802 Study of the Effect of the Antihistamine Agent Fexofenadine on Pruritus Associated with Asteatotic Dermatitis in the Elderly
T. Yudate; Sakai Hospital Kinki University School of Medicine, Sakai, JAPAN.
803 Combination Therapy with Dapsone, Colchine and Hydroxychloroquine in the Treatment of Urticarial Vasculitis
J. Melamed 1, H. Laznickova2; 1Allergy and Asthma Specialists, Chelmsford, MA, 2Allergy and Asthma Clinic P.C., Lexington, MA.
804 Cutaneous Leukocytoclastic Vasculitis in a Patient with HIV
S. A. Hodes, M. Carlson; University of California, Los Angeles, Los Angeles, CA.
805 Tamoxifen, A Possible Novel Therapy For Systemic Mastocytosis
R. Mian, P. E. Korenblat; Washington University School of Medicine, Barnes Jewish Hospital, St Louis, MO.
806 Urticaria: Characterization of 375 cases
M. D. C. Petrola 1, P. Adriana1, F. Maria1, T. Alcira2, Q. Velmar2; 1University of Carabobo, Valencia, VENEZUELA, 2Ciudad Hospitalaria Enrique Tejera, Valencia, VENEZUELA.
807 The use of Danazol in the Management of Refractory Chronic Urticaria
M. Karakelides, C. R. Weiler; Mayo School of Graduate Medical Education, Rochester, MN.
808 A Case of Urticarial Vasculitis Associated with Chronic Lymphocytic Leukemia
J. C. Moore, M. B. Fasano; University of Iowa Hospitals and Clinics, Iowa City, IA.
809 Urticaria And Angioedema Caused By Currant Sauce
A. Rodríguez, M. de Barrio, M. Vázquez, P. Rojas, T. Herrero, M. Baeza; Hospital General Universitario Gregorio Marañón, Madrid, SPAIN.
810 Chronic Urticaria and Non Specific rash from the Herbal Product “Airborne”
R. M. Harris, M. S. Johnson; Allergy & Asthma Associates, Beverly Hills, CA.
811 Urticaria - A Rare Presentation of Sulfite Allergy
L. Yao, R. J. Bloomberg; Generations Medical Center, Tempe, AZ.
812 Contact Dermatitis Following Occupational Exposure to the New U.S. Army Combat Uniform (ACU)
C. B. Soltis 1, C. K. Dolan2, M. R. Nelson1, S. A. Norton3; 1Walter Reed Army Medical Center, Washington, DC, 2National Naval Medical Center, Bethesda, MD, 3Uniformed Serviced University of the Health Sciences, Bethesda, MD.
813 Evaluation of a Moisturizing Cream Containing Sweet Almond Oil and Gyceryl Polymethacrylate in Patients with Chronic Inflammatory Skin Diseases
U. Amon, S. Erndt; PsoriSol-Center for Dermatology & Allergy, Hersbruck, GERMANY.
814 Successful Treatment of Systemic Mastocytosis Associated with AML-M2, t(8:21) in a Child Using MRC-based AML Chemotherapy along with Gemtuzumab
D. K. Jeong, K. Fauman, C. Ross, C. Akin, R. Mody; University of Michigan, Ann Arbor, MI.
815 Tacrolimus Hydrate Ointment Inhibits Skin Plasma Extravasation Induced by Topically Applied m-Xylene But Not Capsaicin in Rat
S. Morii 1, F. Kondo2, Y. Ikai2, M. Miyake1, M. Futamura3, K. Ito3, T. Sakamoto1; 1Nagoya University Graduate School of Medicine, Nagoya, JAPAN, 2Aichi Prefectural Institute of Public Health, Nagoya, JAPAN, 3Division of Allergology, Aichi Children's Health and Medical Center, Obu, JAPAN.
816 Churg-Strauss Syndrome with Colonic Vasculitis
J. Jeong 1, K. You2, S. Nahm1, E. Kim3; 1ILSAN PAIK HOSPITAL, Kyungki-do, REPUBLIC OF KOREA, 2Kun-Kuk University Hospital, Seoul, REPUBLIC OF KOREA, 3Dong-Kuk University Hospital, Kyungki-do, REPUBLIC OF KOREA.
Poster Session
4208
Monday, February 26, 2007
9:45 AM - 10:45 AM
Underserved and Asthma Treatment
817 Dyspnea and Obesity in African-American Females: Is It Really Asthma?
D. Waggoner, J. Stokes, F. A. Romero, T. B. Casale; Creighton University, Omaha, NE.
818 A Systematic Review of Randomized Control Trials Evaluating the Effectiveness of Interactive Computerized Asthma Patient Education Programs
K. L. Bussey-Smith 1, R. D. Rossen1,2; 1Baylor College of Medicine, Houston, TX, 2Micheal E. DeBakey Veterans Affairs Medical Center, Houston, TX.
819 Factors Associated with Increased Passive Cigarette Smoke Exposure in Inner City Asthmatic Children
S. J. Khiani 1, S. J. Sietsema1, L. Curtis2, L. K. Sharp3, C. Catrambone4, K. B. Weiss2,5, J. J. Shannon6, J. N. Moy7,1; 1Section of Allergy and Immunology, Rush University Medical Center, Chicago, IL, 2Institute for Healthcare Studies, Northwestern University, Chicago, IL, 3Department of Medicine, University of Illinois, Chicago, IL, 4Rush University College of Nursing, Chicago, IL, 5Institute for Healthcare Studies, Hines VA, Chicago, IL, 6Divisions of Pulmonary and Critical Care Medicine, Stroger Hospital of Cook County, Chicago, IL, 7Department of Pediatrics, Stroger Hospital of Cook County, Chicago, IL.
820 Recruitment Strategies in Under-Served Populatons for a Web-based Asthma Education Study Integrated with Nurse Case Management
A. D. Pulvermacher 1, K. Kelly-Shanovich1, C. A. Sorkness2, A. Bhattacharya3, D. H. Gustafson1; 1Center for Health Enhancement Systems Studies, University of Wisconsin - Madison, Madison, WI, 2Schools of Pharmacy and Medicine, University of Wisconsin - Madison, Madison, WI, 3Center for the Study of Cultural Diversity in Healthcare, University of Wisconsin - Madison, Madison, WI.
821 Effects of Mepolizumab, an Anti-Interleukin-5 Monoclonal Antibody, on Blood Eosinophil Counts in Patients With Hypereosinophilic Syndrome
P. F. Weller 1, G. J. Gleich2, W. W. Busse3, M. E. Rothenberg, on behalf of the Mepolizumab HES Study4; 1Beth Israel Deaconess Medical Center/Harvard Medical School, Boston, MA, 2Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT, 3Department of Medicine, University of Wisconsin Medical School, Madison, WI, 4Division of Allergy and Immunology, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH.
Poster Session
4209
Monday, February 26, 2007
9:45 AM - 10:45 AM
IgE and FceRI
822 The Allergic Profile Of Infants In The SAM Study: A Large Longitudinal Study Of Development Of Asthma And Allergies In Patients With Atopic Dermatitis
M. Boguniewicz 1, L. Schneider2, D. Leung1, T. Hultsch3, J. Spergel4; 1National Jewish Medical and Research Center, Denver, CO, 2Children's Hospital Boston, Boston, MA, 3Novartis Pharmaceuticals Corp, East Hanover, NJ, 4Children's Hospital of Philadelphia, Philadelphia, PA.
823 Cross-linking of FcɛRI on Dendritic Cells Skews CD4+ T cells towards a TH17 Phenotype
D. S. Cheung, M. M. Rohlfing, R. T. Kitchens, M. J. Holtzman, M. H. Grayson; Washington University School of Medicine, Saint Louis, MO.
824 Identifying the Presence and Function of the FcɛR1 Receptor in Human Normal and Small Airway Epithelium
E. Hochstadter 1, J. Guay1, B. Tolloczko1, A. Soussi-Gounni2, B. D. Mazer1; 1Meakins Christie Laboratories, Montreal, PQ, CANADA, 2University of Manitoba, Winnipeg, MB, CANADA.
825 Identification of Novel Candidate Gene/s Linked to Total Serum IgE Levels: An Integrative Genomic Approach
J. Batra, M. Sharma, R. Nagarkatti, B. Ghosh; Institute of Genomics and Integrative Biology, Delhi, INDIA.
826 Involvement of the High-affinity IgE Receptor (FCER1B) Gene Polymorphisms in the Susceptibility for Childhood Asthma
E. Kim 1, K. Kim1, J. Park1, J. Hong1, G. Jang2, M. Sohn1, K. Kim1; 1Yonsei University College of Medicine, Seoul, REPUBLIC OF KOREA, 2National Health Insurance Corporation Ilsan Hospital, Seoul, REPUBLIC OF KOREA.
827 The Prevalence of IgE Antibodies to Ascaris in Asthmatic Patients Living in a Tropical Environment
L. Caraballo 1, D. Mercado1, C. Vergara1, A. Fernández2, M. Gutiérrez2; 1Institute for Immunological Research, University of Cartagena, Cartagena, COLOMBIA, 2Departamento de Microbiología y Parasitología, Universidad Nacional Autónoma de México, México, MEXICO.
828 Role Of Inhibitory Antibodies For The Prevention Of IgE-allergen Complex Formation/CD-23 Antigen Uptake: Impact Of Antibody Affinity And Clonality Using Defined Ratios Of Recombinant IgE, IgG And Der p 2
J. Holm, L. H. Christensen, J. Skovsgaard, P. A. Wurtzen, K. Lund; ALK-Abelló A/S, Hørsholm, DENMARK.
829 Total and Allergen Specific IgE Antibody Levels During and After Pregnancy in Relation to Maternal Allergic Disease
M. Sandberg, A. Frykman, M. Persson, J. Ernerudh, G. Berg, L. Matthiesen, C. Ekerfelt, M. C. Jenmalm; Linköping University, Linköping, SWEDEN.
830 IgE-dependent Activation Of Human Mast Cells Up-regulates FLIP And Mcl-1 Anti-apoptotic Proteins
B. Berent-Maoz, F. Levi-Schaffer; The Hebrew University of Jerusalem, Jerusalem, ISRAEL.
831 Specific IgE Response to Mites and Phenotypes of Allergic Disease in Childhood
M. I. Kidon 1,2, S. Steinberg1, L. Y. S. Tiong3, T. C. Ong3, H. S. Shang3, F. T. Chew3; 1Children's Health Center, Rishon Lezion, ISRAEL, 2KK Children's Hospital, Singapore, SINGAPORE, 3Department of Biological Sciences, National University, Singapore, SINGAPORE.
832 Omalizumab Therapy in Evolving Allergic Bronchopulmonary Aspergillosis
S. Dave 1, W. B. Cherry1, D. E. Maddox2; 1Mayo School of Graduate Medical Education, Rochester, MN, 2Mayo Clinic College of Medicine, Rochester, MN.
833 Efficacy of Omalizumab Using Extended Dose Intervals
R. M. Katz, A. W. Rafi, L. Do, M. Lin, R. Mangat, N. Azad, S. Sender; Allergy Asthma Care Center/UCLA, Santa Monica, CA.
834 Development Of A Monoclonal Antibody That Binds To Der P I Precursor And Blocks Serum Specific Ige Binding To Mite Allergen
W. Dai 1,1, C. Shieh2, J. Wang3; 1Institude of Basic Medical Sciences, College of Medicine, National Cheng Kung University, Tainan, TAIWAN, 2Institude of Microbilogy&Immunology, College of Medicine, National Cheng Kung University, Tainan, TAIWAN, 3Department of Pediatrics, College of Medicine, National Cheng Kung University, Tainan, TAIWAN.
835 A Systems Theory of Optimality in the Behavior of a Mast Cell
I. Bachelet 1, A. Munitz1, N. Linnenberg2, Y. J. Pollak3, F. Levi-Schaffer1; 1The Hebrew University of Jerusalem, Jerusalem, ISRAEL, 2Freescale, Herzliya Pituach, ISRAEL, 3Mobileye Vision Technologies, Jerusalem, ISRAEL.
836 Regulation of Human Mast Cells by Fluticasone and Salmeterol
L. E. Erdos, R. P. Schleimer, M. Kulka; Northwestern University, Chicago, IL.
837 Effects of the Chinese Herbal Formula CUF2 on Cytokine Release from Human Mast Cell Line
Y. O. Wong, R. Y. T. Sung, K. Li, Y. Zhao, A. M. C. Li, K. P. Fung; The Chinese University of Hong Kong, Hong Kong, HONG KONG.
838 Pharmacological Cell and Tissue Models of Human Mast Cells for Compound Prioritization in Drug Development
C. Prothmann; ALTANA Research Institute, Waltham, MA.
839 Distinct Role Of Il-3 Promoter And Enhancer Region In Murine Mast Cells
A. Park; Chonnam National university, Gwangju, REPUBLIC OF KOREA.
840 Role of Mast Cell Mediators in Basal Cell Carcinoma
S. Z. Salim, F. A. Sorour, E. B. Abdelal, H. M. Hussein, E. E. Fouda; Al-Azhar Allergy & immunology Centre, Cairo, EGYPT.
841 Modulation of Histamine Release (HR) from Peripheral Blood Leukocytes (PBL) by Antioxidants
V. Windhorst, C. Bauer, B. Przybilla; Ludwig-Maximilians-Universität, Munich, GERMANY.
842 Ratio of IgE Receptor to TLR9 on Human Plasmacytoid Dendritic Cells Predicts Allergic Status and Cytokine Response to Innate and Adaptive Immune Stimuli
J. R. Tversky, A. P. Bieneman, K. L. Chichester, J. T. Schroeder; Johns Hopkins University, Baltimore, MD.
843 Circulating IgE and IgG Antigalectin - 1 Antibodies Associated with Asthma
J. Muino 1, C. C. Castro1, M. A. Sanabria1, M. D. Romero2, M. Ferrero2, G. A. Rabinovich3; 1Fac Cs MED - Universidad Nacional de Córdoba, Cordoba, ARGENTINA, 2LIIDO, Cordoba, ARGENTINA, 3Instituto de Inmunogenética - Facultad de Medicina Universidad Nacional de Buenos Aires, Buenos Aires, ARGENTINA.
Poster Session
4210
Monday, February 26, 2007
9:45 AM - 10:45 AM
Eosinophils I
844 IL-5 and the FIP1L1/PDGFRA Fusion Gene Cooperatively Promote Eosinophil Development, Activation, and Signal Transduction
Y. YAMADA 1, J. A. Cancelas2,3, D. A. Williams2, M. E. Rothenberg1; 1Division of Allergy and Immunology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 2Division of Experimental Hematology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 3Hoxworth Blood Center, University of Cincinnati, Cincinnati, OH.
845 Pyk2 Signaling Events Mediate Eosinophil Chemotaxis Along Chemoattractant Gradients In The Lung
C. A. Lipinski 1, R. Schubert1, Z. Yang1, R. S. Pero1, M. Russ2, S. Muller2, H. Kohler3, J. J. Lee1; 1Mayo Clinic Arizona, Scottsdale, AZ, 2ImmPheron, Lexington, KY, 3InNexus Biotechnology, Scottsdale, AZ.
846 Kinetics of Cord Blood Eosinophil Lineage Biomarker mRNA: Co-expression of CysLTR1 with GATA-1
L. Crawford, A. K. Ellis, J. A. Denburg; McMaster University, Hamilton, ON, CANADA.
847 Cockroach Activates and Induces Degranulation of Human Eosinophils Through Protease-Activated Receptor-2
K. Wada, Y. Matsuwaki, T. A. Bingemann, H. Kita; Mayo Clinic College of Medicine, Rochester, MN.
848 Inhaled Budesonide At Low to Moderate Doses Is An Effective Treatment For Children With Eosinophilic Esophagitis
K. M. Maples, M. Graham, A. Irani; Virginia Commonwealth University, Richmond, VA.
849 Does Cigarette Smoke Modify Eosinophil Properties? Implications for Chronic Lung Disease
L. H. Bellehsen; Hebrew University of Jerusalem, Jerusalem, ISRAEL.
850 A Novel Method to Detect and Quantitate Pulmonary Eosinophils
W. W. Stevens 1,2, T. S. Kim1, L. M. Pujanauski1,3, T. J. Braciale1,4; 1Beirne Carter Center for Immunology Research, University of Virginia Health Sciences Center, Charlottesville, VA, 2Department of Microbiology, University of Virginia Health Sciences Center, Charlottesville, VA, 3Department of Biology, University of Virginia, Charlottesville, VA, 4Departments of Pathology and Microbiology, University of Virginia Health Sciences Center, Charlottesville, VA.
851 IP-10 Augments Eosinophil Adhesion To ICAM-1
T. Kobayashi, T. Soma, Y. Takaku, K. Hagiwara, M. Kanazawa, M. Nagata; Saitama Medical University, Saitama-ken, JAPAN.
852 Interferon-γ Enhances Human Eosinophil Effector Functions Induced by Th2-type Cytokines
M. Kato 1,2, T. Yamaguchi1, K. Kozawa1, H. Kimura3; 1Gunma Prefectural Institute of Public Health and Environmental Sciences, Maebashi, Gunma, JAPAN, 2Gunma Children's Medical Center, Shibukawa, Gunma, JAPAN, 3National Institute of Infectious Disease, Tokyo, JAPAN.
853 Eosinophils Respond to Acidic environments with cAMP Generation in a TDAG8-Dependent Manner
L. C. Kottyan 1, A. R. Collier1, K. A. Niese1, C. O. Radu2, O. N. Witte2, M. E. Rothenberg1, N. Zimmermann1; 1Cincinnati Children's Hospital, Cincinnati, OH, 2University of California Los Angeles, Los Angeles, CA.
854 Inhibition of Eosinophil Survival by Peroxisome Proliferator-Activated Receptor (PPAR) alpha Agonists
T. Adachi 1, S. Ueki1, H. Nagase1, J. Chihara2, K. Ohta1; 1Teikyo University School Medicine, Tokyo, JAPAN, 2Akita University School Medicine, Akita, JAPAN.
855 L-plastin Interacts with Receptor for Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) and Transduces Antiapoptotic Signaling in Human Eosinophils
T. W. Young, K. Pazdrak, C. Straub, S. Stafford, A. Kurosky; University of Texas Medical Branch, Galveston, TX.
856 Human Airway Eosinophils Exhibit Differential Regulation of ERK and STAT5-Associated Signaling Responses to Interleukin-5 (IL-5) and Granulocyte Macrophage-Colony Stimulating Factor (GM-CSF)
C. J. Koziol, M. Bates, P. J. Bertics; University of Wisconsin-Madison, Madison, WI.
857 Inhibitor of Apoptosis Proteins in the Regulation of Eosinophil Apoptosis in Allergic Disease
V. Mehta 1, B. Moore2, A. Bewtra1, D. K. Agrawal2; 1Center for Allergy, Asthma and Immunology, Creighton University, Omaha, NE, 2Department of Biomedical Sciences, Creighton University, Omaha, NE.
858 Molecular Markers of Eosinophilopoiesis: Multiplex Q-PCR Analysis of GATA-1, MBP and IL-5 Receptor mRNA Expression in Peripheral Blood
A. K. Ellis, L. Crawford, J. A. Denburg; McMaster University, Hamilton, ON, CANADA.
859 A3 Adenosine Receptors Modulate Eosinophil Function In Bleomycin-Induced Lung Injury
E. Morschl 1, J. B. Volmer1, J. G. Molina1, J. J. Lee2, S. I. Ochkur2, M. R. Blackburn1; 1The Medical School at the University of Texas Houston, Houston, TX, 2Mayo Clinic Scottsdale, Scottsdale, AZ.
860 Expression and Activation of Toll Receptor 7 (TLR7) In Human Eosinophils: Effect on Eosinophil Survival and Cytokine Production
K. Pazdrak, C. Straub, V. Starosta, S. Stafford, T. W. Young, A. Kurosky; University of Texas Medical Branch, Galveston, TX.
861 Differential Effects of Adhesion Molecules on Eosinophil Superoxide Anion Generation Induced by Leukotriene D4
M. Nagata, M. Kushiya, T. Kobayashi, K. Hagiwara, M. Kanazawa; Saitama Medical University, Saitama, JAPAN.
862 TGF-beta Regulation Of Bone Marrow Eosinophil Production
M. Hogan, D. Piktel, L. F. Gibson, K. S. Landreth; West Virginia University, Morgantown, WV.
863 Rapid Selective Priming Of FcαR On Eosinophils By Corticosteroids
M. Bracke 1,2, W. ten Hove1,2, L. A. Houben2, J. A. M. Raaijmakers1, L. Koenderman2; 1Utrecht Institute for Pharmaceutical Sciences, Utrecht, THE NETHERLANDS, 2Dept. Pulmonary Diseases, University Medical Center, Utrecht, THE NETHERLANDS.
864 Nonspecific Bronchial Hyperresponsiveness Caused by T. canis 2nd Stage Larval Infestation
S. Lee 1, S. Kyung1, C. An1, S. Jeong1, Y. Kim1, M. Kim1, K. Ha2, D. Choi3, S. Kang4, Y. Chung5; 1Gachon University of medicine and science, Incheon, REPUBLIC OF KOREA, 2Sung Ae General Hospital, Seoul, REPUBLIC OF KOREA, 3Samsung Medical Center, Seoul, REPUBLIC OF KOREA, 4Chung Ang University, Seoul, REPUBLIC OF KOREA, 5Jeju National University, Jeju, REPUBLIC OF KOREA.
865 Age-related Changes in Eosinophil Function in Asthma Subjects
S. K. Mathur, E. A. Schwantes, R. L. Brandau; University of Wisconsin, Madison, WI.
866 Retinoic Acids Induce Eosinophil Survival and MCP-1 Production
S. Ueki 1, G. Mahemuti2, W. Ito2, Y. Kobayashi2, T. Chiba2, H. Oyamada2, Y. Kamada2, K. Yamaguchi2, M. Takeda2, H. Kayaba2, J. Chihara2; 1Teikyo University School of Medicine, Tokyo, JAPAN, 2Akita University School of Medicine, Akita, JAPAN.
867 TGF-β1 Increases Chloride Channel Activity in and Migration of Human Blood Eosinophils via Intracellular Pathways involving Protein Kinase C
B. Moore 1, G. Cheng1, M. Kim1, D. K. Agrawal1,2; 1Department of Biomedical Sciences, Creighton University School of Medicine, Omaha, NE, 2Department of Internal Medicine, Creighton University School of Medicine, Omaha, NE.
868 Comparison Between Peripheral Blood and Nasal Polyp Eosinophils Reveals a Distinct Profile of Surface Receptors
A. H. Nissim Ben Efraim 1, I. Bachelet1, A. Munitz1, R. Eliashar2, F. Levi-Schaffer1; 1The Hebrew University of Jerusalem, Jerusalem, ISRAEL, 2The Hadassah Ein-Karem University Hospital, Jerusalem, ISRAEL.
869 Bovine Dural Graft: A Unique Cause of Unexplained Fever, Erythroderma and Eosinophilia
W. B. Cherry, M. F. Hartz, M. T. McEvoy, S. T. Pittock; Mayo Clinic, Rochester, MN.
870 A Comparison of Nasal Smear Eosinophil Count via Blow Technique vs the Nasal Scrape Method
M. Varghese, P. Lieberman; University of Tennessee, Memphis, TN.
871 Eosinophilic Leukemoid Reaction in a Woman with Spindle Cell Sarcoma of the Leg
C. B. Lauter 1, M. Snyder1, A. Armin2, I. Jaiyesimi3, M. Kolins4, J. Burdakin3, K. Les5; 1William Beaumont Hospital-Division of Allergy/Immunology, Royal Oak, MI, 2William Beaumont Hospital-Department of Anatomic Pathology, Royal Oak, MI, 3William Beaumont Hospital-Division Hematology/Oncology, Royal Oak, MI, 4William Beaumont Hospital-Department of Clinical Pathology, Royal Oak, MI, 5William Beaumont Hospital-Department of Orthopedic Surgery, Royal Oak, MI.
872 [Withdrawn]
873 The Effects of rhSCF on Human Eosinophil Chemokine Receptor Expression
R. W. Keeton, Jr., N. Lukacs; U. of Michigan, Ann Arbor, MI.
874 PEG-Interferon after Interferon alfa-2b for Hypereosinophilic Syndrome
J. Butterfield; Mayo Clinic, Rochester, MN.
875 Eosinophilia and Adrenal Insufficiency
C. C. Hassett, L. G. Wild; Tulane University, New Orleans, LA.
876 Reactive Eosinophilia to Invasive Candidiasis Responding to Caspofungin
G. Shanmugam, B. L. Buchmiller, D. A. Wierzbicki, M. T. de la Morena; UT Southwestern, Dallas, TX.
877 Churg-Strauss Presenting as Pulmonary Embolism, Lymphadenopathy and Eosinophilia
T. Chacko, R. Frank, D. Ledford, R. F. Lockey; University of South Florida Collge of Medicine, Tampa, FL.
Poster Session
4211
Monday, February 26, 2007
9:45 AM - 10:45 AM
Epidemiology of Rhinitis, Sinusitis and Allergic Ocular Disease
878 Allergens Associated with Ocular and Nasal Symptoms: An Epidemiologic Study
K. Singh, L. Bielory, E. Kavosh; UMDNJ, Newark, NJ.
879 Prevalence of Rhinitis among Children and Teenagers in Quito Ecuador
S. F. Barba, Jr.; Hospital General FF AA, Quito, ECUADOR.
880 High Prevalence of Sensitization to Japanese Cedar Pollen and House Dust Mite in Young Children in Japan
S. Masuda 1,2, T. Fujisawa1,2, M. Nambu3,2, Y. Suehiro4,2, A. Terada5,2, Y. Tohda6,2; 1Mie National Hospital, Tsu, JAPAN, 2Kinki-Hokuriku Airway Disease Conference (KiHAC), Osaka, JAPAN, 3Tenri-Yorozu General Hospital, Tenri, JAPAN, 4Saiseikai Nakatsu Hospital, Osaka, JAPAN, 5Daido Hospital, Nagoya, JAPAN, 6Kinki University School of Medicine, Osaka, JAPAN.
881 Allergic Rhinitis and Immunoglobulin Deficiency in Preschool Children with Frequent Upper Respiratory Illness
S. Siriaksorn 1, M. Trakultivakorn1, S. Suchaitanawanit2; 1Division of Allergy and Clinical Immunology, Department of Pediatrics, Faculty of medicine, Chiang Mai University, Chiang Mai, THAILAND, 2Section of Immunology, Central Laboratory, Faculty of Medicine, Chiang Mai University, Chiang Mai, THAILAND.
882 The Trends of Prevalence of Allergic Rhinitis among Elementary School Children in Seoul from 1995 to 2005: Stable but Increased Recognition
Y. Ahn; Eulji University School of Medicine, Seoul, REPUBLIC OF KOREA.
883 Firstborn Status, Early Day Care Use and Allergen-Specific IgE, Hay Fever, and Asthma in Young Adults
C. C. Johnson 1, G. R. Wegienka1, S. L. Havstad1, K. J. Woodcroft1, L. K. Williams1, C. L. M. Joseph1, D. R. Ownby2, E. M. Zoratti3; 1Dept of Biostatistics and Research Epidemiology, Henry Ford Hospital & Health System, Detroit, MI, 2Medical College of Georgia, Augusta, GA, 3Section of Allergy & Clinical Immunology, Henry Ford Hospital & Health System, Detroit, MI.
884 Assessment Of A Rhinitis Questionnaire In A Seasonal Allergic Rhinitis Population
J. A. Bernstein 1, D. Brandt1, P. Ratner2, W. Wheeler3; 1University of Cincinnati, Cincinnati, OH, 2Sylvana Research Associates, San Antonio, TX, 3MedPointe Pharmaceuticals, Somerset, NJ.
885 Evaluation Of A Rhinitis Questionnaire In Different Regions Within The United States
D. Brandt 1, A. El-Hag2, C. Abbott3, J. A. Bernstein1,3; 1University of Cincinnati, Cincinnati, OH, 2Allergy and Immunology, Plano, TX, 3Bernstein Allergy Group, Cincinnati, OH.
886 The Burden Of Rhinitis In A Managed Care Organization (MCO)
R. Zeiger1, M. Schatz 1, W. Chen2, S. Yang2, M. Corrao3, V. Quinn2; 1Kaiser Permanente, San Diego, CA, 2Kaiser Permanente, Los Angeles, CA, 3GlaxoSmithKline, Research Triangle Park, NC.
887 Symptom Burden During the Winter for Allergic and Non-allergic Rhinitis Sufferers
R. Nathan1, E. Meltzer2, J. Derebery3, P. Stang4, U. Campbell4, M. Corrao5, R. Stanford 5; 1Asthma & Allergy Associates, Colorado Springs, CO, 2Allergy and Asthma Medical Group and Research Center, San Diego, CA, 3House Ear Clinic, Los Angeles, CA, 4Galt Associates, Blue Bell, PA, 5GlaxoSmithKline, Research Triangle Park, NC.
888 Allergies in Canada: AR Patient Perspectives on Prescription Nasal Sprays
M. Desrosiers 1,2, P. Keith3, R. Schellenberg4, S. Waserman5; 1McGill University, Montreal, PQ, CANADA, 2Université de Montréal, Montreal, PQ, CANADA, 3McMaster University, Hamilton, ON, CANADA, 4University of British Columbia, Vancouver, BC, CANADA, 5University of Toronto, Toronto, ON, CANADA.
889 Physicians' Perspectives of Allergic Rhinitis (AR) in Canada
R. Schellenberg 1, P. Keith2, M. Desrosiers3, S. Waserman2; 1University of British Columbia, Vancouver, BC, CANADA, 2McMaster University, Hamilton, ON, CANADA, 3McGill University, Montreal, PQ, CANADA.
890 Subjective Effects of Allergic Rhinitis on Sleep Quality and Amount During the Winter
E. Meltzer1, R. Nathan2, J. Derebery3, P. Stang4, U. Campbell4, M. Corrao5, R. Stanford 5; 1Allergy and Asthma Medical Group and Research Center, San Diego, CA, 2Asthma & Allergy Associates, Colorado Springs, CO, 3House Ear Clinic, Los Angeles, CA, 4Galt Associates, Blue Bell, PA, 5GlaxoSmithKline, Research Triangle Park, NC.
891 The Burden Of Non-Allergic Versus Allergic Rhinitis In A Managed Care Organization (MCO)
M. Schatz 1, W. Chen2, S. Yang2, M. Corrao3, V. Quinn2, R. Zeiger1; 1Kaiser Permanente, San Diego, CA, 2Kaiser Permanente, Los Angeles, CA, 3GlaxoSmithKline, Research Triangle Park, NC.
892 Evaluation and Control of Allergic Rhinitis in Patients with Asthma (CARINA) in Korea
Y. Rha 1, B. Son2; 1Department of Pediatrics, College of Medicine, Kyung Hee University, Seoul, REPUBLIC OF KOREA, 2Department of Pediatrics, College of Medicine, Inha University, Inchon, REPUBLIC OF KOREA.
893 Burden of Illness of Allergic Rhinitis in Canada
P. K. Keith 1, M. Desrosiers2, S. Waserman1, R. R. Schellenberg3; 1McMaster University, Hamilton, ON, CANADA, 2McGill University, Universite de Montreal, Montreal, PQ, CANADA, 3University of British Columbia, Vancouver, BC, CANADA.
894 Characterization of Chronic Rhinitis in Children
R. Kachru, J. Friedrich, J. Corren; Allergy Research Foundation, Los Angeles, CA.
895 Clinical Characteristics of Allergic Rhinitis and Nonallergic Rhinitis in Pediatric Allergy Clinic at Siriraj Hospital, Thailand
C. Suratannon, P. Lertbunnaphong, O. Jirapongsananuruk, N. Visitsunthorn, P. Vichyanond; Siriraj Hospital, Bangkok, THAILAND.
896 Nasal Spray Device And Formulation Attributes May Contribute To Stopping Treatment With Prescription Nasal Sprays
R. Stanford 1, E. Meltzer2, R. Nathan3, J. Derebery4, P. Stang5, U. Campbell5; 1GlaxoSmithKline, Research Triangle Park, NC, 2Allergy and Asthma Medical Group and Research Center, San Diego, CA, 3Asthma & Allergy Associates and Research Center, Colorado Springs, CO, 4House Ear Clinic, Los Angeles, CA, 5Galt Associates, Blue Bell, PA.
897 US and European Perspective on the Burden of Chronic Sinusitis: Survey of Allergists and Otolaryngologists
L. Katz 1, R. Casciano1, A. Stergious1, M. Memran2, J. Willet1; 1Accentia Biopharmaceuticals, New York City, NY, 2Analytica International, New York City, NY.
Poster Session
4212
Monday, February 26, 2007
9:45 AM - 10:45 AM
Therapy of Allergic Conjunctivitis and Allergic and Non-Allergic Rhinitis
898 Efficacy and Safety of Mometasone Furoate Alone or With Concomitant Medication for Perennial and Seasonal Allergic Rhinitis
H. Ulmer; Medizinische Universität Innsbruck, Innsbruck, AUSTRIA.
899 A Real World Open-label Multicenter Single Group Study to Evaluate Patients' Reactions to Mucinex
(Single Entity Long-acting Guaifenesin)
W. W. Storms 1, M. A. Kaliner2, M. Javidi3, J. R. Farrar4, C. S. Efessiou5; 1The Williams Storms Allergy Clinic, Colorado Springs, CO, 2The Institute for Asthma and Allergy, Wheaton and Chevy Chase, MD, 3North Carolina State University, Raleigh, NC, 4SRxA Institute for Professional Education, Washington, DC, 5Strategic Pharmaceutical Advisors, Inc., Washington, DC.
900 Patient Comparison of Sensory Attributes of Olopatadine and Azelastine Nasal Sprays
E. O. Meltzer 1, W. E. Berger2, S. J. Chadwick3, G. Gross4, C. F. LaForce5, R. Garadi6, K. Crenshaw6, G. M. Wall6; 1Allergy & Asthma Medical Group & Research Center, San Diego, CA, 2Allergy & Asthma Associates of Southern California, Mission Viejo, CA, 3ENTA Allergy, Head & Neck Institute, Decatur, IL, 4Pharmaceutical Research and Consulting, Inc., Dallas, TX, 5North Carolina Clinical Research, Raleigh, NC, 6Alcon Research, Ltd., Fort Worth, TX.
901 Acoustic Rhinometry And Symptoms Score Evaluation During The Treatment With Desloratadine In Pediatric Patients With Allergic Rhinitis
A. B. F. Fomin, A. G. A. Oliveira, A. C. Pastorino, C. M. A. Jacob; Faculty of Medicine of University of Sao Paulo, Sao Paulo, BRAZIL.
902 Fluticasone Furoate∗ (FF) Nasal Spray-Ergonomic Considerations for a Next Generation Delivery System
[∗USAN approved name]
J. W. Godfrey, A. C. Grant, A. L. Slater; GlaxoSmithKline Research & Development, Ware, Hertfordshire, UNITED KINGDOM.
903 Once-Daily Fluticasone Furoate∗ Nasal Spray (FFNS) Improves Quality of Life (QoL) in Subjects with Seasonal Allergic Rhinitis (SAR) during the mountain cedar pollen season
∗USAN approved name
J. H. van Bavel 1, T. Toler2, A. Ellsworth2, R. Stanford2, E. Philpot2; 1Allergy & Asthma Associates Research Dept., Austin, TX, 2GlaxoSmithkline, RTP, NC.
904 Do Allergic Rhinitis (AR) Patients Achieve Twenty-four Hour Symptom Control?
A. Dalal 1, A. E. Williams2, S. Kay3; 1GlaxoSmithKline, Research Triangle Park, NC, 2GlaxoSmithKline R&D, London, UNITED KINGDOM, 3Adelphi Group Products, Macclesfield, UNITED KINGDOM.
905 Buffered Hypertonic Saline Nasal Spray and Gel As Treatment Modifiers in Allergic and Vasomotor Rhinitis
J. N. Hausfeld; George Washington University School of Medicine and Health Sciences, Washington, DC.
906 Ocular Efficacy of a Novel, Enhanced Affinity Corticosteroid, Fluticasone Furoate∗ Nasal Spray, in Ragweed-Sensitive Patients
∗USAN-approved name
W. R. Lumry 1, S. H. Cohen2, A. Levy3, E. Philpot4, T. Toler4, A. Ellsworth4; 1Allergy and Asthma Specialists, Dallas, TX, 2Allergic Diseases, Milwaukee, WI, 3Foot Hills Asthma & Allergy Association, Spartanburg, SC, 4GlaxoSmithKline, Research Triangle Park, NC.
907 Fluticasone Furoate∗ (FF) Nasal Spray - Development of a Next-Generation Delivery System for Allergic Rhinitis
[∗USAN approved name]
W. Berger 1, J. W. Godfrey2, A. C. Grant2, A. L. Slater2, S. J. Broughton2; 1Southern California Research, Mission Viejo, CA, 2GlaxoSmithKline Research & Development, Ware, Hertfordshire, UNITED KINGDOM.
908 Once-daily Fluticasone Furoate∗ Nasal Spray (FF) Effectively Treats Ocular Symptoms Of Seasonal Allergic Rhinitis (SAR) Caused By Mountain Cedar Pollen
∗USAN Approved Name
P. Ratner 1, C. Andrews2, J. van Bavel3, T. Toler4, A. Ellsworth4, E. Philpot4; 1Sylvana Research Associates, San Antonio, TX, 2Diagnostics Research Group, San Antonio, TX, 3Allergy and Asthma Associates, Austin, TX, 4GlaxoSmithKline, Research Triangle Park, NC.
909 Lack of Effect on Hypothalamic-Pituitary-Adrenal (HPA)Axis Function by Once-daily Fluticasone Furoate∗ Nasal Spray (FFNS) 110 mcg in Children with Perennial Allergic Rhinitis (PAR)
∗USAN approved name
I. Tripathy 1, R. Sterling2, D. Clements3, W. Wu3, M. Faris3, E. Philpot3; 1Clinical Research of the Ozarks, Rolla, MO, 2Carolina Research, Orangeburg, SC, 3GlaxoSmithKline, Research Triangle Park, NC.
910 Once-daily Fluticasone Furoate∗ Nasal Spray (FFNS) is Effective for the Treatment of Seasonal Allergic Rhinitis (SAR) Caused by Ragweed
∗USAN-approved name
H. B. Kaiser 1, R. Naclerio2, J. Given3, E. Philpot4, T. Toler4, A. Ellsworth4; 1Asthma and Allergy Specialists, Minneapolis, MN, 2University of Chicago Hospitals, Chicago, IL, 3Allergy and Respiratory Center, Canton, OH, 4GlaxoSmithKline, Research Triangle Park, NC.
911 Rhinorrhea Not Responding to Nasal Corticosteroids
P. N. Patel 1, B. Oyefara1, R. Aarstad2, S. L. Bahna1; 1Allergy/Immunology Section, Louisiana State University Health Sciences Center, Shreveport, LA, 2Otolaryngology Department, Louisiana State University Health Sciences Center, Shreveport, LA.
Oral Abstract Session
4601
Monday, February 26, 2007
1:45 PM - 3:00 PM
Antiviral Immunity
912 Viremia is Associated with Sleep Disturbances, Neurocognitive Disorders and Cytokine Dysregulation in Pediatric HIV Infection
S. B. Foster 1, M. E. Paul1, D. G. Glaze1, J. M. Reuben2, L. L. Harris1, E. N. Cohen2, B. Lee2, C. A. Kozinetz1, H. L. Schwarzwald1, M. W. Kline1, C. D. Jackson1, A. J. Loeb1, P. E. Frerking1, J. E. Fehlis1, P. Y. Brouwers1, W. T. Shearer1; 1Baylor College of Medicine, Houston, TX, 2University of Texas, MD Anderson Cancer Center, Houston, TX.
913 Epigallocatechin Gallate Inhibits HIV-1-gp120-Induced Immune Dysregulation and Apoptosis in Human Lymphocytes
C. L. Nance 1,2, S. P. Westerfield2, V. C. Willis2, W. T. Shearer1,2; 1Texas Children's Hospital, Houston, TX, 2Baylor College of Medicine, Houston, TX.
914 Characterization of Antigen Presenting Cells of Peripheral Blood in Patients with HCV infection During Immunotherapy
L. P. Titov 1, U. V. Tarasiuk1, I. A. Karpov2, E. N. Yagovdik-Telezhnaya2, L. M. DuBuske3; 1Belarusian Research Institute for Epidemiology and Microbiology, Minsk, BELARUS, 2Belarusian State Medical University, Minsk, BELARUS, 3Immunology Research Institute of New England, Gardner, MA.
915 Characterization of Peripheral Blood Mononuclear Cells and Dendritic Cells in Patients with Viral Hepatitis C
L. Titov 1, U. V. Tarasiuk1, E. N. Yagovdik-Telezhnaya2, I. A. Karpov2, D. A. Charnashey2, L. M. DuBuske3; 1Belarusian Research Institute for Epidemiology and Microbiology, Minsk, BELARUS, 2Belarusian State Medical University, Minsk, BELARUS, 3Immunology Research Institute of New England, Gardner, MA.
916 Inhibition of Respiratory Syncytial Virus (RSV) Replication in Cell Culture by Small Interfering RNA (siRNA)
M. R. Khaitov 1, V. S. Akimov1, E. B. Faizuloev1, A. A. Nikonova1, L. P. Alexeev1, V. V. Zverev1, L. M. DuBuske2; 1Institute of Immunology, Moscow, RUSSIAN FEDERATION, 2Immunology Research Institute of New England, Gardner, MA.
917 Diminished Airway Inflammation against Double-stranded RNA in Mast Cell-Deficient Mice
H. Nagase 1, K. Noda1, M. Yamaguchi2, H. Yoshihara1, K. Yamamura1, T. Yano1, S. Ueki1, H. Ishida1, O. Ohbayashi1, M. Nakajima1, T. Adachi1, K. Ohta1; 1Teikyo University, Tokyo, JAPAN, 2University of Tokyo, Tokyo, JAPAN.
Oral Abstract Session
4602
Monday, February 26, 2007
1:45 PM - 3:00 PM
Molecular Mechanisms of Allergic and Immunologic Disease
918 Characterization of Bet v 1 Specific CD4+ T cell Responses in Allergic and Non Allergic Individuals
M. Philippe; Stallergenes SA, Antony, FRANCE.
919 Interleukin-5 Receptor Endocytosis is Regulated by Two Distinct Pathways
M. Moczygemba, J. T. Lei; Baylor College Of Medicine, Houston, TX.
920 G-Protein Receptor Kinases (grKs) Play an Important Regulatory Role in the K/BxN Serum Transfer Model of Inflammatory Arthritis
T. K. Tarrant 1, R. R. Rampersad1, C. G. Moore1, L. R. Rothlein1, R. M. Lefkowitz2, D. M. Lee3, D. D. Patel4; 1University of North Carolina, Chapel Hill, NC, 2Duke University, Durham, NC, 3Brigham and Women's Hospital, Boston, MA, 4Novartis, Basel, SWITZERLAND.
921 Flt3 Ligand (FL) Treatment Generates Multiple Subsets of Myeloid Dendritic Cells (DCs) with Differential Phenotypic and Functional Properties in Mouse Model of Asthma
A. S. Bharadwaj, D. K. Agrawal; Creighton University, Omaha, NE.
922 Thymic Stromal Lymphopoietin (TSLP) and Receptor (TSLPR) and CD11c+ Dendritic Cells (DC) in Allergen-induced Cutaneous Late Phase Responses (LPR) in Atopic Subjects
S. Ying 1, Y. H. Wang2, Y. J. Liu2, Q. Meng1, A. B. Kay3, S. Phipps3, T. H. Lee1, C. J. Corrigan1; 1King's College London, London, UNITED KINGDOM, 2Centre of Cancer Immunolgy, MD Anderson Cancer Centre, Houston, TX, 3Imperial College, London, UNITED KINGDOM.
923 Atrial Natriuretic Peptide (ANP)-mediated Maturation and Cytokine Phenotype of Human Dendritic Cells (DCs) Involve Demethylation of the SOCS3 Promoter
W. Zhang, X. Cao, G. Hellermann, R. F. Lockey, S. S. Mohapatra; USF, Tampa, FL.
Oral Abstract Session
4603
Monday, February 26, 2007
1:45 PM - 3:00 PM
The Health Effects of Air Pollutants In and Out of the Workplace
924 Early Childhood Environmental Tobacco Smoke Exposure is Associated with Lower Serum Total IgE at 18 Years
K. J. Woodcroft 1, S. Havstad1, D. R. Ownby2, C. C. Johnson1, E. M. Zoratti1; 1Henry Ford Health System, Detroit, MI, 2Medical College of Georgia, Augusta, GA.
925 Children Demonstrate Diminished Antioxidant Defenses Against Diesel Exhaust Particles
E. M. Lin, L. Zhang, D. Diaz-Sanchez; University of California at Los Angeles, Los Angeles, CA.
926 Characterization of Diesel Exposure and Wheezing in Infants: the Cincinnati Childhood Allergy and Air Pollution Study (CCAAPS)
P. H. Ryan 1, G. K. LeMasters1, P. Biswas2, S. Hu2, D. I. Bernstein1, J. Lockey1, M. Villareal1, G. K. Khurana Hershey3, S. Grinshpun1; 1University of Cincinnati, Cincinnati, OH, 2Washington University, St. Louis, MO, 3Cincinnati Children's Hospital Medical Center, Cincinnati, OH.
927 Th2 Cytokine Profiles Do Not Predict Antibody Responses and Respiratory Hyperresponsiveness Following Dermal Exposure To Isocyanates
M. J. K. Selgrade 1, E. H. Boykin1, N. Haykal-Coates1, M. R. Woolhiser2, C. Wiescinski2, D. L. Andrews1, A. K. Farraj1, D. L. Doerfler1, S. H. Gavett1; 1U.S. Environmental Protection Agency, Research Triangle Park, NC, 2The Dow Chemical Company, Midland, MI.
928 Occupational Latex Allergy in Non-Health Care Workers with Rubber Glove Exposure
R. Lleonart, M. Corominas; Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Barcelona, SPAIN.
929 Beta 2-Adrenergic Receptor Gene 46 A>G Polymorphism May Confer Specific IgE Sensitization In Toluene Diisocyanate-Exposed Workers
Y. Ye 1, H. Park1, S. Kim1, Y. Kang1, C. Kim2, H. Kim3, C. Hong4, A. Jang5, C. Park5, A. V. Wisnewski6, C. A. Redlich6; 1Ajou University School of Medicine, Suwon, REPUBLIC OF KOREA, 2Inha University College of Medicine, Incheon, REPUBLIC OF KOREA, 3The Catholic University of Korea, Seoul, REPUBLIC OF KOREA, 4Yonsei University College of Medicine, Seoul, REPUBLIC OF KOREA, 5Soonchunhyang University Hospital, Bucheon, REPUBLIC OF KOREA, 6Yale School of Medicine, New Heaven, CT.
Oral Abstract Session
4604
Monday, February 26, 2007
1:45 PM - 3:00 PM
Atopic Dermatitis
930 Probiotics in the Prevention of IgE-Associated Eczema: a Double Blind Randomised Placebo-Controlled Trial
T. Abrahamsson 1, T. Jakobsson1, M. Fagerås Böttcher1, M. Fredrikson2, M. C. Jenmalm1, B. Björkstén3, G. Oldaeus4; 1Department of Molecular and Clinical Medicine, Division of Pediatrics, Linköping, SWEDEN, 2Department of Molecular and Clinical Medicine, Division of Occupational and Environmental Medicine, Linköping University, Sweden, Linköping, SWEDEN, 3Institute of Environmental Medicine, Karolinska Institutet, Stockholm, SWEDEN, 4Department of Pediatrics, County Hospital Ryhov, Jönköping, SWEDEN.
931 Role of CD4+CD25high T Cells in the Persistence of Atopic Dermatitis
A. Singh, K. Burmeister, M. L. Jennes-Clough, R. Gangnon, M. Evans, K. A. Roberg, C. Tisler, D. DaSilva, T. Pappas, J. E. Gern, R. F. Lemanske, Jr., C. M. Seroogy; University of Wisconsin - Madison, Madison, WI.
932 GM-CSF Pathway Defects May Account for Reduced Neutrophil Chemotaxis in Atopic Dermatitis
L. G. Bankova 1, M. E. Brummet2, B. S. Bochner2, D. N. Grigoryev2, K. C. Barnes2, L. A. Beck1; 1Department of Dermatology and Division of Allergy/Immunology & Rheumatology, University of Rochester School of Medicine & Dentistry, Rochester, NY, 2Division of Allergy & Clinical Immunology, Johns Hopkins University School of Medicine, Baltimore, MD.
933 Histamine H4 Receptor Antagonists are Superior to H1R Antagonists in the Attenuation of Experimental Allergic Pruritus
P. J. Dunford, K. N. Williams, R. L. Thurmond; Johnson & Johnson PRD, San Diego, CA.
934 Analysis of Discrete Regulatory T Cell Subsets in Patients with Atopic Dermatitis Reveals Th2-Promoting Properties
A. J. Reefer, S. M. Satinover, J. Nguyen, M. D. Solga, J. Lannigan, B. Wilson, J. A. Woodfolk; University of Virginia, Charlottesville, VA.
935 Histamine 4 Receptor (H4R) Antagonism Reduces Edema In A Th2 And IgE Dependent Model Of Atopic Dermatitis
J. M. Cowden, M. Zhang, R. L. Thurmond, P. J. Dunford; Johnson and Johnson, San Diego, CA.
Oral Abstract Session
4605
Monday, February 26, 2007
1:45 PM - 3:00 PM
Food Allergy and Immunologic GI Disorders
936 Dendritic Cell Subsets In The Development Of Allergic Sensitization To Food Allergens In Mice
A. Blazquez Gonzalez, M. Berin; Mount Sinai School of Medicine, New York, NY.
937 Effect of Partially Hydrolyzed Formula in Atopy Prevention of High Risk Infants Identified by Atopic Risk Score
N. Pitaksit, P. Tansupapol, T. Tongkaew, P. Chatchatee, J. Ngamphaiboon; Allergy and Immunology Division, Department of Pediatrics, King Chulalongkorn Memorial Hospital, Bangkok, THAILAND.
938 DBPCFCs In Children With A History Of Anaphylaxis To Foods: Are They Necessary And Safe?
B. J. Vlieg-Boerstra, E. J. Duiverman, S. van der Heide, C. M. A. Bijleveld, J. Kukler, A. E. J. Dubois; University Medical Center Groningen, Groningen, THE NETHERLANDS.
939 Examining Attitudes and Behaviors in Adolescents with Food Allergy: A Telephone Survey
A. S. Murthy 1, R. Seshadri1,2, J. A. Pongracic1; 1Children's Memorial Hospital, Chicago, IL, 2The Mary Ann and J. Milburn Smith Child Health Research Program, Chicago, IL.
940 Il-13 Is Overexpressed In Eosinophilic Esophagitis And Induces Eotaxin-3 Expression In Esophageal Epithelial Cells
C. Blanchard 1, M. K. Mingler1, P. Putnam1, M. E. Rothenberg1,2; 1Cincinnati Children's Hospital, Cincinnati, OH, 2University of Cincinnati, College of Medicine, Cincinnati, OH.
941 Gastrointestinal Priming and Recruitment of Th2 Lymphocytes in Food Allergy
A. K. Knight 1, A. B. Blazquez2, S. Zhang2, L. Mayer2, H. A. Sampson2, M. C. Berin2; 1Louisiana State University Health Sciences Center, Shreveport, LA, 2Mount Sinai School of Medicine, New York, NY.
Oral Abstract Session
4606
Monday, February 26, 2007
1:45 PM - 3:00 PM
Cytokines as Therapeutic Targets in Allergic Disease
942 Overexpression of ClC-3 Channels Prevent TGF-β-induced Apoptosis in Human Airway Epithelial Cells
G. Cheng 1, M. Kim1, B. Chaudhari1, D. K. Agrawal1,2; 1Dept. of Biomedical Science, Creighton University School of Medicine, Omaha, NE, 2Dept. of Internal Medicine, Creighton University School of Medicine, Omaha, NE.
943 IL-4Ra, IL-13 and IL-10 Polymorphisms in Allergic Bronchopulmonary Aspergillosis
A. P. Knutsen, B. Kariuki, M. R. Shah; St. Louis University Health Sciences, Saint Louis, MO.
944 Lymphotacin (XCL1) Improves Suppressive Function of Regulatory T Cells from Allergic Asthmatics
S. W. Berquist; Stanford University, Stanford, CA.
945 A Synthetic Non-peptide Compound Targeting CCR5 Prevents the Development of Asthma in a Murine Model
Y. Suzaki, K. Hamada, Y. Kai, H. Kimura; Nara Medical University, 840 Shijo Kashihara Nara, JAPAN.
946 Allergy-driven Alternative Splicing of Interleukin-13 Receptor Alpha 2 Yields Distinct Membrane and Soluble Forms
Y. Tabata, W. Chen, M. R. Warrier, A. M. Gibson, M. O. Daines, G. K. Khurana Hershey; Cincinnati Children's Hospital Medical Center, Cincinnati, OH.
947 Inflammatory Cytokines Regulate Glucocorticoid Receptor [gr] via Differential Phosphorylation of Serine Residues In the AF1 Domain: Possible Role In Steroid Insensitive Asthma
R. J. Hasan, B. T. Ameredes, W. J. Calhoun; Division of Allergy, pulmonary, Immunology, CCM and Sleep. University of Texas Medical Branch, Galveston, TX.
Oral Abstract Session
4607
Monday, February 26, 2007
1:45 PM - 3:00 PM
Mechanisms of Chronic Rhinosinusitis
948 Analysis of the TLR2 Signaling Pathway in Nasal Epithelial Cells from Patients with Chronic Rhinosinusitis (CRS)
L. C. Grammer, B. Tancowny, Q. Truong-Tran, J. Lee, A. Peters, K. Harris, D. Conley, R. Kern, R. Schleimer; Northwestern University Feinberg Sch. Med., Chicago, IL.
949 Nasal Epithelial Gene Expression In Response To Cigarette Smoke Extract And Toll-Like Receptor Agonists: Relevance To Chronic Rhinosinusitis (CRS)
D. L. Hamilos; Mass Gen Hospital/Harvard Med Sch, Boston, MA.
950 B cell-activating Factor of the TNF Family (BAFF) Expression in Chronic Rhinosinusitis with Nasal Polyps
R. P. Schleimer 1, A. Kato1, A. Tripathi1, B. Tancowny1, L. Suh1, R. Carter1, M. Agashe1, K. E. Harris1, D. Conley2, R. Kern2, L. C. Grammer1; 1Allergy-Immunology Division, Northwestern University Feinberg School of Medicine, Chicago, IL, 2Department of Otolaryngology, Northwestern University Feinberg School of Medicine, Chicago, IL.
951 Staphylococcus Aureus Enterotoxin B Stimulation In Nasal Polyps
J. Patou, T. Van Zele, G. Holtappels, P. Gevaert, P. Van Cauwenberge, C. Bachert; Upper Airways Research laboratory, Department of Otorhinolaryngology, Ghent University, Ghent, BELGIUM.
952 Histologic Examination Reveals Distinct Disease Subsets of Chronic Sinusitis
S. B. Early, J. Han, L. Borish, J. Steinke; University of Virginia, Charlottesville, VA.
953 Regulatory Cytokines In Chronic Rhinosinusitis With And Without Nasal Polyps
K. Scheckenbach, A. Chaker, M. Wagenmann; Heinrich-Heine-University Duesseldorf, Duesseldorf, GERMANY.
Poster Session
5201
Tuesday, February 27, 2007
9:45 AM - 10:45 AM
Asthma Therapy II
954 In Vitro Metabolism of Ciclesonide in the Upper and Lower Airways
R. Nave 1, H. Sato2, E. Mutch3, T. Nonaka2, S. Nishimura2, H. Muroga2, Y. Katsuura2, N. McCracken1; 1Altana Pharma AG, Konstanz, GERMANY, 2Teijin Pharma Limited, Tokyo, JAPAN, 3University of Newcastle, Newcastle upon Tyne, UNITED KINGDOM.
955 The Preferred Regimen Of Corticosteroid Used By Practicing Community Physicians For Treatment Of Acute Asthma In Children
P. Britto-Williams 1, C. Williams2, R. Thomas1, M. Pansare1; 1Wayne State University, Detroit, MI, 2Henry Ford Bon Secour Hospital, Detroit, MI.
956 Efficacy of High-Dose Continuous Nebulized Levalbuterol for Pediatric Status Asthmaticus
T. Andrews, E. McGintee, L. Tyler, M. Mittal, A. Chew, N. Pawlowski, J. Zorc; The Children's Hospital of Philadelphia, Philadelphia, PA.
957 Effect of Gly16Arg β2-Adrenergic Receptor Variation on Response to Formoterol Administered Alone or in Combination With Budesonide in Patients With Moderate to Severe Persistent Asthma
M. Goldman 1, R. Lawrance2, H. Ambrose2; 1AstraZeneca, Wilmington, DE, 2AstraZeneca, Alderley Park, UNITED KINGDOM.
958 Effectiveness of, Adherence to and Satisfaction with Montelukast Treatment in Allergic Rhinitis Patients with Uncontrolled Asthma Symptoms while on Treatment with Low Dose Inhaled Corticosteroids
C. Koch 1, A. Kaplan2, J. Sampalis3, E. Psaradellis3, A. McIvor4; 1Merck Frosst Canada Ltd., Pointe-Claire, PQ, CANADA, 2Investigator, Richmond Hill, ON, CANADA, 3JSS Research Inc., Montreal, PQ, CANADA, 4MacMaster University, Hamilton, ON, CANADA.
959 Effects of Low Dose Fluticasone/Salmeterol Combination (Advair 100/50) on Surrogate Inflammatory Markers in Mild Persistent Asthma
M. A. Pasha 1, S. Patel1, H. Jafri2, P. Feustel1, D. Sarathchandra1, T. Smith1, P. Malone1, F. Jourd'heuil1, D. Jourd'heuil1; 1Albany Medical College, Albany, NY, 2U.T. Southwestern Medical Center, Dallas, TX.
960 Effects of KP-496, a Novel Dual Antagonist for Cysteinyl Leukotriene Receptor (CysLT1R) and Thromboxane A2 Receptor (TP), on Porcine Pancreas Elastase Induced Emphysema in Mice
S. Kurokawa, T. Okuda, M. Amakawa, M. Suda, T. Murata, Y. Hiyama; Kaken Pharmaceutical CO.,LTD., Kyoto, JAPAN.
961 Prevention of Exercise-induced Bronchoconstriction by a Single Dose of Montelukast or Salmeterol
D. S. Pearlman 1, C. Villaran2, T. Loeys3, C. Legrand3, T. F. Reiss3, G. Philip3; 1Colorado Allergy and Asthma Centers, Denver, CO, 2Clinica Ricardo Palma, Lima, PERU, 3Merck Research Labs, Rahway, NJ.
962 Soluble Adhesion Molecules And Cd40l In Asthma And Copd
J. V. Garmendia 1, D. Moreno2, N. E. Larocca1, C. M. Tálamo3, J. B. De Sanctis1; 1Instituto de Inmunología. Universidad Central de Venezuela, Caracas, VENEZUELA, 2Cátedra de Fisiopatología del Instituto de Medicina Experimental y Servicio de Neumonología del Hospital Universitario de Caracas. Universidad Central de Venezuela, Caracas, VENEZUELA, 3Servicio de Neumonología del Hospital Universitario de Caracas. Facultad de Medicina. Universidad Central de Venezuela, Caracas, VENEZUELA.
963 The Effect of Proton Pump Inhibitor on the Exhaled Breath Condensate pH and QOL in QUEST Questionnaire-Positive Asthmatics
T. Yano, H. Nagase, J. Nakano, H. Yoshihara, K. Yamamura, S. Ueki, O. Ohbayashi, M. Nakajima, T. Adachi, K. Ohta; Teikyo University School of Medicine, Tokyo, JAPAN.
964 Budesonide and Formoterol in One Metered-Dose Inhaler Improves Health-Related Quality of Life in Adults with Mild to Moderate Persistent Asthma Previously Treated with Inhaled Corticosteroids
H. Nelson 1, K. Murphy2, B. Parasuraman3, R. Boggs3, C. Miller3, L. O'Dowd3; 1National Jewish Medical and Research Center, Denver, CO, 2Midwest Allergy and Asthma Clinic, Omaha, NE, 3AstraZeneca, Wilmington, DE.
965 Perceived Onset of Effect of Budesonide and Formoterol Administered via One Pressurized Metered-dose Inhaler in Patients With Asthma Previously Receiving Inhaled Corticosteroids
N. K. Leidy 1, D. L. Patrick2, R. Boggs3, B. Parasuraman3, L. O'Dowd3; 1United BioSource Corporation, Bethesda, MD, 2University of Washington, Seattle, WA, 3AstraZeneca, Wilmington, DE.
966 Efficacy Of Ventolin® HFA MDI Cumulative Dosing In Children
A. Davis, W. Lincourt, R. Trivedi, A. Ellsworth, C. Crim; GlaxoSmithKline, RTP, NC.
967 The Safety of Home Therapy with Subcutaneous Anti-Immunoglobulin E Antibody Omalizumab in Twenty-five Patients with Allergic Asthma
M. I. Liebhaber, Z. Dyer; Sansum Santa Barbara Clinic, Santa Barbara, CA.
968 Prophylactic Effects of the Chinese Herbal Formula, ASHMI, in a Murine Model of Late Onset Atopic Asthma
P. J. Busse 1, T. Zhang1, K. Srivastava1, B. Schofield2, X. Li1; 1Mount Sinai School of Medicine, New York, NY, 2Bloomberg School of Publich Health, Baltimore, MD.
969 How Potent Are Inhaled Steroids? Cushing's Syndrome Due To Interaction Between Inhaled Fluticasone And Ritonavir In A Child With Human Immunodeficiency Virus (HIV) Infection
I. S. Randhawa, R. M. Ferdman, J. A. Church; Childrens Hospital Los Angeles, Los Angeles, CA.
970 Effect of long acting β2 agonist patch, Asthma
H. Lee; Cheil General Hospital, Seoul, REPUBLIC OF KOREA.
971 Comparative Bronchodilatory Effects of Formoterol Dry-Powder Inhaler (DPI) Versus the Combination of Formoterol and Budesonide Pressurized Metered-Dose Inhaler (pMDI)
W. S. Mezzanotte 1, C. J. Miller1, S. Senn2; 1AstraZeneca, Wilmington, DE, 2University of Glasgow, Glasgow, UNITED KINGDOM.
972 Comparative Assessment of Asthma Control With Budesonide and Formoterol in One Pressurized Metered-Dose Inhaler (pMDI) Versus Budesonide and Formoterol in Individual Inhalers and Placebo
J. Corren 1, P. E. Korenblat2, C. J. Miller3, C. D. O'Brien3, W. S. Mezzanotte3; 1Allergy Research Foundation, Los Angeles, CA, 2The Clinical Research Center, St Louis, MO, 3AstraZeneca, Wilmington, DE.
973 Cardiac Safety of Ventolin® HFA in Children
J. Hedrick1, A. Davis 2, W. Lincourt2, R. Trivedi2, A. Ellsworth2, C. Crim2; 1Kentucky Pediatric/Adult Research, Bardstown, KY, 2GlaxoSmithKline, RTP, NC.
974 Measured Onset of Bronchodilation With Budesonide and Formoterol Administered via One Pressurized Metered-dose Inhaler (pMDI) in Patients With Asthma Previously Receiving Inhaled Corticosteroids
H. B. Kaiser 1, C. J. Miller2, L. O'Dowd2; 1Clinical Research Institute, Minneapolis, MN, 2AstraZeneca, Wilmington, DE.
975 Effect of a Novel Medical Food (NMF) on Biomarkers of Inflammation and Airway Hyperresponsiveness in Children with Mild Persistent Asthma
R. Covar 1, B. Macomber1, L. Stewart1, M. Gleason1, K. Engelhardt1, J. Murphy1, A. Liu1, S. Wood2, S. DeMichele2, E. Gelfand1, S. Szefler1; 1National Jewish Med Res Ctr, Denver, CO, 2Ross Products, Abbott Laboratories, Columbus, OH.
976 The Significance of the Initiating Time of Inhaled Corticosteroid in Asthma Treatment
J. Jung 1, J. Kim2, J. Lee3; 1Dong-A University Hospital, Busan, REPUBLIC OF KOREA, 2Ulsan University Hospital, Ulsan, REPUBLIC OF KOREA, 3Masan Samsung Hospital, Masan, REPUBLIC OF KOREA.
977 Stability of IgE Levels during Acute Asthma: Implications for Initiation of Omalizumab Therapy after the Emergency Department Visit
C. J. Ahn1, B. M. Baumann2, R. F. Kysia3, M. S. Radeos4, K. Stiffler5, C. A. Camargo, Jr. 1; 1Massachusetts General Hospital, Boston, MA, 2Cooper University Hospital, Camden, NJ, 3Cook County Hospital, Chicago, IL, 4Lincoln Medical and Mental Health Center, Bronx, NY, 5Summa Health System, Akron, OH.
978 Prescribing of Fluticasone Propionate/Salmeterol Combinations as Initial Therapy for Patients With Asthma in a Commercially-Insured Population
H. S. Friedman 1, T. K. Wilcox2, G. Reardon3, S. Crespi4, B. P. Yawn5; 1Analytic Solutions, LLC, New York, NY, 2United Biosource Corporation, Bethesda, MD, 3Informagenics, LLC, Worthington, OH, 4Schering-Plough Corporation, Kenilworth, NJ, 5Olmsted Medical Center, Rochester, MN.
979 Management of Patients with Bronchial Asthma, Elevated IgE and Eosinophilia Including Patients with Churg Strauss Syndrome
V. V. Chopyak 1, G. O. Potomkina1, K. O. Lishchuk-Yakymovych1, R. R. Holovyn1, I. V. DuBuske2, L. M. DuBuske2; 1Lviv National Medical University, Lviv, UKRAINE, 2Immunology Research Institute of New England, Gardner, MA.
Poster Session
5202
Tuesday, February 27, 2007
9:45 AM - 10:45 AM
Immunodeficiency II
980 Reversible Pan-hypogammaglobulinemia Associated With The Antiepileptic Levetiracetam (keppra)
A. E. Azar 1,2, Z. K. Ballas1,2; 1University of Iowa Hospitals and Clinics, Iowa City, IA, 2Veterans Affairs Medical Center, Iowa City, IA.
981 Efficacy of IGIV in Patients With IgG Subclass Deficiency and/or Antibody Deficiency in a One-Year Open Label Study of Quality of Life, Innate Immunity, and Correction of Subclass/Antibody Levels
C. A. Greenwell 1, R. Mehta2, J. D. Hester3, G. V. Yamshchikov3, J. F. Halsey3, N. I. Abdou1; 1Center for Rheumatic Disease, Allergy, and Immunology, Kansas City, MO, 2University of Missouri Kansas City School of Medicine, Kansas City, MO, 3IBT Reference Lab, Lenexa, KS.
982 Why Are Patients Referred to A Non HIV Adult Immunodeficiency Clinic?
J. B. Hagan, R. S. Abraham, M. A. Park, G. W. Volcheck, D. E. Maddox, J. H. Butterfield, J. T. C. Li; Mayo, Rochester, MN.
983 Autoimmune Lymphoproliferative Syndrome (ALPS) in a Patient with Common Variable Immunodeficiency (CVID): Fas Deficiency with Increased Apoptosis
M. B. Narra 1, N. I. Abdou2; 1UMKC School of Medicine, Kansas City, MO, 2Center for Rheumatic Disease, Allergy and Immunology, Saint Luke's Hospital, Kansas City, MO.
984 A Pilot Study of Quality of Life, Mood, Sleepiness and Fatigue in Patients with Primary Immunodeficiency Receiving IVIG
A. S. Kanani, R. R. Schellenberg, D. F. Stark; University of British Columbia, Vancouver, BC, CANADA.
985 11q Terminal Deletion Disorder (Jacobsen Syndrome) with Combined Variable Immunodeficiency (CVID)
G. Puglisi, A. L. Cox, V. R. Bonagura; North Shore - Long Island Jewish Health System, Great Neck, NY.
986 Absent B-cells and Decreased T-cells in a Family With Hypogammaglobulinemia: A Unique Form of Combined Immune Deficiency?
M. H. Land, R. Tachdjian, E. Lin, M. Riedl, R. L. Roberts; UCLA Medical Center, Los Angeles, CA.
987 Recurrent Facial Herpes Simplex Infections in a 4 year Old Female with a Functional Natural Killer Cell Deficiency
A. Marks, R. Hostoffer, Jr.; Case Western Reserve University, Cleveland, OH.
988 IgG Subclasses Deficiency's Clinical Expressions
G. Manfredi, C. Derosa, E. Ventura, R. Caso; Religious Gen. Hospital “F. Miulli”, Acquaviva (BA), ITALY.
989 Partial DiGeorge Anomaly (DGA) with an Unusual Immune Phenotype is Diagnosed in an Adult Parent, after the Diagnosis of his Daughter
B. A. Becker, A. P. Knutsen; Saint Louis University School of Medicine, Saint Louis, MO.
990 Idiopathic CD4+ Lymphocytopenia in a Patient with Progressive Multifocal Leukoencephalopathy Treated with Cidofovir
S. J. McEldowney, R. K. Bush; University of Wisconsin Hospital and William S. Middleton Memorial Veterans Hospital, Madison, WI.
991 Griscelli Syndrome: A Case Report
J. Y. Zhang 1, A. J. MacGinnitie1, B. Ackermann2, C. Galambos3; 1Children's Hospital of Pittsburgh, Allergy and Immunology, Pittsburgh, PA, 2Children's Hospital of Pittsburgh, Pittsburgh, PA, 3Children's Hospital of Pittsburgh, Pathology, Pittsburgh, PA.
992 Hereditary Angioedema: An often Misdiagnosed Dsease
Y. X. Zhi, h. y. Zhang; Peking Union Medical College Hospital, Beijing, CHINA.
993 Heart Surgery Reverses Hypogammagolulinemia And CD4-cytopenia By Correcting Protein-losing Enteropathy
K. Y. Wang, R. L. Roberts; UCLA Medical Center, Los Angeles, CA.
994 A Child with WHIM Syndrome (Warts, Hypogammaglobulinemia, Infections, and Myelokathexis) and a Family History of Cervical Dysplasia Suggesting Generalized Susceptibility to Human Papilloma Virus Serotypes
L. E. Montelibano 1, K. Paris1, R. Howes2, R. U. Sorensen1; 1LSU Health Sciences Center, New Orleans, LA, 2LSU Health Sciences Center - University Medical Center, Lafayette, LA.
995 Autosomal Recessive Chronic Granulomatous Disease in a Two Week Old Arabic Female and Unusual Carrier State Detected on Flow Cytometry of Asymptomatic Siblings
N. Mireku, E. A. Secord; Children's Hospital of Michigan, Detroit, MI.
996 A Novel Case of Gaucher's Disease Associated with Hypogammaglobulinemia
S. Jariwala, J. Fodeman, D. Rosenstreich, G. Hudes, K. Ahuja; Division of Allergy and Immunology, Department of Medicine, Albert Einstein College of Medicine, Bronx, NY.
997 Major Histocompatibility Complex Class II (MHC II) Deficiency in a Child with Panhypogammaglobulinemia and Lymphopenia
A. E. Bailey 1, J. J. H. Bleesing2, S. M. Jones1, T. T. Perry1, U. M. Nagarajan1, A. M. Scurlock1; 1UAMS/Arkansas Children's Hospital, Little Rock, AR, 2Cincinnati Children's Hospital Medical Center, Cincinnati, OH.
998 Severe Mycobacterium Fortuitum Lung Disease Resembling Interstitial Pneumonitis in an 8 Year-old Child - Dilemmas in Diagnosis and Treatment
B. M. Peralejo, H. Aguila, L. Geng, H. Jyonouchi; University of Medicine and Dentistry of New Jersey, Newark, NJ.
999 Nonmyeloablative Matched Unrelated Donor Hematopoietic Cell Transplant for Late-Onset Omenn's with Novel RAG Mutation
D. A. Wierzbicki 1, J. A. Cox2, I. R. Rainville3, R. P. Nelson, Jr.4, M. T. de la Morena1; 1Division of Allergy and Immunology, University of Texas Southwestern Medical Center at Dallas, Dallas, TX, 2Pediatric Hematology/Oncology, University of Texas Southwestern Medical Center at Dallas, Dallas, TX, 3Correlagen Diagnostics, Inc, Cambridge, MA, 4Division of Hematology/Oncology, Indiana University School of Medicine and the Indiana Cancer Center, Indianapolis, IN.
1000 Infliximab Treatment For Common Variable Immunodeficiency (CVID) With Sarcoid-Like Granulomatous Disease: A Pediatric Case Report
R. J. Marchlewski, L. Katz, A. Shende, B. Gottlieb, V. R. Bonagura; North Shore-Long Island Jewish Health System, Great Neck, NY.
1001 Severe Hypogammaglobulinemia And Absent B Cells in an Adult Patient: A Case Report
S. R. Iyengar 1, B. G. Blackburn2, D. B. Lewis2; 1Children's Hospital of Boston, Boston, MA, 2Stanford University Medical Center, Stanford, CA.
1002 Sprue-like Disease Associated with T-Cell Clonality as a Cause of Death in a Patient with Common Variable Immunodeficiency
J. D. Mozena; University of Virginia, Charlottesville, VA.
1003 [Withdrawn]
1004 Granulomatous Disease Mimicking Angioedema in a Patient with Long-Standing Common Variable Immunodeficiency
D. S. Landa, B. Kaplan; North-Shore Long Island Jewish Health System, Great Neck, NY.
1005 A Novel Missense Mutation in CYBB gene in Chronic Granulomatous Disease
J. P. DeMore 1, Y. Dong2, D. B. Lewis2, J. E. Gern1, C. M. Seroogy1; 1University of Wisconsin Hospital and Clinics, Madison, WI, 2Stanford School of Medicine, Stanford, CA.
1006 Acquired C1 Esterase Inhibitor Deficiency in a Patient with Systemic Lupus Erythematosus (SLE)
J. V. Giannobile 1, B. J. Fessler2, J. R. Bonner1; 1University of Alabama at Birmingham, Department of Medicine, Division of Pulmonary, Allergy and Critical Care Medicine, Birmingham, AL, 2University of Alabama at Birmingham, Department of Medicine, Division of Immunology and Rheumatology, Birmingham, AL.
1007 Glucocorticoid Receptor [gr] Translocation Regulation by Inflammatory Cytokines
N. Bulayeva, B. T. Ameredes, W. J. Calhoun; University of Texas Medical Branch, Galveston, TX.
Poster Session
5203
Tuesday, February 27, 2007
9:45 AM - 10:45 AM
Dendritic Cells, Biological Therapies, and Innate Signals
1008 TLR2 Activation By Supernatant From Bifidobacterium Breve Modulates Maturation And Survival Of Human DCs Via Differential Effects On PI3Kinase, p38 And ERK Pathways
C. Hoarau 1, L. Martin1, F. Velge-Roussel1, C. Gontier2, Y. Lebranchu1; 1Public Hospital, Tours, FRANCE, 2Bledina, Stennvorde, FRANCE.
1009 ANP-NPRA Signaling Modulates Immunity By Altering TLR-2 Expression In Human Dendritic Cells (DCs)
X. Cao, W. Zhang, R. F. Lockey, S. S. Mohapatra; USF, Tampa, FL.
1010 Interferon-a Alters IgE Receptor-dependent Cytokine Production by Human Circulating Monocytoid Dendritic Cells
T. V. Le, B. A. Plunkett, R. A. Wood, S. K. Huang, J. T. Schroeder; Johns Hopkins School of Medicine, Baltimore, MD.
1011 Role Of Dendritic Cells In Drug Metabolism
C. Mayorga 1, R. R-Pena1, G. Perez-Cataldo2, M. Castell2, M. J. Torres3, C. Antunez1, P. Chaves1, J. V. Castell2, M. Blanca3; 1Research Laboratory, Fundacion IMABIS-Carlos Haya Hospital, Málaga, SPAIN, 2Experimental Hepathology Unit, University Hospital La Fe, Valencia, SPAIN, 3Allergy Service, Carlos Haya Hospital, Málaga, SPAIN.
1012 Are the Pro-Allergic Properties of House Dust Mite Allergen Explained by the Adjuvant Effects of Mite DNA?
S. Satinover, A. Reefer, K. Hulse, H. Carper, T. Platts-Mills, J. Woodfolk; University of Virginia, Charlottesville, VA.
1013 Gene Expression Profiles in The Plasmacytoid Dendritic Cells Stimulated with Lactobacillus GG or E.coli
S. Toki, H. Saito, K. Matsumoto; National Research Institute for Child Health and Development, Tokyo, JAPAN.
1014 Elucidating the Mechanisms of IL-12 Mediated Alterations of the Tumor Microenvironment
E. W. Sorensen; University of Rochester, Rochester, NY.
1015 Allergen and Antibody Mediated Desensitisation for Mucosal-Induced Respiratory Allergy
W. R. Thomas, P. T. Cunningham, C. E. Elliot, J. C. Lenzo, P. G. Holt; Telethon Institute for Child Health Research, West Perth, AUSTRALIA.
1016 Measurement of Enterovirus-Specific IgG in Intravenous Immunoglobulin Preparations
M. R. Kaplan 1, R. Arora2, M. R. Nelson1; 1Walter Reed Army Medical Center, Washington, DC, 2William Beaumont Army Medical Center, El Paso, TX.
1017 New Treatment Strategy for Systemic Mastocytosis
R. Sullivan, D. J. Stechschulte; University of Kansas, Kansas City, KS.
1018 Rituximab in Lupus Pneumonitis: Breathe Easier
A. L. B. Hersh, P. Efthimiou; UMDNJ - Newark, NJ, Newark, NJ.
1019 Peptide Immunotherapy: The Use of Bovine Colostrum Proline-Rich Polypeptides in Cytokine Modulation for the Alternative Relief of Allergic Symptoms
A. M. Keech; Advanced Protein Systems, Phoenix, AZ.
1020 Mast Cells co-cultured with Astrocytes Evokes the Releases of Mediators via Intracellular Calcium Signal Pathway
D. Kim1,2, Y. Ahn3, Y. Lee1,2, J. Ro 1,2; 1Sungkyunkwan University School of Medicine, Suwon, REPUBLIC OF KOREA, 2Samsung Biomedical Research Institute, Suwon, REPUBLIC OF KOREA, 3Eulji University School of Medicine, Seoul, REPUBLIC OF KOREA.
1021 (1) The Plasma Membrane Shuttling of CAPLI in Mast Cell Activation
M. NAKANISHI; Aichi Gakuin University, Nagoya, JAPAN.
1022 The Role of Innate Immunity in Otitis Media
M. L. Hernandez; University of California, San Diego, La Jolla, CA.
1023 Identification of Protein Related with Maturation of Mouse Bone Marrow-Derived Mast Cells
S. Ryu1,2, D. Kim1,2, B. Lee3, J. Ro 1,2; 1Sungkyunkwan University School of Medicine, Suwon, REPUBLIC OF KOREA, 2Samsung Biomedical Research Institute, Suwon, REPUBLIC OF KOREA, 3Yonsei University College of Medicine, Seoul, REPUBLIC OF KOREA.
1024 Basic Fibroblastic Factor-induced Neurite Outgrowth Suppressed by Nicotine via Inhibition of Nitric Oxide Synthesis in H19-7 Cells
H. Lee, J. Oh, J. Han, Y. Koh, S. Park, J. Cho, D. Oh; Hanyang University Medical Center, Seoul, REPUBLIC OF KOREA.
1025 Activity Of TLR Pathways In Healthy Children And Adults And Patients Taking Immunosuppressive Drugs
N. Khan, M. Helbert, P. D. Arkwright; University of Manchester, Manchester, UNITED KINGDOM.
1026 CATERPILLERS R US: Novel Regulators of Inflammation and Apoptosis Preserved from Plants to Humans
J. P. Y. Ting; Lineberger Comprehensive Cancer Center CB#7295, Chapel Hill, NC.
1027 Characterisation of a New Intravenous Immunoglobulin
M. López, P. Ristol, J. I. Jorquera; INSTITUTO grIFOLS, S.A., Parets del Vallès, Barcelona, SPAIN.
1028 Human Keratinocytes Secrete TNFa Stimulated With Cytomix and D. Pteronyssinus Extract
M. Frieri, A. Capetandes; Nassau University Medical Center-North Shore Long Island Jewish Health Care System, East Meadow, NY.
1029 Capacity of Human Intravenous Immunoglobulin (IGIV3I) Production Process to Eliminate an Experimental TSE-Model Agent
J. M. Diez, H. Biescas, S. Caballero, R. Gajardo, J. I. Jorquera; Instituto Grifols, Barcelona, SPAIN.
1030 Sophorolipids Decrease IgE Production in U266 Cells by Downregulation of BSAP (Pax5), TLR-2, STAT3 and IL-6
M. Hagler1, T. A. Smith-Norowitz1, S. Chice1, S. R. Wallner2, D. Viterbo1, C. M. Mueller1, R. Gross2, M. Nowakowski1, R. Schulze1, M. E. Zenilman1, M. H. Bluth 1; 1SUNY Downstate Medical Center, Brooklyn, NY, 2Polytechnic University, Brooklyn, NY.
1031 Viral Safety Studies of a New Human Intravenous Immunoglobulin (IGIV3I)
H. Biescas, S. Caballero, N. Domingo, R. Gajardo, J. I. Jorquera; Instituto Grifols, Parets del Vallès. Barcelona, SPAIN.
1032 Cytokine and Chemokine Responses of Type II Alveolar Epithelial Cells (AEC) in Monocrotaline-Induced Pulmonary Fibrosis
R. N. Kamal 1, A. Molteni1, M. Zoubine1, M. Norkin1, S. Reppert2, Y. Xue2, R. Baybutt2, B. Herndon2, A. Shnyra1; 1University of Missouri - Kansas City School of Medicine, Kansas City, MO, 2Kansas State University, Manhattan, KS.
Poster Session
5204
Tuesday, February 27, 2007
9:45 AM - 10:45 AM
A Medley of EORD Topics
1033 Prevalence and Titer of Specific IgE Antibodies in Relation to Total Serum IgE: Evaluation of Sensitization to Allergens Derived from Domestic Mice
L. Naccara1, P. Heymann1, M. Carter2, A. Litonjua3, E. Peters4, S. Satinover1, E. Erwin1, T. A. E. Platts-Mills 1; 1University VA Medical Center, Charlottesville, VA, 2NIH/NIAID, Bethesda, MD, 3Harvard Medical Center, Boston, MA, 4Allergy and Asthma Consultants, Austin, TX.
1034 Sequence Analysis of Monoclonal Antibodies Against Group 1 Dust Mite Allergens
K. T. Williams, M. D. Chapman, A. Pomés; INDOOR Biotechnologies, Inc., Charlottesville, VA.
1035 Gender and Age Differences in Component Resolved Sensitization Pattern to Grass Pollen Allergens
A. Marknell DeWitt 1, C. Nordenhall2, T. Lundgren1, M. Nordlund2, G. Lilja2, J. Lidholm1; 1Phadia AB, Uppsala, SWEDEN, 2Department of Paediatrics, Sachs' Children's Hospital, Stockholm, SWEDEN.
1036 Bcg's Scar and Allergic Sensitization in High Risk Atopic Children
C. S. K. La Scala, V. V. E. Rullo, L. C. L. de Oliveira, D. Solé; Sao Paulo Federal University, Sao Paulo, SP, BRAZIL.
1037 Simultaneous Detection of Total and Allergen-specific IgE Using Fluorescent Multiplex Array Technology
E. M. King, C. Earle, A. Tsay, L. Vailes, M. D. Chapman; INDOOR Biotechnologies Inc., Charlottesville, VA.
1038 Settled Barn and Home Dust Induces Distinct Airway Inflammation in Mice not Explained by Endotoxin
M. S. Leino 1, H. Alenius1, T. Haahtela2, L. von Hertzen2, H. Wolff3, M. Salkinoja-Salonen4, M. A. Andersson4, O. Saris4, L. Pylkkänen1, K. Reijula1, M. Mäkelä2; 1Finnish Institute of Occupational Health, Helsinki, FINLAND, 2Department of Allergy, Helsinki University Central Hospital, Helsinki, FINLAND, 3Department of Pathology, Helsinki University Central Hospital, Helsinki, FINLAND, 4Department of Applied Chemistry and Microbiology, University of Helsinki, Helsinki, FINLAND.
1039 Microbial Contaminants Contribute to the Inflammatory Effect of Metal Working Fluid in a Murine Model
M. C. Zacharisen 1, C. S. Barrios2, V. P. Kurup1,2, J. N. Fink1; 1Medical College of Wisconsin, Milwaukee, WI, 2Zablocki VA Medical Research Center, Milwaukee, WI.
1040 Effects of Oral Monosodium Glutamate (MSG) in Mouse Models of Asthma and Atopic Dermatitis
J. Yoneda; Ajinomoto co., INC. Institute of Life Sciences, Kawasaki-shi., JAPAN.
1041 Botanical Combination Product Reduces Late-Phase Response To Nasal Allergen Challenge
M. Lemay 1, Y. Lin1, R. K. Randolph1, L. Rozga1, D. Diaz-Sanchez2, D. Krempin1, J. Corren3; 1Nutrilite Health Institute, Buena Park, CA, 2Department of Medicine, University of California, Los Angeles, CA, 3Allergy Research Foundation, Los Angeles, CA.
1042 Comparative Analysis of Extract-based Skin Test and IgE detection, Singleplexed Molecule-based IgE Detection and a Molecule-based Microarray System
A. Mari 1, P. Palazzo1, D. Pomponi1, M. Helmer-Citterich1, D. Zennaro2,1, M. Giani1, E. Scala1; 1Center for Clinical and Experimental Allergology. IDI-IRCCS, Rome, ITALY, 2Campus-Biomedico University, Rome, ITALY.
1043 Development of a Microarray Assay to Determine the Potency of Allergenic Extracts Using Recombinant Antibodies
N. C. deVore, J. E. Slater; Food and Drug Administration, Rockville, MD.
1044 Exposure To Formaldehyde In Asthmatic And Control Dwellings In The Area Of Strasbourg (France)
C. Marchand 1, S. Le Calvé1, P. Mirabel1, N. Glasser2, A. Casset3, N. Schneider3, F. de Blay3; 1CNRS - Louis Pasteur University, Strasbourg, FRANCE, 2Faculty of Pharmacy, Illkirch, FRANCE, 3Asthma and Allergy Division, Department of Chest Diseases, University Hospital, Strasbourg, FRANCE.
1045 Measurement of Airway Hyperresponsiveness May Be a Incomplete Outcome Parameter in Occupational Asthma
C. Kim, B. Park, J. Cho; Inha University Hospital, Incheon, REPUBLIC OF KOREA.
1046 Occupational Rhinitis and Asthma Caused by Tampico Fibers in a Brush Maker
S. Quirce, M. Fernández-Nieto, C. Pastor, J. Torres, A. Enríquez, J. Sastre; Fundación Jiménez Díaz, Madrid, SPAIN.
1047 Lower Airway Inflammation Assessed by Induced Sputum in a Cluster of Cases Suggestive of Organic Dust Toxic Syndrome
R. Castano, J. L. Malo, C. Lemiere, M. Labrecque, A. Cartier; Hoˆpital du Sacré-Coeur de Montréal, Montréal, PQ, CANADA.
Poster Session
5205
Tuesday, February 27, 2007
9:45 AM - 10:45 AM
Drug Allergy II
1048 Is there Adequate Regulation in the Use of Complementary and Alternative Medicines (CAM)?
H. C. G. Wong 1,2; 1University of British Columbia, Vancouver, BC, CANADA, 2Vancouver General Hospital, Vancouver, BC, CANADA.
1049 Moxifloxacine-induced Drug Hypersensitivity Syndrome
S. Lee; Dong-A University, Busan, REPUBLIC OF KOREA.
1050 Successful Transcatheter Closure of an Atrial Septal Defect in a Nickel-Allergic Patient
B. Vickery, P. Askenase, F. Kantor, J. Asnes; Yale University, New Haven, CT.
1051 Risk Factors For Adults with a History of Penicillin Allergy
A. J. Apter 1, F. Wan1, J. Chittams1, B. Adelsberg2, S. Andrew3, M. Blaiss4, M. Columbo5, A. Davidson6, P. Detjen7, B. De Cotiis8, D. Dvorin9, L. Ford10, S. Gawchik11, S. Gillman12, M. Grijnsztein13, G. Gross14, M. Hoffman15, M. Lanz16, A. Stillerman17, P. Takach18, T. Rebbeck1; 1University of Pennsylvania, Philadelphia, PA, 2Connecticut Medical Group, Hamden, CT, 3Mainland Allergy Clinic, Dickinson, TX, 4Allergy & Asthma Care, Germantown, TN, 5Rohr &Columbo Asthma, Allergy & Immunology Specialists, Bryn Mawr, PA, 6Allergy & Asthma Consultants, Mt. Pleasant, TN, 7Adult & Pediatric Asthma & Allergy, Kenilworth, IL, 8De Cotiis & Grijnszstein, Brick, NJ, 9Allergy and Asthma Research of New Jersey, Forked River, NJ, 10Asthma & Allergy Center, Papillion, NE, 11Crozer Chester Medical Center, Chester, PA, 12Sherwin Gillman, Orange, CA, 13DeCotiis & Grijnsztein, Brick, NJ, 14Atlantic Allergy Asthma & Immunology Associates, Ashbury Park, NJ, 15Allergy, Asthma, and Immunology Associates, Lincoln, NE, 16Allergy, Asthma, Atopic Dermatitis, Rhinitis, and Sinusitis Clinical Research Center, Coral Gables, FL, 17Allergy and Asthma Specialists, Minneapolis, MN, 18Allergy Associates, Chico, CA.
1052 Evidence for Cross-Reactivity Among Proton Pump Inhibitors (PPIs): A Case Report of Hypersensitivity to Three PPIs
A. L. Cox, B. Kaplan; North Shore-Long Island Jewish Health System, Great Neck, NY.
1053 Iodinated Contrast Media Hypersensitivity Diagnosis - Skin Tests and Limphoblastic Transformation Test
A. F. F. Ferrão, R. P. Reis, L. A. Patricio, M. R. Viseu, S. H. Correia, S. H. Correia, M. J. Peres, E. M. Tomaz, F. C. Inácio; Hospital S. Bernardo, Setubal, PORTUGAL.
1054 Desensitization to High-dose Methotrexate (mtx) After Anaphylactoid Reaction, Without Premedication Phase
S. R. Abouhassan 1, S. Alexander2, A. Chouksey2; 1University Hospitals of Cleveland, Cleveland, OH, 2Rainbow Babies & Children's Hospital, Cleveland, OH.
1055 Human Insulin Allergy of Immediate Type and Insulin-induced Vasculitis In a Patient With Diabetes Mellitus Type 1
D. C. Hatzis 1, C. Larmou2, I. Ioannou2, A. Anagnostou - Keramida3, C. Bartsocas1; 1Mitera General Hospital, Athens, grEECE, 2Limassol General Hospital, Limassol, CYPRUS, 3Evangelismos General Hospital, Athens, grEECE.
1056 Oral Aspirin Challenge In Acute Myocardial Infarction
D. S. Walia, D. J. Stechschulte; Kansas University Medical Center, Kansas City, KS.
1057 A Case Study of a Lichenoid Drug Eruption due to Oral Cyclosporine
J. S. Swartz, M. Budev, A. Mehta; Cleveland Clinic, Cleveland, OH.
1058 Allergenic Cross-Reactivity between Echinacea and Ragweed
M. B. Fasano; Universtiy of Iowa, Iowa City, IA.
1059 Assessment of Irritant Skin Test Reactions to Common Vaccines
R. A. Wood, R. Setse, N. Halsey; Johns Hopkins University, Baltimore, MD.
1060 Penicillin Skin Testing and Challenges in the Absence of the Major Penicillin Determinant
P. A. Greenberger, A. T. Peters; Northwestern University, Chicago, IL.
1061 Cytokine and Chemokine Expression in the Skin from Patients with Maculopapular Exanthema to Drugs
T. D. Fernández 1, C. Mayorga1, J. A. Cornejo-García1, M. J. Torres2, C. Rondon2, R. R-Pena1, S. López1, E. Martín2, M. Blanca2; 1Research Laboratory. Fundacion IMABIS-Carlos Haya Hospital, Málaga, SPAIN, 2Allergy Service. Carlos Haya Hospital, Málaga, SPAIN.
1062 Predicting Severity of Reactions During Aspirin Desensitization in Patients with Aspirin Exacerbated Respiratory Disease (AERD)
A. P. Hope, R. A. Simon, D. D. Stevenson; Scripps Clinic/Green Hospital, La Jolla, CA.
1063 Cytokine and Transcription Factors Expression in Patients with Delayed Allergic Reactions to Drugs
J. A. Cornejo-Garcia 1, T. D. Fernandez1, C. Mayorga1, M. J. Torres2, M. Carballo3, I. Hernan3, C. Rondon2, J. L. Rodriguez-Bada1, E. Martin2, M. Blanca2; 1Research Laboratory, Fundacion IMABIS-Carlos Haya Hospital, Málaga, SPAIN, 2Allergy Service, Carlos Haya Hospital, Málaga, SPAIN, 3Laboratory Service, Tarrasa Hospital, Barcelona, SPAIN.
1064 Rapid Desensitization with Imipenem in Penicillin Allergic Patient
M. R. Aquino, A. Wolff, A. Hersh, L. Bielory; UMDNJ Newark, Newark, NJ.
1065 Prompt Recognition And Timely Diagnosis Of Stevens-Johnson Syndrome
S. J. Schuval 1, G. Schwarz1, A. Cox1, P. Ponda1, W. Li2; 1Schneider Children's Hospital, New Hyde Park, NY, 2North Shore University Hospital, Manhasset, NY.
1066 Exaggerated Neurogenic and Allergic Inflammation in the Skin of Rats Treated with Systemically Administered Indomethacin
T. Sakamoto, M. Miyake, R. Kimura, S. Morii, K. Ito; Nagoya University Graduate School of Medicine, Nagoya, JAPAN.
1067 Allergy to Marijuana: Case report
S. Perez-Bustamante, M. Vazquez de la torre, A. Villanueva, R. Pelta, M. Rubio, M. Baeza; Hospital General Universitario Gregorio Marañon, Madrid, SPAIN.
Poster Session
5206
Tuesday, February 27, 2007
9:45 AM - 10:45 AM
Angiodema
1068 Hereditary Angioedema and Pancreatitis
D. Chung, P. Busse, M. Oh; Mount Sinai Medical Center, New York, NY.
1069 Hereditary Angioedema: Clinical Aspects in a Brazilian Family
M. Ferraro, M. Thiesen, L. Arruda, W. Sarti; School of Medicine of Ribeirão Preto-University of São Paulo, Ribeirão Preto, BRAZIL.
1070 Fresh Frozen Plasma for the Treatment of Hereditary Angioedema
M. Prematta, J. Gibbs, T. J. Craig, E. Pratt, T. Stoughton; Penn State University, Hershey, PA.
1071 Absolute Bioavailability of Subcutaneously Administered Icatibant, a Selective and Potent Bradykinin B2 Receptor Antagonist
F. Wagner 1, B. Rosenkranz2, J. Knolle2; 1Charite Research Organisation GmbH, Berlin, GERMANY, 2Jerini AG, Berlin, GERMANY.
1072 Successful Treatment of Chronic Idiopathic Urticaria & Angioedema (CIU), With Xolair (Omalizumab)
C. A. Shapiro 1, N. S. Kapetanos2, E. Sarmiento2; 1Flushing Hospital Med Ctr, Flushing, NY, 2Advanced Allergy & Asthma Assessment & Diagnostics, P.C., Bayside, NY.
1073 Resolution of Angioedema with Omalizumab
J. W. Blume, S. Kiratseavee, M. F. Sands; University at Buffalo, Buffalo, NY.
1074 Angioedema from Angiotensin I-Converting Enzyme Inhibitors May Have a Genetic Basis in African-American Families
A. Shah, D. Shats, V. Rajput; UMDNJ-Robert Wood Johnson Medical School. Cooper University Hospital, Camden, NJ.
1075 Hereditary Angioedema: Clinical Characteristics and Outcome of 36 Patients
L. K. Tanno, L. H. Pinto, A. A. Motta, J. Kalil, P. Giavina-Bianchi; FMUSP, São Paulo, BRAZIL.
1076 Facial Skin Splitting due to Hereditary Angioedema
G. V. Marcotte; Asthma & Allergy Care of Delaware, Wilmington, DE.
1077 Side Effects Of Long-Term Treatment With Danazol And Stanozolol In Hereditary Angioedema
K. Bork 1, L. Zingale2, H. Farkas3, A. Bygum4, L. Bouillet5, C. Bucher6, T. Caballero7, H. Longhurst8, E. Nielsen9, M. Cicardi2; 1Department of Dermatology, University of Mainz, Mainz, GERMANY, 2University Hospital, Milano, ITALY, 3University Hospital, Budapest, HUNGARY, 4University Hospital, Odense, DENMARK, 5University Hospital, Grenoble, FRANCE, 6University Hospital, Zurich, SWITZERLAND, 7University Hospital, Madrid, SPAIN, 8University Hospital, London, UNITED KINGDOM, 9University Hospital, Tromso, NORWAY.
1078 Plasmatic Markers Of Coagulation And Fibrinolysis In Patients With C1 Inhibitor Deficiency During Acute Attacks Of Angioedema
A. Zanichelli 1, M. Cugno1,2, L. C. Zingale1, D. Lambertenghi Deliliers1, L. Maggioni1, S. Griffini1,2, M. Cicardi1; 1University of Milan, Milano, ITALY, 2Ospedale Maggiore Policlinico, Mangialgalli e Regina Elena, Fondazione IRCCS, Milan, ITALY.
1079 The European Register of Hereditary Angioedema: Experience and Preliminary Results
L. C. Zingale 1, K. Bork2, H. Farkas3, A. Bygum4, L. Bouillet5, T. Caballero6, H. Longhurst7, E. Waage Nielsen8, B. Bilo9, C. Bucher10, R. Perricone11, M. Cicardi1; 1University of Milan, Milan, ITALY, 2University of Mainz, Mainz, GERMANY, 3Semmelweis, Budapest, HUNGARY, 4University of Odense, Odense, DENMARK, 5CHU de Grenoble, Grenoble, FRANCE, 6University Hospital La Paz, Madrid, SPAIN, 7St Bartholomew's Hospital, London, UNITED KINGDOM, 8Dept. of Anesthesiology, Bodø, NORWAY, 9University of Cracow, Cracow, POLAND, 10University of Zürich, Zürich, SWITZERLAND, 11University of Rome Tor Vergata, Rome, ITALY.
1080 A New Variant of Hereditary Angioedema Involving Macular Edema With Transient Loss of Vision
A. M. Deener, A. Rubinstein; Albert Einstein College of Medicine, Bronx, NY.
1081 Interim Open-Label Results of EDEMA3sm: A Study of Subcutaneous Ecallantide in Patients with Hereditary Angioedema
H. H. Li 1, R. J. Levy2, D. L. McNeil3, T. K. Schmalbach4; 1Institute for Asthma and Allergy, Wheaton, MD, 2Family Allergy & Asthma Center, PC, Atlanta, GA, 3Optimed Research, LLC, Columbus, OH, 4Dyax Corp., Cambridge, MA.
1082 Unnecessary Abdominal Surgeries Secondary to Undiagnosed Hereditary Angioedema
K. J. Bowie, M. D. Scarupa, H. H. Li; Institute for Asthma & Allergy, PC, Wheaton, MD.
1083 Diagnosis, Clinical Manifestation and Therapy in Children with Hereditary Angiooedema
I. Martinez-Saguer, E. Rusicke, E. Aygören-Pürsün, T. Klingebiel, W. Kreuz; J.-W. Goethe University Hospital Frankfurt, Germany, Frankfurt, GERMANY.
1084 New Mutations of C1 inhibitor (SERPING1/C1NH) Gene Associated with Hereditary Angioedema in a European Population
C. Drouet 1, M. Cicardi2, E. Pappalardo2, N. Monnier1, O. Roche3, A. Tordai4, I. Wagenaar-Bos5, R. Perricone6, A. Bygum7, K. Bork8, M. Tosi9, M. López-Trascasa3; 1University Joseph Fourier, Grenoble, FRANCE, 2University of Milan, Milan, ITALY, 3University Hospital La Paz, Madrid, SPAIN, 4National Medical Center, Budapest, HUNGARY, 5Sanquin Research Center, Amsterdam, THE NETHERLANDS, 6University Tor Vergata, Rome, ITALY, 7University of Odense, Odense, DENMARK, 8Johannes Gutenberg University, Mainz, GERMANY, 9University of Rouen, Rouen, FRANCE.
1085 Treatment With Pasteurized C1 Inhibitor Concentrate In Skin Swelling Attacks Of Patients With Hereditary Angioedema
P. Staubach, K. Bork; Department of Dermatology, University of Mainz, Mainz, GERMANY.
1086 Icatibant, a Potent and Selective Bradykinin B2 Receptor Antagonist, is Effective in Treating Patients with Hereditary Angioedema (HAE)
R. J. Levy, S. Goodman; Family Allergy and Asthma Center, P.C., Atlanta, GA.
1087 Prodromal Symptoms Before Exacerbations of Hereditary Angioedema
J. G. Gibbs, T. J. Craig; Penn State College of Medicine, Hershey, PA.
1088 Treatment Of Acute Edema Attacks In Hereditary Angioedema With A Bradykinin Receptor-2 Antagonist (Icatibant)
B. Grundt 1, K. Bork1, J. Frank2, P. Schlattmann3, J. Nussberger4, B. Rosenkranz5, L. Dong5, J. Knolle5, W. Kreuz6; 1Department of Dermatology, University of Mainz, Mainz, GERMANY, 2Department of Dermatology, University Hospital Maastricht, Maastricht, THE NETHERLANDS, 3Institute of Medical Informatics, Biostatistics and Epidemiology, Charite, University of Berlin, Berlin, GERMANY, 4Department of Medicine, CHUV, University of Lausanne, Lausanne, SWITZERLAND, 5Jerini AG, Berlin, GERMANY, 6Center of Pediatrics, University of Frankfurt, Frankfurt, GERMANY.
1089 Discoid Lupus Erythematosus Presenting as Lower Facial Angioedema
N. J. Nam; Columbia University Medical Center, New York, NY.
1090 Episodic Angioedema Associated with Eosinophilia: Successful Treatment with Imatinib Mesylate
S. E. Scranton 1, C. A. Wild2, R. W. England1; 1Wilford Hall Medical Center, Lackland AFB, TX, 2David Grant Medical Center, Travis AFB, CA.
1091 Different Causes of Angioedema
P. Nordenfelt, L. Maroti, U. Malkolmsson, J. Björkander; Lansjukhuset Ryhov, Jonkoping, SWEDEN.
1092 Resolution of Symptoms in a Patient with Hereditary Angioedema (HAE) Following Treatment with Icatibant, a Potent and Selective Bradykinin-2 Receptor Antagonist
T. Boehm 1, W. R. Lumry2; 1Jerini AG, Berlin, GERMANY, 2AARA Research Center, Dallas, TX.
1093 Lymphoproliferative disease and Acquired C1 inhibitor (C1-INH) deficiency
M. Cicardi, D. Lambertenghi Deliliers, A. Zanichelli, L. C. Zingale, R. Castelli; University of Milan, Milan, ITALY.
Poster Session
5207
Tuesday, February 27, 2007
9:45 AM - 10:45 AM
Atopic Dermatitis
1094 Cutaneous Colonization of Staphylococcus aureus at 4 Months of Age and Eczema at 18 Months of Age
S. Suzuki, N. Shimojo, Y. Inoue, T. Arima, M. Tomiita, Y. Kohno; Department of Pediatrics, Graduate School of Medicine and School of Medicine, Chiba University, Chib, Chiba City, JAPAN.
1095 Altered Expression of Epidermal Differentiation Proteins in Atopic Dermatitis compared to Psoriasis or Nonatopic, Healthy Controls
A. De Benedetto 1, L. Y. McGirt2, M. Brummet3, C. Cheadle3, K. C. Barnes3, L. A. Beck1; 1Department of Dermatology and Division of Allergy/Immunology and Reumatology, University of Rochester School of Medicine and Dentistry, Rochester, NY, 2Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, MD, 3Division of Allergy and Clinical Immunology, Johns Hopkins University School of Medicine, Baltimore, MD.
1096 Association Of Interleukin-10 Gene Promoter Polymorphism In Korean Children With Atopic Dermatitis
K. Kim, J. Hong, J. Park, K. Kim, E. Kim, M. Sohn; Department of Pediatrics, Yonsei University College of Medicine, Seoul, REPUBLIC OF KOREA.
1097 Transepidermal Water Loss As A Biological Marker In Atopic Dermatitis In Children
J. Gupta 1,2, E. Grube2, A. Lucky2, A. Sheth2, A. Assa'ad2, G. K. Khurana Hershey2; 1University of Cincinnati, Cincinnati, OH, 2Cincinnati Children's Hospital Medical Center, Cincinnati, OH.
1098 The Relationships among Severity Score, Behavioral Problem, Parental Stress, Maternal Depression, and Social Support in Children with Atopic Dermatitis
M. Shin 1, S. Chung2, S. Lee2; 1Soonchunhyang university hospital, Bucheon, REPUBLIC OF KOREA, 2Samsung seoul hospital, Seoul, REPUBLIC OF KOREA.
1099 Properties of Circulating Regulatory T Cells Associated with Nascent IgE Responses in Children with Atopic Dermatitis
M. Moloney, S. Satinover, A. Reefer, P. Heymann, D. Murphy, J. Woodfolk; University of Virginia, Charlottesville, VA.
1100 Colonization Of Staphylococcus Aureus On The Cheeks Of 4 Month-old Children At Local Health Centers In Chiba, Japan
N. Shimojo 1, S. Suzuki1, M. Tomiita1, Y. Inoue1, Y. Arima1, Y. Kohno1, Y. Akiba2; 1Chiba University, Chiba, JAPAN, 2Chiba city institute for enviroment and hygiene, Chiba, JAPAN.
1101 Effect of House Dust Mite (HDM) Avoidance Measure on The Clinical Symptoms in Dogs with Atopic Dermatitis (AD)
S. Kawarai 1, H. Shirai2, M. Sakaguchi3, K. Ohmori1, N. Yasuda1, H. Yasuda4, K. Ikeda5, H. Tsujimoto1; 1Department of Veterinary Internal Medicine, Graduate School of Agricultural and Life Sciences, The University of Tokyo, Tokyo, JAPAN, 2Yamasei corporation, Tokyo, JAPAN, 3Division of Otorhinolaryngology, Graduate School of Medicine and School of Medicine, Chiba University, Chiba, JAPAN, 4National Hospital Organization, Sagamihara National Hospital, Kanagawa, JAPAN, 5National Institiute of Public Health, Saitama, JAPAN.
1102 Objective Measurement of Sleep Quality, Scratching, and Cytokine Response in Atopic Dermatitis (AD)
B. G. Bender, R. D. Ballard, D. Y. M. Leung; National Jewish Medical and Research Center, Denver, CO.
1103 Development of a Classification System for Atopic Dermatitis (AD): Correlation Between Subjective Symptoms and Disease Extent or Intensity
A. DiDario 1, E. Yousef2; 1Thomas Jefferson University, Philadelphia, PA, 2A.I. duPont Hospital for Children, Wilmington, DE.
1104 The Effects of Breast-milk Feeding on Severe Atopic Dermatitis In Korean Infant and Toddler
D. Lim, J. Kim, B. Son, Y. Oh; Inha University, Incheon City, REPUBLIC OF KOREA.
1105 Evaluation of Passive Smoking as a Risk Factor for Severity and Allergic Sensitization Among Atopic Dermatitis Children
A. A. C. Leite 1, R. M. S. Leite2, I. M. C. Costa3, G. M. de Paula2, L. O. Rezende2; 1Instituto Saint Louis, Brasilia, BRAZIL, 2Universidade Catolica de Brasilia, Brasilia, BRAZIL, 3Universidade de Brasilia, Brasilia, BRAZIL.
1106 TARC(CCL17) Augments TNF-α Induced CTACK(CCL27) Production in Infantile Atopic Dermatitis
J. Nakazato, J. Fujiwara, M. Inoue, M. Kishida, N. Shinomiya; Toho University Medical Center, Tokyo, JAPAN.
1107 Effectiveness and Safety Of Recombinant Human Interferon γ Therapy for Moderate to Severe Atopic Dermatitis in Childhood
J. Oh 1, H. Lee2, E. Mo3, J. Lee4; 1Hanyang University Guri Hospital, Kyunggi-do, REPUBLIC OF KOREA, 2Hanyang University, Seoul, REPUBLIC OF KOREA, 3Choongnam National University, Daejeon, REPUBLIC OF KOREA, 4Choongnam University, Daejeon, REPUBLIC OF KOREA.
1108 Modulation of Filaggrin by Th2 Cytokines in the Skin of Atopic Dermatitis (AD)
M. D. Howell 1, B. E. Kim2, M. Boguniewicz1, D. Y. M. Leung1; 1National Jewish Medical and Research Center, Denver, CO, 2Sanggye Paik Hospital and Inje University, Seoul, REPUBLIC OF KOREA.
1109 Influence Of Cetirizine On Cytokine Production In Patients With Atopic Dermatitis
G. N. Drannik 1, A. Kurchenko1, L. M. DuBuske2; 1Ukrainian Center for Clinical Immunology, Kiev, UKRAINE, 2Immunology Research Institute of New England, Gardner, MA.
1110 Quantitative Real-time PCR of Staphylococcus aureus DNA Reveals High Levels in Bed, Floor, and Vacuum Dust in Children with Severe Atopic Dermatitis (AD)
A. D. Leung 1, A. M. Schiltz1, C. F. Hall1, A. A. Harris-Deutch1, A. H. Liu1,2; 1National Jewish Medical and Research Center, Denver, CO, 2University of Colorado School of Medicine, Denver, CO.
1111 Severe Refractory Atopic Dermatitis (AD) in Adult Patients, as Compared to Quiescent and Moderate AD is Highly Atopic
B. H. Salt, M. Boguniewicz, D. Y. M. Leung; National Jewish Medical and Research Center, Denver, CO.
1112 The Atopic Dermatitis Questionnaire (ADQ): A 5-minute, Easy-to-use Parent Administered Atopic Dermatitis (AD) Scoring Tool For Home-based Follow Up Compares Well With The SCORAD
K. D. Carel, M. D. Klinnert, K. Kelsay, A. Kelley-Day, N. Miyazawa, E. Gyorkos, K. Walsh, S. Solanyk, E. W. Gelfand, D. L. Bratton; National Jewish Medical and Research Center, Denver, CO.
1113 The Role Of Stat6 In The Murine Model Of Atopic Dermatitis
H. Alenius 1, T. Savinko1, S. Lehtimäki1, N. Fyhrquist-Vanni1, H. Wolff1,2, A. Lauerma1; 1Finnish Institute of Occupational Health, Helsinki, FINLAND, 2Helsinki University Central Hospital, Helsinki, FINLAND.
1114 Immunologic Phenotype in the Atopic March (AM)
J. M. Spergel 1,2, M. Boguniewicz3, V. Tsai1, R. Harbeck3, K. Pinzone1, S. B. Leung3, D. Y. M. Leung3; 1Children's Hospital of Philadelphia, Philadelphia, PA, 2University of Pennsylvania School of Medicine, Philadelphia, PA, 3National Jewish Medical and Research Center, Denver, CO.
Poster Session
5208
Tuesday, February 27, 2007
9:45 AM - 10:45 AM
Adherence and Health Behavior and Education
1115 Reasons Why Patients Leave Against Medical Advice (AMA) Following an Asthma Hospitalization
R. Arora, I. Warrier, A. P. Baptist; Wayne State University, Detroit, MI.
1116 Asthma Controller Awareness, Knowledge, Health Beliefs and Behaviors
M. Tsoukleris 1,2, V. Hsu1, C. L. Vibbert2, M. E. Bollinger2, A. M. Butz3; 1University of Maryland School of Pharmacy, Baltimore, MD, 2University of Maryland School of Medicine, Baltimore, MD, 3The Johns Hopkins University School of Medicine, Baltimore, MD.
1117 Curriculum Development for the Theory-driven, Research-guided, School-based Staying Healthy-Asthma Responsible & Prepared Education and Counseling Program
E. K. Kintner, M. Clary, G. D. Cook; Michigan State University, East Lansing, MI.
1118 Adolescents' Disease Empowerment and Persistency Technology (ADEPT) Increases Asthma Knowledge among Inner City African American Teenagers Using MP3 Players
G. S. Mosnaim 1, C. Rhoads2, M. Cohen3; 1Rush University Medical Center, Chicago, IL, 2Northwestern University, Chicago, IL, 367Khz Inc., Chicago, IL.
1119 Educational Asthma Summer Camp Including Exercise Challenge Test Improved Adherence
N. Kojima 1, Y. Takeda2, M. Akashi1, A. Akasawa1; 1National Center for Child Health and Devepolment, Tokyo, JAPAN, 2Division of Health and Welfare, Kita Ward, Tokyo, JAPAN.
Poster Session
5209
Tuesday, February 27, 2007
9:45 AM - 10:45 AM
Signaling
1120 Modulation of Nitric Oxide (NO) production by Histamine Receptor Antagonists
R. A. Khanferyan 1, D. V. Lesik1, L. M. DuBuske2; 1Kuban State Medical University, Krasnodar, RUSSIAN FEDERATION, 2Immunology Research Institute of New England, Gardner, MA.
1121 Activation of Mast Cells Induces PKC-dependent Phosphorylation of Serine-273 of the LILRB4 Inhibitory Receptor that is Self-Regulated
D. I. Hong, T. R. Murphy, K. F. Austen, H. R. Katz; Brigham & Women's Hospital, Boston, MA.
1122 Neutralization of CD86 Reduced the Th2 Immune Response in Murine Allergic Aspergillosis
C. Barrios 1, B. Johnson1, J. Fink1, V. Kurup1,2; 1Medical College Of Wisconsin, Milwaukee, WI, 2V A Medical Center, Milwaukee, WI.
1123 Paracrine Involvement of LTD4-induced TGFbeta1 Secretion by Epithelial Cells in Bronchial Smooth Muscle Cell proliferation
Y. Bossé, C. Thompson, S. McMahon, C. M. Dubois, J. Stankova, M. Rola-Pleszczynski; Université de Sherbrooke, Sherbrooke, PQ, CANADA.
1124 Parthenolide, a Sesquiterpene Lactone From the Medicinal Plant, Feverfew, Inhibits IκB kinase, Nuclear Factor-κB activation and Inflammatory response in CF cell lines and Mice
A. Saadane 1, S. Masters1, J. DiDonato2, J. Li1, M. Berger1; 1CWRU, Cleveland, OH, 2Lerner Research Institute, Cleveland Clinic, Cleveland, OH.
1125 Constitutive Association of Lyn A and B Kinases with the High Affinity IgE Receptor (FceRI) Positively Regulates Mast Cell Secretion
S. J. Killedar, S. Gibbons, Jr., H. Chang, E. Lin, B. M. Vonakis; Johns Hopkins Asthma and Allergy Center, Baltimore, MD.
1126 Activation of Effector Memory CD8+ T Cells Following Ligation of BLT1 by Leukotriene B4
H. Ohnishi1, N. Miyahara1, C. H. Swasey1, K. Takeda1, A. Dakhama1, J. Domenico1, J. J. Lucas1, S. Mathis2, B. Haribabu2, E. W. Gelfand 1; 1National Jewish Medical and Research Center, Denver, CO, 2James Graham Brown Cancer Center, Louisville, KY.
1127 MK2 Controls the Level of Negative Feedback in the NFκB Pathway and is Essential for Endothelial Permeability and Airway Inflammation
M. M. Gorska 1, Q. Liang1, S. J. Stafford2, N. Goplen1, N. Dharajiya2, L. Guo1, S. Sur2, M. Gaestel3, R. Alam1; 1National Jewish Medical and Research Center, Denver, CO, 2University of Texas Medical Branch, Galveston, TX, 3Hannover Medical School, Hannover, GERMANY.
1128 Interleukin-4 Receptor Alpha Chain ITIM Motif Mutant Mice Potentiate Stat6 Activation and IgE Production
R. Tachdjian, N. Truong, T. A. Chatila; UCLA School of Medicine, Los Angeles, CA.
1129 Signaling Interactions Between IL-4 or IL-13 and Leukotrienes in Allergic Inflammation
M. O. Daines, P. A. Zornes, G. K. Khurana Hershey; Cincinnati Children's Hospital, Cincinnati, OH.
1130 Inhibitory Functions of Siglec-8 in Transfected RBL-2H3 Cells
H. Lee 1, S. Ryu2, S. A. Hudson2, C. Bikel2, O. H. Choi2, B. S. Bochner2; 1Kwandong University College of Medicine, Goyang, REPUBLIC OF KOREA, 2Johns Hopkins University School of Medicine, Baltimore, MD.
1131 Lipoxin A4 Antagonizes Granulocyte and Macrophage Activation Evoked by Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) by Inhibition of Protein Phosphorylation
V. Starosta, K. Pazdrak, A. Kurosky; UTMB, Galveston, TX.
1132 Surfactant Protein D (SP-D) Inhibits TNF-α Production In CpG-induced Alveolar Macrophages Via Irak-1 Inactivation
K. Yeh 1,1, L. Wang2, C. Liu3, W. Chang1, J. Wang1, C. Shieh1; 1Dept of Microbiology&Immumology, College of Medicine, National Cheng Kung University, Tainan, TAIWAN, 2Dept of Biochemistry, College of Medicine, National Cheng Kung University, Tainan, TAIWAN, 3Institude of Basic Medical Sciences, College of Medicine, National Cheng Kung University, Tainan, TAIWAN.
1133 A Phospho-site Screen Identifies Baseline Activation of PKR As a Survival-limiting Factor For Eosinophils
N. P. Goplen 1, S. J. Stafford2, Q. Liang1, M. Gorska1, S. Rozario1, R. Alam1; 1National Jewish Medical Research Center, Denver, CO, 2University of Texas Medical Branch, Galveston, TX.
1134 Effect of Chitinase on Il-8 Gene Expression in Human Respiratory Epithelial Cells
J. Y. Hong 1, K. E. Lee2, K. W. Kim1, E. S. Kim1, J. Y. Park1, M. H. Sohn1, K. E. Kim1; 1Department of Pediatrics, Severance Children's Hospital,Yonsei University College of Medicine Brain Korea 21 Project for Medical Science, Yonsei University, Seoul, REPUBLIC OF KOREA, 2Department of Pediatrics, Severance Children's Hospital,Yonsei University College of Medicine Brain Korea 21 Project for Medical Science, Yonsei University, Seoul, REPUBLIC OF KOREA.
1135 Scavenging of Reactive Oxidative Species (ROS) Generated by Pollen NADPH Oxidases Inhibits Th2 and Th17 Cytokine Production from Johnson Grass (JG)Sensitized Human Peripheral Blood Mononuclear Cells (PBMCs)
M. C. Saavedra, N. G. Dharajiya, D. R. Redding, I. Boldogh, C. Y. Lee, S. Sur; UTMB, Galveston, TX.
1136 Multiple Granulocyte Priming Phenotypes In Peripheral Blood Of Allergic Asthmatics
L. Koenderman 1, W. Ten Hove2, B. Luijk1, B. Leufkens2, J. Lammers1, J. Raaijmakers2, M. Bracke2; 1University Medical Center Utrecht, Utrecht, THE NETHERLANDS, 2Utrecht Institute for Pharmaceutical Sciences, Utrecht, THE NETHERLANDS.
1137 The Effect of Daily Apolipoprotein A-I Mimetic Therapy on Pro-Inflammatory High Density Lipoprotein in a Murine Model of Asthma
S. D. Nandedkar 1, K. S. Konduri1, J. Wang1, H. Xu1, Y. Shi1, D. A. Rickaby1, N. Duzgunes2, K. A. Pritchard1; 1Medical college of Wisconsin,Children's Research Institute, and Zablocki VA Medical Center, Milwaukee, WI, 2University of Pacific School of Dentistry, San Franscisco, CA.
1138 NADPH Oxidases in Johnson Grass Extract (JGE) Induce Intracellular ROS (iROS) in Bronchial Epithelial Cells
D. R. Redding, M. C. Saavedra, J. G. Patel, N. Dharajiya, I. Boldogh, S. Sur; University of Texas Medical Branch at Galveston, Galveston, TX.
1139 Leukocyte and Eosinophil Progenitor Cells in Peripheral Blood Correlate with Asthma Severity
J. S. Makowska, J. Grzegorczyk, B. Bienkiewicz, M. Cieslak, M. L. Kowalski; Medical University of Lodz, Poland, Lodz, POLAND.
1140 Exhaled Bronchial Nitric Oxide in Chronic Nasal Inflammation
M. F. Kramer 1, H. Dressel2, A. Bihler2, F. Jund1, D. de la Motte2, R. Joerres2, D. Nowak2; 1Oto-Rhino-Laryngology, Head and Neck Surgery; Ludwig-Maximilians-University, Munich, GERMANY, 2Institute and Outpatient Clinic for Occupational and Environmental Medicine; Ludwig-Maximilians-University, Munich, GERMANY.
1141 Increased Leukotriene B4 In Exhaled Breath Condensate From Asthmatic Children
J. Y. Park 1, K. W. Kim1, E. S. Kim1, J. Y. Hong1, C. H. Kim2, M. H. Sohn1, K. E. Kim1; 1Department of Pediatrics, Severance Children's Hospital, Yonsei University College of Medicine, seoul, REPUBLIC OF KOREA, 2Department of Pediatrics, Kwandong University College of Medicine, Goyang, REPUBLIC OF KOREA.
1142 A Novel Mouse Model of Whole Pollen Grain Induced Rhinitis
J. Brimnes, J. Kildsgaard, H. Jacobi, K. Lund; ALK-Abello, Hoersholm, DENMARK.
1143 Effect of Forced Swimming Exercise Stress on Allergic Pulmonary Inflammation in Mice
G. P. Shome, L. E. Hulbert, N. Krebs, M. A. Sutherland, M. Watchell, J. J. McGlone; Texas Tech University, Lubbock, TX.
1144 Formaldehyde Exposure Induces Airway Inflammation Via Regulation Of The Production Of Eotaxin And Reactive Oxygen Species
H. Yoon; Chonnam national university, Gwang-ju, REPUBLIC OF KOREA.
1145 Lack of Filaggrin Expression in the Human Bronchial Mucosa
T. H. Lee, S. Ying, Q. Meng, C. J. Corrigan; King's College London, London, UNITED KINGDOM.
1146 Age-Dependent Ontogeny of TLR4 Expression on Peripheral Lymphocytes and their Modulation by Interleukin-4
J. An, A. Banville-Langelier, P. O. Fiset, D. Prefontaine, M. B. Mazer, J. Guay, O. Hajoui, Q. Hamid, B. D. Mazer; Meakins Christie Laboratories, Montreal, PQ, CANADA.
Poster Sessions
5210
Tuesday, February 27, 2007
9:45 AM - 10:45 AM
MAAI Topics
1147 Effect of Fluticasone on Airway Smooth Muscle (ASM) in Mice Treated with IL-13
J. Evans, P. R. Gendapodi, P. Abel, F. Romero, R. G. Townley; Creighton University, Omaha, NE.
1148 Different Roles of Aspirin during Antigen Challenge in Murine Model of Asthma
S. Kim 1, Y. Kim2, J. Lee1, T. Kim1, J. Sohn1, H. Yoon1, D. Shin1, S. Park1, S. Chang3, D. Choi4; 1Hanyang University College of Medicine, Seoul, REPUBLIC OF KOREA, 2Postech Biotech Center, Pohang University of Science and Technology, Pohang, REPUBLIC OF KOREA, 3Sungae Hospital, Seoul, REPUBLIC OF KOREA, 4Sungkyunkwan University School of Medicine, Seoul, REPUBLIC OF KOREA.
1149 Ngf (Nerve Growth Factor) Regulates Collagen Deposition Independent Of Tgf-β
A. Kilic, S. Sonar, D. Schwinge, A. Yildirim, S. Achenbach, H. Fehrenbach, A. Nockher, H. Renz; Hospital of the Philipps University, Marburg, GERMANY.
1150 Role of Endogenous Estrogen in Regulating Airway Hyperresponsiveness Induced by Allergen Inhalation Without Adjuvant
S. Matsubara, C. H. Swasey, A. Dakhama, J. E. Loader, H. Ohnishi, A. Joetham, A. Balhorn, N. Miyahara, K. Takeda, E. W. Gelfand; National Jewish Medical and Research Center, Denver, CO.
1151 Increase of CD25 and RLA II Positive-Cells Population in Perivascular Infiltrate in Lungs from Ovalbumin (OVA) Sensitized and Challenged Rabbits
M. A. Vinuesa, Sr., G. Fontanella, Sr., N. Bassan, Sr., O. Soldano, Sr., S. Chaparro, Sr., N. Caviglia, Sr.; Facultad de Ciencia Medicas, Rosario, ARGENTINA.
1152 Grass Hypersensitivity Causing Bronchopulmonary Obstruction In A Patient With Cystic Fibrosis
L. Ree-Kim, J. El-Dahr; Tulane University Health Sciences Center, New Orleans, LA.
1153 Effect of Fluticasone and/or β-agonists on Airway Hyperresponsiveness (AHR) In Mice Either Sensitized to Allergen or Pre-treated with IL-13
R. G. Townley, P. R. Gendapodi, J. Evans, F. Romero; Creighton University, Omaha, NE.
1154 Type-I Allergic Reaction In Recently Diagnosed Untreated Pulmonary Tuberculosis
H. M. Elboshy, A. M. Nafei, E. N. Ali, A. I. Ali, T. A. Attia, M. S. Abdalla, E. E. Fouda; Al-Azhar University Allergy & Immunology Center, Cairo, EGYPT.
1155 Analysis of a LAM-derived Cell Transcriptome Identifies Similarity to Other Pulmonary Diseases
T. J. Whitney 1, M. Brandon1, L. Ma2, B. Camoretti-Mercado2; 1Idaho State University, Pocatello, ID, 2University of Chicago, Chicago, IL.
1156 Nasal Fibroblasts Derived from Allergic Patients Retain Their Typical Gene Expression Profile In Culture
M. Yoshikawa 1, T. Yoshimura1, N. Okada2, H. Saito2, H. Moriyama1; 1Department of Otorhinolaryngology, Jikei University School of Medicine, Tokyo, JAPAN, 2Department of Allergy and Immunology, National Research Institute for Child Health and Development, Tokyo, JAPAN.
1157 Micro Flora Associated Characteristics and Changes in Allergic Sensitization During the First Four Years of Life
A. Sandin 1, E. Norin2, B. Björkstén3, L. Bråbäck4; 1Department of Clinical Science, Paediatrics, Umeå, SWEDEN, 2Department of Cellular and Microbial Biology, Division of Microbial Ecology, Karolinska Institute, Stockholm, SWEDEN, 3The National Institute of Environmental Medicin, Division of Physiology, Karolinska Institute, Stockholm, SWEDEN, 4Mid-Sweden Research and Development Center, Sundsvall Hospital, Sundsvall, SWEDEN.
1158 Modulation of Effects of Albuterol Enantiomers on IL-6 Release in Human Airway Smooth Muscle Cells as a Function of Cell Stimulation
E. A. Duru, J. L. Parks, IV, W. J. Calhoun, B. T. Ameredes; Unuversity of Texas Medical Branch, Galveston, TX.
1159 Regulation of Dendritic Cell Function by Surfactant Protein D
S. Kierstein, L. Hortobagyi, K. Krytska, A. Haczku; University PA School Medicine, Philadelphia, PA.
1160 Glucocorticoid Induced Leucine Zipper Mediates the Anti-Inflammatory Effects of Dexamethasone in Airway Epithelial Cells
J. Eddleston 1,2, J. Herschbach2, A. L. Wagelie-Steffen1, S. C. Christiansen1,3, B. L. Zuraw1,2; 1UCSD, La Jolla, CA, 2VMRF, San Diego, CA, 3Kaiser Permanente, San Diego, CA.
1161 Analysis of Chemokine and Cytokine Production by a Human Alveolar Epithelial Cell Line in Response to Pollen Surface Proteins
J. M. Ward; The University of Chicago, Chicago, IL.
1162 Oral Sulforaphane Induces Antioxidant Phase II Enzymes in the Human Airway
M. A. Riedl, A. Saxon, D. Diaz-Sanchez; UCLA - David Geffen School of Medicine, Los Angeles, CA.
1163 Increased Plasma Levels Of Vascular Endothelial Growth Factor And Plasminogen Activator Inhibitor-1 In Children With Frequent Asthma Exacerbations
H. Chung, S. Kim, S. Kim; School of Medicine, Catholic University of Taegu, Taegu, REPUBLIC OF KOREA.
1164 Identification of Allergen-Susceptibility Genes Using Recombinant Inbred Mouse Model of Allergic Asthma
D. N. Grigoryev 1, E. P. Hoffman2, M. Wills-Karp3, K. C. Barnes1; 1Johns Hopkins University, School of Medicine, Baltimore, MD, 2Children's National Medical Center, Washington, DC, 3Cincinnati Children's Hospital Medical Center, Cincinnati, OH.
1165 Effect Of ISS And TGF-β1 On MLg Lung Fibroblast Proliferation In Vitro
S. Deane, M. Miller, J. Cho, D. H. Broide; UC San Diego, San Diego, CA.
1166 A Novel Inducible Transgenic Histamine Releasing Factor Construct
L. Xie, Z. Zhu, S. M. MacDonald; JHUSM, Baltimore, MD.
1167 A Neuroactive Steroid Inhibits Guinea-pig Airway Sensory Nerves via Maxi-K+ Channels Activation
S. Yoshihara 1, H. Morimoto2, M. Ohori2, Y. Yamada1, T. Abe1, O. Arisaka1; 1Dokkyo University School of Medicine, Mibu,Tochigi, JAPAN, 2Department of Pharmacology, Medical Biology Research Laboratories,Fujisawa Pharmaceutical Co., Ltd., Osaka, JAPAN.
1168 The effect of Kawasaki Disease on Allergy in childhood
W. K. Liew 1, T. C. W. Lim2, H. V. Bever2, S. C. Quek2, T. H. Tan1, K. Y. Wong1; 1Kerdang Kerbau Hospital, Singapore, SINGAPORE, 2National University Hospital, Singapore, SINGAPORE.
1169 Relation of Elevated Plasma Complement Split Product Levels to Their Peripheral Blood Leukocyte Receptors and Asthma Severity
H. Solomon, I. Kalampokis, D. Dure, S. Chice, M. Nowakowski, H. G. Durkin, R. Joks; Center for Allergy and Asthma Research, SUNY Downstate, Brooklyn, NY.
1170 Ligands for Siglec-8 and Siglec-F: Binding Characteristics and Tissue Distribution
J. P. Guo 1, A. C. Myers1, O. Choi1, H. S. Lee1, Z. Zhu1, S. A. Hudson1, M. Brummet1, N. V. Bovin2, P. R. Crocker3, B. S. Bochner1; 1Johns Hopkins Asthma and Allergy Center, Baltimore, MD, 2Russian Academy of Sciences, Moscow, RUSSIAN FEDERATION, 3University of Dundee, Dundee, UNITED KINGDOM.
1171 Ngf (nerve Growth Factor): A Key Player In Events Ensuing Lung Epithelium Injury And Repair
S. Sonar, D. Schwinge, A. Kilic, A. Yildirim, S. Achenbach, H. Fehrenbach, A. Nockher, H. Renz; Hospital of the Philipps University, Marburg, GERMANY.
1172 Association Between Thromboxane A2 Receptor Gene Polymorphisms (+924T>C, +795T>C) and Asthma in Korean Children
J. Kim 1, H. Kim2, M. Kang3, S. Lee4, B. Kim5, S. Jang3, S. Hong3; 1Ulsan University Hospital, Ulsan, REPUBLIC OF KOREA, 2Inje University Sanggye Paik Hospital, Seoul, REPUBLIC OF KOREA, 3Asan Medical Center, Seoul, REPUBLIC OF KOREA, 4Hallym University College of Medicine, Hangang Sacred Heart Hospital, Seoul, REPUBLIC OF KOREA, 5Gangneung Asan Hospital, Gangneung, REPUBLIC OF KOREA.
1173 Is CRP a Useful Marker for Inflammation in Different Forms of Rhinitis?
A. Baccιoglu, F. Kalpaklioglu; Kirikkale University Faculty of Medicine, Kirikkale, TURKEY.
1174 Expression of the Novel ER-α36 Variant of Estrogen Receptors in Murine Lung: Effects of Antigen Sensitization
S. Jia, X. Zhang, Z. Wang, T. B. Casale; Creighton University, Omaha, NE.
1175 Airway Fibroblasts Isolated from Mouse Model of Allergic Asthma Display Distinct Cellular and Phenotypic Characteristics as Compared to Normal Fibroblasts
A. I. Berro 1, H. Sugiura2, X. Liu2, F. Duan2, S. Kawasaki2, S. Togo2, K. Kamio2, X. Q. Wang2, L. Mao3, Y. Ahn2, R. F. Ertl2, T. B. Casale1, S. I. Rennard2; 1Creighton University, Omaha, NE, 2University of Nebraska Medical Center, Omaha, NE, 3Third Hospital of Peking University, Beijing, CHINA.
1176 Effect Of Cetirizine On Early- And Late-phase Airway Responses In A Brown Norway Rat Model Of Allergic Asthma
X. Zhang, P. Siegel; Centers for Disease Control and Prevention, Morgantown, WV.
1177 Nor-nordihydroguaiaretic Acid (NDHGA) Ameliorates C5a-Induced Acute Peritonitis
P. N. Pushparaj 1, S. D. Kumar1, J. J. Aarthi2; 1National University of Singapore, Singapore, SINGAPORE, 2Singapore General Hospital, Singapore, SINGAPORE.
1178 Biochemical Efficacy and Tolerability of a New Augmentation Preparation in Two Patients with MMALTONZ Alpha1-Antitrypsin Deficiency
J. M. Stocks 1, M. Brantly2; 1The University of Texas Health Center at Tyler, Tyler, TX, 2University of Florida College of Medicine, Gainesville, FL.
Poster Sessions
5211
Tuesday, February 27, 2007
9:45 AM - 10:45 AM
Mechanisms and Treatment of Rhinitis, Sinusitis, Otitis and Allergic Conjunctivitis
1179 Fungal Etiology of Chronic Sinusitis: Knowledge and Attitudes Survey in the US and Europe
A. Stergious 1, R. Casciano1, L. Katz1, M. Memran2, J. Willet1; 1Accentia Biopharmaceuticals, New York City, NY, 2Analytica International, New York City, NY.
1180 Differences in Treatment Practices of Chronic Sinusitis in Europe and US
R. Casciano 1, A. Stergious1, L. Katz1, M. Memran2, J. Willet1; 1Accentia Biopharmaceuticals, New York City, NY, 2Analytica International, New York City, NY.
1181 Oral Itraconazole in the Treatment of Chronic Rhinosinusitis
A. Y. Kung, H. Kita, J. C. Guarderas, R. O. Gustafson, M. A. Park; Mayo Clinic, Rochester, MN.
1182 Aspirin Desensitization: The University Of Michigan Experience
T. A. Miller 1,2, J. L. Baldwin1; 1University of Michigan, Ann Arbor, MI, 2Capital Allergy & Respiratory Disease Center, Sacramento, CA.
1183 Relationship Between IFN-γ Genotypes and the Development of Otitis Media (OM) During Respiratory Syncytial Virus (RSV) Infection in Young Children
J. M. Koehrsen, D. P. Skoner, D. A. Gentile, A. Patel, M. Varga, T. J. Schaffner, C. A. Schad; Allegheny General Hospital, Pittsburgh, PA.
1184 Inflammation And Remodelling Parameters In Induced Sputum Of Nonasthmatic Seasonal Allergic Rhinitis
A. B. Dursun 1, G. Celik1, M. Melli2, Z. Misirligil1; 1Ankara University, School of Medicine, Department of Respiratory Medicine, Allergic Diseases Division, Ankara, TURKEY, 2Ankara University, School of Medicine, Department of Clinical Pharmacology, Ankara, TURKEY.
1185 Comparison of ICAM-1, HLA-DR, TLR2, and TNFR1 Expression in Response to Staphylococcus aureus and Pro-Inflammatory Cytokines between Primary Conjunctival Epithelial Cells and the Cell Line, IOBA-NHC
J. L. Stahl, E. B. Cook, N. P. Barney, F. M. Graziano; University of Wisconsin-Madison, Madison, WI.
1186 Effect of Treatment with Montelukast on Otitis Media (OM) in Children
D. A. Gentile, J. M. Koehrsen, D. P. Skoner, A. Patel, M. Varga, C. A. Schad, T. J. Schaffner; Allegheny General Hospital, Pittsburgh, PA.
1187 Knemometric Assessment of Short-Term Lower-Leg Growth in Children with Allergic Rhinitis (AR) treated with Fluticasone Furoate∗ (FF) Nasal Spray
∗USAN approved name
J. Gradman 1, M. Caldwell2, O. Wolthers1; 1Asthma and Allergy Clinic, Children's Clinic Randers, Randers, DENMARK, 2GlaxoSmithKline, Greenford, UNITED KINGDOM.
1188 Once-Daily Fluticasone Furoate∗ Nasal Spray (FFNS) 110mcg Improves Quality of Life (QoL) in Subjects with Seasonal Allergic Rhinitis (SAR) during the ragweed season
∗USAN approved name
J. Given 1, T. Toler2, A. Ellsworth2, R. Stanford2, E. Philpot2; 1Allergy Respiratory & Sleep Center, Canton, OH, 2GlaxoSmithkline, RTP, NC.
1189 Once-daily Fluticasone Furoate∗ Nasal Spray (FF) is Safe and Effective in The Long-term Treatment of Perennial Allergic Rhinitis (PAR) in Children Ages 2 to 11 Years
∗USAN approved name
J. F. Maspero 1, A. Rosenblut2, A. Finn, Jr.3, J. Lim4, W. Wu4, M. Faris5, E. Philpot4; 1Allergy and Clinical Immunology Buenos Aires University, Buenos Aires, ARGENTINA, 2Hospital Dr. Sotero del Rio, Santiago, CHILE, 3National Allergy, Asthma, Urticaria Center of Charleston, Charleston, SC, 4GlaxoSmithKline, RTP, NC, 5GlaxoSmithKline, Greenfort, UNITED KINGDOM.
1190 Once-daily Fluticasone Furoate∗ Nasal Spray (FF) Provides 24-hour Symptom Relief In Subjects With Seasonal Allergic Rhinitis (SAR) Caused By Mountain Cedar Pollen
∗USAN approved name
F. C. Hampel, Jr. 1, R. Jacobs2, B. Martin3, T. Toler4, A. Ellsworth4, E. Philpot4; 1Central Texas Health Research, New Braunfels, TX, 2Biogenics Research Institute, San Antonio, TX, 3Southwest Allergy and Asthma Research, San Antonio, TX, 4GlaxoSmithKline, Research Triangle Park, NC.
1191 Lack of Effect on Hypothalamic-Pituitary-Adrenal (HPA) Axis Function by Once-daily Fluticasone Furoate∗ Nasal Spray(FFNS) 110 mcg in Adolescents and Adults with Perennial Allergic Rhinitis (PAR)
∗USAN approved name
D. Patel 1, P. Ratner2, D. Clements3, W. Wu3, M. Faris3, E. Philpot3; 1Allied Research International Inc, Mississauga, ON, CANADA, 2Sylvana Research Associates, San Antonio, TX, 3GlaxoSmithKline, Research Triangle Park, NC.
1192 Effect Of Desloratadine On The Bronchial Reactivity During Allergen Provocation Tests In Rhinitics Allergic To Grass Pollen
A. Purohit 1, C. Donnay1, A. Casset1, M. Kopferschmitt1, I. Dreyfus2, F. Sevenier3, F. de Blay1; 1Asthma and Allergy Division, Department of Chest Diseases, University Hospital Strasbourg, Strasbourg, FRANCE, 2Schering-Plough laboratories, Levallois-Perret, FRANCE, 3Fovea, Paris, FRANCE.
1193 Once-daily Fluticasone Furoate∗ Nasal Spray (FF) Provides 24-hour Relief of the Nasal Symptoms of Seasonal Allergic Rhinitis (SAR) in Children ages 2-11 Years
∗USAN approved name
E. O. Meltzer 1, I. Tripathy2, J. Lee3, J. Lim4, A. Ellsworth4, E. Philpot4; 1University of California, San Diego, San Diego, CA, 2Clinical Research of Ozarks, Rolla, MO, 3Advance Care Research Center, Dallas, TX, 4GlaxoSmithKline, RTP, NC.
1194 Lack of Correlation Between Physical Exam(PE), Mini RQLQ (MRQLQ), and Nasal Peak Inspiratory Flow (nPIF) as Measures of Nasal Congestion in Obstructive Sleep Apnea (OSA) Patients With Rhinitis
M. R. Rupp, Jr. 1, A. S. Baran2, G. D. Marshall, Jr.2; 1Allergy and Asthma Clinic of Southern New Mexico, Las Cruces, NM, 2University of Mississippi Medical Center, Jackson, MS.
1195 Videophone Technology, a Novel Measure of True Treatment Compliance in a 6-week Pediatric Safety Study of Fluticasone Furoate∗ Nasal Spray
∗USAN approved name
D. Clements, W. Wu, E. Philpot; GlaxoSmithKline, Research Triangle Park, NC.
1196 Positron Emission Tomography of the Airway Distribution of Intranasal Challenge Solutions
L. Conejero 1, M. L. Soto1, J. J. Vaquero1, M. L. Baeza1, E. Lage1, I. Varela-Nieto2, M. Desco1, J. M. Zubeldia1; 1Hospital Gregorio Maranon, Madrid, SPAIN, 2Instituto Investigaciones Biomedicas Alberto Sols. CSIC-UAM, Madrid, SPAIN.
Oral Abstract Session
5601
Tuesday, February 27, 2007
2:00 PM - 3:15 PM
Pharmacotherapy of Asthma
1197 VEGF Receptor 2 (KDR) is Up-regulated in the Nasal Mucosa of Seasonal Allergic Rhinitics
A. Tarun1, D. Shusterman 2; 1Seattle Biomedical Research Institute, Seattle, WA, 2University of Washington, Seattle, WA.
1198 Andolast, a Novel Calcium-activated Potassium-channel Opener, Inhibits AMP and Exercise Induced Bronchoconstriction in Asthma
S. H. Arshad 1, M. D'Amato2, L. Rovati2, S. T. Holgate1; 1University of Southampton, Southampton, UNITED KINGDOM, 2Rotta Research Laboratorium/Rottapharm, Monza, ITALY.
1199 Differential Contribution Of Cysteinyl Leukotriene Receptor Type 1 Gene In Patients With Aspirin Hypersensitivity
S. Kim 1, E. Yang1, J. Choi2, H. Lee1, C. Suh1, D. Nahm1, H. Park1; 1Ajou University School of Medicine, Suwon, REPUBLIC OF KOREA, 2Bundang Jesaeng general Hospital, Seongnam, REPUBLIC OF KOREA.
1200 Modulation Of Cysteinyl Leukotriene (CysLT) Production And Responsiveness By Corticosteroids (CCS)
J. A. Negri, L. Borish, J. W. Steinke; University Of Virginia Health Systems, Charlottesville, VA.
1201 Exploring the Effect on Asthma Control of Omalizumab Reduction After 28 Weeks Treatment
R. Slavin 1, P. Lowe2, C. Ferioli2, H. Fox3, L. Carpenter3, C. Martin3, W. Sallas4; 1Saint Louis University School of Medicine, Saint Louis, MO, 2Novartis Pharmaceuticals AG, Basel, SWITZERLAND, 3Novartis Horsham Research Centre, Horsham, UNITED KINGDOM, 4Novartis Pharmaceuticals Corporation, East Hanover, NJ.
1202 Exploring the Relationship Between Asthma and Rhinitis Response Following Omalizumab Therapy: Patients who Achieve Greatest Benefit for their Asthma Experience Greatest Benefit for Rhinitis
L. Boulet 1, Z. Panahloo2, M. Blogg2, G. Ayre2; 1Institut de Cardiologie et de Pneumologie de l'Université Laval, Hoˆpital Laval, Sainte-Foy, PQ, CANADA, 2Novartis Horsham Research Centre, Horsham, UNITED KINGDOM.
Oral Abstract Session
5602
Tuesday, February 27, 2007
2:00 PM - 3:15 PM
T Regulatory Cells in Immunopathology
1203 CD4+CD25+ T cells Regulate TLR4 Signaling in Pulmonary Dendritic Cells
H. Chen, D. A. Piggott, L. Xu, K. Bottomly; Yale University, New Haven, CT.
1204 Th2 Inflammation reduces Toll-Like Receptor 4 Expression and Regulatory Functions of T Cells
D. Préfontaine, M. Mazer, A. Banville-Langelier, P. Fiset, B. D. Mazer, Q. Hamid; Meakins-Christie Laboratories, McGill University, Montreal, PQ, CANADA.
1205 TGF-beta Stimulated Human CD4+CD25-FOXP3- Cells Express FOXP3, But Lack Regulatory Function
D. Tran, E. M. Shevach; NIH/NIAID, Bethesda, MD.
1206 Suppression Induced By In Vitro Expanded Human Tregs Is Antigen-independent And Is Partly Abrogated By GITR Signalling
A. Domdey1, A. H. Millner1, K. Lund1, I. Søndergaard2, P. A. Würtzen 1; 1ALK-Abello, Hørsholm, DENMARK, 2BioCentrum-DTU, Technical University of Denmark, Lyngby, DENMARK.
1207 Kinetics of Gene Related to Anergy in Lymphocytes (grAIL) expression in CD4+ CD25+ T Regulatory Cells and Correlation with Suppression and T:APC Conjugate Formation
J. M. Schartner, A. Timmel, W. Simonson, M. Jennens-Clough, A. Huttenlocher, C. M. Seroogy; University of Wisconsin - Madison, Madison, WI.
1208 The Functional Insufficiency of Natural Regulatory T Cells in Allergic Asthma May Due to TNF Downregulation
Y. Lin 1,2, J. Wang1; 1Dept of Ped, College of Medicine, National Cheng Kung University, Tainan, TAIWAN, 2Institute of Microbiology and Immunology, National Cheng Kung University, Tainan, TAIWAN.
Oral Abstract Session
5603
Tuesday, February 27, 2007
2:00 PM - 3:15 PM
Animal Allergens and Asthma
1209 Cat Ownership Is A Risk Factor For Developing Sensitization To Cat But Not Wheeze By Age 5 In A Low Income New York City Birth Cohort
M. S. Perzanowski 1,2, G. L. Chew1, A. Divjan1, A. Johnson1, K. Panjwani1, B. J. Sheares1, T. A. Platts-Mills3, F. P. Perera1, R. L. Miller1; 1Columbia Children's Center for Environmental Health (CCCEH), New York, NY, 2Department of Environmental Health Sciences, Columbia University, New York, NY, 3Asthma and Allergic Diseases Center, University of Virginia, Charlottesville, VA.
1210 Is the Attenuation in Risk of Sensitisation and Wheezing observed at High Allergen Exposures due to a Modified Th Response?
M. G. Jones, J. Harris, W. Atkinson, P. Mills, S. A. Moffat, C. W. White, A. Newman Taylor, P. Cullinan; NHLI
1211 Immunomodulatory Effects of Allergen-specific Sublingual Immunotherapy in a Rat Model of Allergic Sensitization
L. A. Rosenthal 1, X. Su1, R. J. Szakaly1, R. L. Sorkness1,2; 1University of Wisconsin School of Medicine and Public Health, Madison, WI, 2School of Pharmacy, University of Wisconsin-Madison, Madison, WI.
1212 Sensitization to Mouse Allergen and Asthma Morbidity in a Population of Boston Women
W. Phipatanakul 1,2, A. A. Litonjua2, T. A. E. Platts-Mills3, L. Naccara3, J. C. Celedon2, H. Abdulkerim2, S. T. Weiss2, D. R. Gold2; 1Children's Hospital, Boston, Harvard Medical School, Boston, MA, 2Channing Laboratory, Brigham and Women's Hospital, Boston, MA, 3University of Virginia, Charlottesville, VA.
1213 Changes in IgE and IgG Antibody Responses to Cat with Decreased Exposure to Cat Allergen
E. A. Erwin, S. M. Satinover, A. J. Reefer, J. A. Woodfolk, T. A. E. Platts-Mills; University VA, Charlottesville, VA.
1214 Dog Exposure at Birth through Age 3 Reduces the Risk of Asthma at Age 6
N. A. Hallett, K. A. Roberg, E. L. Anderson, L. E. P. Salazar, R. A. Grabher, D. F. DaSilva, J. D. Bufford, K. T. Sullivan Dillie, R. Gangnon, M. D. Evans, J. E. Gern, R. F. Lemanske, Jr.; University of Wisconsin School of Medicine and Public Health, Madison, WI.
Oral Abstract Session
5604
Tuesday, February 27, 2007
2:00 PM - 3:15 PM
Urticaria and Angiodema
1215 Over 10 Years Of Experience With The Use Of C1-inhibitor Concentrate In Hereditary Angioedema, In Retrospect
H. Farkas 1, G. Temesszentandrási1, B. Visy2, G. Harmat2, L. Varga1, G. Füst1, G. Széplaki1, I. Karádi1, B. Fekete1, L. Jakab1; 1Semmelweis University, Budapest, HUNGARY, 2Madarász street Hospital of the Heim Pál' Pediatric Hospital, Budapest, HUNGARY.
1216 Functional Study Of Histamine N-methyltransferase (hnmt) Genetic Polymorphisms In Patients With Aspirin-intolerant Chronic Urticaria
Y. KANG 1, S. Kim1, Y. Ye1, G. Hur1, S. Lee2, H. Lee1, C. Suh1, D. Nahm1, H. Park1; 1Ajou university, Su-won, REPUBLIC OF KOREA, 2Dong-A University, Busan, REPUBLIC OF KOREA.
1217 Longitudinal Examination of Basophil Functional Phenotypes and Disease Activity in Chronic Idiopathic Urticaria (CIU)
L. M. Gober, P. M. Sterba, R. Baker, K. Vasagar, B. M. Vonakis, S. S. Saini; Johns Hopkins University, Baltimore, MD.
1218 Discovery of Ecallantide: A Potent and Selective Inhibitor of Plasma Kallikrein
R. Ladner, R. Kent, A. Ley, A. Nixon, D. Sexton; Dyax Corp., Cambridge, MA.
1219 Efficacy of Omalizumab for the Treatment of Allergic Urticaria and Angioedema
A. Rafi, L. Do, R. Mangat, S. Sender, R. M. Katz; Allergy Asthma Care Center of Santa Monica, Santa Monica, CA.
1220 Intraindividual And Interindividual Variations Of Symptoms In Patients With Hereditary Angioedema
E. Rusicke, I. Martinez-Saguer, E. Aygören-Pürsün, T. Klingebiel, W. Kreuz; JWG-University Hospital Frankfurt/Germany, Frankfurt/Main, GERMANY.
Oral Abstract Session
5605
Tuesday, February 27, 2007
2:00 PM - 3:15 PM
Mast Cells and Basophils
1221 Intestinal Expression of Interleukin 9 (IL-9) Induces Mast Cell-Mediated Intestinal Permeability
K. R. Groschwitz, E. E. Forbes, E. B. Brandt, R. Ahrens, F. D. Finkelman, P. Abonia, M. E. Rothenberg, S. P. Hogan; Cincinnati Children's Hospital Medical Center, Cincinnati, OH.
1222 Treatment of RSV-Infected Newborn Mice With Anti-IgE Antibody Attenuates the Subsequent Enhancement of Airway Hyperresponsiveness on Re-Infection
A. Dakhama, Y. Lee, A. Balhorn, A. Joetham, E. W. Gelfand; National Jewish Medical and Research Center, Denver, CO.
1223 Human recombinant Histamine Releasing Factor (HrHRF) Induced Histamine Release (HR) is Associated with SHIP Knockdown (k/d) in both the Cultured Human Mast Cell (MC) and Basophil Models
J. M. Langdon, J. T. Schroeder, A. P. Bieneman, B. M. Vonakis, S. M. MacDonald; JHUSM, Baltimore, MD.
1224 The Immunosuppressant Drug FTY720 Inhibits Cytosolic Phospholipase A2 Independently of Sphingosine-1-Phosphate Receptors
S. Spiegel, S. Payne, C. Oskeritzian, S. Milstien; VCU School of Medicine, Richmond, VA.
1225 Activation of Protein Kinase D1 (PKD1) in Mast Cells by TLR, Kit, and FcepsilonRI ligands
T. R. Murphy, H. R. Katz; Harvard Med. Sch./Brigham & Women's Hosp., Boston, MA.
1226 CysLT2 Receptors Negatively Regulate CysLT1 Receptor Functions on Mast Cells Through Heterodimerization
J. A. Boyce, Y. Jiang; Brigham and Women's Hospital, Boston, MA.
Oral Abstract Session
5606
Tuesday, February 27, 2007
2:00 PM - 3:15 PM
Mechanisms of Allergic and Non Allergic Rhinitis
1227 The Ability of the Nose to Warm and Humidify Inspired Air is Heritable
J. Pinto, A. Sahin-Yilmaz, F. Baroody, M. deTineo, S. Elwany, C. Ober, R. M. Naclerio; The University of Chicago, Chicago, IL.
1228 Positive Nasal Allergen Provocation Test and Nasal Specific-IgE to Grass Pollen in Patients with Idiopathic Rhinitis
C. Rondon 1, J. J. Romero1, S. Lopez2, R. R-Pena2, J. L. Rodriguez-Bada2, P. Chaves2, I. Doña1, M. Blanca1; 1Allergy Service, Carlos Haya Hospital, Málaga, SPAIN, 2Research Laboratory, Fundacion IMABIS-Carlos Haya Hospital, Málaga, SPAIN.
1229 Importance of Both Allergen-Specific (ANR) and Non-Specific Nasal Reactivity (NNR) in the Development of Early- and Late-Phase Nasal Responses
S. Miyahara, N. Miyahara, S. Matsubara, A. Joetham, E. W. Gelfand; National Jewish Medical and Research Center, Denver, CO.
1230 Effect of Montelukast on Nasal Secretion Weights During Naturally Acquired vURIs in Adults
D. P. Skoner, D. A. Gentile, J. M. Koehrsen, A. Patel, M. Varga, T. J. Schaffner, C. A. Schad; Allegheny General Hospital, Pittsburgh, PA.
1231 Influence of Allergen Immunotherapy on Substance P Release by Nasal Challenge of Grass Pollen Sensitized Allergic Rhinitis Patients
R. Gawlik 1, B. Jawor1, B. Rogala1, L. M. DuBuske2; 1Silesian University School of Medicine, Zabrze, POLAND, 2Immunology Research Institute of New England, Gardner, MA.
